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Abstract 
I 
Abstract 
 
In this thesis the photooxygenation of several substrates in polymer matrix as solid support 
using a solvent-free protocol was investigated. Two microreactor systems were used: (1) the 
commercially available polystyrene beads (PS) crosslinked with divinylbenzene (DVB) and 
loaded with adsorbed tetraarylporphyrine dye sensitizers; (2) synthesized polymers covalently 
bound to porphyrin sensitizers. The solvent-free approach using both polymer matrices was 
found to be suitable for a broad variety of photooxygenation reactions resulting in sensitizer-
free peroxidic products. 
 
A two-step route for the synthesis of the 1,2,4-trioxane subunit (the pharmacophore of the 
naturally occurring antimalarial drug artemisinin) was developed. The first step is based on 
the conversion of different chiral allylic alcohols to sensitizer-free unsaturated β-hydroperoxy 
alcohols in (syn) diastereoselectivities by the ene reaction of singlet oxygen with allylic 
alcohols using the solvent-free photooxygenation approach (Scheme I.1).  
 
R
OH
R
OH
OOH
R
OH
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syn anti  
Scheme I.1 
 
Secondly, BF3-catalyzed inter- and intramolecular peroxyacetalization reaction with different 
carbonyl compounds, resulted in a wide variety of mono-, polycyclic-, and spiro-1,2,4-
trioxanes (Scheme I.2). Furthermore, the reaction was adapted to yield spiroannelated 1,2,4-
trioxane dimers, a literature-unknown class of compounds. 
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Scheme I.2 
 
 
Kurzzusammenfassung 
II 
Kurzzusammenfassung 
 
Im Rahmen dieser Arbeit wurden eine Reihe von Substraten mit Hilfe von Polymer-Matrix-
Systemen als Träger lösungsmittelfrei photooxygeniert. Hierzu wurden zwei verschiedene 
Mikroreaktorsysteme verwendet.: (1) kommerziell erhältliche, mit Divinylbenzol (DVB) 
quervernetzte, Polystyrolkügelchen (PS) welche mit Tetraarylphorphyrin-Sensibilisator-
Farbstoffen beladen wurden; (2) synthetisierte Polymere mit kovalent gebundenem 
Porphyrin-Sensibilisator. Die lösungsmittelfreien Verfahren lieferten unter Verwendung der 
oben beschriebenen Polymer-Träger für ein weites Spektrum von 
Photooxygenierungsreaktionen gute Ergebnisse. Außerdem waren die erhaltenen Peroxide 
farbstofffrei. 
 
Es wurde eine zweistufige Syntheseroute zur Darstellung des 1,2,4-Trioxan-Grundgerüstes 
entwickelt, welches als pharmakophore Grundstruktur im natürlich vorkommenden 
Antimalaria Mittel Artemisinin enthalten ist. Der erste Schritt dieser Synthese besteht in der 
Umwandlung von verschiedenen Allylalkoholen durch die syn-diastereoselektive Reaktion 
mit Singulett-Sauerstoff zu (farbstofffreien) vic-Hydroperoxyallylhydroperoxiden unter 
Verwendung der lösungsmittelfreien Methode (Schema I.1). 
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Schema I.1 
 
Im zweiten Schritt lieferte die BF3-katalysierte inter- und intramolekulare Peroxy-
acetalisierung mit verschiedenen Carbonyl-Verbindungen ein weites Spektrum von mono-, 
polycyclischen- und spirocyclischen 1,2,4-Trioxanen (Schema I.2). Darüberhinaus wurde die 
Reaktion auf die Synthese von spiroanellierten 1,2,4-Trioxan-Dimeren, eine noch 
literaturunbekannte Verbindungsklasse, erweitert. 
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1. Introduction 
 
1.1 Photochemical versus Thermal Reactions 
 
Thermal reactions take place between molecules in the electronic ground singlet state (So) 
(electronic configuration having minimum energy where the electrons in the highest occupied 
molecular orbital, HOMO, have an antiparallel spin). On the other hand, in photochemical 
reactions one of the molecules is raised from its electronic ground state (So) to a higher 
electronic state. Absorption of electromagnetic radiation (mostly ultraviolet or visible light) 
promotes an electron from the HOMO to the lowest unoccupied molecular orbital (LUMO) 
where the total spin of the electrons remains zero and the molecule exists in the first excited 
singlet state (S1). This excitation corresponds to the most prominent transition band in the 
absorption spectrum of many organic molecules. 
An electronically excited molecule in the S1 state can loose its excitation energy either by 
chemical change (chemical deactivation) or by one of different physical processes which may 
be radiative or non-radiative (Figure 1.1). 
 
 
S1
T1
So
hν
E
F
ISC
PIC
 
Figure 1.1: Simplified Jablonski diagram: hν = excitation (10-15s), 
IC = internal conversion, ISC = intersystem crossing 
F = fluorescence (10-9-10-5s), P = phosphorescence (10-5-10-3s)  
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1.2 Electronic States of Molecular Oxygen1 
 
The ground state of all organic molecules having a closed-shell electronic configuration is So. 
Molecular oxygen represents an exception and exists in its electronic ground state in a triplet 
state. 
The electronic configuration of ground state oxygen (3O2) has the two highest energy 
electrons unpaired and with parallel spins in πx* and π y* molecular orbitals (Figure 1.2). 
These orbitals are energetically degenerate and the electrons have identical spins in order to 
produce the maximum multiplicity and hence the lowest electronic energy state (Hund´s rule). 
The ground state of oxygen is thus a triplet state and because of the unpaired electrons 
paramagnetic state having a diradical character. This state has the spectroscopic notation 3Σ-g 
or To. 
Two relevant excited states are known for molecular oxygen (Figure 1.2), the first excited 
electronic state (1∆g) lying 22.4 kcal mol-1 above the triplet ground state, having both 
electrons paired in a single orbital leaving the other vacant; hence this state might be expected 
to undergo two electrons reactions. The second excited electronic singlet state (1Σg+) lying 37 
kcal mol-1 above the ground state comes from spin pairing of electrons in different orbitals 
and hence is expected to undergo one-electron free radical reactions. This state is also 
characterized by shorter lifetime in solution (10-12 sec) due to the rapid spin-allowed transition 
to the longer lived first excited state 1∆g (10-3–10-6 sec).  
The more stable singlet oxygen species (1∆g) is considered to be one of the most active 
intermediates involved in chemical and biochemical oxidation processes. I shall refer to the 
1∆g form of oxygen as “singlet oxygen” or even simpler as 1O2. 
 
 
22.4  kcal/mol
37  kcal/mol
3Σg
1Σg
1∆g
 
Figure 1.2: Electron distribution in the HOMO 
of O2 in its three different electronic states. 
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1.3 Singlet Oxygen 
 
1.3.1 Generation of singlet oxygen 
 
Singlet oxygen (1O2) can be generated in solution by a variety of processes1 including the 
reaction of hydrogen peroxide with sodium hypochlorite,2 the decomposition of 9,10-
diphenylanthracene endoperoxide,3 the thermolysis of triarylphosphite ozonides,4 exciting 
gaseous oxygen by electrodeless discharge,5 and the photochemical energy transfer from an 
excited dye sensitizer to triplet oxygen6. The latter technique is not only the most efficient but 
also it circumvents the separation of the byproducts such as 9,10-diphenylanthracene and 
triphenyl phosphate produced in the chemical pathways. This accounts for the utility of 
energy transfer approach in the vast majority of 1O2 reactions in organic synthesis. 
The energy transfer sensitization mechanism to generate 1O2 involves the excitation of an 
appropriate dye with visible light from the ground state (1Sens) to its excited singlet state 
(1Sens*), after which rapid ISC takes place and the excited triplet state of the dye (3Sens*) is 
formed. Although both singlet and triplet excited states of the sensitizer can transfer energy to 
3O2, the triplet state of the sensitizer has a longer lifetime (since deactivation needs spin 
inversion) and with very few exceptions energy transfer takes place from the triplet excited 
state of the sensitizer. A prerequisite for this energy transfer to occur is that the triplet energy 
of the sensitizer must exceed the excitation energy of triplet oxygen which is 22.4 kcal mol-1. 
After this energy transfer to the triplet state of molecular oxygen, 1O2 is formed with 
concomitant regeneration of the ground state of the sensitizer molecule (Scheme 1.1). Some 
common sensitizers for generation of singlet oxygen and their triplet energies are given in 
Table 1.1.7 
Sens.*
hν
1O2
3O2
Sens.
Energy transfer
 
Scheme 1.1: Photosensitized generation of singlet oxygen. 
 
Sensitizer 
Triplet energy
(kcal mol-1) 
Tetraphenylporphyrin (TPP) 34.0 
Methylene blue 33.5-34.0 
Rose Bengal 39.2-42.2 
Eosin 43.2-46.0 
Hematoporphyrin 37.2 
Table 1.1: Singlet oxygen photosensitizers and their triplet energies. 
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1.3.2 Quenching of singlet oxygen1 
 
The term “quenching of singlet oxygen” can be used to refer to both “chemical” and 
“physical” quenching. In the former case, singlet oxygen reacts with the quencher (Q) to give 
a new product (QO2). In the latter case, the interaction with the quencher (which can be the 
solvent, substrate, or sensitizer molecule) leads only to deactivation of singlet oxygen to its 
triplet ground state with neither oxygen consumption nor product formation (Scheme 1.2). 
 
1O2 Q
1O2 Q
QO2
3O2 Q
+
+ +
 Chemical quenching
Physical quenching  
Scheme 1.2: Chemical versus physical quenching of singlet oxygen 
 
Two major mechanisms of physical singlet oxygen quenching have been established, energy 
transfer and charge transfer quenching. 
(a) Energy-Transfer Quenching:1 
The electronic-electronic energy transfer mechanism is rare and was first suggested for 
quenchers as β-carotene. It is the reverse of the reaction by which singlet oxygen is formed 
(Scheme 1.3). For this mechanism to be efficient the triplet state energy of the quencher must 
be very near or lower in energy of 1O2 (22.4 kcal mol-1).  
 
1O21Q 3O23Q*+ +  
Scheme 1.3: Energy-transfer quenching of singlet oxygen. 
 
The observation that the rate of quenching of 1O2 is related to vibrational frequencies of the 
quencher led to the theory that the rate of 1O2 quenching is determined by the ease with which 
the electronic transition energy (produced by 1O2 quenching) is distributed as vibrational and 
rotational energy to the quencher. This affects the rate of 1O2 quenching since as the quencher 
has higher vibrational frequency, the electronic energy produced by 1O2 quenching will lead 
to excitation of the quencher to the first or second vibrational energy level. These are rapid 
processes when they are almost resonant (i.e. all the electronic energy of 1O2 quenching can 
be taken up causing easily excited vibrational modes and allowed rotational transitions in the 
quencher). 
Since the highest vibrational frequencies are found in molecules which contain hydrogen 
atoms strongly bound to another atom as in O-H, S-H, N-H, C-H bonds, so it is not surprising 
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to find H2O, alcohols, amines and alkanes to be good 1O2 quenchers. These compounds are 
excited to higher vibrational states often to the second vibrational level which is an easy 
accessible vibrational mode. On the other hand, the fact that CCl4 is considered as a suitable 
solvent for 1O2 reactions is explained by the low vibrational frequency (800-900 cm-1) of the 
C-Cl bond whereby 1O2 deactivation excites CCl4 to a high vibrational energy level which is a 
less probable transition. In a similar manner, since deuteration results in lowering of the 
vibrational frequency, 1O2 quenching rates in deuterated solvents are lower than in the 
nondeuterated.8 As seen in Table 1.2, the singlet oxygen lifetime is increased by a factor of 
about 20 in deuterated solvents compared to the protonated compounds and by a factor of 
about 700 by exchanging CH with CF. 
 
Solvent 
1O2-Lifetime 
(µs) 
Solvent 
1O2-Lifetime 
(µs) 
H2O 3.1 D2O 68 
CH3OH 9.1 CD3OD 2709 
C6H6 30 C6D6 681 
C6F14 68000 C6F6 21000 
(CH3)2CO 51 (CD3)2CO 992 
CHCl3 229 CDCl3 7000 
C6H5CH3 2910 air 8600011 
CH3CN 307, 6112 CFCl3 100013 
CCl4 59000 - - 
Table 1.2: Singlet-oxygen lifetimes in different solvents. 
 
 
(b) Charge-Transfer Quenching: 
In this mechanism singlet oxygen as an electron-poor compound interacts with an electron 
donor to give a charge-transfer complex in the singlet state (in some cases, complete electron 
transfer takes place) which subsequently undergoes ISC to the triplet state. Dissociation and 
back electron transfer (BET) results in the donor molecule and deactivation of singlet oxygen 
to the ground state triplet oxygen (Scheme 1.4). 
 
D + 1O2 D.....O2
1
D.....O2
3
D + 3O2
BET
 
Scheme 1.4: Charge-transfer quenching of singlet oxygen. 
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The rate of this reaction can be estimated from the Rehm-Weller equation using the oxidation 
potential of the donor (EDox), reduction potential of the acceptor (EAred), coulombic energy 
(Ecoul) and the excitation energy of the excited component (E*).14 
 
∆G° = EDox- EAred- Eoo*+ ECoul.  
 
Compounds with low oxidation potential (low ionization energy) such as amines and phenols 
or electron rich compounds as azides, iodide and superoxide ions are good 1O2 quenchers that 
operate by this mechanism. It is also noteworthy to say that compounds with low triplet 
energies and low oxidation potentials can quench 1O2 by both mechanisms. 
 
1.3.3 Chemical reactivity of singlet oxygen 
 
In contrast to the paramagnetic triplet oxygen (3O2), which is mostly involved in free radical 
reactions (Type-I photooxygenation reactions) and Type-III photooxygenation reactions 
(electron transfer induced photooxygenation) involving the superoxide radical anion or the 
reaction of the substrate radical cation with triplet oxygen, singlet oxygen (1O2) is an 
electrophilic species that undergoes two-electron reactions analogous to electron-poor 
ethylenes. Reactions involving 1O2 are called Type-II photooxygenation reactions. Singlet 
oxygen can undergo heteroatom oxidation (e.g. sulfides to sulfoxides15) or chemically react 
with olefins in different modes, the most important are as follows: (Scheme 1.5) 
(a) Conjugated dienes react preferentially by [4+2]-cycloaddition (Diels-Alder type) resulting 
in endoperoxides.16,17 
(b) Electron rich activated olefins react by [2+2]-cycloaddition to give 1,2-dioxetanes.1,16,18,19 
(c) Not-activated olefins with allylic hydrogens react by an ene reaction to give allylic 
hydroperoxides.1,20 
1O2O
O
O
O
H
OOH
[π2+π2+σ2]
[π2+π2][π4+π2]
 
Scheme 1.5: Reaction modes of 1O2 with alkenes and dienes. 
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1.3.4 Ene reaction of singlet oxygen  
 
1.3.4.1 History and definition of the reaction  
 
In 1943, G. O. Schenck was the first to describe in a patent the singlet oxygen ene reaction21 
(therefore often termed Schenck reaction). In the course of this reaction, 1O2 attacks one 
center of a CC double bond with abstraction of an allylic hydrogen atom or an allylic silyl 
group (bound to oxygen, in case of the silyl-ene reaction) with simultaneous allylic shift of 
the double bond. As a result of this reaction, allylic hydroperoxides or O-silylated α-
hydroperoxy carbonyl compounds are formed (Scheme 1.6). Since the first report, the 1O2 ene 
reaction has attracted major interest not only in the mechanistic photochemistry but also in 
modern organic synthesis.20  
 
Z
Y
1O2 ZYOO
 
Scheme 1.6: Ene reaction (Z=C, Y=H) 
versus silyl-ene reaction (Z=O, Y=SiR3) 
 
1.3.4.2 Mechanism of the ene reaction 
 
Several mechanisms have been postulated for this reaction with concerted or “concerted two-
stage” mechanisms,22 as well as 1,4-biradicals,23 1,4-zwitterions,24 perepoxide, dioxetane25 or 
exciplex intermediates. (Figure 1.3).  
 
O
H
O
H
O O
H
O O
O
H
O
H
(A) (B) (C) (D) (E)
O=O
H
(F)
O
O
 
Figure 1.3 
 
The dioxetane suggestion (F) was excluded after the isolation of dioxetanes, showing that 
they decompose to carbonyl fragments rather than rearrange to the hydroperoxides. Also the 
diradical (B) and the zwitterionic (C) mechanisms have been dismissed due to the absence of 
cis-trans isomerization of the substrates24 and the lack of Markovnikov directing effects in the 
photooxygenation of trisubstituted olefins,20d that radical scavengers have no effect on the 
reaction and since only minor solvent effects have been observed for the reaction.26 The 
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results of Stephenson’s inter- and intramolecular isotope effect experiment27a with isotopically 
labeled tetramethylethylenes provide an evidence for the perepoxide intermediate and not the 
concerted pathway. Also, the small negative activation enthalpies and highly negative 
activation entropies observed for the singlet oxygen ene reaction and kinetic 
measurements26b,c have shown that the reaction of 1O2 with electron-rich olefins proceed 103 
times slower than the diffusion rate of 1O2 which proves the presence of non-productive 
encounters between 1O2 and the olefin27a favoring the participation of a reversibly formed 
exciplex as intermediate.28 As a result a three-step mechanism involving an exciplex and 
perepoxide can be assumed for the ene reaction (Scheme 1.7) 
 
O2
H
H
O O HOO1O2 k1 k2
 
Scheme 1.7: Mechanism of ene reaction of singlet oxygen. 
 
1.3.4.3 Regioselectivity of the ene reaction 
 
The ene reaction of singlet oxygen with substrates possessing different allylic hydrogen atoms 
often results in a complex mixture of products. The regiochemistry of the reaction was 
extensively studied and some general effects were found useful to predict the regioselective 
introduction of the hydroperoxy group: 
(a) cis-effect29 (syn-effect) 
In the reaction of 1O2 with trisubstituted alkenes30 or enol ethers31, the allylic hydrogen atoms 
on the more substituted side of the double bond are more reactive for H-abstraction by 1O2 
(Figure 1.4). 
 
         side 1
(more  substituted)
       side 2
(less  substituted)
48 52
10
22 68
4
43 53
7
4053
OMe
> 98
< 2
 
Figure 1.4: cis-effect of different substrates.  
The numbers indicate % hydrogen abstraction. 
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(b) gem-effect32 
Leads to highly selective abstraction of an allylic hydrogen atom from a substituent at the α 
position of an α,β-unsaturated carbonyl compound (Figure 1.5). 
 
X
Hydrogen abstraction
COOR
982
X = COR, CHO, COOH, COOR, CONH2, CN  
Figure 1.5: gem-effect. 
 
(c) large-group effect33 
Leads to selective (moderate) abstraction of an allylic hydrogen from the substituent geminal 
to a large group (Figure 1.6). 
 
SiMe3
100
83 17 66 34  
Figure 1.6: Large-group effect. The numbers 
indicate % hydrogen abstraction. 
 
1.3.4.4 Stereoselectivity of the ene reaction 
 
Stereochemistry of the reaction 
The singlet oxygen ene reaction is a suprafacial process where the addition of oxygen and 
abstraction of hydrogen occurs from the same face of the olefinic π-system. This was 
elegantly demonstrated by Stephenson34 in the ene reaction of the optically active 
monodeuterated olefin A. This olefin has two diastereotopic faces, and its photooxygenation 
results in 82 % of the regioisomer formed by H/D-abstraction from the benzylic group with 
exclusive formation of the trans allylic hydroperoxide rather than the cis isomer (Scheme 
1.8). In the model reaction, no isotope discrimination was observed and only the allylic 
hydroperoxides from the suprafacial hydrogen / deuterium abstraction by singlet oxygen from 
both faces (B and C) are obtained.  
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Me
D
Ph
H
S
O2 / RB / hν
acetone / R.T.
Me
OOD
R
Me S
A B
OOH
H
Ph
D
Ph
+
Top attack from re face
 leads to D abstraction
Bottom attack from si face
   leads to H abstraction
C
 
Scheme 1.8: Stephenson’s experiment showing the suprafacial character of the ene reaction. 
 
Diastereoselectivity of the reaction 
Many factors that control the π-facial selectivity of singlet oxygen ene reaction are known and 
can be summarized as follows: 
(1) Steric factors 
In view of the small size of the reactive molecule singlet oxygen, steric interactions are 
expected to be less important in directing the facial approach. However, in rigid (cyclic and 
polycyclic) substrates where changes in conformation to minimize such steric factors are 
impossible this effect is more pronounced and steric factors on one face of the double bond 
may bias 1O2 attack to occur predominantly on the other face of the π-system (Scheme 1.9).35 
 
H
OOH
OOH
H
+
1O2
H
OOH
OOH
H
+
1O2
66 :1
0.19 : 1  
Scheme 1.9: Steric effects in the ene reaction. 
 
(2) Conformational effects 
For an efficient hydrogen abstraction to occur, the reactive allylic hydrogen atoms must adopt 
a low energy conformation which places them perpendicular to the olefinic plane.36 This 
factor is often highly effective in rigid compounds in which allylic hydrogen atoms are 
conformationally blocked at one face of the double bond. 
(3) Electronic effects and hydrogen bonding 
The electronic factors can be simply demonstrated by the fact that the tetrasubstituted alkene, 
2,3,-dimethyl-2-butene with the more nucleophilic double bond reacts more than 30 times 
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faster than the corresponding trisubstituted alkene, 2-methyl-2-butene, and the latter reacts 
about 15 times faster than the disubstituted olefin Z-2-butene.27a 
Adam et al. elegantly used hydrogen bonding interactions between the substrate and the 
incoming singlet oxygen for dictating the diastereoselectivity in the photooxygenation of 
allylic alcohols and other substrates.37,141 The coordination of the conformationally fixed 
hydroxyl group (by 1,3-allylic strain) to the incoming singlet oxygen preferentially directs the 
incoming enophile to one face of the double bond.  
 
Enantioselectivity of the reaction 
In contrast to the high diastereoselective control of singlet oxygen ene reaction, 
enantioselective reactions are still rare. Several attempts to control the enantioselectivity were 
reported. The use of β-cyclodextrins covalently bound to porphyrin sensitizers in the 
photooxygenation of linoleic acid resulted in low ee values (10-20 %).38 The 
photooxygenation of 2-methyl-4-phenyl-2-butene in NaY zeolite in presence of (+)-ephedrine 
as chiral inductor also resulted in 15 % ee hydroperoxide product.39 Recently, Cόrdova et al.40 
reported the unprecedented amino acid-catalyzed asymmetric incorporation of molecular 
oxygen into the α position of a series of aldehydes and ketones. The mechanism is assumed to 
proceed through an ene reaction of singlet oxygen with the intermediate enamine to give the 
corresponding hydroperoxide which is in situ reduced to afford the vicinal diol in high ee 
values (Scheme 1.10). 
 
R
H
O
hν / Ο2 / TPP
L-Proline
   DMF R
H
O
HOO NaBH4
R
OH
HO
 
Scheme 1.10: Enantioselectivity in the ene reaction. 
 
 
1.4 Type-II Photooxygenation: Experimental Scope and Limitations 
 
Since the discovery of singlet oxygen by Kautsky,41 most of the reactions involving molecular 
oxygen activation by triplet-triplet sensitization from dye sensitizers were conducted in 
solution phase. For each sensitizer used, a series of appropriate solvents are relevant in which 
the sensitizer’s photophysical properties and chemical stability as well as singlet oxygen 
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quantum yields are known.42 However, these condensed phase photooxygenation conditions 
suffer from at least five major drawbacks: 
(a) Since the sensitizer must be soluble in the solvent, only a limited number of dye-solvent 
combinations can be used. 
(b) Separation of the dye from the product after the reaction either by chromatography or 
distillation is an elaborate process. 
(c) Singlet oxygen has longer lifetimes in environmentally problematic solvents (carbon 
tetrachloride, freons, etc.) and much shorter lifetime in benign solvents (water and 
methanol).43 
(d) Irreversible photobleaching of the dye is often observed in halogenated solvents due to the 
formation of acid or is induced by singlet oxygen itself or the formed oxygenated products.44 
(e) Solution purging with oxygen or even air is hazardous for industrial purposes and 
sometimes even for lab scale reactions. 
In the last decade, the area of polymer-supported organic reactions45 and polymer-supported 
catalysts46 has blossomed. This is exemplified in solid phase synthetic chemistry where 
reactions carried out in resins and reactions that are catalyzed by polymer-supported catalysts. 
Photooxygenation in solution using insoluble polymer-bound sensitizers may solve the 
problem of dye recovery. The first polymer-bound sensitizer was the commercially available 
polystyrene-bound Rose Bengal discovered by Schaap,47 followed by a series of immobilized 
sensitizers, e.g. immobilized fullerene (C60) sensitizers,48 ionic porphyrins immobilized on 
cationically functionalized polystyrene,49 tetrakis(4-hydroxyphenyl)porphyrin supported to 
polyethylene glycol,50 aluminum(III) tetracarboxyphthalocyanine bound to poly(styrene-co-
chloromethylstyrene),51 polystyrene-bound benzophenones,52 immobilized pyrylium salts on 
Merrifield resins,53 sensitizer-incorporated nafion membranes,54 and ion-exchange resins 
ionically bound to photosensitizers.55 Other heterogeneous catalysts using clay,56 silica57 and 
zeolites58 were also recently developed as solid supports. However, the use of the non-polar 
solvents enhances dye oxidation and bleeding especially if long reaction times are needed 
which decreases the singlet oxygen quantum yield and hence the reaction efficiency. On the 
other hand, photooxygenation reactions carried out in aqueous solutions are also not favored 
due to low solubility of most organic substrates, low singlet oxygen lifetime and hydrophobic 
aggregations for nonpolar sensitizers (porphyrin-porphyrin self quenching) and as a 
consequence show marked reduction of the triplet life time.59,60  
An unprecedented solution to circumvent the above problems was lately reported by 
Griesbeck and Bartoschek.61 A sustainable solvent-free photooxygenation reaction conditions, 
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in which the substrates are embedded in a porphyrin-loaded polystyrene polymer matrix, 
irradiated and the product (sensitizer-free) is simply extracted by ethanol offers a shortcut to 
green photooxygenation reactions.  
 
 
1.5 Malaria 
 
1.5.1 Introduction and facts about the disease 
 
As early as 6000 B.C., the malaria disease has tormented humankind.62 In 400 B.C., the greek 
physician Hippocrates was the first to describe an intermittent and often relapsing fever which 
is followed by sweating, dizziness and shaking chills (known symptoms of malaria 
nowadays). Later, the Romans described malaria as “a horrid disease that comes every 
summer and kills”.62,63 Today, malaria is the third-most cause of death by infectious diseases, 
after tuberculosis and AIDS. The annual mortality estimations range between 1 and 2.5 
million deaths,64 and according to the World Health Organisation (WHO) at least 240 million 
people are chronically affected and there are 120 million new cases reported every year.65 
This number is expected to double by the year 2010 if no new antimalaria strategies were 
developed.66 
 
1.5.2 Types of malaria 
 
The female Anopheles mosquito (Figure 1.7) is the vector 
responsible for transmitting the parasite. The life cycle of the 
protozoa is complex occurring both in the mosquito (sexual cycle) 
and in man (asexual cycle). Plasmodium is the class of the parasites 
causing malaria.67 According to the plasmodium class different types 
of malaria are known. 
Plasmodium Vivax causing Malaria Tertiana. 
Plasmodium Ovale causing Malaria Tertiana. 
Plasmodium Malariae causing Malaria Quartana.    Figure 1.7: Anopheles mosquito 
Plasmodium Falciparum causing Malaria Tropica. 
The last type is the most lethal causing most of malaria infections and death of millions of 
people in the parts of world where malaria is endemic. 
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1.5.3 Drugs for malaria treatment 
 
In 1820, a revolution in malaria treatment was achieved by isolation of the efficient 
antimalarial alkaloid quinine68 from the bark Cinchona “Peruvian fever tree” (Figure 1.8). 
Quinine was the main treatment for malaria until 1930s, the date of development of several 
synthetic quinoline-based antimalaria drugs (as chloroquine, mefloquine and amodiaquine). 
Now quinine is considered as toxic for prophylaxis or treatment of malaria. Chloroquine was 
the gold standard for treating malaria for several decades until many parasite strains have 
developed now high resistance to it and nearly to all quinoline drugs.69 
Combination chemotherapy, where a mixture of different drugs such as mefloquine combined 
with sulfadoxine or pyrimethamine is also used to enhance the antimalarial efficacy. 
However, parasite resistance to such combinations has also emerged.70  
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Figure 1.8: Antimalaria drugs. 
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Artemisinin (also known as qinghaosu, Figure 1.9) is an enantiomerically pure tetracyclic 
sesquiterpene lactone, the first natural 1,2,4-trioxane reported. In 1972, artemisinin was firstly 
isolated in China by low-temperature extraction from the leaves of Artemisia annua, and due 
to its remarkable antimalarial activity at the nanomolar concentration scale, artemisinin and 
its derivatives have been important as antimalarial drugs with the most effective activity 
against multidrug-resistant forms of Plasmodium falciparum.83 The high pharmacological 
potential of artemisinin combined with its synthetically challenging structure have prompted 
Hofheinz,71 Zho,72 Avery,73 Liu,74 Yadav75 and many others to carry out total syntheses of 
such structure. Consequently, another combination therapy was developed in which one of the 
1,2,4-trioxane-containing artemisinin drugs is used in the drug mixture (artemisinin 
combination therapy, ACT). This is due to the fast antiparasitic action of such moieties76. 
However, high prices and shortage in amounts of such drugs have limited their use on patients 
of the developed countries, which is very problematic for under-developed countries in Africa 
or South-Asia. 
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Figure 1.9 
 
It is also noteworthy to mention here that many antimalaria-active compounds with different 
functionalities such as endoperoxide,72a,77 isonitrile:78 and naphthylisoquinoline79 and many 
others were discovered (Figure 1.10) 
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Figure 1.10: Antimalaria drugs with different functionalities. 
 
1.5.4 Mechanism of action of antimalarial 1,2,4-trioxanes like artemisinin 
 
The mode of action of antimalarial 1,2,4- trioxanes exemplified by the natural sesquiterpene-
endoperoxide artemisinin and its derivatives has been an enduring subject of research.80,74 The 
mechanism is different from that of the traditional alkaloid quinoline-based drugs such as 
quinine and chloroquine.81 The fact that deoxyartemisinin (an artemisinin derivative lacking 
the endoperoxide bridge and obtained by reduction of artemisinin) is devoid of antimalarial 
activity compared to artemisinin indicating that the peroxide functionality in the 1,2,4-
trioxane ring is the key factor for the pharmacological activity of these trioxane drugs.82 
(Scheme 1.11). 
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Scheme 1.11 
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This mechanism of action is probably based firstly on a reductive cleavage of the peroxidic 
linkage in the 1,2,4-trioxane moiety by the ferrous ions of the hemoglobin leading to the 
formation of oxygen-centered radicals.83 Subsequently, the oxy-radical intermediates undergo 
either bond scission or 1,5-hydrogen atom shift to form primary and secondary carbon-
centered radicals (A and B in Scheme 1.12).84 The formation of the carbon centered radicals 
was proven by isotope labeling,84 and spin trapping techniques.85 The formation of the highly 
reactive ethyl radical A through bond scission is a spontaneous process driven by the 
formation of the thermodynamically stable acetate group. One (or more) of the formed 
reactive intermediates (e.g. oxy-radicals, carbon radicals and high valent iron-oxo species) is 
responsible for modification of the parasitic proteins causing the death of the malaria 
parasite.86 
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Scheme 1.12: Mechanism of action of artemisinin. 
 
The importance of the secondary carbon radical intermediates for the high antimalarial 
activity was demonstrated by a study of the activity of some simplified 4-methylated 
trioxanes 87 (Figure 1.11). From the antimalarial activities in Table 1.3 it was deduced that 4-
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β-methyl trioxane (entry 1) can undergo 1,5-hydrogen atom shift and is about 100 times more 
potent than the 4-α-methyl derivative (entry 2) that can not undergo such a hydrogen atom 
transfer. Likewise, 4-β-methyl trioxane (entry 1) is at least 100 times more potent than 4,4-
dimethyl derivative (entry 3) that can not undergo such a hydrogen atom transfer. 
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Figure 1.11 
 
IC50 (ng/mL) 
entry R1 R2 
W-Indochina clone D-6 African clone 
1 H Me 4.5 3.5 
2 Me H > 500 > 500 
3 Me Me > 500 > 500 
Table 1.3 
 
Jefford et al.88 also reported, that epiartemisinin (having an α-Me group in the lactone ring) 
shows drastically reduced antimalarial activity in comparison to the artemisinin (having the 
Me group in the lactone ring in the β−position). This was rationalized by a steric hindrance 
arising from the α-disposed methyl group which hinders or bias the complexation of 
epiartemisinin with the heme of the hemoglobin causing reduction of its activity. 
Many reducing agents were used to mimic the heme role in the reduction of artemisinin 
including iron-(II) chloride in acetonitril89 as well as the catalytic reaction in the presence of 
other reducing agents as ascorbic acid or cysteine.90 Iron-(II) bromide in tetrahydrofuran was 
also efficiently used.82a The ring-contracted furano acetate was formed beside 3α-
hydroxydeoxyartemisinin (Scheme 1.13). Meunier et al. also investigated the reaction of the 
artemisinin-derived radicals with manganese(II)-tetraphenylporphyrin91 and the 
pharmacologically more relevant iron(II)-protoporphyrin-IX dimethyl ester as heme models, 
the reaction leads to a mixture of heme-artemisinin adducts resulting from alkylation 
alkylation at the α, β and δ carbon atoms (Scheme 1.14).92 
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Scheme 1.13: Reduction of artemisinin with heme models. 
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Scheme 1.14: Reduction of artemisinin with heme models. 
Adducts are also obtained from reaction at the α and δ carbon atoms. 
 
1.5.5 Selected routes to 1,2,4-trioxane and peroxidic antimalarial compounds 
 
1.5.5.1 Semi synthetic routes stemming from the parent artemisinin 
 
One of the major drawbacks of artemisinin is its poor solubility in both water and oil.93 To 
overcome this problem the Chinese researchers reduced artemisinin to dihydroartemisinin93 
which led to the preparation of a series of semisynthetic first-generation artemisinin 
analogues, including artemether, arteether, and artesunate which are used broadly in many 
areas of the world where malaria is endemic (Figure 1.12).94 
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Figure 1.12 
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Also, Venugopalan et al. synthesized various ethers and thioethers of dihydroartemisinin by 
treatment with alkyl, aryl, alkynyl and heteroalkyl alcohols or thiols in the presence of 
BF3.Et2O (Figure 1.13). The products were tested in vivo and some show antimalarial activity 
comparable to arteether.95  
 
O
O
O
O
H
H
X
R
R = Alkyl, alkynyl, 
       heteroalkyl
X = O, S, SO  
Figure 1.13 
 
The poor bioavailability and rapid clearance (short pharmacological half-life) observed with 
these artemisinin-derived drugs are a major disadvantage. This results from the poor chemical 
and metabolic stability of the acetal function group present in such derivatives. To overcome 
this problem, many C-10 carba analogues and C-10-aryl analogues of dihydroartemisinin that 
are metabolically more robust were synthesized (Figure 1.14). Of relevance are the C-10 
alkyl and the C-10-aryl or heteroaromatic derivatives prepared by Haynes et al.,96 Posner et 
al.,97 O’Neill et al.,98 Jung et al.99 and Ziffer et al.100  
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Figure 1.14 
 
Recently, several groups reported the synthesis of C-10 carba artemisinin dimers lead 
compounds which are not only potent in vitro and in vivo antimalarials but also show 
anticancer properties (Figure 1.15) 101 
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Figure 1.15: Artemisinin dimers. 
 
Despite the high efficacy of artemisinin and artemisinin-derived drugs, the synthesis of these 
analogues from the extracts of the original plant Artemisia annua with all its drawbacks and 
costs is highly problematic (the growing of Artemisia annua is possible only in limited 
geographic areas, namely in the South Chinese and Vietnamese uplands, and the yield of 
extraction is low, about 0.4 %.102 Also, neurotoxicity has been reported for some of these 
derivatives as arteether at high doses in monkeys).103 Under these circumstances, it will be 
difficult to extend the use of such artemisinin-derived drugs to a scale of billions of people. 
This has drawn the attention that design and full synthesis of analogues, structurally simple 
and easily accessible 1,2,4-trioxanes and peroxides as inexpensive antimalaria drugs that 
share the benefits of artemisinin high efficacy without its disadvantages. This is considered 
now by the WHO (world Health Organization) as a crucial matter. 
 
1.5.5.2 Synthesis of antimalarial 1,2,4-trioxanes and peroxidic compounds 
 
The danger accompanying the spreading of this infectious disease prompted many groups in 
the medicinal community to initiate synthetic studies for these biologically active compounds 
and develop new methodologies and design of alternative leading compounds that could be 
used as new efficious pharmaceuticals for malaria treatment. A Literature survey for the 
synthesis of peroxidic and 1,2,4-trioxane antimalarials results in thousands of candidates and 
the rate of synthesis of such compounds is increasing exponentially. Here, I will try to give a 
brief account on the research groups mostly siting in this area and some examples for their 
synthetic strategies to construct such units. 
 
The Posner group applied the fundamental aspects of the artemisinin mechanism of action to 
the synthesis of some simple symmetrical endoperoxides that would undergo a mechanistic 
route similar to that of artemisinin (Figure 1.16)104 The parent diphenyl endoperoxide (R = 
Ph) has considerable antimalarial activity (IC50 = 89 nM versus IC50 = 9-11 nM for 
artemisinin). 
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Figure 1.16 
 
Nojima et al.105 reported the synthesis of highly antimalaria active peroxides analogous to the 
antimalaria Yingzhaosu by the use of Co(II)-catalyzed peroxidation of dienes including (S)-
limonene. The use of molecular oxygen and triethylsilane was elaborated by Isayama and 
Mukaiyama106 with subsequent intramolecular cyclization of the unsaturated peroxy radical 
intermediates (Figure 1.17). 
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Figure 1.17 
 
Wataya and coworkers107 reported the synthesis of novel antimalaria-active 1,2,4,5-
tetraoxacycloalkanes by cesium hydroxide or silver oxide mediated cycloalkylation of 
bishydroperoxides with dihaloalkanes (Scheme 1.15). 
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Scheme 1.15 
 
Bloodworth et al. reported that the peroxyhemiacetals derived from reaction of aldehydes 
with allyllic hydroperoxides undergo cyclization with N-iodosuccinimide or NBS to afford 
1,2,4-trioxanes (Scheme 1.16).108 
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Scheme 1.16 
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In an analogous reaction, Dussault et al.109 used the electrophilic cyclization of unsaturated 
hydroperoxy acetals or ketals with different electrophilic reagents for the synthesis of 1,2,4-
trioxanes with moderate diastereoselectivity (Scheme 1.17). The unsaturated hydroperoxy 
acetals or ketals used in the reaction were prepared by trapping of ozonolysis-derived 
carbonyl oxides with allylic alcohol. 
 
H3C(H2C)6 H
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Scheme 1.17 
 
1,2,4-Trioxanes were also synthesized by the condensation reaction of vic-hydroperoxy 
alcohols with carbonyl compounds using anhydrous CuSO4 (Scheme 1.18). The vic-
hydroperoxy alcohols used as starting materials in this reaction were obtained by acid-
catalyzed perhydrolysis of epoxides with 98% H2O2.110  
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Scheme 1.18 
 
Maruyama et al.111 reported on the synthesis of different tricyclic 1,2,4-trioxanes upon 
irradiation of a series of alkenoyl-1,4-quinones in presence of oxygen. The reaction was 
assumed to proceed by trapping of the formed biradical by oxygen molecules (Scheme 1.19). 
The same concept was also utilized by Werbin112 and Wilson.113 
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Scheme 1.19 
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Wilson et al.114 were also able to trap the biradical formed in Paternò-Büchi reaction by 
molecular oxygen leading to formation of 1,2,4-trioxanes (Scheme 1.20).  
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Scheme 1.20 
 
Bunnelle et al.115 used the cationic ring expansion of 1,2,4-trioxolanes (alkene ozonides) 
triggered by elimination of a good leaving group which leads to a 1,2-shift of the peroxide 
group and formation of 1,2,4-trioxanes (Scheme 1.21). 
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Scheme 1.21 
 
Bloodworth et al. used also the peroxyhemiacetals to undergo cyclization with mercury-(II) 
trifluoroacetate (modified cyclooxymercuriation) followed by reductive demercuriation with 
sodium borohydride to afford diasteriomeric mixtures of 1,2,4-trioxanes (Scheme 1.22).116 
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Scheme 1.22 
 
Jefford et al.117 used the reaction of endoperoxides or 1,2-dioxetanes with carbonyl 
compounds in presence of a catalytic amount of trimethylsilyl trifluoromethanesulfonate 
(Me3SiOTf) in methylene chloride at -78 °C to prepare a wide series of 1,2,4-trioxanes 
(Scheme 1.23) 
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Scheme 1.23 
 
O´Neill and coworkers118 used the regioselective Co-(II)-mediated peroxysilylation reaction 
of allylic alcohols to give the corresponding β-peroxysilyl alcohol derivatives in good yields 
which condensed under acidic conditions with aldehydes and ketones to afford the 1,2,4-
trioxanes. (Scheme 1.24).  
 
HO R
HO CH3
ROO
Et3Si
O O
O
R
CH3
R1
R2
Co(acac)2
RT / O2 cat. TsOH
R = CH3, Ph
Et3SiH R1 R2
O
 
Scheme 1.24 
 
Singh et al.119 has also prepared a series of 1,2,4-trioxanes which showed good in vitro 
antimalarial activity by condensation of carbonyl compounds with β-hydroxy hydroperoxides, 
prepared by dye sensitized photooxygenation of different allylic alcohols (Scheme 1.25).  
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Scheme 1.25 
 
The development of the artemisinin combination therapy concept was recently achieved by 
the synthesis of effective drugs that simultaneously contain the 1,2,4-trioxane moiety 
covalently bound with another active antimalarial pharmacophore, such as aminoquinolines120 
or aliphatic diamines121. The high activity of these molecules, termed trioxaquines (Scheme 
1.26), is rationalized by the combination of a peroxidic entity that is a fast and potential 
alkylating agent, in the same molecule with the aminoquinoline unit which is characterized by 
easy penetration of the infected erythrocytes.120b,c,122 
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Scheme 1.26 
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2. Aim of the Work  
 
The 1,2,4-trioxane substructure is the pharmacophore in the naturally occurring antimalarial 
drug artemisinin. My research efforts have been primarily devoted to develop an efficient 
route to synthesize a broad series of mono-, polycyclic, and spiro-1,2,4-trioxanes using the 
photooxygenation ene reaction of singlet oxygen with different allylic alcohols. 
 
Beside the previous synthetic aspect, the application of a new solvent-free photooxygenation 
reaction in polymer matrices will also be investigated. Commercially available polystyrene 
beads crosslinked with divinylbenzene and loaded with adsorbed tetraarylporphyrine dye 
sensitizers as well as synthesized polymers that are covalently bound to porphyrine sensitizers 
will be examined as reaction media for the photooxygention reaction of different substrates. 
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3. Results and Discussion 
 
3.1 Polystyrene Matrix with Covalently Linked Singlet Oxygen Sensitizers 
 
3.1.1 Synthesis of 5,10,15,20-tetrakis(4-ethenylphenyl)-21H,23H-porphine (tetra-
styrylporphyrin,TSP) 
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Scheme 3.1: TSP synthesis. 
 
The synthesis of TSP (4) may be achieved either by Wittig reaction of 5,10,15,20-tetrakis(4-
formylphenyl)porphyrin (prepared from terephthalaldehyde and pyrrole)123 with 
methyltriphenylphosphonium bromide or by dehydrohalogenation of the porphyrin 3 (Scheme 
3.1).124 The latter method appeared advantageous because of higher yield and better 
reproducibility.  
Formylation of 2-bromoethylbenzene (1) using dichloromethyl methyl ether in presence of 
Lewis acid as TiCl4 gives the aldehyde 2 showing the aldehyde characteristic signal at 9.93, 
191.8 ppm in 1H and 13C-NMR, respectively. Applying the usual Adler’s procedure125 used 
for porphyrin synthesis to the aldehyde 2 resulted in a deep violet crystals corresponding to 3. 
The 1H-NMR spectrum of 3 is characterized by the two triplet signals of the vicinal 
methylene groups at 3.50, 3.86 ppm as well as the olefinic singlet signal of pyrrole ring at δ = 
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8.82 ppm. Also and like all porphyrin systems, the highly shielded NH protons (due to 
anisotropic ring current effect) resonate highly up-field at δ = -2.80 ppm. 
Treatment of 3 with alcoholic KOH in DMF resulted in dehydrobromination reaction with the 
formation of 4 in good yield. Similarly to 3, the structure of TSP (4) was confirmed by NMR 
showing its characteristic vinylic proton signals at 5.48, 6.05 and 7.05 ppm (Figure 3.1). 
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Figure 3.1: 1H-NMR spectra of compounds 3 (left) and 4 (right). 
 
3.1.2 Polymerization, morphology and characterization of the sensitizer-bound 
resins  
 
The synthetic TSP (4) and the natural protoporphyrin-IX (5) (PP), Figure 3.2, are peripheral 
substituted porphyrins with unsaturated side chains and hence having crosslinking properties. 
PP (5) is the biological precursor for plant and animal pigments, it gained with its dimethyl 
ester derivative a considerable attention as efficient candidates in photodynamic therapy.126 
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Figure 3.2: Protoporphyrin-IX (PP). 
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Both singlet oxygen sensitizers 4 and 5 were copolymerized with styrene (S) and divinyl 
benzene (DVB) using an emulsifier-free emulsion polymerization. This technique was chosen 
for the copolymerization reaction since it allows the synthesis of the resin particles (TSP-S-
DVB and PP-S-DVB copolymers) in a simple and reproducible way (Scheme 3.2 and 3.3). 
Styrene, DVB and the crosslinking sensitizer (TSP or PP) were suspended in an excess of an 
immiscible water phase (the continuous phase) that is maintained at pH = 2.3 and heated to 70 
°C. On addition of a radical initiator (potassium peroxodisulfate) the polymerization starts and 
over a polymerization period of about 7 h, the monomer droplets are converted to polymer 
beads which are referred to as “resins”. 
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Scheme 3.2: Synthesis of the tetrastyrylporphyrin-loaded polymer (TSP-S-DVB). 
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Scheme 3.3: Synthesis of the protoporphyrin-IX-loaded polymer (PP-S-DVB). 
 
The TSP-S-DVB polymer particles are translucent in color, polyhedral in shape having size 
range from 200 to 500 nm. On the other hand, the PP-S-DVB resin is faint rose in color, 
spherical in shape having size range from 200 to 400 nm. (Figure 3.3). It is also noteworthy 
to mention that these resin nanoparticles are characterized by high surface area, accounting 
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for their high substrate loading capacity (up to 100 % by wt. for both catalysts, vide infra). 
SEM pictures of samples of each polymer (unswollen) is shown in Figure 3.3. 
 
  
 
  
Figure 3.3:Scanning electron microscope (SEM) pictures 
of PP-S-DVB sample (right) and TSP-S-DVB sample (left). 
 
Copolymerization of TSP and PP is expected to enhance the 1O2 generation efficiency 
compared to the non-polymerized TSP and PP sensitizers due to saturation of the side-chain 
double bonds (styrene-type double bonds are oxidative labile).127 Both macromolecular 
sensitizers, TSP-S-DVB and PP-S-DVB, have high photo and mechanical stability, efficiently 
generating 1O2 and show good resistance toward bleeding and the irreversible photobleaching 
(oxidative degradation) by 1O2 and/or the strong oxidizing peroxidic products (peroxides or 
hydroperoxides).128 I also expect an enhancement of the porphyrin triplet lifetimes for the 
covalently-linked porphyrins in comparison with the free sensitizers in solution, because 
polymerization should prevent dye-aggregations that is known to cause self-quenching of the 
excited sensitizers and thereby reduces the triplet lifetimes.129 
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3.1.3 Determination of the sensitizer percentage in the resins 
 
Estimation of the percentage of TSP (or PP) covalently bound in TSP-S-DVB (or PP-S-DVB) 
resins was achieved by running two parallel photooxygenation reactions using identical 
amounts of the synthesized TSP-S-DVP (or PP-S-DVB) resin and the commercially available 
PS-DVB copolymer (loaded with a given amount of the sensitizer). Both reactions were 
carried out under identical conditions using identical amount of the substrate 6b (Scheme 
3.4). From the comparison of the degree of conversion in both experiments, a loading degree 
of about 0.1 % of TSP in TSP-S-DVB resin (or PP in PP-S-DVB resin) was determined. 
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Scheme 3.4 
 
3.1.4 Solvent-free photooxygenation reactions using covalently-bound sensitizers 
 
Motivated by developing an efficient, inexpensive, highly reproducible and reusable approach 
for 1O2 photooxygenation reaction which can also avoid the aforementioned solution 
photochemistry drawbacks (and since filtration is one of the simplest and fastest methods for 
isolating a substance from a liquid, such as a solution of reactants), I developed a solvent-free 
pathway combining the use of visible light as a reagent in the presence of the polymer-fixed 
sensitizers microreactors as a reaction medium. This offers a new and convenient approach 
towards green singlet-oxygen photooxygenation reactions, where not only the production of 
side products is retarded due to enhanced selectivity but also the amount of expensive and 
environmentally problematic solvents is highly reduced (vide infra). 
 
In this approach the polymer-bound sensitizer is placed in a small Petri-dish and swollen by a 
small amount of the substrate solution in dichloromethane followed by evaporation of excess 
solvent, gram scale reactions can be carried out applying a loading degree up to 100 % by wt. 
for both catalysts. The Petri-dish is irradiated with halogen lamp or sodium street lamp simply 
under atmospheric air needing no oxygen purging. In contrast to solid phase organic synthesis 
(SPOS)130 in which the substrate is covalently attached to the solid support during a reaction 
sequence and the product has to be cleaved from the support at the end of the reaction, in the 
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solvent-free approach the substrate is only adsorbed to the solid support. This facilitates the 
product isolation by a simple routine of extraction with methanol or ethanol, filtration and 
evaporation. In order to explore the potential of the new TSP-S-DVB or PP-S-DVB solvent-
free photooxygenation approach and identify its influence on the chemo-, regio-, and 
stereoselectivity patterns in type-II photooxygenation reaction, several substrates for both ene 
and [4+2]-cycloaddition reactions with singlet oxygen have been investigated. 
 
3.1.4.1 Diastereoselectivity of the ene and [4+2]-cycloaddition reactions using TSP-S-
DVB and PP-S-DVB 
 
The diastereoselectivity of the ene reaction of 1O2 was investigated using the chiral allylic 
alcohols 6a-c.37,141 The photooxygenation of 6a-c (Scheme 3.5) yielded the syn-hydroxy 
allylic hydroperoxide as major diastereomers referring to the hydroxy-directing effect of 1O2 
in the conformationally fixed (by 1,3A-strain) substrates (Table 3.1). 
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Scheme 3.5:Photooxygenation of the allylic alcohols 6a-c 
 
compound R 
d.r. (syn:anti)[a] 
TSP-S-DVB 
d.r. (syn:anti)[a] 
PP-S-DVB 
d.r. (syn:anti)[a] 
TTP/TPP in CCl4 
7a CH3 81:19 80:20 93:7 
7b Et 78:22 - 93:7 
7c i-Pr 82:18 - 93:7 
Table 3.1: Diastereoselectivities of the photooxygenation of 6a-c in different environments. 
[a] d.r. values were calculated by 1H NMR from the crude reaction mixture (5 % error). 
 
As seen in Table 3.1, both TSP-S-DVB and PP-S-DVB gave similar diastereoselectivities, 
however considerably lower than that obtained in the non-polar solvents as CCl4. This can be 
rationalized by the intermolecular hydrogen-bonding between the the highly concentrated 
allylic alcohol molecules encapsulated in both nanocontainer beads (the hydrophobic nature 
of the beads interior also enhances aggregation of the highly polar substrate). This assumption 
was further supported by the fact that solvent-free photooxygenation of 6a in a rose 
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bengal/cellulose acetate film (showing additional intermolecular hydrogen-bonding between 
the matrix and the substrate) results in even lower syn diastereoselectivity (d.r. 70:30). 
The relative (syn) configuration of the major diastereoisomers has been confirmed by several 
chemical transformations of the β-hydroxy allylic hydroperoxides among them also the 
peroxyacetalization reaction to form 1,2,4-trioxanes (vide infra). The first unambiguous proof 
was achieved by successful crystallization of the homologous compound syn-7j prepared by 
identical procedure (Figure 3.4). 
 
  
Figure 3.4: X-ray analysis for syn-7j. 
(First X-ray of acyclic vic-hydroperoxy alcohol in literature). 
 
The formation of the 1,2-hydroperoxy alcohols was confirmed by the characteristic signals of 
the hydroperoxy carbons for both syn-7a-c,j and anti-7a-c,j diastereomers (Table 3.2). 
 
syn-diastereomer anti-diastereomer 
Compound R 
1HNMR 13CNMR 1HNMR 13CNMR 
7a CH3 4.08 94.8 4.25 92.1 
7b Et 4.15 93.4 4.30 91.4 
7c i-Pr 4.28 92.0 4.34 89.9 
7j t-Bu 4.33 88.0 4.33 90.1 
Table 3.2: 1H- and 13C-NMR chemical shifts (ppm) of the hydroperoxy carbon  
(CH-OOH) of syn and anti diastereomers of 7a-c,j (in CDCl3). 
 
The chiral dienol 8 was used to probe the diastereoselectivity of the [4+2]-cycloaddition 
reaction of 1O2.131 The photooxygenation of 8 under solvent-free conditions using the 
sensitizer-bound polymer matrix gives a mixture of the endoperoxides syn- and anti-9 in good 
yield but with low diastereoselectivity (d.r. 59:41) in pronounced opposition to monoalkenes 
reactions (Scheme 3.6). The poor facial selectivity in the formation of 9 is expected due to the 
negligible hydroxy-directing effect of 1O2 since it is not conformationally fixed on one 
diastereotopic face of the diene 8. The structure of the products was confirmed on the bases of 
OOH
OH
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disappearance of a double bond and appearance of two peroxidic carbon atoms in 1H as well 
as 13C-NMR of both diastereomers. 
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Scheme 3.6: Photooxygenation of the dienol (8). 
 
3.1.4.2 Regioselectivity of the ene reaction using TSP-S-DVB and PP-S-DVB 
 
In order to study the effect of this polymer environment on the regioselectivity of the ene 
reaction, I investigated the photooxygenation of citronellol (10). Citronellol is the industrial 
precursor of the fragrant speciality rose oxide.132 The photooxygenation reaction using the 
polymer-bound sensitizer yielded the regioisomers 11 and 12 in ratio 1.3:1, respectively 
(Scheme 3.7). Fortunately, compound 11 is the major regioisomer that is needed for rose 
oxide production. The regioisomer 12 is formed as 1:1 diastereomerc mixture (from 13C-
NMR). The structure of both compounds was confirmed by the characteristic signals of the 
hydroperoxy carbons in 1H- and 13C-NMR as shown in Table 3.3. 
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Scheme 3.7: Photooxygenation of citronellol (10). 
 
11 12 
1HNMR 13CNMR 1HNMR 13CNMR 
- 81.6 4.14 89.1/89.5 
Table 3.3: Chemical shifts (ppm) of the hydroperoxy carbon  
(CH-OOH) of compounds 11, 12 (in CDCl3). 
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3.1.4.3 Sorbinol and ethyl tiglate photooxygenations using TSP-S-DVB and PP-S-DVB 
 
The solvent-free photooxygenation reaction of the reactive alcohol derived from sorbic acid 
(sorbinol) 13 using the sensitizer-bound polymer proceeded in excellent yields forming the 
corresponding endoperoxide 14 (Scheme 3.8). The NMR of the product is consistent with 14 
showing the two characteristic peroxidic carbons at 4.39, 4.77 ppm in 1H-NMR and at 74.3 
and 79.7 ppm in 13C-NMR. 
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Scheme 3.8: Photooxygenation of sorbinol (13). 
 
Similarly, photooxygenation of the tiglate ester 15 affords in a clean reaction the 
corresponding hydroperoxide 16 (Scheme 3.9). The hydroperoxide is formed as one 
regioisomer as expected by the gem-effect (vide supra). The formation of 16 was 
unambiguously proved by the hydroperoxide carbon resonating as quartet at δ = 4.9 ppm in 
1H-NMR and at δ = 79 ppm in 13C-NMR. 
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Scheme 3.9: Photooxygenation of ethyl tiglate (15). 
 
One of the major advantages of this solvent-free technique with the sensitizer-bound resins is 
the reusability. The recovered TSP-S-DVB and PP-S-DVB beads were recycled in three 
consecutive cycles simply by washing with methylene chloride (to remove any residual 
amount of the substrate or product) and reused again without any appreciable decrease in the 
catalytic efficiency. Minimum turn over number (TON) are 3000 for the TSP-S-DVB and 
slightly lower for the PP-S-DVB system. 
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3.1.4.4 Photooxygenation of 5-methoxyoxazoles using TSP-S-DVB and PP-S-DVB 
 
A set of the substrates 2,4-dialkylated-5-methoxyoxazoles were synthesized from the amino 
acids in a three-step procedure (Scheme 3.10). Firstly the amino acid was converted to the 
ester of its hydrochloride salt by treatment with thionylchloride in dry methanol, followed by 
acylation of the amino group with acid chloride in presence of triethylamine. The oxazole 
synthesis is completed by dehydration of the acylated amino acid ester with phosphorous 
pentachloride in chloroform. The oxazoles 20a-f were obtained in high purity and their 
chemical structures were proven by NMR spectroscopy. For example in 1H-NMR, the 
methoxy group resonates at about 3.7 ppm, in 13C-NMR the two characteristic signals of C-5 
and C-2 resonate for the different oxazoles between 152-155 and 154-161 ppm, respectively. 
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Scheme 3.10: Synthesis of 2,4-dialkylated-5-methoxyoxazoles. 
 
Oxazoles in general show high reactivity as electron-rich dienes in thermal 1,4-cycloaddition 
reactions133 as well as in the type-II photooxygenation reaction.134 The cycloaddition of 
singlet oxygen to 5-alkoxy-oxazoles involves an endoperoxide intermediate which could be 
trapped by nucleophiles such as methanol or rearranges to a peroxyimide, the 1,2,4-dioxazole 
(Scheme 3.11).135,136  
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Scheme 3.11: Photooxygenation of 5-alkoxy-oxazoles: products. 
 
The 1O2 photooxygenation reaction of 20a-f using the sensitizer-bound polymers TSP-S-DVB 
and PP-S-DVB resulted in 100 % conversion of the starting materials with the formation of 
the 1,2,4-dioxazoles 21a-f (Scheme 3.12). The structure determination of the compounds 21a-
f was based on the characteristic chemical shifts of quaternary, peroxyimide, and the carbonyl 
carbon atoms in 13C-NMR (Table 3.4). 
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Scheme 3.12: Photooxygenation of 5-methoxyoxazoles 20a-f on solid support. 
 
Compound R1 R2 Yield (%)[a] Yield (%)[b]
Cq 
(ppm) 
C=N 
(ppm) 
C=O 
(ppm) 
21a Me Me 60 44 106.1 160.7 168.4 
21b Et Me 86 90 106.0 164.9 168.6 
21c t-Bu Me - 84 105.9 170.0 168.6 
21d Me i-Pr - 79 111.3 160.3 168.8 
21e Et i-Pr 90 86 111.0 164.3 168.6 
21f Et i-Bu 89 79 108.3 164.4 168.7 
Table 3.4: 1,2,4-dioxazoles 21a-f using [a]TSP-S-DVB and [b]PP-S-DVB support systems, 
 the characteristic signals in 13C-NMR (CDCl3) are also shown. 
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The peroxides are unstable and decompose slowly to give the corresponding amides and 
dicarbonyl fragments.136 The amide formation was unambiguously confirmed by X-ray 
analysis of pivaloylamide derived from the decomposition of 21c (Figure 3.5). 
 
 
 
 
 
 
 
 
 
Figure 3.5: X-ray analysis of pivaloylamide (with and without showing 
the hydrogen bonding) obtained from decomposition of 21c. 
 
3.2 Homogeneous versus heterogeneous photooxygenation conditions 
 
The photooxygenation reactions in solution can be performed either homogeneously or 
heterogeneously. In the former case, the dye sensitizer is completely soluble in the reaction 
mixture forming one phase reaction. In the latter case, one of the ingredients of the reaction 
(here the sensitizer) exist in a different phase (Figure 3.6).137 Both PP-S-DVB and TSP-S-
DVB sensitizers were also applied in a heterogeneous photooxygenation reaction. 
 
  
Figure 3.6: Homogeneous (left) and heterogeneous (right) 1O2 photooxygenation reactions in solution. 
NH2
O
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Comparison of the efficiency of both the homogeneous and heterogeneous photooxygenation 
conditions was accomplished by studying the oxygen uptake in the 1O2 photooxygenation 
reaction of the reactive model substrate 2,3-dimethyl-2-butene (23) (Scheme 3.13). All 
reactions were carried out in CCl4 and under pseudo-first order conditions using large excess 
of substrate concentration (> 0.1 M alkene concentration) in order to make sure that the 
reaction rate is only dependent on the 1O2 concentration that is produced by the sensitizer 
molecules. 
 
OOH
3O2, CCl4, hν
Sensitizer
23 24  
Scheme 3.13: Photooxygenation reaction of 23. 
 
Two concentrations of tetraphenylporphyrin (TPP) in CCl4 were used for the homogeneous 
reaction condition (1.6 x 10-5 and 1.6 x 10-6 M). On the other hand, suspensions of the TSP-S-
DVB and PP-S-DVB resins in CCl4 were used for the heterogeneous reactions. The amount of 
sensitizer covalently bound in the polymer beads corresponds to a homogeneous solution of 
2 x 10-6 M porphyrin (assuming 100 % integration of the sensitizer in the network during 
polymerization). 
From the (linear) oxygen uptake it is concluded that the pseudo first-order conditions exist for 
a longer period of time without bleaching or degradation of the polymer-bound dyestuff.127,138 
From Figure 3.7, it can be seen that the sensitizer activity is nearly identical comparing 
homogeneous conditions (1.6 x 10-6 M TPP) with the polymer bound tetrastyrylporphyrin 
(TSP-S-DVB) and only slightly lower for the polymer-bound protoporphyrin-IX (PP-S-
DVB). 
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Figure 3.7: Oxygen-gas uptake under homogeneous and heterogeneous 
conditions using the model compound 2,3-dimethyl-2-butene 23 (0.15 M in CCl4). 
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3.3 Polystyrene Matrix with Adsorbed Singlet Oxygen Sensitizers 
 
In this approach the non-polar dye sensitizer (para-substituted tetraaraylporphyrins or the 
parent meso-tetraphenylporphyrin TPP) for the generation of singlet oxygen was transferred 
in a catalytic amounts into the beads of the commercially available PS-DVB (polystyrene 
resin crosslinked with 1 % DVB) by swelling the resin with a solution of the sensitizer in 
dichloromethane with subsequent evaporation of the solvent. Then the substrate was 
transferred into the polymer by similar procedure where the molar ratio of the sensitizer to the 
substrate in the polymer matrix is about 1:1000. After evaporation of the solvent, the obtained 
sandy layer is irradiated under atmospheric oxygen. Based on the polarity difference between 
nonpolar sensitizer and polar reaction products as well as the extreme low solubility of the 
meso-tetraarylporphyrins in more polar solvents, the product is extracted after irradiation by 
repeated washing with methanol or ethanol. By this way the dye sensitizer stays nearly 
completely in the solid support and the reloading process can repeated.  
The solvent-free approach of 1O2 photooxygenation reactions is the basic reaction applied for 
a wide variety of substrates among them the allylic alcohols that are considered as the parent 
precursors for the antimalarial 1,2,4-trioxanes prepared in this thesis. 
 
3.4 Synthesis of the Allylic Alcohols Starting Materials 
 
A series of allylic alcohols 6b-j was prepared in good yields from 3-methyl-2-butenal (25) by 
reaction either with Grignard reagents (method A) or with organolithium compounds (method 
B) in dry ether or THF as solvent. (Scheme 3.14). 
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Scheme 3.14: Synthesis of the allylic alcohols 6b-j from 3-methyl-2-butenal. 
 
All allylic alcohols prepared showed 1H- and 13C-NMR data that are consistent with the data 
in literature. The allylic alcohols prepared by these two methods and their characteristic 
signals of the carbinol carbons are summarized in Table 3.5.  
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Compound R 
Synthesis 
method[a] 
1H-NMR 
(ppm)[b] 
13C-NMR 
(ppm)[b] 
Yield 
(%) 
6b Et (A) 4.20 70.0 52 
6c i-Pr (A) 3.96 73.5 67 
6d n-Pr (A) 4.28 68.3 83 
6e CH2CH=CH2 (A) 4.32 67.6 76 
6f CH(Me)CH=CH2 (A) 4.17/4.03[c] 71.6/71.5[c] 57[c] 
6g n-Bu (B) 4.26 68.6 81 
6h i-Bu (A) 4.32 66.6 70 
6i sec-Bu (B) 4.19[d] 68.8[d] 60[d] 
6j t-Bu (B) 3.93 75.9 20 
Table 3.5: Synthesis of allylic alcohols 6b-j: [a] Method (A) correspond to the use of Grignard  
reagent, while method (B) correspond to the use of organolithium compounds in synthesis. 
[b] The values correspond to the carbinol carbon (CH-OH) in CDCl3. 
[c] Two diastereomers 
in ratio 53:47 are formed. [d] Two diastereomers in ratio 1:1 are formed. 
 
The reaction of prenylmagnesium bromide (the potential reagent used for “isoprene unit” 
synthesis) with 25 in dry ether proceeds through a SN2´ mechanism to afford the natural C-10 
terpene artemesia alcohol 6k (Scheme 3.15). Confirmation of the structure of 6k was 
achieved by comparison with literature data as well as NMR analyses. 139  
 
H
O dry Et2O
MgBr
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25 6k  
Scheme 3.15: Synthesis of artemesia alcohol 6k. 
 
Unexpectedly, treatment of 25 with phenyllithium in dry THF afforded the conjugated tertiary 
allylic alcohol 6m rather than the desired secondary allylic alcohol 6l (Scheme 3.16). The 
formation of 6m is explained in terms of the acid-catalyzed 1,3-hydroxy group shift, in the 
work-up step or induced by the acidic nature of the silica gel during purification.140 The 
driving force for the rearrangement is the formation of the more conjugated (and hence more 
stable) tertiary allylic alcohol 6m. The chemical structure of 6l is established by the two 
olefinic signals resonating at δ = 6.22, 6.45 ppm with a coupling constant of 16.1 Hz 
indicating trans configuration. The two methyl groups are magnetically equivalent and appear 
as singlet at δ = 1.29 Hz, the absence of both the carbinol proton in 1H-NMR and the carbinol 
carbon in DEPT also supports this structure. 
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Scheme 3.16 
 
Another two allylic alcohols were prepared from the commercially available mesityl oxide 26. 
Reduction of 26 with lithium aluminum hydride in ether results in the formation of mesitylol 
(6a); on the other hand, treatment of 26 with methyl magnesium iodide gives the tertiary 
allylic alcohol 6n (Schemes 3.17). Similarly, the reduction of ethyl tiglate (15) affords the 
alcohol 6o in good yield (Schemes 3.18). All compounds show identical analytical data 
consistent with that reported in literature. 
 
OH LiAlH4
O
MeMgI
dry Et2Odry Et2O OH
266a 6n  
Scheme 3.17: Syntheses of 6a and 6n from mesityl oxide (26). 
 
COOEt OH
LiAlH4
dry Et2O
15 6o  
Scheme 3.18: Synthesis of 6o from ethyl tiglate 15. 
 
Starting from methyl ketones, another approach was optimized for the synthesis of allylic 
alcohols in three steps. Firstly, the methyl ketones are converted to an aldol by treatment with 
LDA and acetone, followed by dehydration of the aldol by p-toluenesulfonic acid in 
methylene chloride to give the corresponding α,β-unsaturaed carbonyl compound which is 
finally reduced with lithium aluminum hydride in dry ether to afford the allylic alcohol 
(Scheme 3.19). 
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Scheme 3.19: Synthesis of allylic alcohols 6p,q. 
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The two aldol compounds 28a,b were synthesized from the first step by addition of the 
methyl ketones 27a,b to acetone. The constitution of the aldol products was based on 
spectroscopic methods (NMR, IR and mass spectra) as well as elemental analysis. The most 
characteristic signal in 1H-NMR for 28a,b is the signal of the methylene group (α to the 
carbonyl group) appearing as singlet. Table 3.6 shows the most significant signals in 1H- as 
well as in 13C-NMR.  
 
CH2CO (ppm) 
Compound R 
Cq-OH
(ppm) 
C=O 
(ppm) 1HNMR 13C-NMR 
Yield 
(%) 
28a c-Pr 69.3 212.4 2.59 53.6 56 
28b c-Hex 69.5 216.4 2.55 50.7 55 
Table 3.6: Characteristic signals of 28a,b in 1H- and 13C-NMR (in CDCl3). 
 
As a representative example, compound 28a shows in the IR spectrum the characteristic band 
stretching at 3600-3200 cm-1 corresponding to the hydrogen-bonded OH group and the band 
corresponding to the carbonyl group at 1687 cm-1. Its mass spectrum fragmentation pattern is 
also consistent with the structure (Scheme 3.20). 
 
O
OH
O
OH
O
OH
- CH3- H2O
O
OO
- C4H9O
m/z = 69
m/z = 127
m/z = 142
m/z = 124
 
Scheme 3.20: Fragmentation pattern of 28a. 
 
The dehydration of the aldol products 28a,b led to the formation of the corresponding α,β-
unsaturated carbonyl compounds (Michael systems) 29a,b in good yield and high purity. The 
structure of the products is confirmed by NMR. The characteristic olefinic carbons as well as 
the carbonyl carbon chemical shifts in the 1H- and 13C-NMR are shown in Table 3.7. 
 
 
 
3. Results & Discussion 
45 
CH= (ppm) 
Compound R 
C=O 
(ppm) 
Cq= 
(ppm) 1HNMR 13C-NMR 
Yield 
(%) 
29a c-Pr 200.5 153.9 6.13 124.2 82 
29b c-Hex 204.0 155.1 6.06 122.9 81 
Table 3.7: Characteristic signals in 1H- and 13C-NMR of 29a,b (in CDCl3). 
 
Reduction of the enones 29a,b with LiAlH4 in ether afforded the corresponding allylic 
alcohols 6p,q in good purity. Confirmation of the structure was based on NMR. The chemical 
shifts of the characteristic olefinic carbons as well as the carbinol carbon (CH-OH) in the 1H- 
and 13C-NMR are shown in Table 3.8.  
 
CH-OH (ppm) 
Compound R 
CH= 
(ppm) 
Cq= 
(ppm) 1HNMR 13C-NMR 
Yield 
(%) 
6p c-Pr 126.5 135.0 3.76 72.5 67 
6q c-Hex 126.7 135.2 4.0 72.9 79 
Table 3.8: Characteristic signals in 1H- and 13C-NMR of 6p,q (in CDCl3). 
 
The acetylation of cyclohexene (30) with acetic anhydride in presence of stannic chloride 
results in the formation of 1-acetylcyclohexene (31), which was reduced with lithium 
aluminum hydride in dry ether to afford the allylic alcohol 32 in high purity showing 
spectroscopic data identical to the reported in literature (Scheme 3.21). 
 
OHO
Ac2O/SnCl4 LiAlH4
dry Et2O
3130 32  
Scheme 3.21 
 
The terpene myrtenal (34) was synthesized by singlet-oxygen photooxygenation of β-pinene 
(33) in presence of acetic anhydride and pyridine / DMAP as bases. The reaction proceeds 
through the formation of the acetylated allylic hydroperoxide which eliminates acetic acid 
under the basic conditions to give 34. The reaction of 34 with methyl lithium results in the 
formation of the allylic alcohol 35 in 2:3 diastereomeric mixture (Scheme 3.22). The allylic 
alcohol 35 shows in 1H-NMR the characteristic signal corresponding to the proton of the 
carbinol carbon (CH-OH) at δ = 4.05 and in 13C-NMR at 69.7/70.2 ppm. 
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Scheme 3.22 
 
 
3.5 Solvent-Free Photooxygenation Reactions of Allylic Alcohols 
 
The photooxygenation of a series of allylic alcohols 6a-k,p,q using PS-DVB polymer matrix 
doped with adsorbed porphyrin sensitizer (TPP or TTP) resulted in the formation of a syn (or 
threo) and anti (or erythro) diastereomeric mixture of the vic-hydroperoxy alcohols in good 
yields (Scheme 3.23). The β-hydroperoxy alcohols are stable at r.t. and can be kept in the 
refrigerator for weeks without decomposition. 
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Scheme 3.23: Solvent-free photooxygenation of the allylic  
alcohols 6a-k,p,q using TPP embedded in PS-DVB matrix. 
 
It is found that the diastereoselectivity of the ene reaction using the commercial PS-DVB with 
physically adsorbed sensitizer (Table 3.9) showed similar values to that obtained with the 
polymer-bound sensitizers, TSP-S-DVB or PP-S-DVB (somewhat higher with the polymer-
bound sensitizers, Table 3.1), accounting for the aforementioned intermolecular hydrogen-
bonding between the highly concentrated substrate molecules in both polymer systems. The 
reaction diastereoselectivity as well as regiochemistry is dictated by the steering effect of the 
hydroxy group discovered by Adam and coworkers.37,141 The 1,3-allylic strain with the 
stereogenic center provides stereodifferentiation between the two π-faces. This 1,3-allylic 
strain constrains the hydroxy group to be conformationally fixed on one face of the double 
bond and hence capable of directing the incoming enophile (1O2) by hydrogen bonding 
leading to preferential formation of the major syn-diastereomer (Scheme 3.24). Comparison 
of the chemical yields and the diastereoselectivities in the solvent-free photooxygenation 
reaction of the allylic alcohols 6a-k,p,q is shown in Table 3.9.  
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Scheme 3.24: Hydroxy group directing the diastereoselectivity of 1O2 attack. 
 
Compund R d.r.
[a] 
syn:anti 
Yield 
(%) 
7a Me 75 : 25 83 
7b Et 77 : 23 72 
7c i-Pr 81 : 19 72 
7d n-Pr 79 : 21 78 
7e CH2CH=CH2 75 : 25 69 
7f CH(Me)CH=CH2 d.l. 63 
7g n-Bu 79 : 21 78 
7h i-Bu 80 : 20 77 
7i sec-Bu d.l. 73 
7j t-Bu 78 : 22 59 
7k C(Me)2CH=CH2 72 : 28 73 
7p c-Pr 62 : 38 80 
7q c-Hex 88 : 12 65 
Table 3.9: The photooxygenation of the allylic alcohols 6a-k,p,q using solvent-free 
approach with PS-DVB copolymer. [a] The diastereoselectivity is determined from 
the integration of the characteristic signals in the NMR of the crude reaction mixture. 
d.l.: Four diastereomers are obtained which are discussed later.  
 
The chemical constitution of these hydroxy allylic hydroperoxides was based on 1H- and 13C-
NMR analysis. The literature-known hydroperoxide 7a was confirmed by comparison with 
literature data.37a Both syn and anti diastereomers show mostly a pronounced difference in the 
chemical shifts of their characteristic signals (Table 3.10). The proton of the hydroperoxy 
carbon (CH-OOH) resonates in the range from 4.0 to 4.40 ppm and always appears as doublet 
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due to vicinal coupling with the adjacent carbinol proton (CH-OH). The latter resonates more 
up-field between 3.0 and 4.0 ppm and its multiplicity is variable depending on each 
compound. The shift of the double bond as a result of the ene reaction leads also to the 
formation of a vinylic methyl group resonating between 1.60 and 1.80 ppm and appearing as 
singlet (in some cases appears as multiplet with very small coupling constant (4J) due to the 
allylic coupling with the two olefinic protons).  
Assignment of the relative configuration of the major diastereomer (syn) was based on X-ray 
analysis achieved by compound 7j (vide supra), as well as by chemical correlation to 1,2,4-
trioxanes derived from the BF3-peroxyacetalization reaction of the β-hydroperoxy alcohols 
with carbonyl compounds (vide infra). 
 
An interesting trend is observed on comparing the chemical shifts of the protons attached to 
both the hydroperoxy carbon (CH-OOH) and the carbinol carbon (CH-OH) for each 
diastereomeric pair, where these protons resonate always more up-field in the syn-
diastereomer than in the anti-isomer (exception is 7k where the syn-diastereomer resonate 
more down-field probably due to more the effective deshielding for both protons in syn-7k 
rather than the anti-isomer by the bulky tertiary alkyl groups attached to the stereogenic 
center). 
 
CH-OOH CH-OH 
Compound R 
1H-NMR 13C-NMR 
1H-NMR 13C-NMR 
syn-7a Me 4.08 94.8 3.80 67.1 
anti-7a Me 4.25 92.1 3.94 67.0 
syn-7b Et 4.15 93.4 3.55 71.8 
anti-7b Et 4.30 91.4 3.69 72.2 
syn-7c i-Pr 4.28 92.0 3.49 74.5 
anti-7c i-Pr 4.34 89.9 3.51 74.2 
syn-7d n-Pr 4.13 93.8 3.63 70.3 
anti-7d n-Pr 4.29 91.6 3.78 70.5 
syn-7e CH2CH=CH2 4.17 92.8 3.71 70.0 
anti-7e CH2CH=CH2 4.31 91.0 3.82 69.9 
syn-7f CH(Me)CH=CH2 4.12/4.22 90.8/91.3 3.50/3.52 73.1/73.4 
anti-7f CH(Me)CH=CH2 n.s. 89.2/89.5 n.s. 72.5/72.5 
syn-7g n-Bu 4.15 93.7 3.64 70.6 
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CH-OOH CH-OH 
Compound R 
1H-NMR 13C-NMR 
1H-NMR 13C-NMR 
anti-7g n-Bu 4.30 91.7 3.75 70.7 
syn-7h i-Bu 4.09 94.2 3.68 68.7 
anti-7h i-Bu 4.26 92.0 3.83 68.9 
syn-7i sec-Bu 4.15[a] 93.4/93.5 3.60[a] 70.8/70.6 
anti-7i sec-Bu 4.29[a] 92.3/92.4 3.73[a] 70.9/71.1 
syn-7j t-Bu 4.33 88.0 3.28 78.6 
anti-7j t-Bu 4.33 90.1 3.28 76.1 
syn-7k C(Me)2CH=CH2 4.28 87.5 3.34 77.8 
anti-7k C(Me)2CH=CH2 4.27 89.8 3.26 75.1 
syn-7p c-Pr 4.29 93.3 3.07 75.0 
anti-7p c-Pr 4.41 91.2 3.14 75.6 
syn-7q c-Hex 4.24 91.0 3.43 74.3 
anti-7q c-Hex 4.29 89.2 n.s. n.s. 
Table 3.10: Characteristic signals of the hydroxy allylic hydroperoxides 7a-k,p,q (in CDCl3). 
[a] Both diastereomers have the same chemical shift. 
 n.s.: Not seen due to overlap with other signals. 
 
The photooxygenation of the allylic alcohols 6f,i (possessing two stereogenic centers) 
afforded four diastereomers of the β-hydroxy allylic hydroperoxides, two correspond to the 
major products (assigned as syn,syn-7f,i and syn,anti-7f,i) and two to the minors (assigned as 
anti,syn-7f/i and anti,anti-7f/i). As a representative example, the photooxygenation of 6f is 
depicted in Scheme 3.25. The diastereomeric ratio of both major products syn,syn-7f and 
syn,anti-7f is about 1:1 and that of the anti,syn-7f and anti,anti-7f minor isomers is also about 
1:1. However, both major diastereomers constitute around 85 % of the product mixture 
(determined from 13C-NMR). Similar behavior is also found in the photooxygenation of 6i 
that results in the formation of both diastereomeric major products syn,syn-7i and syn,anti-7i 
in about 83 % from the product mixture. 
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Scheme 3.25: Solvent-free photooxygenation reaction of 6f. 
 
Unlike the photooxygenation reaction of ethyl tiglate 15 proceeding with excellent 
regioselectivity (due to the geminal effect), the solvent-free photooxygenation of the allylic 
alcohol derived from it 6o proceeds with very poor regioselectivity giving the allylic 
hydroperoxy alcohols 36a,b in a ratio about 53:47, respectively (Scheme 3.26). This poor 
regioselectivity as well as the inactivity of the carbinol protons (CH2-OH) towards abstraction 
by 1O2 derives from the previously discussed cis-effect. The chemical constitution of both 
isomers was evaluated by NMR analysis. Compound 36b shows a doublet signal at 1.25 ppm 
having integration of three protons which correspond to the methyl group adjacent to a 
methine carbon, the proton on the hydroperoxy carbon (CH-OOH) resonates as quartet at 4.59 
ppm. Also, in 13C-NMR the hydrperoxy carbon appears at 82.9 ppm. Compound 36a shows 
two diastereomeric methylene protons on the carbinol carbon that resonate at different 
chemical shifts (3.57 and 3.70 ppm), showing geminal coupling of 12 Hz and appearing as 
doublet of doublet (due to another long-range coupling with the CH of the double bond, J = 
1.62 Hz) and doublet, respectively. The hydroperoxy carbon resonates at 84.6 ppm in 13C-
NMR. 
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Scheme 3.26: Solvent-free photooxygenation reaction of 6o. 
 
In contrast to the photooxygenation of 6a affording the vic-hydroperoxy alcohol 7a (vide 
supra), the photooxygenation of the allylic alcohol 6n in tetrachloromethane gives the 1,4-
hydroperoxy alcohol 37b (Scheme 3.27). The formation of 37b is explained by 1,3-allyic shift 
of the hydroperoxy group.142 It is well known that allylic hydroperoxides rearrange by a free-
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radical mechanism in dilute, non-polar solutions and produce an equilibrium mixture of 
allylic isomers.143 That the photooxygenation reaction afforded no 37a shows that steric 
effects strongly influence the relative stabilities of the hydroperoxides. The presence of the 
steric strain on the C1-C2 bond in 37a (five substituents) is the driving force favoring 
rearrangement of 37a to 37b where this steric strain is released (Scheme 3.28). Another 
argument for the higher stability of 37b stem from the presence of a trisubstituted double 
bond in 37b compared to the disubstituted double bond in 37a. 
 
OH OH
OOH
3O2 / hν
TPP / CCl4
1,3- OOH shift
OH
HOO
6n 37a 37b
1
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Scheme 3.27: Photooxygenation of 6n. 
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Scheme 3.28: Newmann projections of 37a and 37b. 
 
In order to examine the reactivity of the allylic alcohols 32,35 towards 1O2 and identify the 
product pattern, an analytical scale photooxygenation reaction in CCl4 was performed in the 
oxygen-uptake apparatus. The allylic alcohol 32 reacts with 1O2 to afford a complex product 
mixture (Scheme 3.29). From the 13C-NMR of the reaction product one can assume the 
presence of two diastereomeric mixtures (syn and anti) of both the vic-hydroperoxy alcohols 
32a as well as the 1,3-hydroxy hydroperoxide 32b as indicated by the presence of eight 
signals in the region from 69-85 ppm corresponding to four carbinol carbons and four 
hydroperoxy carbons. This is further supported by the eight signals in the region 122-138 ppm 
that correspond to the four double bonds in these compounds. The presence of another small 
signal resonating at 209 ppm may be also related to the hydroperoxy ketone 32c existing in 
minor amount in the product mixture. 
OH OH
OHOOH
OOH
1O2 / CCl4
+
32
O
OOH
+
32a 32b 32c  
Scheme 3.29: Photooxygenation of 32. 
3. Results & Discussion 
52 
The allylic alcohol 35 reacts slowly with singlet oxygen in CCl4 where the oxygen-gas uptake 
by 35 is about 20 times slower than that of 6b under the same photooxygenation conditions 
accounting for the steric effects in 1O2 reactions. The reaction is assumed to furnish 35a as 
indicated by a small signal at 207.2 ppm corresponding to the carbonyl group, and the signal 
at 75.7 ppm indicating the hydroperoxy carbon. The singlet oxygen is expected to attack from 
the less hindered side due to the steric factors with the bulky bridge having the two geminal 
methyl groups (Scheme 3.30). 
 
OH
35
1O2 / CCl4
O
H
OOH
35a  
Scheme 3.30: Photooxygenation of 35. 
 
3.6 Deuterium Isotope Effects on the Diastereoselectivity of 1O2 Ene 
Reaction with Allylic Alcohols 
 
In order to explore the role of hydrogen bonding between the attacking singlet oxygen and the 
hydroxy group in dictating the facial selectivity of the ene reaction with allylic alcohols, I also 
studied the effect of exchanging the OH group by an OD group in the allylic alcohols. 
Different photooxygenation runs were carried out in the oxygen-uptake apparatus using 
identical concentrations of the substrate 6a in pure tetrachloromethane as well as 
tetrachloromethane with increasing amounts of methanol or methanol-D4, and the differences 
in the oxygen-gas uptake rates as well as the diastereoselectivities of the reaction were 
compared (Figure 3.8). Three points can be addressed:  
(a) For identical methanol percentages, the initial rates of the oxygen-gas uptake are always 
higher in case of methanol-D4 / CCl4 than in the methanol / CCl4 solvent mixtures. This is 
expected due to the higher singlet oxygen lifetimes in presence of the deuterated versus non-
deuterated solvents (the solvent-quenching rate constant of singlet oxygen increases by more 
than 25 folds on changing from methanol-D4 to methanol).144 Also, the initial rates of the 
oxygen-gas uptake are always decreasing with increasing the percent of methanol-D4 or 
methanol in CCl4, since both solvents are more effective 1O2-quenchers than CCl4. 
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Figure 3.8: Oxygen-uptake rates by 6a in CCl4 with increasing amount of CH3OH (left), CD3OD (right). 
 
(b) Since the addition of methanol or methanol-D4 (hydrogen bond acceptors and donors) 
decrease the steering effect of the substrate hydroxy group by intermolecular hydrogen 
bonding, lower diastereoselectivities were observed with increasing the amount of these 
solvents.  
(c) Since the hydrogen bonding is expected to play a decisive factor in controlling the 
diastereoselectivity, we expect that it can be influenced by H- versus D-bonding interactions. 
From the Figure 3.9 we can see that the diastereoselectivities in the presence of deuterated 
methanol is always lower than in the presence of non-deuterated methanol, this is also 
indicated by comparison of the diastereoselectivities in pure tetrachloromethan versus CH3OH 
and CD3OD (Scheme 3.31). This derives from competitive solvent-induced deactivation of 
the hydrogen bonding of the allylic hydroxy group with 1O2 by the more effective OD versus 
OH bonding.145 
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Figure 3.9: Solvent dependence of the syn/anti ratio 
 in the singlet oxygen ene reaction with 6a. 
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Scheme 3.31: Ene reaction of 6a: solvent effect on syn/anti-diastereoselectivity. 
 
 
3.7 Synthesis of 1,2,4-Trioxanes 
 
For the synthesis of the 1,2,4-trioxane skeleton, a Lewis-acid catalyzed peroxyacetalization 
reaction of β-hydroperoxy alcohols with carbonyl compounds was developed (Scheme 3.32).  
 
O
O
O
O
OH
OHR2
R1
R1
R2O
 
Scheme 3.32 
 
This approach is especially attractive since sensitizer-free β-hydroperoxy alcohols are 
available by our convenient solvent-free 1O2-photooxygenation reaction of the easily 
accessible allylic alcohols as substrates. Furthermore, this way enables the introduction of 
different functional groups at the level of the nonperoxidic starting materials. Catalytic 
amounts of borontrifluoride etherate in dry CH2Cl2 or dry Et2O as solvent turned out to be the 
optimal condition for efficient condensation reaction of the vic-hydroxy hydroperoxides with 
aldehydes, ketones, acetals and orthoesters resulting in the formation of wide variety of the 
target 1,2,4-trioxanes. BF3 is not only advantageous by its catalytic efficiency but also it can 
be easily removed in the work-up step and it tolerates the labile peroxidic linkage. Using the 
intermolecular peroxyacetalization reaction we were able to vary the substituents at C-3 and 
C-5 in the 1,2,4-trioxane unit. Since all the β-hydroxy hydroperoxides are synthesized as 
racemic mixtures, all the 1,2,4-trioxanes derived from them are also racemic mixtures. 
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3.7.1 Derived from 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol 
 
3.7.1.1 By peroxyacetalization reaction with symmetric ketones 
 
The BF3-catalyzed peroxyacetalization reaction of the vic-hydroperoxy alcohol 7p with 
different symmetric ketones in CH2Cl2 resulted in the formation of the corresponding 1,2,4-
trioxanes 38-41 (Scheme 3.33, Table 3.11). Thin layer chromatography revealed the 
disappearance of the spot corresponding to the hydroperoxy alcohol starting material and the 
appearance of a new spot with higher Rf-value (indicating a less polar product). The products 
were chromatographically purified and their chemical structures were confirmed by 1H- as 
well as 13C-NMR, elemental analysis, IR, mass spectrometry and X-ray analysis.  
 
OH
OOH
BF3.Et2O / CH2Cl2
R R
O
O O
O R
7p 38-41
R
 
Scheme 3.33 
 
OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
38 adamantane 3.33 73.0 4.38 87.9 105.0 7 
39 (CH2)2CO(CH2)2 3.30 74.6 4.43 87.6 101.1 17 
40 CH3 CH3 3.24 74.8 4.35 87.4 102.6 41 
41 Et Et 3.28 73.4 4.33 87.2 105.8 10 
Table 3.11: Characteristic signals of 38-41 in 1H- and 13C-NMR (in CDCl3). 
 
As representative example, compound 38 shows in 1H-NMR two highly up-field multiplets (δ 
= 0.40, 0.78 ppm) corresponding to the two methylene and the methine protons of the 
cyclopropyl group, respectively. The signals related to the adamantane protons are found as 
broad multiplet at δ = 1.50-2.19 ppm. Surprisingly, one of the protons of the adamantane 
residue is more deshielded by the effect of the ring oxygen atoms and consequently resonates 
more downfield as a broad signal (at about 2.82 ppm). The previous behavior was observed 
for all synthesized 1,2,4-trioxanes possessing adamantane subunit (Figure 3.10). A multiplet 
with small coupling constants absorbs at 1.79 ppm that corresponds to the methyl of the 
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isopropenyl group. The splitting of this methyl group is ascribed to the allylic coupling (4JHH) 
with the protons of the olefinic methylene group (a behavior often seen in the prepared 
trioxanes). The proton of the peroxy carbon (H-6) resonates at 4.38 ppm with doublet 
multiplicity (3JHH = 9.40 Hz) due to vicinal coupling with the neighbouring H-5. The doublet 
of doublet at 3.33 ppm is related to H-5 that couples with H-6 (3JHH = 9.40 Hz) and with the 
CH proton of the cyclopropyl group (3JHH = 7.35 Hz). The olefinic signal is absorbing at 5.04 
ppm as multiplet due to the small olefinic geminal coupling as well as the allylic coupling 
(4JHH) with the methyl group. In 13C-NMR the peroxyacetal carbon (OOCO or C-3) represent 
the most characteristic signal used to confirm the formation of the 1,2,4-trioxane unit (Figure 
3.10). Complete assignment of the carbon atoms and their multiplicity was confirmed by 
DEPT as well as 2D-NMR experiments. The most characteristic signals of the products 38-41 
in 1H- and 13C-NMR are summarized in Table 3.11. 
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Figure 3.10: 1H- and 13C-NMR spectrum of 38. 
 
From the IR spectrum, the absence of the broad band corresponding to the OH groups 
(between 3200 and 3600 cm-1) is an indication for the peroxyacetalization reaction and 
disappearance of the vic-hydroperoxy alcohol starting material. Some of the characteristic IR 
bands (in cm-1) of the 1,2,4-trioxane 38 are at 3079 (olefinic CH), 2931 (aliphatic CH), 1653 
(isolated C=C), 1112, 1079, 1025 (C-O) and 926, 910 (O-O). The peaks obtained in the mass 
spectrum of compound 38 are depicted in Scheme 3.34. 
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Scheme 3.34: Fragmentation pattern of 38. 
 
The relative configuration of compound 38 was unambiguously established by X-ray analysis 
(Figure 3.11). 
 
 
 
 
 
 
 
Figure 3.11: X-ray structure of 38. 
 
The Karplus equation146 was also used to deduce the relative configurations of the synthesized 
1,2,4-trioxanes. According to Karplus, the vicinal coupling constant (3J) between two trans-
diaxial vicinal protons (having a dihedral angle in the vicinity of 180°) is expected to be in the 
range 9-12 Hz (Figure 3.12). Obviously, the two protons on C-5 and C-6 in 38 have a trans-
diaxial orientation with calculated coupling constant of 9.4 Hz. By analogy, since the other 
1,2,4-trioxanes show similar coupling constants, they must adopt the same configuration at 
the C-5,C-6 bond i.e. trans-diaxial configuration. It is also noteworthy to mention that that 
formation of the trans configuration is also expected since it comes from the major syn-
hydroperoxy alcohol. In all cases, no cis-1,2,4-trioxanes (that may arise from the reaction 
with the minor anti-hydroxy allylic hydroperoxide) were observed in the purified product. 
O
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Figure 3.12 
 
3.7.1.2 By peroxyacetalization reaction with asymmetric ketones 
 
The use of asymmetric ketones for the condensation reaction with hydroperoxy alcohols leads 
to the formation of a third stereogenic center at C-3. As an example, the peroxyacetalization 
of 7p with 2-butanone resulted in a 72:28 mixture of diastereomeric 1,2,4-trioxanes 42a and 
42b, respectively (Scheme 3.35). The formation of 42a and 42b was proven by the presence 
of the peroxyacetal carbon resonating at 103.9, 104.9 ppm in 13C-NMR. Table 3.12 
summarizes the main differences in 1H- and 13C-NMR characteristic signals for 42a and 42b. 
Both 1,2,4-trioxanes have a 5,6-trans configuration since the coupling constant between the 
protons on C-5 and C-6 in both cases is 9.4 Hz, which is consistent value with a dihedral 
angle near to 180°. The major diastereomer is assumed to be 42a since it is the more 
thermodynamically stable isomer having the ethyl group in equatorial position.  
 
OH
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BF3.Et2O / CH2Cl2
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O O
O
O O
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7p 42a 42b  
Scheme 3.35 
 
OCH OOCH OCOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
42a 3.34 73.6 4.31 87.6 103.9 
42b 3.16 74.5 4.34 87.1 104.9 
62 
Table 3.12: Characteristic signals of 42a and 42b in 1H- and 13C-NMR (in CDCl3) 
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3.7.1.3 By peroxyacetalization reaction with aldehydes 
 
OH
OOH
O O
O
H
O
BF3.Et2O / CH2Cl2
7p 43  
Scheme 3.36 
 
The peroxyacetalization reaction of 7p with 2-naphthaldehyde afforded the 1,2,4-trioxane 43 
in moderate yield (Scheme 3.36). The chemical structure of 43 is based on NMR, IR, 
elemental analyses and HRMS. The IR spectrum shows the absorption bands at 3088 cm-1 
(vinylic CH), 2968 cm-1 (aliphatic CH), 1647 cm-1 (isolated C=C), 1603 cm-1 (aromatic C=C); 
1126, 1071 cm-1 (C-O), 904, 859 cm-1 (O-O). The proton of the peroxyacetal carbon appears 
in 1H-NMR as singlet at 6.31 ppm, whereas this carbon appears in 13C-NMR at 104.0 ppm. 
The all-equatorial relative configuration of 43 at C-3, C-5 and C-6 was undoubtedly assigned 
by X-ray analysis (Figure 3.13). The protons H-5 and H-6 show a trans diaxial-configuration 
(3JHH = 9.1 Hz) and the 2-naphthyl substituent is located as expected in an equatorial position 
(thermodynamically favored) cis to the cyclopropyl group. 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: X-ray structure of 43. 
 
3.7.1.4 By peroxyacetalization reaction with acetals 
 
The peroxyacetalization reaction with acetals is highly advantageous over using the 
corresponding aliphatic aldehydes since in the latter case trimerization of the aldehydes to 
1,3,5-trioxanes is a competing reaction (vide infra). 
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Treatment of 7p with acetaldehyde diethylacetal or propionaldehyde diethylacetal afforded in 
each case three 1,2,4-trioxanes as estimated by the presence of sets of three signals in 13C-
NMR for almost all characteristic carbons in both reaction (Scheme 3.37, Table 3.13). 
 
OH
OOH
O O
O R
O O
O R+
OEt
OEt
R
O O
O R
BF3.Et2O / CH2Cl2
+
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Scheme 3.37 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
44a CH3 3.03 80.6 4.39 87.3 5.26 101.1 
44b,c CH3 3.10[a] 78.7/81.4 4.05[a] 83.5/84.0 5.67[a] 95.9/101.4 
26 
45a Et 3.08 80.3 4.41 87.6 5.08 105.1 
45b,c Et 3.10[a] 78.6/81.4 4.07[a] 83.8/84.3 5.48[a] 99.9/105.4 
21 
Table 3.13: Characteristic signals of 44a-c and 45a-c in 1H- and 13C-NMR (in CDCl3). 
 [a] Both diasetereomers have the same chemical shift. 
 
Elucidation of the relative configuration of the representative example 45a,b,c by 1H-NMR 
revealed the presence of two characteristic doublets related to H-6 due to vicinal coupling 
with H-5. The doublet corresponding to the major product has a coupling constant of 9.1 Hz 
indicating a trans-diaxial orientation of the H-5, H-6 protons, hence assigning 45a as the 
major product. Clearly, the most stable conformation of 45a has all substituents in equatorial 
positions. On the other hand, the doublet corresponding to the minor isomer has a coupling 
constant of 3.84 Hz indicating cis-relationship with dihedral angle of about 60°. Two 
configurations of the minor products (cis-1,2,4-trioxanes) are possible, 45b and 45c. Both 
show identical chemical shifts in 1H-NMR and can be only distinguished in the 13C-NMR. In 
both cases, the most stable conformation of this configuration should have the alkyl group on 
C-3 in the equatorial position. It is also noteworthy to mention that due to the presence of the 
oxygen atoms in the ring, compounds 44c / 45c with no 1,3-diaxial interaction are expected to 
be more stable than 44b / 45b with one destabilizing 1,3-diaxial interaction. Compound 44a 
represents about 92 % and 45a represents about 87 % of the product mixtures. 
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3.7.2 Derived from 1-cyclohexyl-2-hydroperoxy-3-methylbut-3-en-1-ol  
 
3.7.2.1 By peroxyacetalization reaction with aldehydes 
 
Combination of 2-naphthaldehyde with the hydroperoxy alcohol 7q in CH2Cl2 and in the 
presence of catalytic amount of BF3 led to the formation of the 1,2,4-trioxane 46 (Scheme 
3.38). Assignment of structure of 46 was proven by 1H- as well as 13C-NMR, IR, elemental 
analyses and HRMS. 
 
OH
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H
O
O O
O
BF3.Et2O / CH2Cl2
7q 46  
Scheme 3.38 
 
The IR spectrum shows the characteristic signals of the aliphatic CH at 2933 cm-1, isolated 
C=C at 1653 cm-1, aromatic C=C at 1605 cm-1, C-O stretching at 1112, 1074 cm-1, O-O at 
906, 822 cm-1. The 1H-NMR shows the characteristic singlet at 6.38 ppm corresponding to the 
peroxyacetal proton (H-3) and the doublet at 4.87 ppm related to the peroxy proton (H-6) due 
to coupling with H-5 (3JHH = 9.5 Hz) indicating trans configuration. Surprisingly, H-5 appears 
also as doublet (and not doublet of doublet as expected) this can be ascribed to a dihedral 
angle in the vicinity of 90° between this proton and the CH proton of the cyclohexyl group 
leading to no coupling between them (Figure 3.14). The 2-naphthyl group is located in 
equatorial position as confirmed by X-ray for the analogous examples. The mass 
fragmentation pattern of 46 is depicted in Scheme 3.39. 
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Figure 3.14: 1H- and 13C-NMR spectrum of 46. 
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Scheme 3.39: Fragmentation pattern of 46. 
 
3.7.2.2 By peroxyacetalization reaction with symmetric ketones 
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Using adamantanone instead of 2-naphthaldehyde afforded two different 1,2,4-trioxanes 
(Scheme 3.40). The expected product 47 is formed by the usual condensation reaction 
whereas the product 48 is formed by another mechanism and does not involve the 
adamantanone moiety. Both 1,2,4-trioxanes show a trans configuration as estimated from the 
3JHH coupling constant between H-5 and H-6 (9.9, 9.5 Hz for 47, 48, respectively). Again, for 
both trioxanes, H-5 exhibits no coupling with the neighboring CH group of the cyclohexyl 
group and hence appears as doublet. The formation of compound 48 is ascribed to Lewis-acid 
catalyzed partial fragmentation reaction of the vic-hydroxy allylic hydroperoxides 7p 
resulting in the corresponding carbonyl components which subsequently condense with the 
rest of 7p to yield 48. This behavior of the hydroperoxy alcohols will be discussed separately 
in details using different substrates. 
 
3.7.3 Derived from 3-hydroperoxy-2-methyloct-1-en-4-ol 
 
3.7.3.1 By peroxyacetalization reaction with aldehydes 
 
Different 1,2,4-trioxanes were synthesized in yields between 29-48 % from the condensation 
reaction of the β-hydroxy allylic hydroperoxide 7g with aldehydes (Scheme 3.41). In all 
cases, only the 5,6-trans isomer having the aryl group on C-3 in equatorial position is formed. 
Full characterization of all the synthesized compounds 49-51 was achieved by IR, NMR, 
elemental analyses, mass spectrometry and HRMS. The significant signals observed in 1H- 
and 13C-NMR are summarized in Table 3.14. 
 
OH
OOH
O O
On-Bu R
BF3.Et2O / CH2Cl2
49- 517g
R H
O
 
Scheme 3.41 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
49 β-naphthyl 4.01 77.4 4.64 87.7 6.41 104.1 43 
50 2-Br-C6H4 3.88 77.5 4.48 87.7 6.42 103.1 29 
51 Ph 3.92 77.3 4.54 87.6 6.22 104.0 48 
Table 3.14: Characteristic signals of 49-51 in 1H- and 13C-NMR (in CDCl3). 
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As an example (Scheme 3.42), compound 50 shows the characteristic singlet signal at 6.42 
ppm in 1H-NMR which is related to the proton on the peroxyacetal carbon (H-3). The 
peroxyacetal carbon (C-3) absorbs at 103.1 ppm confirming the formation of the 1,2,4-
trioxane structure. The IR spectrum is also consistent with the structure of 50, the most 
significant absorption bands are found at 3078 cm-1 (aromatic CH), 2955 cm-1 (aliphatic CH), 
1651 cm-1 (isolated C=C), 1570 cm-1 (conjugated C=C), 1125, 1081, 1025, 1000 cm-1 (C-O) 
and 948, 911 cm-1 (O-O).  
 
OH
OOH BF3.Et2O / CH2Cl2
O O
On-Bu
H
O
507g
Br
Br
 
Scheme 3.42 
 
The molecular ion peak in the mass spectrum of the 1,2,4-trioxane 50 is not observed and 
fragments spontaneously to smaller fragments. A plausible fragmentation pattern of 50 
showing the isotopic effect of the bromine atom is depicted in Scheme 3.43. 
 
O
O
O
m/z = 340 / 342
a / b
a / d
H
O
m/z = 184 / 186
(a)
m/z = 183 / 185
-H
O
- CO
m/z = 155 / 157
b / d
m/z = 254 / 256
O
O
m/z =124
(b) - n-Bu-CHO
c(c)
H
H
Br
Br
m/z =95
H
H
- Et
Br Br
Br
(d)
O
-H
m/z = 69
m/z = 76
-Br
m/z =50
HC CH
 
Scheme 3.43: Mass fragmentation pattern of 50. 
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3.7.3.2 By peroxyacetalization reaction with ketones 
 
OH
OOH BF3.Et2O / CH2Cl2
O
O O
On-Bu
527g  
Scheme 3.44 
 
The 1,2,4-trioxane 52 with trans configuration is formed on treating 7g with adamantanone 
(Scheme 3.44). Elucidation of the structure was based on 1H- and 13C-NMR analyses. The 
relative configuration is based on the vicinal coupling constant between H-5 and H-6 (vide 
supra). 
 
3.7.3.3 By peroxyacetalization reaction with acetals 
 
Treatment of the hydroperoxy homoallylic alcohol 7g with acetals affords the corresponding 
all-equatorial 1,2,4-trioxanes stereoisomers 53, 54 (Scheme 3.45). Elucidation of the structure 
is based as before on spectroscopic data (IR, 1H- and 13C-NMR). The chemical shifts of the 
three CH groups of the trioxane ring are depicted in Table 3.15. The NMR of 53 is 
represented in Figure 3.15. 
 
OH
OOH
O O
On-Bu R
OEt
OEt
R
BF3.Et2O / CH2Cl2
53 / 547g  
Scheme 3.45 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
53 CH3 3.65 76.8 4.33 87.4 5.36 101.5 26 
54 Et 3.65 76.7 4.32 87.7 5.16 105.5 26 
Table 3.15: Characteristic signals of 53 and 54 in 1H- and 13C-NMR (in CDCl3). 
 
 
3. Results & Discussion 
66 
0
.
9
9
1
9
2
.
0
8
5
0
1
.
0
0
0
0
0
.
9
6
5
4
3
.
1
3
7
4
9
.
2
1
6
2
3
.
5
8
6
4
I
n
t
e
g
r
a
l
5
.
3
8
3
7
5
.
3
6
5
5
5
.
3
4
7
9
5
.
3
2
9
8
5
.
0
5
9
9
5
.
0
5
5
5
5
.
0
5
0
6
4
.
3
4
1
4
4
.
3
1
0
5
3
.
6
8
8
0
3
.
6
6
4
0
3
.
6
5
7
6
3
.
6
5
1
3
3
.
6
2
0
4
1
.
7
0
9
7
1
.
7
0
4
8
1
.
7
0
0
9
1
.
4
1
8
8
1
.
4
1
1
4
1
.
4
0
6
5
1
.
3
9
9
2
1
.
3
8
6
4
1
.
2
7
1
8
1
.
2
5
3
7
0
.
8
9
2
2
0
.
8
6
8
7
0
.
8
4
4
2
( p p m)
0 . 40 . 81 . 21 . 62 . 02 . 42 . 83 . 23 . 64 . 04 . 44 . 85 . 25 . 6
1
3
8
.
7
8
5
0
1
1
8
.
3
0
9
7
1
0
1
.
5
4
8
4
8
7
.
4
4
6
5
7
6
.
7
5
8
3
3
0
.
1
3
0
1
2
7
.
0
3
8
7
2
2
.
5
7
7
3
1
9
.
6
8
3
7
1
7
.
8
8
8
9
1
3
.
9
1
8
3
( p p m)
1 02 03 04 05 06 07 08 09 01 0 01 1 01 2 01 3 01 4 01 5 0
Figure 3.15: 1H- and 13C-NMR spectra of 53. 
 
3.7.4 Derived from 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol  
 
3.7.4.1 By peroxyacetalization reaction with aldehydes 
 
The BF3-catalyzed peroxyacetalization reaction of the vic-hydroxy allylic hydroperoxide 7h 
with benzaldehydes or 2-naphthaldehyde affords the 1,2,4-trioxanes 55 and 56, respectively 
(Scheme 3.46). Both compounds are fully characterized by 1H-, 13C-NMR, IR, elemental 
analyses as well as mass spectrometry. The introduction of the naphthyl group in the trioxane 
moiety is of special relevance since it is the carbocyclic analogue of quinoline which is the 
effective antimalaria pharmacophore in the quinoline drugs (as chloroquine, mefloquine and 
amodiaquine). 
 
OH
OOH BF3.Et2O / CH2Cl2
55 / 567h
R H
O
O O
O R
 
Scheme 3.46 
 
As a representative example, compound 55 shows in 1H-NMR a signal (ddd) at 4.0 ppm 
corresponding to H-5 that couples with the two diastereotopic methylene protons of the i-Bu 
group (3JHH = 2.34, 12.04 Hz) as well as with H-6. The two diastereotopic methylene protons 
absorb expectedly as multiplets at different chemical shifts (1.25, 1.57 ppm). The proton H-6 
couples only with H-5 and appears as doublet at 4.51 ppm. The coupling constant between H-
5 and H-6 was found to be 9.24 Hz accounting for the trans configuration of the trioxane. 
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Both the singlet signal at 6.22 ppm in 1H-NMR (attributed to H-3) and that corresponding to 
the C-3 in 13C-NMR (absorbing at 103.9 ppm) undoubtedly confirm the formation of the 
1,2,4-trioxane. Interestingly, in all the 1,2,4-trioxanes possessing i-Bu group the methylene 
carbons are shifted more downfield (at about 39 ppm) with respect to the methine carbons (at 
about 23 ppm) of the i-Bu group. For both compounds 55 and 56 only one diastereomer was 
detected with the substituents on C-3 and C-5 are cis to each other. The NMR characteristic 
signals for 55 and 56 and the spectra corresponding to 55 are shown in Table 3.16 and Figure 
3.16. 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
55 Ph 4.0 75.6 4.51 88.1 6.22 103.9 20 
56 β-naphthyl 4.12 75.6 4.65 88.0 6.45 104.0 21 
Table 3.16: Characteristic signals of 55 and 56 in 1H- and 13C-NMR (in CDCl3). 
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Figure 3.16: 1H- and 13C-NMR spectra of 55. 
 
The mass spectrum of 55 shows no molecular ion peak, with the formation of the fragment at 
m/z 105 as the base peak. Plausible fragmentation patterns for the peaks obtained from 55 and 
56 are depicted in Schemes 3.47, 3.48, respectively. 
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O
O
O
m/z =262
H
O
m/z =106 m/z = 105
-H
O
- CO
m/z = 77m/z =51
- C2H2
 
Scheme 3.47: Fragmentation pattern of 55. 
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O
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m/z = 312
a / b
a
H
O
m/z = 156
(a)
m/z = 155
-H
O
- CO
m/z = 127
- CO
m/z = 128
b
m/z = 226
O
O
m/z =124
(b) - i-Bu-CHO
c
(c)
H
H
c
 
Scheme 3.48: Fragmentation pattern of 56. 
 
Using 2-chlorobenzaldehyde as the carbonyl component afforded a diastereomeric mixture of 
the two 1,2,4-trioxanes 57a and 57b in a 88:12 ratio, respectively (Scheme 3.49). The major 
isomer was assigned as explained before. Surprisingly, the 1H-NMR of the minor 
diastereomer shows a strong upfield shift of the doublet signal corresponding to H-6 with 
respect to the multiplet signal corresponding to H-5 which is be attributed to the ring current 
effect of the aryl group on this proton in this configuration (Table 3.17).  
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OH
OOH
O O
Oi-Bu
H
O
Cl
Cl
BF3.Et2O / CH2Cl2
+
7h 57a 57b
O O
Oi-Bu
Cl
 
Scheme 3.49 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
57a 2-Cl-C6H4 3.96 75.9 4.44 88.2 6.46 101.0 
57b 2-Cl-C6H4 4.30 75.6 4.06 85.1 6.50 101.4 
19 
Table 3.17: Characteristic signals of 57a,b in 1H- and 13C-NMR (in CDCl3). 
 
The fact that the coupling constant between H-5 and H-6 in the minor diastereoisomer is 3.8 
Hz indicates according to Karplus curve a dihedral angle in the vicinity of 60° and 
consequently a cis relationship between these protons. However, two configurations A and B 
may fulfill this arrangement (Figure 3.17).  
 
O O
OH
H
3.82 Hz
35
6
Cl
O O
OH
H
35
6
Cl
3.82 Hz i-Pr
A B
H H
i-Pr
 1,3-diaxial
 interaction
 
Figure 3.17 
 
Based on NOE measurements (Figure 3.19), saturation of H-5 results in clear enhancement in 
the signal intensity of peroxyacetal proton (H-3) indicating a spatial proximity (cis 
relationship) between them, hence the configuration of the minor diastereomer is B (having 
the isopropenyl group axial, i-Bu and 2-chlorophenyl groups in equatorial positions as the 
most stable conformation of this configuration) and not A. This is further supported by the 
fact that configuration B exhibits no 1,3-diaxial interactions (due to the presence of the 
oxygen atoms in the ring) and thus is expected to be more stable than A which suffers from 
this destabilizing interaction. The destabilization effect due to 1,3-diaxial interaction in A is 
expected to be even more pronounced (i.e. the compound is less stable) than in the 
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corresponding carbocyclic analogue C (Figure 3.18) due to the shorter C-O bond length 
(about 1.42 Å) compared to the C-C bond (about 1.53 Å).147,149 
 
H
H
35
6
Cl
H
i-Pr
 1,3-diaxial
 interaction
C  
Figure 3.18 
 
Also, the significant down-field shift of the signal corresponding to the isopropenyl methyl 
group in the minor diastereomer (δ = 2.02 ppm) indicates that this group is located in a spatial 
proximity to the ring proxidic oxygen atoms which is also consistent with the configuration B 
rather than A. 
 
H-5H-3
( p p m)
0 . 51 . 01 . 52 . 02 . 53 . 03 . 54 . 04 . 55 . 05 . 56 . 06 . 5
O O
OHi-Bu
ClH H
 
Figure 3.19: 1D-NOE experiment of 57b. 
 
3.7.4.2 By peroxyacetalization reaction with symmetric ketones 
 
The Lewis-acid catalyzed condensation of 7h with adamantanone, cyclohexanone, 
cyclopentanone, acetone and 4-heptanone in CH2Cl2 furnished the 1,2,4-trioxanes 58-62 in 
10-48 % yields (Scheme 3.50, Table 3.18). 
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OH
OOH
BF3.Et2O / CH2Cl2
R R
O
O O
O R
7h 58-62
R
 
Scheme 3.50 
 
OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
58 adamantane 3.99 66.6 4.20 87.8 104.7 10 
59 (CH2)5 3.98 67.2 4.22 88.0 102.8 48 
60 (CH2)4 3.85 70.1 4.29 87.9 114.7 11 
61 CH3 CH3 3.93 68.0 4.17 87.8 102.6 33 
62 n-Pr n-Pr 3.95 67.4 4.17 87.8 105.6 18 
Table 3.18: Characteristic signals of 58-62 in 1H- and 13C-NMR (in CDCl3). 
 
 
All the trioxanes 58-62 showed a vicinal coupling constant between C-5 and C-6 in the range 
of 9.4-9.6 Hz which confirms the trans configuration. As a representative example, the 
chemical structure of compound 58 was confirmed by 1H,1H-COSY and HMQC (Figure 
3.20, 3.21). Clearly, the broad downfield signal at 2.91 ppm belongs to the adamantane 
subunit. Three off diagonal cross peaks correspond to H-5 due to coupling with the two 
diastereotopic methylene protons of the isobutyl group and with H-6. The proton H-6 has only 
one off diagonal cross peak due to coupling with H-5. The allylic coupling between the 
olefinic methylene protons with the methyl of the isopropenyl group can be also seen. The 
cross peaks in HMQC correlates the proton signals with the signals of the carbons directly 
attached to them (1J coupling). 
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Figure 3.20: 1H,1H-COSY of 58. 
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Figure 3.21: HMQC of 58. 
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The stereochemical assignment for 58 is further supported by a NOESY experiment showing 
off diagonal cross peaks between protons of spatial proximity. The key NOEs are indicated by 
double headed arrows (Figure 3.22). The X-ray analysis is a definite proof of the relative 
configuration of this compound (Figure 3.23). 
 
O
O
O
H
H
H
H
H
H
H
 
Figure 3.22: NOESY of 58. 
 
 
 
 
 
 
 
 
 
 
Figure 3.23: X-ray structure of 58. 
O
O
O
H
H
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3.7.4.3 By peroxyacetalization reaction with asymmetric ketones 
 
Two asymmetric ketones were used in this study, 3,3-dimethyl-2-butanone and 2-butanone. In 
the former case (Scheme 3.51), the trioxanes 63 and 129c were obtained in 89:11 ratio. 
Compound 63 was proven to have the trans configuration as discussed before with the 
anchoring t-Bu group is in an equatorial position. The formation of compound 129c is 
attributed to the observed Lewis-acid catalyzed fragmentation of β-hydroperoxy alcohols / 
cross-peroxyacetalization sequence (vide infra). 
 
OH
OOH
O O
O
O
O O
O+
BF3.Et2O / CH2Cl2
7h 63 129c  
Scheme 3.51 
 
In the second reaction using 2-butanone a complex mixture of products was obtained in 52 % 
yield (Scheme 3.52). The formation of the trioxanes 64a-d was estimated from the presence 
of four signals corresponding to the peroxycarbon (C-6) and four signals corresponding to C-
5. in the 13C-NMR of the product mixture (Table 3.19). Coupling constant measurements 
revealed that the thermodynamically most stable trioxane 64a with trans configuration and 
having an equatorial ethyl group at C-3 is the major product constituting about 85 % of the 
product mixture. 
 
OH
OOH
O O
O R1
O
BF3.Et2O / CH2Cl2
7h 64a,b 64c,d
+
R2
O O
O R1
R2
 
Scheme 3.52 
 
OCH OOCH OCOO 
No. R1 R2 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
64a Et CH3 3.96 67.9 4.17 88.0 104.0 
64b CH3 Et 3.89 67.6 4.10 87.6 105.0 
64c Et CH3 3.83 68.8 4.24 94.1 [a] 
64d CH3 Et [a] 68.6 [a] 92.1 [a] 
 
52 
Table 3.19: Characteristic signals of 64a-d in 1H- and 13C-NMR (in CDCl3). 
[a] The signal is overlapping. 
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The diminished tendency for a t-Bu group to adopt an axial position in the 1,2,4-trioxane 
moiety (due to severe 1,3-diaxial interaction) led to the fact that no products analogous to 
64b,d in case of using pinacolone as the carbonyl component were formed. 
 
3.7.4.4 By peroxyacetalization reaction with acetals 
 
OH
OOH
O O
Oi-Bu
OEt
OEt
BF3.Et2O / CH2Cl2
657g  
Scheme 3.53 
 
Using propionaldehyde diethylacetal for the condensation reaction furnished the trioxane 65 
in 50 % (Scheme 3.53). The characteristic signal of proton of the peroxyacetal carbon 
resonates in 1H-NMR at 5.14 ppm as triplet (actually doublet of doublet with identical 
coupling constants of 5.58 Hz) due to coupling with the two diastereotopic protons of the 
ethyl group. This carbon is also absorbing in the 13C-NMR at 105.5 ppm confirming the 
formation of 65. Similar to the products obtained from the condensation reaction with 
aldehydes, the trioxane 65 has a trans configuration with equatorial ethyl group at the 
peroxyacetal carbon. 
 
3.7.5 Derived from 4-hydroperoxy-2,2,5-trimethylhex-5-en-3-ol  
 
3.7.5.1 By Peroxyacetalization Reaction with Ketones 
 
In contrast to the peroxyacetalization reaction of the hydroperoxy homoallylic alcohol 7j with 
cyclopentanone or cyclohexanone furnishing in each case only one 1,2,4-trioxane 
diastereomer 66, 67, respectively (Scheme 3.54, Table 3.20), carrying out the condensation 
reaction with 2-adamantanone results in a 84:16 mixture of two trioxane diastereomers 68a,b 
(Scheme 3.55). 
OH
OOH
BF3.Et2O / CH2Cl2
R R
O
O O
O R
7j 66 / 67
R
 
Scheme 3.54 
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Ot-Bu
7j 68a 68b
+
 
Scheme 3.55 
 
OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
66 (CH2)4 3.57 77.7 4.90 85.8 114.3 8 
67 (CH2)5 3.67 74.9 4.43 85.8 102.4 11 
68a 3.70 74.4 4.43 85.5 104.3 
68b 
2-adamantan 
3.63 63.4 4.83 89.0 102.4 
12 
Table 3.20: Characteristic signals of 66-68 in 1H- and 13C-NMR (in CDCl3). 
 
Compounds 66, 67, 68a showed coupling constants between H-5 and H-6 of 9.7 Hz which, 
according to the Karplus curve, is consistent with a dihedral angle around 180° supporting 
that these compounds have the trans configuration. On the other hand, the coupling constant 
between H-5 and H-6 in the minor diastereoisomer 68b is about 3.40 Hz which is indicative 
of a dihedral angle in the vicinity of 60° and consequently a cis relationship between these 
protons. Two conformations A and B can be suggested for the minor configuration (Figure 
3.24). 
 
O O
OH
H
3.40 Hz
5
6
O O
OH
H
5
6
3.40 Hz
A B  
Figure 3.24: Two suggested conformations for the minor diastereomer 68b. 
 
Based on NOE measurements, double irradiation of H-5 of the minor diastereomer resulted in 
enhancement in the signals corresponding to H-6, the adamantane residue and the t-Bu group 
indicating a spatial proximity between the protons of these groups with H-5 (Figure 3.25). 
Hence, the minor diastereomer adopts the A conformation (having the isopropenyl group in 
axial and the t-Bu group in equatorial positions) and not B. Also, the absence of any 
3. Results & Discussion 
77 
enhancement in the adamantane signals under saturation of the protons of the t-Bu group of 
the minor diastereomer clearly excludes the conformation B. This result is in agreement with 
the expectation since the conformation B is highly disfavored by a severe 1,3-diaxial 
interaction between the bulky t-Bu group with the adamantane residue. Also, the high 
propensity of the t-Bu group to anchor in an equatorial position prefers the formation of A 
rather than B. 
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      (CH)
O O
Ot-Bu
H
H
 
Figure 3.25: 1D-NOE experiment of 68b. 
 
The relative configuration of 66 was also established by NOESY experiment showing off 
diagonal cross peaks for the protons in spatial proximity. The key NOEs are represented by 
double headed arrows (Figure 3.26). 
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Figure 3.26: NOESY experiment of 66. 
 
3.7.6 Derived from 3-hydroperoxy-2,5-dimethylhept-1-en-4-ol 
 
3.7.6.1 By peroxyacetalization reaction with ketones 
 
Condensation of adamantanone with the two diastereomeric mixtures of the β-hydroperoxy 
alcohol 7i furnished a 1:1 diastereomeric mixture of the spiro-fused 1,2,4-trioxanes 69a,b 
(Scheme 3.56). Both products are undistinguishable by 1H-NMR. In 13C-NMR sets of twin 
signals for most of the carbon atoms could be observed. For example the two signals 
corresponding to C-5 and C-6 for each diastereomer are shown in Table 3.21. The chemical 
structure of the trioxanes was based on NMR, IR and elemental analyses. The characteristic 
absorption bands in the IR spectrum are stretching at 3081; 2914; 1648; 1109, 1096, 1024; 
925, 908 cm-1 corresponding to the vinylic CH, aliphatic CH, nonconjugated C=C, C-O and 
O-O, respectively. The relative configuration was assigned as trans by the vicinal coupling 
constant between H-5 and H-6 which was found to be 9.54 Hz indicating a dihedral angle of 
180°. 
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O
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OOH
OH
OOH
7i 69a 69b  
Scheme 3.56 
 
OCH OOCH OCOO 
No. 
1H-NMR 13C-NMR 1H-NMR 13C-NMR 13C-NMR 
 
Yield 
(%) 
69a,b 3.83[a] 68.6/69.1 4.22[a] 87.6/87.7 104.7[a] 20 
Table 3.21: Characteristic signals of 69a,b in 1H- and 13C-NMR (in CDCl3). 
[a] Both diastereomers have the same chemical shift. 
 
3.7.6.2 By peroxyacetalization reaction with aldehydes 
 
Similarly, the reaction with 2-naphthaldehyde afforded the two diastereomeric 1,2,4-trioxanes 
70a,b in 17 % yield. Also, both compounds show a trans configuration having the 
substituents at C-3 and C-5 cis to each other (Scheme 3.57). The most characteristic signals 
for both diastereomers are summarized in Table 3.22. 
 
O O
O
O O
O
H
O
BF3.Et2O / CH2Cl2
+
OH
OOH
OH
OOH
7i
70a
70b  
Scheme 3.57 
 
OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
70a,b 3.98 77.6 4.62 87.7 6.39 104.1 17 
Table 3.22: Characteristic signals of 70a,b in 1H- and 13C-NMR (in CDCl3). 
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3.7.7 Derived from 3-hydroperoxy-2-methylhept-1-en-4-ol  
 
3.7.7.1 By peroxyacetalization reaction with ketones 
 
The 1,2,4-trioxanes 71-75 were synthesized in 14-49 % yields by BF3-catalyzed condensation 
reaction of adamantanone, cycloheptanone, cyclohexanone, cyclopentanone and 3-pentanone 
with 7d (Scheme 3.58). The characteristic signals for each product are summarized in Table 
3.23. All the isolated products were formed as one diastereomer (trans at C-5 and C-6) that 
were fully characterized by spectroscopic and analytical methods as well as mass 
spectrometry. Compound 74 showed a remarkable downfield shift of the peroxyacetal carbon 
in 13C-NMR (this behavior was also observed for all 1,2,4-trioxanes involving 
cyclopentanone subunit). Also, for all the synthesized monocyclic and polycyclic spiro-1,2,4-
trioxanes (synthesized by condensation with cyclopentanone, cyclohexanone, cycloheptanone 
and adamantanone) a common behavior was observed: one (sometimes two) of the 
carbocyclic ring protons is absorbing down-field from the rest of the ring protons. This is 
ascribed to through-space electronic effects of the oxygen atoms in the trioxane ring causing 
more deshielding of this proton (Figure 3.27). Comparison of the antimalarial activity of the 
series 71-74 might be helpful to study the effect of the lipophilicity in these spiro compounds 
on the activity. Comparing the activity of 74 and 75, having the same number of carbons, may 
be also informative about the spiroannelation effect on the antimalarial activity.  
 
OH
OOH
BF3.Et2O / CH2Cl2
R R
O
7d 71-75
O O
O R
R
 
Scheme 3.58 
 
OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
71 adamantane 3.88 68.3 4.22 87.6 104.7 30 
72 (CH2)6 3.85 69.1 4.22 87.6 107.2 18 
73 (CH2)5 3.87 68.8 4.21 87.7 102.7 49 
74 (CH2)4 3.77 71.6 4.30 87.5 114.7 19 
75 Et Et 3.86 69.1 4.21 87.3 106.0 14 
Table 3.23: Characteristic signals of 71-75 in 1H- and 13C-NMR (in CDCl3). 
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Figure 3.27: 1H- and 13C-NMR of 72. 
 
3.7.7.2 By peroxyacetalization reaction with aldehydes 
 
Similar to the reaction of 7h with aldehydes, the peroxyacetalization reaction of the 1,2-
hydroperoxy alcohol 7d with 2-naphthaldehyde and benzaldehyde afforded only the trans 
1,2,4-trioxanes 76, 77, respectively, with the aryl groups in equatorial position as the more 
stable configuration (Scheme 3.59 ). The structures of the products were proven by 1H-, 13C-
NMR, IR, elemental analyses, mass spectrometry and HRMS. The characteristic signals in 
NMR are summarized in Table 3.24. An indisputable assignment of the relative configuration 
of 76 was based on X-ray analysis (Figure 3.28). 
 
OH
OOH
BF3.Et2O / CH2Cl2
R H
O
7d 76 / 77
O O
O R
 
Scheme 3.59 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
76 2-naphthyl 4.04 77.1 4.67 87.7 6.43 104.0 40 
77 Ph 3.95 77.0 4.56 87.6 6.24 103.9 36 
Table 3.24: Characteristic signals of 76 and 77 in 1H- and 13C-NMR (in CDCl3). 
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Figure 3.28: X-ray structure of 76. 
 
The mass fragmentation pattern of the representative example 76 is summarized in Scheme 
3.60. 
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H
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Scheme 3.60. 
 
Also similar to the reaction of 7h with 2-chlorobenzaldehyde, treatment of 7d with this 
aldehyde furnished a 88:12 mixture of diastreomers 78a,b, respectively. The major product is 
expected to have the trans configuration (78a) since it exhibits a coupling constant between 
H-5 and H-6 of 9.26 Hz. On the other hand, the coupling constant between H-5 and H-6 in the 
minor product is 3.82 Hz indicating a cis configuration (78b). Again, in both compounds the 
aromatic residues are located in equatorial position (Scheme 3.61). Saturation of H-5 of the 
O
O
O
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minor product in an NOE experiment resulted in clear enhancement in the intensity of H-3 
(Figure 3.29). Compound 78b is expected to be stable since it is free of any 1,3-diaxial 
interactions (due to the presence of the oxygen atoms in the ring). A strong upfield shift in the 
doublet signal of H-6 in the minor product 78b was also observed. Also, the methyl of the 
isopropenyl group of the minor diastereomer is located near to the peroxidic oxygen atoms 
and hence absorbs downfield at 2.03 ppm. The characteristic signals of 78a,b are summarized 
in Table 3.25. 
 
OH
OOH BF3.Et2O / CH2Cl2
7d 78a
O O
On-Pr O O
O
78b
+
H
O
Cl Cl
Cl
n-Pr
 
Scheme 3.61 
 
OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
78a 3.90 77.3 4.48 87.7 6.47 101.0 
78b 3.62 77.1 4.09 85.0 6.49 101.4 
40 
Table 3.25: Characteristic signals of 78a,b in 1H- and 13C-NMR (in CDCl3). 
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Figure 3.29: 1D-NOE experiment of 78b. 
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3.7.7.3 By peroxyacetalization reaction with acetals 
 
Whereas only one 1,2,4-trioxane diastereoemer 79 was isolated in case of condensing 7d with 
propionaldehyde diethylacetal, a 90:10 mixture of two 1,2,4-trioxane diastereomers 80a,b 
were isolated on using acetaldehyde dimethylacetal (Scheme 3.62). The less propensity of the 
ethyl compared to the methyl group to adopt an axial position may account for that. All the 
three products have a trans configuration confirmed by spectroscopic methods as mentioned 
before. The characteristic NMR signals are summarized in Table 3.26. 
 
OEt
OEt
ROH
OOH
BF3.Et2O / CH2Cl2
7d 79 / 80a
O O
O R
O O
O
R
80b
+
 
Scheme 3.62 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
79 Et 3.66 76.5 4.33 87.7 5.15 105.5 41 
80a CH3 3.66 76.4 4.32 87.4 5.35 101.4 
80b CH3 3.75 75.9 4.38 84.5 [a] 101.6 
48 
Table 3.26: Characteristic signals of 79 and 80 in 1H- and 13C-NMR (in CDCl3). 
[a] The signal is overlapping. 
 
3.7.8 Derived from 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol  
 
3.7.8.1 By peroxyacetalization reaction with symmetric ketones 
 
The BF3-catalyzed reaction of 7c with different symmetric ketones resulted in the formation 
the 1,2,4-trioxanes 81-84 in yields 15-50 %. Due to the symmetry at C-3, the stereochemistry 
of the products is controlled by substituents at C-5 and C-6. Coupling constant measurements 
(9.8-9.9 Hz) revealed that in all products the protons H-5 and H-6 are in trans-diaxial 
conformation (Scheme 3.63). As an example, compound 81 is characterized by NMR, IR, 
elemental analyses, mass spectrometry and HRMS. The characteristic signals in 1H-, 13C-
NMR for all compounds are shown in Table 3.27.  
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81-84  
Scheme 3.63 
 
OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
81 adamantane 3.78 72.1 4.41 85.4 104.4 28 
82 (CH2)4 3.67 75.6 4.49 85.6 114.7 15 
83 CH3 CH3 3.79 73.6 4.41 85.5 102.6 43 
84 Et Et 3.72 72.8 4.37 85.2 105.6 50 
Table 3.27: Characteristic signals of 81-84 in 1H- and 13C-NMR (in CDCl3). 
 
The characteristic IR bands for compound 81 are stretching at 3081 cm-1 (olefinic CH), 2913 
cm-1 (aliphatic CH), 1649 cm-1 (nonconjugated C=C), 1110, 1097, 1077, 1025 cm-1 (C-O), 
925, 908 cm-1 (O-O). The mass spectrum of 81 shows the fragments depicted in Scheme 3.64. 
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Scheme 3.64: Fragmentation pattern of 81. 
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3.7.8.2 By peroxyacetalization reaction with asymmetric ketones 
 
Incorporation of a new stereogenic center at C-3 by condensing 7c with asymmetric ketones 
such as 2-pentanone and 3,3-dimethyl-2-butanone affords a 87:13 of 85a,b and 83:17 of 
86a,b diastereomeric mixtures, respectively. The fact that all 1,2,4-trioxane products have 
vicinal coupling constants between H-5 and H-6 in the range from 8.22-9.99 Hz is indicative 
that all have the trans configuration at these centers. Consequently, the difference between the 
diastereomers is at the third chiral center C-3. The major product in both reactions is assumed 
to have the more bulky substituent at C-3 (n-Pr or t-Bu) cis to the isopropyl group at C-5 
(Scheme 3.65). Signals characteristic to the diastereomers as well as the chemical yields are 
summarized in Table 3.28. 
 
BF3.Et2O / CH2Cl2
R1 R2
O
7c
OH
OOH
O O
O
R2
R1
85-86a,b  
Scheme 3.65 
 
OCH OOCH OCOO 
No. R1 R2 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
85a n-Pr CH3 3.80 73.4 4.41 85.6 103.8 
85b CH3 n-Pr 3.74 73.0 [a] 85.1 104.3 
17 
86a t-Bu CH3 3.78 73.1 4.37 85.3 106.3 
86b CH3 t-Bu 3.50 74.7 4.29 91.7 104.8 
36 
Table 3.28: Characteristic signals of 85a,b and 86a,b in 1H- and 13C-NMR (in CDCl3). 
[a] Signal is overlapping 
 
3.7.8.3 By peroxyacetalization reaction with aldehydes 
 
As discussed previously for the condensation reaction of 7h, 7d with 2-chlorobenzaldehyde, 
the vic-hydroxy allylic hydroperoxide 7c reacts in similar way affording a mixture of the 
trans-1,2,4-trioxane 87a as the major product as well as the cis-1,2,4-trioxane 87b as the 
minor product in 91:9 ratio and 33 % yield (Scheme 3.66, Table 3.29). 
 
3. Results & Discussion 
87 
BF3.Et2O / CH2Cl2
87a
O O
Oi-Pr O O
O
87b
+
H
O
Cl Cl
Cl
7c
OH
OOH
i-Pr
 
Scheme 3.66 
 
OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
87a 3.78 81.2 4.64 85.8 6.46 101.0 
87b 3.74 83.1 4.15 83.7 6.44 101.5 
33 
Table 3.29: Characteristic signals of 87a,b in 1H- and 13C-NMR (in CDCl3). 
 
Confirmation of the relative configuration at C-3 for the major product 87a was also based on 
an NOE experiment (Figure 3.30). Saturation of H-5 resulted in a clear positive enhancement 
in the singlet signal corresponding to H-3 proving that they are in spatial proximity and hence 
cis to each other. Other enhancements were also observed for the olefinic signal, the methyl 
of the isopropenyl group, the methyl and the methine of the isopropyl group. Compound 87b 
represents the most stable conformation of the configuration corresponding to the minor 
diastereomer showing no 1,3-diaxial interactions (vide supra). 
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Figure 3.30: 1D-NOE experiment of 87a. 
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3.7.8.4 By peroxyacetalization reaction with acetals 
 
Similar to the peroxyacetlization reaction of 7d with propionaldehyde diethylacetal, carrying 
out the reaction using the with 7c results in the all-equatorial 1,2,4-trioxane 88 in 44 % yield. 
The stereochemical assignment at the three stereogenic centers was confirmed by NMR as 
before (Scheme 3.67).  
 
OEt
OEt
BF3.Et2O / CH2Cl2
7c
OH
OOH
88
O O
Oi-Pr
 
Scheme 3.67 
 
3.7.9 Derived from 4-hydroperoxy-5-methylhex-5-en-3-ol  
 
3.7.9.1 By peroxyacetalization reaction with aldehydes 
 
Treatment of the hydroperoxy homoallylic alcohol 7b with 2-naphthaldehyde or 2-
chlorobenzaldehyde in presence of catalytic amount of BF3 furnished the peroxyacetals 89 
and 90, respectively, in moderate yields (Scheme 3.68). As confirmed by X-ray analysis of 89 
(Figure 3.31), these trioxanes have also the trans configuration with the aryl groups in 
equatorial position. Both products were fully characterized by spectral data (IR, NMR), 
elemental analysis and low resolution as well as high resolution mass spectrometry. The 
significant NMR signals are summarized in Table 3.30. For 1H-NMR of compound 90, H-5 
appears as ddd at 3.82 ppm due to coupling with H-6 (appearing as doublet at 4.48 ppm with 
3JHH = 9.24 Hz) and with the two diastereotopic methylene protons of the ethyl group 
(appearing as multiplet at 1.42-1.62 ppm). The vicinal coupling constant between H-5 and H-
6 is therefore 9.24 Hz (trans diaxial protons) while that between H-5 and the methylene 
protons is 3.54 and 8.10 Hz. The characteristic peroxyacetal proton (H-3) absorb as singlet at 
5.48 ppm. As a result of the allylic coupling, the two olefinic protons (showing small geminal 
coupling) and the methyl protons of the isopropenyl group appear as multiplets. The methyl 
protons in the ethyl group couple with the two diastereotopic methylene protons with identical 
coupling constants of 7.41 Hz and hence the doublet of doublet appears triplet. The multiplet 
at 7.21-7.65 ppm corresponds to the aromatic protons. The IR spectrum of 90 shows the 
characteristic absorption bands at 3079 cm-1 (vinylic and aromatic CH), 2971 cm-1 (aliphatic 
CH), 1647 cm-1 (isolated C=C), 1597 cm-1 (aromatic C=C), 1086, 1053, 1003 cm-1 (C-O) and 
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960, 916 cm-1 (O-O). The mass fragmentation patterns for both compounds are depicted in 
Scheme 3.69 and 3.70. 
 
OH
OOH
BF3.Et2O / CH2Cl2
R H
O
7b 89 / 90
O O
O R
 
Scheme 3.68 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
89 2-naphthyl 3.96 78.5 4.67 87.4 6.43 104.0 24 
90 2-Cl-C6H4 3.82 78.7 4.48 87.4 5.48 101.0 22 
Table 3.30: Characteristic signals of 89 and 90 in 1H- and 13C-NMR (in CDCl3). 
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Scheme 3.69: Fragmentation pattern of 89. 
 
 
 
 
 
 
 
 
Figure 3.31: X-ray structure of 89. 
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Scheme 3.70: Fragmentation pattern of 90. 
 
3.7.9.2 By peroxyacetalization reaction with symmetric ketones 
 
As the previous hydroperoxy alcohols, condensation of 7b with symmetric ketones gives the 
corresponding trans-1,2,4-trioxane as sole product (Scheme 3.71). The products were 
assigned as reported previously. Examples for the significant signals of each compound in 
NMR are summarized in Table 3.31.  
 
OH
OOH
BF3.Et2O / CH2Cl2
R R
O
91-93
O O
O R
R
7b  
Scheme 3.71 
 
OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
91 adamantane 3.80 70.0 4.24 87.5 104.8 5 
92 CH3 CH3 3.81 71.2 4.24 87.2 102.7 32 
93 Et Et 3.78 70.5 4.21 87.0 106.0 22 
Table 3.31: Characteristic signals of 91-93 in 1H- and 13C-NMR (in CDCl3). 
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3.7.9.3 By peroxyacetalization reaction with asymmetric ketones 
 
Whereas condensation of 7b with pinacolone resulted in one trioxane diastereomer, using 2-
pentanone afforded a 83:17 trioxane diastereomeric mixture (Scheme 3.72). All trioxanes 
were formed as trans configuration (from the coupling constant between H-5 and H-6) with 
the more bulky group in equatorial position for the major product. 1H- and 13C-NMR 
characteristic signal are shown in Table 3.32. 
 
OH
OOH
BF3.Et2O / CH2Cl2
R1 R2
O
94 / 95a,b
O O
O R1
R2
7b  
Scheme 3.72 
 
OCH OOCH OCOO 
No. R1 R2 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
94 t-Bu CH3 3.82 70.6 4.20 87.1 106.4 39 
95a n-Pr CH3 3.82 70.9 4.23 87.3 104.0 
95b CH3 n-Pr 3.76 70.1 [a] 87.0 104.6 
38 
Table 3.32: Characteristic signals of 94 and 95 in 1H- and 13C-NMR (in CDCl3). 
[a] Signal is overlapping. 
 
3.7.9.4 By peroxyacetalization reaction with acetals 
 
Reaction of 7b with acetals such as acetaldehyde dieethylacetal or propionaldehyde 
diethylacetal afforded the corresponding 1,2,4-trioxanes in 37 and 49 % yields, respectively 
(Scheme 3.73). Whereas in the condensation with acetaldehyde diethylacetal only the trans 
isomer was isolated, in the condensation with propionaldehyde diethylacetal both cis (minor) 
and trans (major) isomers were detected. The most significant signals in NMR of all 
compounds are summarized in Table 3.33. Notably is the downfield shift of the signal 
corresponding to H-5 in the cis isomer 97 (located in equatorial position) which is ascribed to 
the deshielding effect by the ring oxygen atoms on this equatorial proton. 
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Scheme 3.73 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
96 CH3 3.57 77.9 4.30 87.2 5.33 101.5 37 
129b Et 3.57 77.9 4.32 87.5 5.16 105.5 
97 Et 3.88 77.7 4.02 84.6 5.16 105.6 
49 
Table 3.33: Characteristic signals of 96,97 and 129b in 1H- and 13C-NMR (in CDCl3). 
 
3.7.10 Derived from 3-hydroperoxy-4-methylpent-4-en-2-ol  
 
3.7.10.1 By peroxyacetalization reaction with symmetric ketones 
 
The Lewis-acid catalyzed peroxyacetalization reaction of the hydroperoxy homoallylic 
alcohol 7a with a series of symmetric ketones furnished the corresponding 1,2,4-trioxanes 98-
103 (Scheme 3.74). Full characterization of the products through spectral data (NMR, IR) as 
well as elemental analysis, mass spectrometry and X-ray analysis revealed the formation of 
5,6-trans isomer as sole product in all cases (the vicinal coupling constant between H-5 and 
H-6 is found to be in all products about 9.5 Hz). The chemical shifts of some significant 
signals in 1H and 13C-NMR of the products were summarized in Table 3.34. 
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Scheme 3.74 
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OCH OOCH OCOO 
No. R R 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
98 adamantane 4.04 65.0 4.17 88.7 104.8 12 
99 (CH2)6 4.01 65.9 4.17 88.7 107.5 16 
100 (CH2)5 4.07 65.6 4.18 88.8 102.8 26 
101 (CH2)4 3.29 68.4 4.24 88.6 114.7 73 
102 n-Pr n-Pr 4.01 65.9 4.14 88.5 105.6 14 
103 CH3 CH3 3.91 66.2 4.03 88.4 102.3 65 
Table 3.34: Characteristic signals of 98-103 in 1H- and 13C-NMR (in CDCl3). 
 
The 1H,1H-COSY of 99 shows that the two down-field multiplet signals at 2.15, 2.33 ppm 
belong to the cycloheptanone moiety. Two off diagonal cross peaks are observed for H-5 due 
to coupling with the methyl group and H-6. The proton H-6 couples only with H-5 and hence 
has only one cross peak. The allylic coupling between the methyl protons of the isopropenyl 
group with the olefinic methylene group can be also clearly seen (Figure 3.32). 
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Figure 3.32: 1H,1H-COSY of 99. 
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The protons of spatial proximity could be assigned by the off diagonal cross peaks in NOESY 
experiment (Figure 3.33). The key NOEs are indicated by the double headed arrows.  
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Figure 3.33: NOESY of 99. 
 
Unambiguous confirmation of the relative configuration was achieved by X-ray analysis for 
compound 98 (Figure 3.34). 
 
 
 
 
 
 
 
 
Figure 3.34: X-ray structure of 98. 
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The IR spectrum of 98 shows absorption bands at 2912 cm-1 (aliphatic CH), 1648 cm-1 
(isolated C=C), 1222, 1109, 1023, 999 cm-1 (C-O), 926 cm-1 (O-O). The mass fragmentation 
pattern of 100 is depicted in Scheme 3.75. 
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Scheme 3.75: Mass fragmentation pattern of 100. 
 
Condensing a 73:27 syn/anti diastereomeric mixture of the vic-hydroperoxy alcohol 7a 
(synthesized by photooxygenation reaction of 6a in MeOH as solvent) with 3-pentanone 
furnished a 78:22 mixture of two 1,2,4-trioxne products 104a,b beside the minor 1,2-
dioxolane derivative 104c (Scheme 3.76). The coupling constants (3JHH) clearly indicate that 
the major diastereomer (3JHH = 9.5 Hz) has the trans configuration (also expected since it is 
derived from the major syn-hydrperoxy alcohol), and the minor diastereomer (3JHH = 5.4 Hz) 
has the cis configuration (also expected since it is derived from the minor anti-isomer). The 
most significant signals in 1H-NMR corresponding to 124a,b are shown in Figure 3.35. 
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Scheme 3.76 
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Figure 3.35: Part of the 1H-NMR spectrum showing signals of 104a,b. 
 
Dual display parts of the 1H-NMR spectra for 124a isolated as sole product as well as that of a 
diastereomeric mixture of 124a,b are shown in Figure 3.36 and 3.37. The spectral data of the 
minor products 124b and 124c can be determined by spectral substraction. 
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Figure 3.36: Dual display for two parts of two 1H-NMR spectra showing signals of: 
1) trans-1,2,4-trioxane 104a as sole product (down). 
2) Diastereomeric mixture of trans and cis 1,2,4-trioxanes 104a,b (up). 
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Figure 3.37: Dual display for part of the 1H-NMR spectra showing H-6 signals in: 
1) trans-1,2,4-trioxane 104a as sole product (down). 
2) Diastereomeric mure of trans- and cis-1,2,4-trioxanes 104a,b (up). 
 
The byproduct 104c proceeds is formed by cyclization of the other hydroperoxy alcohol 
regioisomer (Scheme 3.77). 
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OOH
O
O OH
1O2
104c6a  
Scheme 3.77: Formation of the byproduct 104c. 
 
3.7.10.2 By peroxyacetalization reaction with asymmetric ketones 
 
Using 1,5-diphenylpentan-1,5-dione as the carbonyl compound afforded only the trans-1,2,4-
trioxne diastereomer 105 having the phenyl group at C-3 in axial position (as proved by the 
NOE experiment in Figure 3.38, where on saturation of H-5 a characteristic enhancement of 
the phenyl group at C-3 is observed and hence cis relationship between them is predicted). In 
contrast, both acetophenone and 2-butnone afforded dastereomeric mixtures of two trans-
1,2,4-trioxanes 106a,b and 107a,b, respectively. Assignment of the structures was based on 
NMR and IR data. The characteristic NMR signals for the products are shown in Table 3.35.  
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OH
OOH
BF3.Et2O / CH2Cl2
R1 R2
O
7a
O O
O
R2
R1
105 / 106-107a,b  
Scheme 3.78 
 
OCH OOCH OCOO 
No. R1 R2 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield
(%) 
105 (CH2)3COPh Ph 3.74 67.2 4.27 88.6 106.4 4 
106a Ph CH3 3.99 76.0 3.84 86.3 108.4 
106b CH3  Ph 3.71 75.0 4.05 87.4 108.3 
30 
107a Et CH3 4.06 66.3 4.16 88.8 104.1 
107b CH3  Et 4.0 66.1 4.18 88.4 105.0 
77 
Table 3.35: Characteristic signals of 105-107 in 1H- and 13C-NMR (in CDCl3). 
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Figure 3.38: 1D-NOE experiment of 105. 
 
The trioxanes 106a,b are formed in 1:1 ratio. Interestingly, the ring current effect causes an 
up-field shift of H-5 signal in 106b and of H-6 signal in 106a, as shown by NOE experiment 
(Figure 3.39).  
O O
O
H
H HO O
O
H
H  
Figure 3.39: NOE experiment of 106a,b. 
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3.7.10.3 By peroxyacetalization reaction with aromatic aldehydes 
 
Condensation of 7a with aromatic aldehydes such as furfural, 1-naphthaldehyde, 2-
bromobenzaldehyde afforded only the more stable trioxane diastereomer with all substituents 
equatorial. In case of using benzaldehyde as the carbonyl component, a 97:3 diastereomeric 
mixture of two trans 1,2,4-trioxanes 111a,b was formed. The diastereomer 111a having the 
phenyl group equatorial is also the major product (Scheme 3.79). The chemical constitution 
as well as the relative configuration were unequivocally confirmed by a full characterization 
with 1H-, 13C-NMR, IR, elemental analyses, mass spectrometry and X-ray analysis. The most 
significant signals in NMR are summarized in Table 3.36. 
 
OH
OOH
BF3.Et2O / CH2Cl2
R H
O
7a
O O
O R
O O
O
R
+
108-110 / 111a  111b  
Scheme 3.79 
 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield
(%) 
108 2-furyl 4.0 74.1 4.45 88.7 6.25 98.4 34 
109 1-naphthyl 4.20 74.2 4.61 88.9 6.84 102.6 46 
110 2-Br-C6H4 4.08 73.8 4.47 88.7 6.52 102.9 53 
111a Ph 4.05 73.8 4.46 88.8 6.21 104.1 
111b Ph 3.90 79.7 [a] 84.2 6.40 [a] 
33 
Table 3.36: Characteristic signals of 108-111 in 1H- and 13C-NMR (in CDCl3). 
[a] Signal is overlapping. 
 
 
 
 
 
 
 
 
Figure 3.40: X-ray structure of 109. 
O O
O
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The mass fragmentation pattern of the trioxane 111 is depicted in Scheme 3.80. 
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Scheme 3.80: Fragmentation pattern of 111. 
 
3.7.10.4 By peroxyacetalization reaction with aliphatic aldehydes 
 
In contrast to aromatic aldehydes, the BF3-catalyzed peroxyacetalization of 7a with aliphatic 
aldehydes afforded inseparable mixtures of 1,2,4-trioxanes as well as 1,3,5-trioxanes (Scheme 
3.81). The latter products are formed by the competing Lewis-acid catalyzed trimerization 
reaction of the aldehydes. Only one diastereomer was detected for the 1,2,4-trioxanes 129e, 
113, 115 having all substituents equatorial. The characteristic signals corresponding to the 
1,2,4-trioxanes and 1,3,5-trioxanes are summarized in Table 3.37 and 3.38, respectively. The 
trimerization problem in case of using aliphatic aldehydes was overcome by using the 
corresponding acetals for the peroxyacetalization reaction, by this way only the desired 1,2,4-
trioxanes are formed (vide supra). 
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Scheme 3.81 
 
 
 
3. Results & Discussion 
101 
OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
129e CH3 3.79 73.2 4.25 88.5 5.36 101 
113 Et 3.78 73.0 4.24 88.7 5.15 105 
115 i-Pr 3.76 73.1 4.24 88.8 4.96 108 
Table 3.37: Characteristic signals of 129e,113 and 115 in 1H- and 13C-NMR (in CDCl3). 
 
OCHO No. R 
1H-NMR 13C-NMR 
112 CH3 5.0 98 
114 Et 4.73 102 
116 i-Pr 4.45 105 
Table 3.38: Characteristic signals of 112,114 and 116 in 1H- and 13C-NMR (in CDCl3). 
 
3.7.10.5 By peroxyacetalization reaction with orthoesters 
 
Previously we discussed many condensation reactions of the hydroperoxy homoallylic 
alcohols with aldehydes or acetals were two trans-1,2,4-trioxanes are formed. In these 
reactions we found a high diastereomeric preference for the formation of the diastereomer 
having an equatorial alkyl substituent at C-3. This was explained by the less tendency for such 
substituents to adopt the axial position due to the 1,3-diaxial interaction found in the minor 
diastereomer. In contrast to this behavior we found that treatment of the vic-hydroperoxy 
allylic hydroperoxide 7a with different orthoesters resulted in two 5,6-trans-1,2,4-trioxanes 
mostly with very poor stereoselectivities (Scheme 3.82). The diastereomeric ratios are 57:43 
for 117a,b; 72:28 for 118a,b and about 1:1 for 119a,b. Unequivocally, strong anomeric effect 
of the axial alkoxy group is responsible for the extra stability of these diastereomers. This 
extra stability was not found in the previous examples with C-3 alkyl-substituted analogues 
and hence the participation of the minor diastereomers with an axial C-3 alkyl-substituted 
trioxanes in the product mixture was significantly lower. The trans configuration was 
confirmed by the coupling constant as described before and all products were characterized by 
1H- and 13C-NMR analyses (Table 3.39). The most characteristic signal is that corresponding 
to the peroxyortho ester carbon resonating at 110-115 ppm in 13C-NMR. To the best of my 
knowledge, compounds 117-119a,b are the first perortho esters with 1,2,4-trioxane 
substructure described in literature.  
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Scheme 3.82 
 
OCH OOCH OCHOO 
No. R1 R2 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
117a,b 
H Me 4.02 
(4.30) 
74.2 
(65.9) 
4.20 
(4.36) 
87.5 
(88.9) 
5.72 
(5.48) 
113.6 
(111.0) 
118a,b 
H Et 4.02 
(3.60) 
63.8 
(65.8) 
4.20[a] 87.5 
(88.9) 
5.77 
(5.58) 
113.3 
(110.0) 
119a,b 
Me Et 4.14[a] 66.1[a] 4.24[a] 87.8[a] - 113.8 
(114.3) 
Table 3.39: Characteristic signals of 117-119a,b in 1H- and 13C-NMR (in CDCl3). 
The chemical shifts between parentheses correspond to minor diastereomer. 
 
3.7.11 Derived from 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol 
 
3.7.11.1 By peroxyacetalization reaction with aldehydes 
 
Compound 120 was obtained in low yield on treatment of a solution of 7e with 2-
naphthaldehyde in dichloromethane with BF3 as catalyst (Scheme 3.83). The chemical 
structure as well as the stereochemical assignment were based on NMR data (as before), 
elemental analysis, mass spectrometry and HRMS. Some significant NMR signals are 
summarized in Table 3.40. 
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Scheme 3.83 
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OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
120 4.06 76.8 4.64 87.1 6.37 104.1 4 
Table 3.40: Characteristic signals of 120 in 1H- and 13C-NMR (in CDCl3). 
 
3.7.11.2 By peroxyacetalization reaction with ketones 
 
Similarly, the trioxane 121 was isolated from the reaction of 7e with acetone (Scheme 3.84). 
The product was assigned on the basis of NMR (Table 3.41). 
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Scheme 3.84 
 
OCH OOCH OCOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
13C- 
NMR 
 
Yield 
(%) 
121 3.98 69.6 4.28 86.7 102.7 17 
Table 3.41: Characteristic signals of 121 in 1H- and 13C-NMR (in CDCl3). 
 
3.7.11.3 By peroxyacetalization reaction with acetals 
 
The peroxyacetalization reaction of 7e with benzaldehyde dimethylacetal furnished the 1,2,4-
trioxane diastereomeric mixture 122a,b in 93:7 diastereomeric ratio and 26 % chemical yield 
(Scheme 3.85). Based on the coupling constant between H-5 and H-6 it was found that the 
major product has a 5,6-trans configuration 122a and the minor isomer has 5,6-cis 
configuration 122b. In both compounds the phenyl group is in equatorial position to 
circumvent any destabilizing 1,3-diaxial interaction. Characteristic signals in NMR are shown 
in Table 3.42. 
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+
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Scheme 3.85 
 
OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
122a 4.03 76.6 4.61 86.9 6.23 103.9 
122b 4.31 76.4 4.22 84.1 6.38 104.4 
26 
Table 3.42: Characteristic signals of 122a,b in 1H- and 13C-NMR (in CDCl3). 
 
The configuration of the minor diastereomer was also based on NOE experiment. Saturation 
of H-5 resulted in clear enhancement in the singlet signal corresponding to H-3. This indicates 
that the allyl group is equatorial and hence the isopropenyl group should be in axial position 
(Figure 3.41). 
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Figure 3.41: 1D-NOE experiment of 122b. 
 
Changing the acetal component to acetaldehyde diethylacetal led only to the more stable 
1,2,4-trioxane diastereomer 123, having all the substituents in equatorial positions. 
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BF3.Et2O / CH2Cl2
O O
OOEt
OH
OOH
OEt
7e 123  
Scheme 3.86 
 
3.7.11.4 By peroxyacetalization reaction with orthoesters 
 
The peroxyacetalization of the vic-hydroperoxy allylic hydroperoxide 7e with orthoesters 
such as trimethyl orthoformate resulted in two 5,6-trans-1,2,4-trioxanes with very low 
stereoselctivity, about 45:55 (Scheme 3.87). Unequivocally, the strong anomeric effect of the 
axial methoxy group in 124b is responsible for the extra stability of this diastereomer.  
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Scheme 3.87 
 
OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
124a 4.25 68.8 4.45 87.0 5.48 111.0 
124b 3.94 76.9 4.28 85.5 5.69 113.5 
21 
Table 3.43: Characteristic signals of 124a,b in 1H- and 13C-NMR (in CDCl3). 
 
Confirmation of the chemical structure was based on NMR analysis. The most characteristic 
signal is that corresponding to the peroxyortho ester carbons resonating as singlet at 5.69, 
5.48 ppm in 1H-NMR and at 113.5, 111.0 ppm in 13C-NMR. Interestingly, a large difference 
in the chemical shifts for C-5 in both diastereomers (∆δ = 8.1 ppm). Clearly, C-5 in 124b is 
more deshielded by the effect of the axial methoxy group than in case of 124a. Other 
significant signals corresponding to C-6 were also shown in Table 3.43. Fortunately, the 
major diastereomer (124b) could be separated from the diastereomeric mixture by 
chromatography, the NMR of the separated major diastereomer and that of the diastereomeric 
mixture 124a,b are shown in Figure 3.42. 
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Consistent with the NMR, PM3 calculations (Figure 3.43) revealed that the heat of formation 
(∆Hf) of 124a is -78.86 kcal/mol while that for 124b is -80.68 kcal/mol. Clearly, the 
diastereomer 124b with an axial methoxy group at C-3 is more stable by about 1.8 kcal/mol. 
The anomeric effect of alkoxydioxanes and 2-alkoxytetrahydropyrans has also been reported 
and an alkoxide group preferentially favors an axial position by approximately 0.2-0.8 
kcal/mol.148,149 
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Figure 3.42: 1H- and 13C-NMR of 124a,b diastereomeric mixture (up)  
and 1H- and 13C-NMR of the major diastereomer 124b (down). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure3.43: Model of 1,2,4-trioxane 124a,b in a minimum energy 
conformations. The model was generated using PM3. 
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3.7.12 Derived from 3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol 
 
3.7.12.1 By peroxyacetalization reaction with aldehydes 
 
The condensation reaction of 2-naphthaldehyde with the two diastereomeric mixtures of the 
vic-hydroxy allylic hydroperoxide 7f furnished a 1:1 diastereomeric mixture of the 1,2,4-
trioxanes 125a,b (Scheme 3.88). In both 1H- and 13C-NMR, many sets of twin signals could 
be observed (Figure 3.44, Table 3.44). The chemical structure of the trioxanes was based on 
NMR, IR and elemental analyses as well as low and high resolution mass spectrometry. The 
characteristic absorption bands in the IR spectrum are stretching at 3078 cm-1 (aromatic or 
vinylic CH), 2978, 2923 cm-1 (aliphatic CH), 1653, 1647 cm-1 (isolated C=C), 1605 cm-1 
(aromatic C=C), 1127, 1076, 999 cm-1 (C-O) and at 904, 866 cm-1 (O-O). Proton H-6 appears 
as doublet (with coupling constant about 3JHH = 9.5 Hz for both diastereomers) while H-5 
appears as doublet of doublet (3JHH = 1.9, 9.54 Hz for one diastereomer and 2.51, 9.57 Hz for 
the other). Clearly, the vicinal coupling constant between H-5 and H-6 is assigned to be about 
9.5 Hz indicating a dihedral angle of 180° (and hence the relative configuration of both 
trioxane diastereomers is trans), while the small coupling constants correspond to the 
coupling of H-5 with the allylic proton. As confirmed before, the 2-naphthyl group in both 
diastereomers is located cis to the substituent on C-5. Notoriously, both isolated 1,2,4-
trioxanes result from the two major diastereomers of the vic-hydroxy allylic hydroperoxide 
syn,syn-7f and syn,anti-7f (vide supra). The NMR of 125a,b is shown in Figure 3.44. 
 
O O
O
O O
O
H
O
BF3.Et2O / CH2Cl2
+
OH
OOH
OH
OOH
7f
125a
125b  
Scheme 3.88 
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OCH OOCH OCHOO 
No. 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
 
Yield 
(%) 
125a,b 
4.02/ 
4.12 
79.9/ 
80.0 
4.83/ 
4.89 
85.4/ 
85.6 
6.40/ 
6.41 
103.9/ 
104.0 
15 
Table 3.44: Characteristic signals of 125a,b in 1H- and 13C-NMR (in CDCl3). 
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Figure 3.44: 1H- and 13C-NMR of 125a,b (CDCl3). 
 
3.7.12.2 By Peroxyacetalization Reaction with Ketones 
 
Similarly, the reaction with symmetric ketones as adamantanone or acetone afforded the 
diastereomeric 1,2,4-trioxanes 126a,b and 127a,b in 4 and 14 % yield, respectively. Also, all 
compounds show a trans configuration of H-5 and H-6 (Scheme 3.89). Surprisingly, whereas 
about 1:1 diastereomeric mixture of 127a,b is formed, higher stereoselectivity was observed 
for the two diastereomers 126a,b (about 31:69). The most characteristic signals for both 
diastereomers are summarized in Table 3.45. 
 
+ O O
O
O O
O
BF3.Et2O / CH2Cl2
+
OH
OOH
OH
OOH
7f 126a/ 127a
R1 R2
O
R1
R2 R2
R1
126b/ 127b  
Scheme 3.89 
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OCH OOCH OCOO 
No. R1 R2 1H-
NMR 
13C-
NMR 
1H-
NMR 
13C-
NMR 
13C-
NMR 
 
Yield 
(%) 
126a,b adamantane 
3.86/ 
3.93 
71.5/ 
71.5 
4.39/ 
4.44 
85.3/ 
85.2 
104.6/ 
103.5 
4 
127a,b CH3 CH3 
3.84/ 
3.94 
72.8/ 
72.7 
4.36/ 
4.43 
85.3/ 
85.1 
102.6[a] 
 
14 
Table 3.45: Characteristic signals of 126a,b and 127a,b in 1H- and 13C-NMR (in CDCl3). 
[a] Both diastereomers have the same chemical shift. 
 
Interestingly, for each pair of the trioxane diastereomers (125a,b; 126a,b and 127a,b) a large 
difference in the chemical shift of the allylic methyl group (CH3CH) between each pair of the 
trioxane diastereomers was observed (in 13C-NMR of 125a,b, 126a,b and 127a,b ∆δ = 5.0 
±0.3 ppm where one methyl resonate at about 13 ppm and the other at 18 ppm) and (in 1H-
NMR of 126a,b and 127a,b ∆δ = 0.4 ppm). This can be interpreted by drawing the Newmann 
projection of the most stable conformer (possessing only two gauche interactions) for each 
diastereomer (Figure 3.45). Clearly, the methyl group in conformer B is located in spatial 
vicinity to the oxygen atom of the ring and hence is expected to be more deshielded and 
absorb more down-field than the shielded methyl group in the conformer A. 
 
O
O
O
H
Me
H
O
O
O
H
Me
H
   Deshielded by the
oxygen atom (down-field)
More shielded
     (up-field)
A B
 
Figure 3.45: The most stable conformation of each 1,2,4-trioxane diastereomer. 
 
3.7.13 Derived from 3-hydroperoxy-2,5,5-trimethylhepta-1,6-dien-4-ol 
 
3.7.13.1 By peroxyacetalization reaction with ketones 
 
Condensing the β-hydroperoxy alcohol 7k (derived from the natural terpene artemisia 
alcohol) with acetone in dichloromethane and in presence of a catalytic amount of BF3 
furnished a single isomeric 1,2,4-trioxane product 128 (Scheme 3.90).  
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OH
OOH
O
BF3.Et2O / CH2Cl2 O
OO
7k 128  
Scheme 3.90 
 
The 1H-NMR of 128 shows four singlet signals corresponding to the protons of the four 
methyl groups on saturated carbons, and a multiplet (due to allylic coupling) corresponds to 
the methyl group on the unsaturated carbon. Both H-5 (at 3.74 ppm) and H-6 (at 4.34 ppm) 
absorb as doublet due to vicinal coupling between them (with coupling constant of 9.7 Hz 
indicating 180° dihedral angle between them and hence trans diaxial-configuration of the 
trioxane). The two isopropenyl olefinic protons couple to each other with small olefinic 
geminal coupling and also to the allylic methyl group with small allylic coupling and hence 
appearing as multiplet. Whereas the signals of both olefinic methylene groups overlap at 4.90-
5.10 ppm, the signal corresponding to the CH of the vinyl group shows at 5.92 ppm a 
characteristic doublet of doublet pattern with coupling constants 17.5 and 10.9 Hz 
corresponding to the olefinic vicinal coupling with the trans and cis protons respectively. The 
most significant signal in 13C-NMR is that related to the peroxyacetal carbon (C-3) resonating 
at 102.4 ppm. 
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3.8 Lewis-Acid Catalyzed Cleavage of β-Hydroperoxy Alcohols and 
Subsequent Cross-Peroxyacetalization Reaction 
 
A series of 1,2,4-trioxanes was synthesized by treating the β-hydroxy hydroperoxides with 
catalytic amount of BF3 in absence of any external carbonyl compounds (Scheme 3.91).150 
The reaction is chemoselective with the formation of the 1,2,4-trioxanes 129a-h as the major 
components in all cases (Table 3.46). 
 
R
OH
OOH
BF3.Et2O / CH2Cl2 O O
OR R O O
OR+
7a-e,g,h,p 129a-h 130a-h  
Scheme 3.91 
 
Entry R 129 : 130[a] Yield
[c] 
(%) 
1 c-Pr 61 : 39 33 
2 Et 63 : 37 41 
3 i-Bu 83 : 17 59 
4 n-Bu 68 : 32 60 
5 Me 79 : 21 62 
6 n-Pr 95 : 5[b] 24 
7 allyl 80 : 20 52 
8 i-Pr 91 : 9 50 
Table 3.46: Chemoselectivity of the BF3-catalyzed cleavage and peroxyacetalization of β-hydroxy 
hydroperoxides 7a-e,g,h,p. [a] Calculated from the characteristic signals in the 1H-NMR of the crude 
reaction mixture. [b] Calculated from the characteristic signals in the 1H-NMR of the pure reaction mixture. 
[c] Total yield of the crude 1,2,4-trioxanes mixture.  
 
The reaction is entropically favored and is assumed to proceed through a slow cleavage 
(Hock-type cleavage) of the β-hydroperoxy alcohols, catalyzed by the Lewis acid, leading to 
the corresponding carbonyl fragments that subsequently reacts with the excess β-hydroperoxy 
alcohols to give the mixed trioxanes 129a-h, 130a-h, respectively (Scheme 3.92). β-
Hydroperoxy alcohols are known to undergo decomposition with the formation of carbonyl 
compounds.110a,b The fact that the 1,2,4-trioxanes 129 were always formed as the major 
product is expected since the non-conjugated carbonyl fragments (a) show more electrophilic 
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carbonyl carbon than the carbonyl carbon of the α-methylacrolein fragment (b). 
Consequently, the nucleophilic attack of the hydroperoxy group on the former carbon is 
expected to be faster leading to the formation of 129 as the major product (kinetic control of 
product formation).  
 
O
R
O
O
O
O
R
R
O
O
O
R
+
H
O R
O
H+
O
O
OH
R
O
O
OH
R
+
OH
H
BF3
(a)(b)
HO HO R
BF3
129130  
Scheme 3.92: BF3-catalyzed fragmentation of β-hydroperoxy 
alcohols and subsequent peroxyacetalization reaction. 
 
Confirmation of the chemical structures and the relative configuration was based on 1H- and 
13C-NMR (Table 3.47). For all the synthesized trioxanes, the coupling constant between the 
two protons H-5 and H-6 was found in the range 3JHH = 9.0-9.6 Hz indicating a dihedral angle 
of 180° and consequently, a trans diaxial-configuration. The substituents at the peroxyacetal 
carbon (C-3) in 129 and 130 are always located cis to the substituents at C-5. 
The 1,2,4-trioxanes 130 are characterized in 1H-NMR by a singlet signal absorbing at about 
5.50-5.60 ppm corresponding to H-3 (the downfield shift of this signal is due to the double 
bond anisotropic effect of the geminal isopropenyl group). Another broad singlet signal 
resonating at about 5.20 ppm corresponds to the olefinic proton of the isopropenyl group on 
C-3 is also characteristic of this series. Beside the peroxyacetal carbon in 13C-NMR, the 
appearance of another signal at about 116 ppm corresponding to the methylene carbon of the 
isopropenyl group at C-3 is very indicative of 130 trioxanes. The 1,2,4-trioxanes 129 are 
confirmed in 1H-NMR by the characteristic H-3 appearing with a very significant multiplicity. 
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OCH OOCH OCHOO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
1H-
NMR 
13C- 
NMR 
129a c-Pr 3.06 80.8 4.45 87.4 4.73 106.4 
130a c-Pr 3.21 79.8 4.43 87.5 5.45 104.5 
129b Et 3.57 77.9 4.32 87.5 5.16 105.5 
130b Et 3.77 76.8 4.38 86.8 5.60 104.1 
129c i-Bu 3.72 75.0 4.30 88.1 5.26 103.8 
130c i-Bu 3.80 75.2 4.34 88.0 5.54 104.6 
129d n-Bu 3.65 76.8 4.33 87.7 5.21 104.8 
130d n-Bu 3.74 76.8 4.38 87.6 5.55 104.7 
129e Me 3.79 73.2 4.25 88.5 5.36 101.4 
130e Me 3.88 73.2 4.32 88.7 5.56 104.8 
129f n-Pr 3.65 76.5 4.32 87.7 5.21 104.5 
130f n-Pr 3.76 76.6 4.39 87.6 5.56 104.7 
129g allyl 3.77 76.3 4.40 87.0 5.27 103.7 
130g allyl 3.85 76.2 4.45 86.9 5.57 104.7 
129h i-Pr 3.54 80.3 4.49 85.7 4.95 107.6 
130h i-Pr 3.65 80.5 4.56 85.7 5.55 104.8 
Table 3.47: Characteristic signals in 1H- and 13C-NMR of 129a-h and 130a-h (in CDCl3). 
 
In most cases the major trioxane products could be separated by chromatography as shown in 
Figure 3.46 for the 129d and 130d. 
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Figure 3.46: 1H- and 13C-NMR of 129d, 130d mixture (up)  
and 1H- and 13C-NMR of 129d (down). 
 
It is also worth mentioning that the formation of the 1,2,4-trioxanes 129 and 130 is sometimes 
a competitive side reaction to the previously used condensation reaction of vic-hydroxy allylic 
hydroperoxides with carbonyl compounds, acetals and orthoesters where it becomes more 
pronounced for reactions involving less reactive condensing reagents (e.g. due to steric 
effects) especially those which are less volatile (cannot be added in large excess). Also, it was 
found that the vic-hydroxy allylic hydroperoxides with bulky alkyl group on the carbinol 
carbon are more susceptible to this fragmentation-condensation reaction since as the size of 
the alkyl group increases, the stability of the β-hydroperoxy alcohols becomes lower due to 
steric strains. The driving force of this fragmentation to the carbonyl compounds by C(OOH)-
C(OH) bond fission is sterically assisted by releasing this steric strain.  
 
I have also tried to synthesize an allylic alcohol which, after photooxgenation, yields β-
hydroperoxy alcohols that when treated with BF3 fragments slowly into only one carbonyl 
component, by this way only one 1,2,4-trioxane can be isolated. The allylic alcohol 6t 
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represents a simple candidate that fulfills the previous conditions. However, on treatment of 
25 with isopropenyl magnesium bromide the allylic alcohol 6t was not isolated. Instead, an 
acid-catalyzed 1,3-allylic shift of the hydroxy group in 6t took place leading to the formation 
of the dieneol 6u. The formation of 6u was further supported by [4+2]-cycloaddition reaction 
with 1O2 resulting in the formation of the endoperoxide 131 which was characterized by NMR 
analysis (Scheme 3.93). Compound 131 shows only one olefinic proton in 1H-NMR 
appearing as multiplet (due to vicinal and allylic coupling) at 5.65 ppm, the methine proton 
appearing as multiplet at 4.20 ppm while the methylene is appearing as singlet at 4.28 ppm. In 
an APT experiment, the most characteristic signals are the olefinic carbons at 117.1 and 133.5 
ppm, the quaternary carbinol carbon at 72.8 ppm as well as the peroxidic methylene and 
methine carbons resonating at 72.6 and 84.3 ppm, respectively. 
 
O
O
OH
1O2
OH
HO1,3-OH shiftCHO MgBr
131
Et2O
25 6t 6u
1O2
OH
OOH
BF3
O
O
O
 
Scheme 3.93 
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3.9 Bis Spiro-1,2,4-Trioxanes Synthesis 
 
In the light of combinational chemotherapy in fighting malaria (vide supra) and the 
semisynthetic artemisinin dimers mentioned before, I used similar concept to enhance the 
antimalarial activity of the prepared 1,2,4-trioxanes by integration of two trioxane 
pharmacophoric moieties in the same molecule. The idea is based on condensing two 
hydroperoxy alcohols to a central dicarbonyl component (as cyclohexane-1,4-dione) resulting 
in bis spiro-1,2,4-trioxanes, a literature-unknown class of compounds (Scheme 3.94).  
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H H
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OOH BF3.Et2O / CH2Cl2
7c-e,g,h
 
Scheme 3.94: syn and anti bis spiro-1,2,4-trioxanes. 
 
The crude product mixture of the reaction seemed to be a complex mixture of products 
involving in some cases the trioxanes obtained by the Lewis acid catalyzed fragmentation-
peroxyacetalization reaction of the 1,2-hydroperoxy alcohols as side products. However, on 
chromatographic purification it was efficiently feasible to separate the monocyclic 1,2,4-
trioxanes from the 1,2,4-trioxane dimers. 
Based on 1H-NMR of all the synthesized bis spiro-1,2,4-trioxane dimers, the two vicinal 
methine protons in each 1,2,4-trioxane ring adopt a trans diaxial-orientation with coupling 
constant in the range of 9.55-9.84 Hz. This means that, both 1,2,4-trioxane rings in all the 
synthesized bis spiro-1,2,4-trioxanes are derived only from the major diastereomer of the vic-
hydroxy allylic hydroperoxide (syn-isomer). The bis spiro-1,2,4-trioxanes were formed as 
mixtures of two diastereomers that can be referred to as syn (the peroxidic bond on the same 
side) and anti (the peroxidic bonds in opposite sides). Both diastereomers were formed in the 
most stable configuration showing all substituents in equatorial positions (RS,RS/RS,RS for 
the syn isomer and RS,RS/SR,SR for the anti isomer)  
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The chemical constitution of the bis spiro-1,2,4-trioxanes dimers was confirmed by 1H-, 13C-
NMR and in some cases also by IR and elemental analyses. The high volatility and low 
thermal stability was problematic for any mass analysis technique. In contrast to 1H-NMR 
where both syn and anti isomers of the synthesized bis spiro-1,2,4-trioxanes dimers show 
identical spectra (exception is 135 were some signals of the syn and anti isomers showing 
different chemical shifts), 13C-NMR was more advantageous showing mostly different signals 
corresponding to the syn and anti isomers (Table 3.48). A multiplet with integration of three 
protons and a small coupling constant (allylic coupling) is absorbing at 1.60 ppm and is 
related to the isopropenyl methyl group. 
 
OCH OOCH OCOO 
No. R 1H-
NMR 
13C-NMR 
1H-
NMR 
13C-NMR 13C-NMR 
 
Yield 
(%) 
132 n-Bu 
3.86[a] 69.8/ 
69.8 
4.25[a] 87.7/ 
87.7 
102.4/ 
102.3 
4 
133 i-Pr 3.76[a] 73.4[a] 4.45[a] 85.7[a] 102.2[a] 18 
134 n-Pr 
3.89[a] 69.5/ 
69.5 
4.25[a] 87.6/ 
87.6 
102.3/ 
102.3 
19 
135 allyl 
3.97/ 
3.35 
69.5/ 
69.5 
4.31/ 
4.30 
86.9/ 
87.1 
102.4/ 
102.4 
8 
136 i-Bu 
3.97[a] 67.8[a] 4.24[a] 88.1/ 
88.1 
102.3/ 
102.3 
15 
Table 3.48: Characteristic signals of syn- and anti-132-136 in 1H- and 13C-NMR (in CDCl3). 
[a] Both diastereomers have identical chemical shifts for this signal. 
 
It is clear that while the anti bis-1,2,4-trioxane diastereomer possesses a center of symmetry, 
the syn diastereomer has a twofold axis of symmetry. This symmetry tends to produce NMR 
spectral and magnetic equivalence of pairs of the groups located on both sides of each 
diastereomer (e.g. at position 5 and 5`, or 6 and 6` of the trioxane rings, or the two vicinal 
methylene groups of the central cyclohexane ring). Compound 132, as a representative 
example (Figure 3.47), shows in 1H-NMR a triplet signal at 0.86 ppm related to the methyl 
group vicinal to a methylene group, a multiplet at 1.05-1.72 correspond to four methylene 
groups (three of the n-butyl and one of the central cyclohexane ring). The multiplet signal at 
about 2.20 ppm is consistent with the other methylene group of the cyclohexane ring (two 
diastereotopic protons). At 3.86 ppm a multiplet with integration of one proton correspond to 
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H-5 of the trioxane ring which couples with the vicinal two diastereotopic methylene protons 
of the n-butyl group as well as the vicinal H-6 (appearing as doublet at 4.25 ppm). Finally, the 
signal at 5.04 ppm is related to the olefinic methylene protons. For all bis spirotrioxane 
dimers, the most characteristic signal in 13C-NMR is the peroxyacetal carbon appearing more 
up-field (at about δ = 102 ppm) than the previously synthesized monocyclic-1,2,4-trioxanes 
probably due to more shielding effect by the electronic cloud generated by the lone pairs of 
the six oxygen atoms in the molecule. The 13C-NMR of 132 shows two signals at 102.3 and 
102.4 ppm corresponding to the peroxyacetal carbons of the syn and anti diastereomers. The 
two methylene carbons of the central cyclohexane ring are resonating at 25.2, 30.8 ppm for 
one isomer and at 24.9, 31.2 ppm for the other. The isopropenyl methyl group is resonating at 
19.7 and 19.8 ppm for the syn and anti isomers. Also each isomer shows two distinct signals 
corresponding to C-5 and C-6. While the olefinic methylene carbon in both isomers have 
identical chemical shift, the olefinic quaternary carbon is absorbing at 139.1 and 139.2 ppm 
for both diastereomers. 
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Figure 3.47: 1H- and 13C-NMR spectra of syn- and anti-132. 
 
The IR spectrum of compound 132 shows the following characteristic bands: 3083 cm-1 
(vinylic CH), 2957 cm-1 (aliphatic CH), 1648 cm-1 (isolated C=C), 1253, 1105, 1007 cm-1 (C-
O) and 928, 911 cm-1 (O-O). The relative configuration of the synthesized bis spiro-1,2,4-
trioxane dimers was unambiguously assigned by means of X-ray analysis (Figure 3.48). 
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Figure 3.48: X-ray structure of compounds 133, 136, 134, 132. 
 
It can be anticipated that the antiparasitic activity of such compounds is higher than for mono-
1,2,4-trioxanes since they might act twice as electron acceptors when reduced by Fe(II) of the 
hemoglobin and hence are expected to be more potent. Calculations revealed that in the syn 
spiro compounds the electron-accepting pharmacophoric peroxo-bridges are less shielded and 
thus better exposed to the reactive iron center than the corresponding anti isomers (Figure 
3.49). 
 
 
 
 
Figure 3.49: Space-filling structures of syn (right) and anti (left) isomers of the bis 1,2,4-trioxanes 133. 
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3.10 Intramolecular 1,2,4-Trioxanes Synthesis 
 
The 1,2,4-trioxane pharmacophore in the natural occurring antimalarial drug artemisinin is a 
part of a bicyclo[3.2.2]nonane sekeleton (vide supra). In this part I tried to develop a new 
route for a simplification of this pharmacophore. Four possible isomers for the 
trioxabicyclo[3.2.1]octane peroxides are known (Figure 3.50). However, the 2,3,8-trioxa 
isomer D is the only isomer that has a 1,2,4-trioxane unit and hence can be considered as a 
ring-contracted analogue to the pharmacophore in artemisinin. 
 
O
O
O
O O
O
O
O
O
O O
O
A B C D
 
Figure 3.50: All possible trioxabicyclo[3.2.1]octane peroxides. 
 
There is only one route to the 2,3,8-trioxabicyclo-[3.2.1]octane skeleton that is known in 
literature which is based on trapping of the triplet biradicals formed in intramolecular 
photochemical quinone-alkene addition by molecular oxygen (Scheme 3.95).151,111,113 
However, the yields of this reaction are generally low due to competition with unimolecular 
radical reactions. 
 
O
O
O
O
R1
R2 O
O
O
O
R1
R2
3O2hν
R3
R4
R3
R4
R3
R4
 
Scheme 3.95: Synthesis if bicyclo[3.2.1]octanes by triplet biradicals trapping. 
 
Retrosynthetic analysis of such skeleton assumes the involvement of an intramolecular 
peroxyacetalization reaction as the key step in synthesis (Scheme 3.96). Here, the carbonyl 
component and the allylic alcohol must be involved in the same substrate molecule.  
 
O
O
O O
OHOH OH
O O
1O2  
Scheme 3.96: Retrosynthesis of the 2,3,8-trioxabicyclo[3.2.1]octane skeleton. 
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Two direct routes to such substrates were investigated (Scheme 3.97). However, secondary 
products were obtained in both cases. In the first route, the NMR spectra of the isolated 
product showed no carbinol signals, instead, four olefinic signals absorbing in 13C-NMR at δ 
= 124.0, 127.9, 139.4, 147.4 ppm were observed. This is consistent with spontaneous 
dehydration of the primarily formed allylic alcohol giving the more conjugated dienol 137. In 
the second route, the allylic hydroxylation of the non-conjugated enone 138 with SeO2 took 
place at the methyl group leading to the formation of the 1,6-dicarbonyl compound 139. The 
formation of 139 was confirmed by the aldehyde singlet signal resonating at δ = 9.32 ppm in 
1H-NMR and at δ = 195.0 ppm in 13C-NMR as well as by the absence of the carbinol signals.  
 
O H
O
+
O
LDA, workup
O CHOO
SeO2, workup
13725
139138  
Scheme 3.97 
 
An old publication by Stetter et al. reported on the synthesis of unsaturated 1,4-diketones by 
thiazolium salt catalyzed addition of unsaturated aliphatic aldehydes to vinyl ketones 
prompted me to follow this concept.192 The addition of 3-methylcrotonaldehyde 25 to methyl 
vinyl ketone or ethyl vinyl ketone in presence thiazolium salt resulted in the corresponding 
1,4-diketones 140 and 141 in good purity (Scheme 3.98). In order to reduce the conjugated 
carbonyl group to the corresponding allylic alcohol, protection of the isolated carbonyl group 
as acetal was carried out by the conventional acid catalyzed acetalization with ethylene 
glycol. Subsequent reduction of the enone acetal 142 and 143 with lithium aluminum hydride 
in ether followed by basic workup furnished the corresponding allylic alcohols 144 and 145 in 
62 % yield.  
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H
O
R
O
O
R
O
+
CH3COONa / 80 °C
O
R
O O
HO OHPPTS / benzene / ∆
OH
R
O O
LiAlH4
Et2O
thiazolium salt / EtOH
25
144,145 142,143
140,141
 
Scheme 3.98 
 
The 1O2 photooxygenation reaction of 144 and 145 using the developed solvent-free approach 
afforded the 1,2-hydroperoxy alcohols 146 and 147 with moderate syn diastereoelectivity 
(Scheme 3.99, Table 3.49). The characteristic hydroperoxy signals corresponding to both 
diastereomers are summarized in Table 3.50. 
 
OH
R
O O
OH
R
O O
OOH
3O2 / hν / TPP
PS-DVB
146,147144,145  
Scheme 3.99 
 
Compound R d.r.
[a] 
syn:anti 
Yield 
(%) 
146 Me 77 : 23 84 
147 Et 74 : 26 91 
Table 3.49: The photooxygenation of the allylic alcohols 144 and 145 using solvent-free 
approach with PS-DVB copolymer. [a] The diastereoselectivity is determined from 
the integration of the characteristic signals in the NMR of the crude reaction mixture. 
 
syn-diastereomer anti-diastereomer 
Compound R 
1HNMR 13CNMR 1HNMR 13CNMR 
146 CH3 4.07 93.2 n.s. 91.5 
147 Et 4.05 93.1 4.17 91.4 
Table 3.50: 1H- and 13C-NMR chemical shifts (ppm) of the hydroperoxy carbon  
(CH-OOH) of syn and anti diastereomers of 147 and 147 (in CDCl3). 
n.s. Not seen due to overlap with other signals. 
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Transperoxyacetalization reaction of 146 and 147 in methylene chloride using catalytic 
amount of BF3 afforded in both cases a 77:23 diastereomeric mixture of 2,3,8-
trioxabicyclo[3.2.1]octane derivatives (Scheme 3.100). Clearly, the exo-bicyclic derivatives 
(exo-148 and exo-149, with the two hydrogen atoms of the vicinal stereogenic centers in the 
same direction) are the major products resulting from the major syn-hydroperoxy alcohols, 
while the endo-diastereomers (endo-148 and endo-149) are the minor product that results 
from the minor anti-hydroperoxy alcohol. 
 
BF3.Et2O
OH
R
O O
OOH CH2Cl2
+
exo-148, exo-149146,147 endo-148, endo-149
O
O
O
R
HSR
O
O
O
R
H
S S
 
Scheme 3.100 
 
The constitution of both 2,3,8-trioxabicyclo[3.2.1]octane derivatives 148 and 149 was proven 
by 1D- and 2D-NMR data as well as IR and elemental analyses. As representative example, 
the IR spectrum of 148 showed the following characteristic absorption bands: at 3092 cm-1 
(vinylic CH), 2993, 2954 cm-1 (aliphatic CH), 1650 cm-1 (nonconjugated C=C), 1189, 1147, 
1055 cm-1 (C-O) and 900, 865 cm-1 (O-O). The most characteristic signals in 1H- and 13C-
NMR are shown in Table 3.51. 
 
OCH OOCH OOCO 
No. 
R 
 
1H-
NMR 
13C-
NMR 
1H-
NMR 
13C- 
NMR 
13C- 
NMR 
 
Yield 
(%) 
exo-148 CH3 4.60 75.0 3.94 85.8 111.0 
endo-148 CH3 4.30 76.3 4.65 84.4 110.0 
19 
exo-149 Et 4.54 74.8 3.89 85.8 113.1 
endo-149 Et 4.35 76.3 4.70 84.8 112.4 
12 
Table 3.51: Characteristic signals of 148 and 149 in 1H- and 13C-NMR (in CDCl3). 
 
Fortunatly, it was possible to separate the major exo-148 isomer from the diastereomeric 
mixture. Comparison of the NMR of the diastereomeric mixture and the separated exo-148 
isomer is shown in Figure 3.51. Obviously, the peroxyacetal carbon atoms in the 2,3,8-
trioxabicyclo[3.2.1]octanes are absorbing more downfield (δ = 110-113 ppm) since they 
represent the bridgehead of the bicyclic system. 
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Figure 3.51: 1H- and 13C-NMR spectra of exo-148 and endo-148 diastereomeric mixture (up) 
and only exo-148 isomer (down)  
 
Consistent with the NMR data, PM3 calculations (Figure 3.52) revealed that the heat of 
formation (∆Hf) of exo-148 is -56.53 kcal/mol while that for endo-148 is -52.87 kcal/mol. 
Clearly, the exo-148 diastereomer is more stable by about 3.7 kcal/mol than the endo isomer 
(due to the steric interactions between the isopropenyl group and the the bicyclic bridge in the 
endo isomer). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.52: Model of 1,2,4-trioxane endo-148 (left) and exo-149 (right) in a minimum energy 
conformations. The model was generated using PM3. 
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3.11 Hydroperoxides as Oxygen Donor in Dihydroxylation Reaction 
 
The introduction of oxygen functionalities to double bonds is a valuable transformation in the 
synthesis of polyoxygenated natural products such as macrolides and carbohydrates. The 
dihydroxylation reaction (also termed bishydroxylation) is an efficient route to diols from 
olefins.152 OsO4 is the most efficient oxidant often used for such conversion. It may be 
applied either in stoichiometric or catalytic amounts. However, due to the high price and 
extreme toxicity of this oxidant catalytic reactions are favored. Catalytic dihydroxylation 
reactions require the presence of another external oxygen donor (used in excess) to reoxidize 
the reduced “Os” species and regenerate OsO4 in the reaction mixture. Several cooxidants 
with variable efficiency such as alkali metal chlorates and hypochlorites,153 H2O2,154 t-
BuOOH,155 N-methylmorpholine N-oxide,156 and potassium ferricyanide157 were used. 
 
Using the allylic alcohols as substrates serves as template reaction in carbohydrate chemistry. 
One of the several routes to allylic alcohols is the reduction of the allylic hydroperoxides 
obtained by 1O2-ene reaction with olefins (vide supra). While intensive work on the 
dihydroxylation reaction of allylic alcohols was performed, the dihydroxylation of the parent 
hydroperoxides is almost absent in literature. In this part, I examined the feasibility of 
transforming allylic hydroperoxides into triols using a catalytic dihydroxylation reaction not 
only in presence but also in absence of the external cooxidant (Scheme 3.101). 
 
OOH
OH
OH
HO
OH
1O2
Red.
OsO4
?
 external
"O" donor  
Scheme 3.101 
 
Optimization of the reaction conditions for the catalytic dihydroxylation reaction of allylic 
hydroperoxides was performed for the substrate 24 (Scheme 3.102). As a reaction solvent I 
chose a polar solvent mixture to ensure the homogeneity of the reaction since osmium 
tetraoxide is soluble in polar solvents. Equivolume mixture of MeOH and water is the most 
convenient solvent not only for the reaction efficiency but also from the stand point of green 
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chemistry. By this way, no phase transfer conditions are needed making the reaction rate 
faster than heterogeneous conditions. Compared to the conventional bishydroxylation 
procedures that needs long reaction times, in our case, complete conversion to the 
corresponding triols proceeded smoothly at ambient temperature in only 15 minutes. No 
starting compounds could be identified in the product (by NMR). At the end of the reaction, 
the catalyst and any excess hydroperoxide reactant are decomposed by aqueous solution of an 
alkali metal sulfite with subsequent extraction of the triol by ethyl acetate. The reaction is 
simple, efficient, and cost effective procedure can lead to up to three chirality centers in a 
single step.  
 
HOO HO
HO
OH
cat. OsO4
MeOH : H2O
15 min. / r.t.
24 150  
Scheme 3.102 
 
The formation of 150 was unequivocally confirmed by the disappearance of the olefinic 
signals in 1H- and 13C-NMR. 1H-NMR is characterized by two new doublets (having coupling 
constant of about 11.5 Hz) resonating at 3.45 and 3.86 ppm are corresponding to the two 
diastereotopic protons of the methylene group. The large coupling constant is expected since 
it is geminal coupling on a saturated carbon. In 13C-NMR the two new methylene and 
quaternary carbinol carbons are absorbing at 68.3 and 75.3 (or 76.1) ppm respectively (Figure 
3.53).  
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Figure 3.53: 1H- and 13C-NMR of the triol 150 (CDCl3). 
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Analogous to the titanium catalyzed direct hydroxy-epoxidation reaction of the allylic 
hydroperoxide,158 in the catalytic bishydroxylation reaction in absence of external cooxidants, 
the allylic hydroperoxide plays a double role as the oxygen donor (for osmium tetraoxide 
regeneration) and after the oxygen transfer step, as the oxygen acceptor. A suggested 
mechanism for the reaction is depicted in Scheme 3.103. 
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O
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O
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Scheme 3.103: Mechanism of dihydroxylation of allylic hydroperoxides in absence of external cooxidant. 
 
I compared also the catalytic dihydroxylation reaction of the less reactive allylic 
hydroperoxide of the acrylate derivative 16 (OsO4 is electrophilic in nature) in presence of 
two equivalent of NMO as an external oxygen donor versus the no cooxidant conditions were 
the substrate itself is the cooxidant (Scheme 3.104). For the former reaction I used a substrate 
concentration of 0.31 M while in the latter reaction two fold this substrate concentration was 
used (0.6 M). In both reactions a diastereomeric mixture of the triol is obtained (about 85:15 
for the former while 79:21 for the latter reaction as calculated from 13C-NMR). However, the 
procedure where the substrate it self act simultaneously as an oxygen donor and acceptor is 
clearly advantageous since less reagents and shorter reaction times were needed even at a 
two-fold substrate concentration.  
cat. OsO4
MeOH : H2O
15 min. / r.t.
COOEt
OOH
COOEt
OH
OH
OH
COOEt
OOH
cat. OsO4
t-BuOH : H2O
24 h / r.t.
NMO
16 16151  
Scheme 3.104 
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The chemical constitution of 151 was assigned on the basis of 1D-NMR as well as 2D-NMR 
analysis. In 1H-NMR, the disappearance of the olefinic signal and the appearance of the 
characteristic signal corresponding to the two diastereotopic protons of the methylene group 
adjacent to the newly formed chiral center is indicative of the formation of 151. Each proton 
from the two diastereotopic protons appear as doublet (e.g. for the major diastereomer they 
resonate at 3.65 and 3.78 ppm) with large coupling constant (about 11.5 Hz) due to the 
geminal coupling on a saturated carbon. In 13C-NMR, the two signals corresponding to the 
double bond are no more detected, and the two new carbinol carbons absorbing at 64.8 and 
81.5 for the methylene and the quaternary carbons, respectively, of the major diastereomer are 
observed. While in 1H-NMR some signals of the minor diastereomer are partially overlapped 
with those of the major isomer, all signals of the minor diastereomer in 13C-NMR could be 
identified.  
 
To evaluate the effect of catalyst loading on the reaction efficiency, several runs of 
dihydroxylation reactions comprising different amounts of the oxidant catalyst (ranging from 
0.1 to 0.001 equiv.) were run for 24 under identical conditions and the yield of the products as 
well as their purity were examined (Table 3.52). Neither longer reaction times nor any 
noticeable decrease in the reaction efficiency was observed even on going to catalyst 
concentration of 0.1 mol %. However, in all cases due to the high hydrophilicity of the 
products modest reaction yields were obtained. 
 
Entry mol % OsO4 Reaction time (min) % Yielda 
1 10 15 37 
2 5 15 25 
3 1 15 37 
4 0.5 15 19 
5 0.1 15 31 
Table 3.52: Effect of catalyst loading on the bishydroxylation reaction of 24. 
a Yields correspond to the isolated triol. 
 
It is worth mentioning that this approach is advantageous over that with an external cooxidant 
where the reagents used in this reaction stem from renewable sources: One oxygen atom 
comes from water (since the reaction is highly catalytic) and the other two oxygen atoms 
come from air and they could be incorporated in the substrate with complete atom economy 
by activating molecular oxygen with visible light using a green photooxygenation approach 
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(solvent-free for the less volatile tiglate ester). This provides a simple and highly sustainable 
approach to triols from olefins.  
 
Searching for other catalysts which may catalyze such reaction is also advantageous due to 
the high toxicity of osmium tetraoxide. A patent159 concerning the synthesis of glycerol from 
allyl alcohol using catalytic amount of WO3 stimulated my attention to this oxidant. 
Repeating the reaction using the more benign WO3 for the hydroperoxide 24 led also to the 
corresponding triol. However, longer reaction time (3 days) was needed. This is attributed to 
the less solubility of WO3 compared to OsO4 in the reaction mixture and hence it’s less 
reactivity as oxygen donor. 
 
Whereas, acyclic terminal olefins could be efficiently converted to the corresponding triols in 
absence of external cooxidants, attempts to prepare the triols derived from cyclic allylic 
hydroperoxides such as 152-154 under similar conditions were not successful (Figure 3.54). 
A plausible explanation may be that due to the rigidity of such compounds, low energy 
conformational changes in the molecule in order to locate the hydroperoxy group in an 
optimum geometry for oxygen transfer reaction to the oxidant is not possible. It is known that 
these conformational effects in the cyclic substrates can retard the analogous oxygen-transfer 
epoxidation reaction.160 Also, the attack of OsO4 catalyst on the double bond may also be 
retarded by steric factors with the cyclic substrates. 
 
OOH
152 153
OOH
H
OOH
154  
Figure 3.54 
 
Studies directed toward the nature of the oxygen transfer step (intra- or intermolecular 
mechanism), regiochemistry of the reaction using diene hydroperoxides as well as effect of 
addition of chiral ligands on the reaction enantioselectivity should be accomplished in the 
future.  
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3.12 Antimalarial Activity of some Synthesized 1,2,4-Trioxane Compounds 
 
In a cooperative work, many synthesized 1,2,4-trioxanes were submitted to the Swiss Tropical 
Institute for testing the antimalarial activity. The compounds were tested in vitro against 
Plasmodium falciparum strain. It seems that lipophilicity plays an important factor in 
determining the antimalarial activity of the 1,2,4-trioxanes probably by causing fast diffusion 
through membranes. The obtained IC-50 data of some compounds are summarized in Table 
3.53. 
 
Compound 
P. falciparum. 
IC-50 
Cytotoxicity 
IC-50 
Artemisinin 0.0008 1.9 
Chloroquine 0.0638 1.9 
38 0.00054 0.74 
40 0.0055 4.3 
42 0.118 9.2 
43 0.1698 n.a. 
52 0.0061 2.3 
55 0.3656 4.1 
58 0.0014 2.6 
59 0.0078 2.6 
60 0.0038 2.5 
61 0.07975 6.8 
64 0.1374 4.7 
65 0.02475 1.8 
66 0.0088 3.7 
71 0.00053 1.4 
72 0.0020 2.5 
74 0.0053 1.7 
82 0.0024 0.82 
83 0.04825 n.a. 
85 0.00965 9.4 
86 0.0116 n.a. 
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88 0.3948 n.a. 
90 0.1696 1.2 
92 > 5 > 90 
96 > 5 36.5 
98 0.0013 1.7 
99 0.0127 > 10.0 
101 0.178 n.a. 
102 0.00615 n.a. 
103 0.225 n.a. 
104a 0.276 n.a. 
111 0.0895 3.0 
117 0.160 3.0 
118 1.495 7.1 
129b 2.031 53.8 
Table 3.53: All data are in µg/mL. 
n.a. Not applicable, data did not substantiate a cytotoxicity test. 
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4. Experimental Part 
 
 
4.1 General Remarks 
 
Chromatographic methods:  
 
Column Chromatography (CC): Silica gel 60, 0.063-0.200 mm (70-230 mesh ASTM) 
purchased from Merck company or silica gel 60, 0.040-0.063 mm (230-240 mesh ASTM) 
purchased from Macherey-Nagel company was used as stationary phase. All solvents used for 
the mobile phase were predried. 
 
TLC: Thin layer chromatography was performed on plastic sheets precoated with silica gel 
60 F254 (Merck) or aluminum sheets precoated polygram SIL-G/UV254 (Macherey-Nagel) 
spots were visualized by adsorption of iodine or under UV lamp (254 or 366 nm). Peroxidic 
compounds could be also visualized as yellow to brown spots by spraying with 10% KI 
solution and then subjecting the plate to hot air. Rf (rate of flow values) were used to 
characterize each compound. 
 
Preparative thick layer chromatography: 20 x 20 cm glass plates precoated with silica gel 
G F254 purchased from Merck company were used. The sample is placed as a line about 1 cm 
from the plate’s edge and the plate is eluted. The spots were visualized and the spot 
corresponding to the compound is scratched and collected. The pure product is extracted by 
adding dry CH2Cl2 to the silica gel, filtration and evaporation of the solvent. 
 
Spectroscopic methods 
 
IR: Infrared spectra were obtained using Perkin-Elmer 1600 series FTIR spectrometer and are 
given in cm-1 units. Solid samples are measured as CsI or KBr discs while liquids are 
measured as neat between two NaCl plates. 
 
UV-Vis: Beckman Coulter DU 800 spectrophotometer was used for measurement of 
absorption spectra. 
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1H-NMR: The 1H-NMR spectra were recorded on Bruker AC 300, Bruker DPX 300 
spectrometers operating at 300 MHz or on Bruker DRX 500 spectrometer instrument 
operating at 500 MHz. Chemical shifts are reported as δ in ppm and the coupling constant, J, 
in Hz units. In all spectra solvent peaks were used as internal standard. Solvent used are 
CDCl3 (δ = 7.24 ppm), DMSO-d6 (δ = 2.49 ppm), acetone-d6 (δ = 2.04 ppm), and MeOH-d4 
(δ = 3.35, 4.78 ppm). Splitting patterns are designated as follows: s, singlet; d, doublet; t, 
triplet; q, quartet; m, multiplet; br, broad. 
 
13C-NMR: The 13C-NMR spectra were recorded either on a Bruker AC 300 spectrometer 
instrument operating at 75 MHz or on Bruker DRX 500 spectrometer instrument operating at 
125 MHz.. In all spectra solvent peaks were used as internal standard. Solvent used are CDCl3 
(δ = 77 ppm), DMSO-d6 (δ = 39.7 ppm), acetone-d6 (δ = 29.8, 206.3 ppm), and MeOH-d4 (δ = 
49.2 ppm). Carbon multiplicities are determined either by DEPT experiment (distortionless 
enhancement by polarization transfer) or by APT experiment (attached proton test). 
 
Ms: Mass spectra were recorded on Finnigan Incos 500 quadrupole mass spectrometer 
applying 20 or 70 eV as ionization potential. Fragments masses are designated as m/z 
followed by the intensity (%). 
 
HRMS: High resolution mass spectra were recorded on Finnigan MAT 900 spectrometer and 
are measured for the molecular ion peak (M+). 
 
Analytical methods 
 
Elemental analysis: CHN-combustion analyses were measured using Elementar Vario EL 
Instrument. 
 
M.p: Melting points were measured using Büchi melting point apparatus type B-535 and they 
are uncorrected. 
 
X-ray analysis: All X-ray measurements were Nonius KappaCCD diffractometer (2Θmax = 
54°, MoKα radiation, λ = 0.71073 Å), graphite monochromator, ϕ / ω-scans. The structures 
were solved using direct methods (SHELXS-97, SHELXL-97). 
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Conversion: The conversion of the reactions was determined using the integration of 
characteristic signals in the NMR spectra (± 5 % error). 
 
Reagents and solvents: Solvents used are dried by distillation over the appropriate drying 
agent, THF and Et2O (over Na / benzophenone), n-hexane, CH2Cl2, CHCl3, ethyl acetate 
(over CaCl2), methanol and ethanol (over Mg), Et3N and pyridine (over KOH). All 
chlorinated hydrocarbons are also pretreated with potassium carbonate to remove HCl traces. 
Sensitizers as meso-tetraphenylporphyrin (TPP) and meso-tetratolylporphyrin (TTP) 
purchased from porphyrin-systems company and were used for chlorinated solvents or 
benzene while rose Bengal (RB) purchased from Fluka company was used for polar solvents. 
 
Nomenclature: New compounds were named according to AutoNom program.161 
 
Photolyses: Solvents used for irradiations are purchased from Fluka company (puriss. P.a.) 
and are used without further purification. Pyrex irradiation vessels purchased from Normag 
company were used for photooxygenation reaction in solutions.  
Halogen lamps or sodium street lamps (150 W) are used as irradiation source for gram scale 
photooxygenation experiments while High-pressure mercury lamp (150 W) in combination 
with a 370-nm cutoff filter was used for O2-uptake kinetic measurements in 30 mL irradiation 
unit.162 
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4.2 General Procedures 
 
General procedure for synthesis of allylic alcohols by Grignard reaction (GP-1): 
Under an inert atmosphere (note 1), a three-necked, round bottomed flask, fitted with a reflux 
condenser, pressure-equalized addition funnel and gas inlet, was charged with a suspension of 
magnesium turnings in dry Et2O (20 mL)(note 2). Then a solution of alkyl halide in dry Et2O 
(20 mL) was added dropwise at such a rate that the solvent refluxed smoothly. The reaction 
mixture was heated at reflux for 30 min and then left to come to r.t. and then a solution of 3-
methyl-2-butenal in dry Et2O (25 mL) was added dropwise. After complete addition, reflux 
was continued for 4 h, then the solution was cooled to r.t. and excess reagent was hydrolyzed 
by cold saturated NH4Cl solution (50 mL). The phases were separated and the aqueous phase 
was extracted with Et2O (3 x 30 mL), the combined organic phases were collected, washed 
with brine (2 x 50 mL) and dried over Na2SO4. Evaporation of the solvent by rotary 
evaporation (at ca. 20 °C, 15 torr) afforded the crude allylic alcohol which was further 
purified either by column chromatography or fractional distillation.  
Notes 
1. The reaction can be carried out either under Ar atmosphere, using a balloon, or under 
nitrogen, passing a continuous flow of nitrogen gas over the solution. 
2. The magnesium turnings were preactivated by heating with some crystals of iodine. 
 
General procedure for synthesis of allylic alcohols by organolithium compounds (GP-2): 
A 250 mL, three-necked, round-bottomed flask equipped with a pressure-equalized dropping 
funnel, N2 gas inlet and reflux condenser. The flask was charged with 3-methyl-2-butenal 
(4.41 g, 52.4 mmol) dissolved in dry THF or Et2O (100 mL). The organolithium compound 
(62.5 mmol) was carefully added dropwise at 0 °C under an atmosphere of N2. After complete 
addition the mixture was stirred at 0 °C for 4 h, and then the reaction was quenched with cold 
saturated NH4Cl solution (50 mL). The layers were separated and the aqueous layer was 
extracted with Et2O (3 x 30 mL), the combined organic layers were collected, washed with 
brine (3 x 50 mL) and dried over Na2SO4. The solvent was evaporated under reduced pressure 
and the residue was purified either by fractional distillation or column chromatography. 
 
General procedure for synthesis of aldol products (GP-3): 
To a stirred cold (-78 °C using dry ice/acetone bath) solution of LDA (1.1 equiv.) (Note 1) in 
30 mL dry Et2O (or THF) was added dropwise under an inert atmosphere a solution of the 
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methyl ketone (1 equiv.) in Et2O (or THF) (30 mL) over a period of 30 min. After complete 
addition the mixture was stirred for an additional 1 h at the same temperature. Then a solution 
of the appropriate carbonyl compound (1 equiv.) in 20 mL Et2O (or THF) was added and 
stirring was continued for 30 min. The temperature of the reaction mixture was raised to r.t. 
then it was poured into aqueous 1M HCl. The phases were separated and the aqueous phase 
was successively extracted with Et2O (3 x 50 mL). The combined organic phase was washed 
with aqueous NaHCO3, brine and dried over Na2SO4. Evaporation of the solvent followed by 
fractional distillation or column chromatography afforded the pure aldol. 
Notes 
1. LDA was prepared by addition of n-BuLi (caution !) at 0 °C to an equivalent amount of 
diisopropyl amine in dry Et2O (or THF) under an inert atmosphere. 
 
General procedure for the dehydration of aldol products to α,β-unsaturated carbonyl 
compounds (GP-4): 
To a solution of the β-hydroxy carbonyl compounds (1 equiv.) in CH2Cl2 (100 mL) was 
added 10 mol % solid p-toluenesulfonic acid (0.1 equiv.) and the mixture was stirred at r.t 
overnight. The mixture was partitioned between CH2Cl2 and aqueous NaHCO3 then the 
aqueous layer was extracted with CH2Cl2 (3 x 30 mL). The combined organic layer was 
washed with brine and dried over Na2SO4. Solvent evaporation under reduced pressure 
followed by fractional distillation or column chromatography afforded the pure α,β-
unsaturated carbonyl compounds. 
 
General procedure for the reduction of α,β-unsaturated carbonyl compounds to allylic 
alcohols (GP-5): 
Under an inert atmosphere, an ether solution of the enone (1 equiv.) was added dropwise at 
r.t. to a suspension of LiAlH4 (1 equiv.) in dry ether at such a rate as to maintain gentle reflux. 
After stirring at r.t. overnight the reaction mixture was treated slowly (caution, vigorous 
evolution of hydrogen gas !) with 1 mL water then 1 mL 15 % aqueous NaOH and at last with 
3.5 mL water (For each gram of the reducing agent used unless otherwise mentioned). The 
precipitate was removed by filtration, digested with ether and the combined ether extracts 
were washed with water, brine and dried over MgSO4. Evaporation of the solvent under 
reduced pressure followed by fractional distillation or column chromatography afforded the 
pure allylic alcohol. 
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General procedure for the polymerization of sensitizers with styrene and divinylbenzene 
(GP-6): 
Deionized water (200 ml), acidified to pH = 2.3 with sulfuric acid, was purged with nitrogen 
and heated to 70 °C for 20 min in a 500 ml three-necked flask equipped with stopper, reflux 
condenser and gas inlet. Subsequently, 10 g of styrene (S), 100 mg of divinylbenzene (DVB) 
and 10 mg of the polymerizable sensitizer were added rapidly and the system was sealed in 
order to prevent contamination with air. While the mixture was being vigorously stirred, 120 
mg of potassium peroxodisulfate in 10 ml of water was added at once. As the polymerization 
proceeds, the color of the reaction mixture turns faint red and after a polymerization period of 
about 7-9 h, the reaction mixture was quenched with methanol (200 mL) and then cooled to 
room temperature. The polymer particles were separated by centrifugation at 3500 rpm, and 
any free (non-polymerized) sensitizer particles were removed by extraction with methylene 
chloride several times until the dye in the washing solvent is no more detected. The beads 
dried at 40 °C under vacuum to afford the polymer-bound sensitizer. 
(a) Polymerization of tetrastyrylporphyrin (TSP) with styrene and divinylbenzene: 
Following GP-6, using 10 mg of TSP, 4.2 g (42 %) of the polymer-bound sensitizer TSP-S-
DVB was obtained as sandy solid. 
(b) Polymerization of protoporphyrin-IX (PP) with styrene and divinylbenzene: 
Following GP-6, using 10 mg of PP, 3.25 g (33 %) of the polymer-bound sensitizer PP-S-
DVB was obtained as sandy solid. 
 
General procedure for the homogeneous type-II photooxygenation reaction (GP-7): 
The substrate (ca. 10 mmol) and the photosensitizer were dissolved in the appropriate solvent 
(100 mL) and irradiated with two external 150 W halogen lamps (sodium street lamps could 
be also used) while a stream of air (or oxygen) was passed through the reaction mixture. The 
course of the reaction was monitored over time by means of TLC. After complete 
consumption of the starting material, the solvent was distilled off under reduced pressure 
(caution, water bath temperature should not exceed 30 °C) and the composition of the crude 
reaction mixture was determined by 1H- as well as 13C-NMR. 
(a) Using rose Bengal (RB) as sensitizer: 
10-3 M solution of RB in dry MeOH (100 mL) was used as solvent. 
(b) Using meso-tetraphenylporphyrin (TPP) as sensitizer: 
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5 x 10-4 M solution of TPP in dry CCl4 (100 mL) was used as solvent. Other p-substituted 
meso-tetraarylporphyrin as meso-tetratolylporphyrin (TTP) and other halogenated solvents as 
CH2Cl2 or CHCl3 can be also used. 
 
General procedure for the heterogeneous type-II photooxygenation reaction (GP-8): 
The substrate (ca. 5 mmol) was dissolved in CCl4 (30 mL) and the polymer-bound sensitizer 
(ca. 35 mg) was suspended in the solution and the whole mixture is irradiated in the oxygen-
uptake apparatus. The reaction progress was monitored against time. At the end of the 
reaction, the sensitizer-bound to polymer was filtered off (for regeneration and reuse) and the 
filtrate was distilled off under reduced pressure to afford the product (caution, water bath 
temperature should not exceed 30 °C). 
 
General procedure for solvent-free type-II photooxygenation reaction in polymer 
matrices (GP-9): 
(a) Using commercial PS-DVB copolymer: 
The polymer particles (ca. 2-3 g) were introduced into a Petri dish (19 cm diameter) and were 
swollen by CH2Cl2 (20 mL). The substrate (ca. 10 mmol) and the nonpolar sensitizer (TPP or 
TTP, ca. 3-6 mg) in ethyl acetate (20 mL) were subsequently added and the excess solvent is 
evaporated by leaving the Petri dish in a well ventilated hood. The Petri dish is covered with a 
glass plate and the sandy solid is irradiated with halogen lamp or sodium street lamp. The 
polymer beads were subsequently rinsed with ethanol (3 x 30 mL) and filtered (the beads are 
kept for regeneration and reuse). The solvent was evaporated under reduced pressure (caution, 
water bath temperature should not exceed 30 °C) and the composition of the product was 
determined by 1H- as well as 13C-NMR. 
(b) Using synthesized TSP-S-DVB or PP-S-DVB copolymers: 
The dye-cross-linked polymer beads (TSP-S-DVB or PP-S-DVB, ca. 0.60 g) in a Petri dish 
(14 cm in diameter) were swollen by CH2Cl2 (20 mL) then the substrate (ca. 5 mmol) in ethyl 
acetate (20 mL) was added. Subsequent treatment as in protocol (a) affords the product. 
 
General procedure for analytical-scale type-II photooxygenation reaction for kinetic 
measurements (GP10): 
For kinetic runs, developed O2-uptake measuring instrument with automatic oxygen-
consumption recording system was used.163 An irradiation unit with capacity up to 30 mL was 
used as reaction vessel (Duran glass with a quartz side window and cooling jacket). The 
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irradiation unit is connected to a graduated burette (having cooling jacket too) which in turn 
connected to a moving reservoir filled with water by means of tubing. Ethanol adapted at the 
required reaction temperature was circulated through the system by a pumping thermostat. 
The irradiation unit is filled with the solution of the sensitizer and substrate then the whole 
system is saturated with oxygen and closed.  
The amount of oxygen consumed during the reaction results in a decrease in the internal 
pressure in the burette which is compensated by transfer of water from the reservoir into the 
burette. This change in pressure is detected by a small sponge in a U-shaped tube surrounded 
by a light beam. As a consequence of cutting this light beam during the sponge’s movement 
the reservoir moves. The reservoir movement over time is recorded on a xt-writing instrument 
and from the curve obtained (cm/h) or from the recalculated oxygen volume per unit time 
(mL/h), photooxygenation reaction rate of different substrates can be compared.164,162 
 
General procedure for synthesis of amino acids methyl ester hydrochloride (GP-11):  
To a cold (NaCl/crushed ice bath) absolute methanol (50 mL) is added dropwise thionyl 
chloride (4.2 mL, 60 mmol) over a period of 5-10 min. The solution is stirred for 5 min then 
solid amino acid (30 mmol) is added in one portion. Stirring is continued for 30 min at the 
same temperature then the ice bath is removed and the solution is refluxed for 3 h. The 
solution is allowed to cool to r.t. and the excess solvent is removed under reduced pressure to 
afford the amino acid methyl ester hydrochloride as white solid which is used without further 
purification. 
 
General procedure for synthesis of N-acylamino acids methyl ester (GP-12):  
To a cold (0 °C, NaCl/crushed ice bath), suspension of the amino acid methyl ester 
hydrochloride (100 mmol) in dry CHCl3 (150 mL), is added dropwise under stirring triethyl 
amine (20.20 g, 200 mmol). Stirring is completed 15 min followed by dropwise addition of 
the acid chloride (100 mmol) and the solution is allowed to warm to room temperature. After 
stirring for 1 h, the solvent is evaporated and the remaining solid is digested by ethyl acetate, 
filtered through a pad of silica gel. Evaporation of ethyl acetate under reduced pressure 
affords the corresponding amide in high purity which is used without further purification. 
 
General procedure for synthesis of 2,4-disubstituted-5-methoxyoxazoles (GP-13):  
To a solution of the N-acyl-L-amino acid methyl ester (100 mmol) in dry CHCl3 (30 mL) is 
added phosphorous pentachloride (20.8 g, 100 mmol) and the flask is protected from moisture 
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by a reflux condenser having calcium chloride-filled drying tube. The solution is gently 
warmed in a water bath at about 60 °C (until no HCl gas is evolved). When the solution 
becomes yellow, Et2O (50 mL) and ice were added followed by dropwise addition of 20 % 
aqueous KOH or saturated NaCO3 solution until neutralization then the mixture is stirred at 
r.t. for 30 min. The layers are separated and the aqueous phase is extracted with Et2O (3 x 100 
mL). The combined organic phase is washed with water, brine and dried over Na2SO4. The 
solvent is evaporated under reduced pressure and the residue is fractionally distilled to give 
the product. 
 
General procedure for solvent-free photooxygenation of oxazoles (GP-14): 
The dye-crosslinked polymer beads, TSP-S-DVB or PP-S-DVB (0.50 g) were added into a 
Petri dish (14 cm diameter) and treated with 20 ml methylene chloride, subsequently the 
oxazole dissolved in 20 ml ethyl acetate and the excess solvent was evaporated. The Petri dish 
was covered with a glass plate and irradiated with a 150 W halogen or sodium street lamp. 
The product was extracted with 2 x 30 ml of methanol or ethyl acetate and filtrated. After 
evaporation of the solvent the corresponding 1,2,4-dioxazole was isolated as pure product. 
The peroxides are not infinitely stable and decompose slowly to give the corresponding amide 
and dicarbonyl fragments.165 
 
General procedure for the peroxyacetalization reaction and 1,2,4-trioxanes synthesis 
(GP-15) 
To a stirred solution of β-hydroxy hydroperoxides and the condensing reagent in dry CH2Cl2 
(100 mL) was added at r.t. a catalytic amount of boron trifluoride etherate (ca. 0.2 mL) and 
the mixture was further stirred for about 12 h (overnight) at the same temperature. The 
reaction mixture was partitioned between CH2Cl2 and saturated NaHCO3 solution then the 
phases were separated. The aqueous phase was extracted with CH2Cl2 (3 x 30 mL) and the 
combined organic phases were washed with brine, water, dried over Na2SO4. Solvent 
evaporation (caution, water bath temperature should not exceed 30 °C) followed by 
chromatographic purification afforded the 1,2,4-trioxane as pure product. 
 
General procedure for Lewis-acid catalyzed cleavage of β-hydroxy hydroperoxides and 
their cross-peroxyacetalization reaction into 1,2,4-trioxanes (GP-16) 
To a stirred solution of β-hydroxy hydroperoxides in dry CH2Cl2 (100 mL) was added at r.t. a 
catalytic amount of boron trifluoride etherate (ca. 0.2 mL) and the mixture was further stirred 
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for about 12 h (overnight) at the same temperature. The reaction mixture was partitioned 
between CH2Cl2 and saturated NaHCO3 solution then the phases were separated. The aqueous 
phase was extracted with CH2Cl2 (3 x 30 mL) and the combined organic phases were washed 
with brine, water, dried over Na2SO4. Solvent evaporation (caution, water bath temperature 
should not exceed 30 °C) followed by chromatographic purification afforded the 1,2,4-
trioxanes as pure products. 
Note  
All β-hydroxy allylic hydroperoxides used in 1,2,4-trioxane syntheses are prepared according 
to GP-9a unless otherwise is mentioned. 
 
General procedure for synthesis of triols from allylic hydroperoxides or allylic alcohols 
using catalytic OsO4 and N-methylmorpholine N-oxide as cooxidant (GP-17): 
To a stirred solution of the allylic hydroperoxide or allylic alcohol (0.62 mmol) in tert-butanol 
(1 mL) and H2O (1 mL) is added N-methylmorpholine N-oxide (145 mg, 1.24 mol, 2 equiv.) 
followed by 2.5 % solution of OsO4 in tert-butanol (0.03 mmol, 0.05 equiv.) (caution, highly 
toxic !). The reaction mixture is stirred at r.t. for 24 h then quenched with aqueous sodium 
sulfite solution. The phases were separated and the aqueous phase is extracted with ethyl 
acetate (3 x 30 mL), then the combined organic layers are dried over MgSO4. Evaporation of 
the solvent under reduced pressure affords the corresponding triol in good purity. 
 
Synthesis of triols from allylic hydroperoxides using catalytic OsO4 and in absence of 
external cooxidant (GP-18): 
To a stirred solution of the allylic hydroperoxide (1.2 mmol) in H2O (1 mL) and methanol (1 
mL) is added 2.5 % solution of OsO4 in tert-butanol (0.1-0.001 equiv.) (caution, highly toxic 
!). The reaction mixture is stirred for 15 min at r.t. then quenched with aqueous sodium sulfite 
solution. The phases were separated and the aqueous phase is extracted with ethyl acetate (3 x 
30 mL), then the combined organic layers are dried over MgSO4. Evaporation of the solvent 
under reduced pressure affords the corresponding triol in good purity. 
 
Synthesis of triols from allylic hydroperoxides using catalytic WO3 and in absence of 
external cooxidant (GP-19): 
To a solution of the allylic hydroperoxide (1.2 mmol) in H2O (1 mL) and methanol (1 mL) is 
added under stirring solid WO3 (0.1-0.05 equiv.). The reaction mixture is stirred for 3-5 days 
at r.t. then quenched with aqueous sodium sulfite solution. The phases were separated and the 
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aqueous phase is extracted with ethyl acetate (3 x 30 mL), then the combined organic layers 
are dried over MgSO4. Evaporation of the solvent under reduced pressure affords the 
corresponding triol in good purity. 
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4.3 Synthesis of tetrastyrylporphyrin (TSP) 
 
4-(2-Bromoethyl)benzaldehyde (2) 
(elid 296c) 
 
Br
CHO  
 
To a cold (0°C using ice bath) solution of 2-bromoethylbenzene (1) (18.5 g, 100 mmol) in 
CH2Cl2 (100 mL) is added in one portion TiCl4 (22 mL) followed by gradual addition of 
dichloromethyl methyl ether (11.5 g, 100 mol). The reaction mixture is stirred for 1 h then it 
is poured into ice cold water and the phases are separated. The aqueous phase is extracted 
with CH2Cl2 (2 x 30 mL), and the combined organic phases are washed with saturated 
NaHCO3, water and brine. Solvent is evaporated under reduced pressure and the residue is 
purfied by fractional distillation (116-118 °C, 2.3 torr, Lit. 108-110 °C, 1 torr166) to give the 
pure aldehyde (5.58 g, 26.2 mmol). 
 
Yield: 26 % 
1H-NMR: (300 MHz, CDCl3)  
δ (ppm) = 3.19 (t, 2H, J = 7.20 Hz, CH2), 3.54 (t, 2H, J = 7.20 Hz, CH2Br), 7.32 (d, 
2H, J = 8.07 Hz, 2 x CHarom), 7.77 (d, 2H, J = 8.25 Hz, 2 x CHarom), 9.93 (s, 1H, 
CHO). 
13C-NMR: (75.5 MHz, CDCl3)  
δ (ppm) = 31.9 (t, CH2Br), 39.1 (t, CH2C), 129.3 (d, 2 x CHarom), 130.0 (d, 2 x CHarom), 
135.2 (s, Cqarom), 145.7 (s, Cqarom), 191.8 (d, CHO). 
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5,10,15,20-Tetrakis-[4-(2-bromo-ethyl)-phenyl]-porphyrin (3) 
(elid 299a) 
 
H
N
N
N
H
N
Br
Br
Br
Br
 
 
4-(2-Bromoethyl)benzaldehyde (2) (5.58 g, 26.2 mmol) and pyrrole (1.75 g, 26.1 mmol) are 
heated in propionic acid for 20 min then cooled to r.t., filtered, washed with ethanol and water 
then dried. The residue is purified with column chromatography (SiO2, CCl4/CHCl3, 1:1, Rf = 
0.58) to give the product (5.73 g, 5.5 mmol) as violet solid.  
 
Yield: 21 % 
1H-NMR: (300 MHz, CDCl3)  
δ (ppm) = -2.80 (s, 2H, 2 x NH), 3.50 (t, 8H, J = 7.59 Hz, CH2), 3.86 (t, 8H, J = 7.52 
Hz, 4 x CH2Br), 7.57 (d, 8H, J = 8.10 Hz, 8 x CHarom), 8.15 (d, 8H, J = 7.92 Hz, 8 x 
CHarom), 8.82 (s, 8H, 4 x CH=CH). 
IR: (CsI) 
ν (cm-1) = 3471, 3419, 3386, 3316, 3023, 2963, 2925, 1603, 1349, 1261, 1095, 1021, 
803, 661 
UV: (CH2Cl2) 
 λmax = 419 nm (ε419 nm = 448990 M-1 cm-1), C = 9.41 x 10-7 M. 
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5,10,15,20-Tetrakis-(4-vinyl-phenyl)-porphyrin (4) 
(elid 301a, 491g, 369a) 
 
H
N
N
N
H
N
 
 
A solution of (3) (90 mg, 0.086 mmol) in N,N-dimethylformamide and 25 % alcoholic 
potassium hydroxide were heated at 50 °C for 7 h. then cooled to r.t., filtered, washed with 
ethanol and water then dried. The residue is purified with column chromatography (SiO2, 
CCl4/CHCl3, 3:1, Rf = 0.71) to give the pure product (58.7 mg, 0.082 mmol) as violet solid.  
 
Yield: 95 % 
1H-NMR: (300 MHz, CDCl3)  
δ (ppm) = -2.77 (s, 2H, 2 x NH), 5.48 (d, 4H, J = 11.52 Hz, 4 x CH2=CH), 6.05 (dd, 
4H, J = 0.57, 17.58 Hz, 4 x CH2=CH), 7.05 (dd, 8H, J = 10.98, 17.73 Hz, 4 x 
CH=CH2), 7.79 (d, 8H, J = 8.22 Hz, 8 x CHarom), 8.16 (d, 8H, J = 8.04 Hz, 8 x 
CHarom), 8.86 (s, 8H, 4 x CH=CH). 
UV: (CH2Cl2) 
 λmax = 421 nm (ε421 nm = 483468 M-1 cm-1), C = 1.73 x 10-6 M. 
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4.4 Synthesis of Substrates for 1O2 Photooxygenation Reaction 
 
4-Methylpent-3-en-2-ol167 (6a) 
(elid 84)  
OH
 
 
The preparation and work-up were carried out according to GP-5 using mesityl oxide (26) 
(5.0 g, 50.9 mmol) and LiAlH4 (1.0 g, 26.4 mmol). The crude product was fractionally 
distilled (b.p. 87-89 °C, 90 torr) to give the pure allylic alcohol (4.23 g, 42.3 mmol) as 
colorless oil. 
 
Yield:  83 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.16 (d, 3H, J = 6.3 Hz, CH3CH), 1.62 (d, 3H, J = 1.3 Hz, CH3C=), 1.65 (d, 
3H, J = 1.3 Hz, CH3C=), 4.49 (dq, 1H, J = 6.3, 8.6 Hz, CH-OH), 5.14 (d, 1H, J = 8.6 
Hz, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3CH), 23.5 (q, CH3C=), 25.6 (t, CH2), 64.7 (d, CH-OH), 129.3 
(d, CH=C), 133.9 (s, C=CH). 
 
5-Methylhex-4-en-3-ol168 (6b) 
(elid 318d)  
OH
 
 
The preparation and work-up were carried out according to GP-1 using ethyl bromide (6.13 g, 
56.3 mmol), magnesium turnings (1.37 g, 56.3 mmol) and 3-methyl-2-butenal (25) (3.79 g, 
45.0 mmol). Büchi distillation of the crude product at about 112 °C, 90 torr using water 
vacuum pump (Lit. 63 °C, 12 torr168) afforded 2.64 g (23.2 mmol) of the pure allylic alcohol 
as colorless oil. 
 
Yield:  52 % 
1H-NMR: (300 MHz, CDCl3) 
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δ (ppm) = 0.83 (dd, 3H, J = 7.42, 7.42 Hz, CH3CH2), 1.32-1.63 (m, 2H, CH2CH3), 
1.64 (d, 3H, J = 1.32 Hz, CH3C=), 1.68 (d, 3H, J = 1.32 Hz, CH3C=), 4.20 (ddd, 1H, J 
= 6.60, 6.60, 8.67 Hz, CH-OH), 5.08 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.7 (q, CH3CH2), 18.1 (q, CH3C=), 25.7 (q, CH3C=), 30.5 (t, CH2CH3), 70.0 
(d, CH-OH), 128.0 (d, CH=C), 135.0 (s, C=CH). 
 
2,5-Dimethylhex-4-en-3-ol168 (6c) 
(elid 476u)  
OH
 
 
The preparation and work-up were carried out according to GP-1 using isopropyl bromide 
(9.23 g, 75.0 mmol), magnesium turnings (1.80 g, 75.0 mmol) and 3-methyl-2-butenal (25) 
(4.92 g, 58.6 mmol). Büchi distillation of the crude product at about 125 °C, 90 torr using 
water vacuum pump (Lit. 59 °C, 12 torr168) afforded the pure allylic alcohol (5.0 g, 39.0 
mmol) as colorless oil. 
 
Yield:  67 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.77 (d, 3H, J = 6.78 Hz, CH3CH), 0.87 (d, 3H, J = 6.75 Hz, CH3CH), 1.58 
(m, 1H, CH(CH3)2), 1.60 (d, 3H, J = 1.47 Hz, CH3C=), 1.66 (d, 3H, J = 1.47 Hz, 
CH3C=), 3.96 (dd, 1H, J = 6.75, 8.97 Hz, CH-OH), 5.12 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3CH), 18.2 (q, CH3CH), 18.2 (q, CH3C=), 25.7 (q, CH3C=), 34.3 
(d, CH(CH3)2), 73.5 (d, CH-OH), 126.4 (d, CH=C), 135.2 (s, C=CH). 
 
2-Methylhept-2-en-4-ol (6d) 
(elid 465c)  
OH
 
 
The preparation and work-up were carried out according to GP-1 using n-propyl bromide 
(6.15 g, 50 mmol), magnesium turnings (1.20 g, 50 mmol) and 3-methyl-2-butenal (25) (3.36 
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g, 40 mmol). Büchi distillation of the crude product at about 137 °C, 90 torr using water 
vacuum pump gives the pure allylic alcohol (4.25 g, 33.2 mmol) as colorless oil. 
 
Yield:  83 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.86 (t, 3H, J = 7.20 Hz, CH3CH2), 1.18-1.57 (m, 4H, CH2CH2), 1.62 (d, 
3H, J = 1.32 Hz, CH3C=), 1.66 (d, 3H, J = 1.47 Hz, CH3C=), 4.28 (ddd, 1H, J = 6.46, 
6.46, 8.67 Hz, CH-OH), 5.08 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.0 (q, CH3CH2), 18.1 (q, CH3C=), 18.6 (t, CH2CH3), 25.7 (q, CH3C=), 
39.8 (t, CH2CH), 68.3 (d, CH-OH), 128.3 (d, CH=C), 134.6 (s, C=CH). 
 
6-Methylhept-1,5-dien-4-ol170 (6e) 
(elid 481d)  
OH
 
 
The preparation and work-up were carried out according to GP-1 using allyl bromide (6.05 g, 
50 mmol), magnesium turnings (1.20 g, 50 mmol) and 3-methyl-2-butenal (25) (3.36 g, 40 
mmol). The crude product was purified by column chromatography (SiO2, EA/n-hex, 1:8, Rf 
= 0.48) to give the pure allylic alcohol (3.83 g, 30.4 mmol) as colorless oil. 
 
Yield:  76 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.62 (s, 3H, CH3C=), 1.66 (s, 3H, CH3C=), 2.20 (m, 2H, CH2CH=), 4.32 
(ddd, 1H, J = 6.84, 6.84, 7.65 Hz, CH-OH), 5.01-5.15 (m, 3H, CH=C and CH2=CH), 
5.75 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.1 (q, CH3C=), 25.6 (q, CH3C=), 42.1 (t, CH2CH=), 67.6 (d, CH-OH), 
117.5 (t, CH2=CH), 127.3 (d, CH=C), 134.5 (d, CH=CH2), 135.0 (s, C=CH). 
 
3,6-Dimethylhepta-1,5-dien-4-ol169 (6f) 
(elid 486j)  
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OHOH
 
 
The preparation and work-up were carried out according to GP-1 using 3-chlorobut-1-ene 
(9.05 g, 100 mmol), magnesium turnings (3.6 g, 150 mmol) and 3-methyl-2-butenal (25) (8.4 
g, 100 mmol). The crude product was fractionally distilled (67-69 °C, 5 torr169) to give the 
pure allylic alcohol (8.0 g, 57.1 mmol, 57 %) as colorless oil in a 53:47 diastereomeric 
mixture a,b. 
 
1H-NMR: (300 MHz, CDCl3, diastereomer a) 
δ (ppm) = 0.97 (d, 3H, J = 6.93 Hz, CH3CH), 1.63 (d, 3H, J = 3.09 Hz, CH3C=), 1.69 
(d, 3H, J = 4.56 Hz, CH3C=), 2.29 (m, 1H, CHCH3), 4.17 (dd, 1H, J = 5.73, 8.97 Hz, 
CH-OH), 5.0-5.13 (m, 3H, CH=C and CH2=CH), 5.74 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, diastereomer a) 
δ (ppm) = 14.8 (q, CH3CH), 18.3 (q, CH3C=), 25.8 (q, CH3C=), 43.8 (d, CHCH3), 71.6 
(d, CH-OH), 115.2 (t, CH2=CH), 125.8 (d, CH=C), 135.8 (s, C=CH), 140.1 (d, 
CH=CH2). 
 
1H-NMR: (300 MHz, CDCl3, diastereomer b) 
δ (ppm) = 0.91 (d, 3H, J = 6.90 Hz, CH3CH), 1.63 (d, 3H, J = 3.09 Hz, CH3C=), 1.69 
(d, 3H, J = 4.56 Hz, CH3C=), 2.14 (m, 1H, CHCH3), 4.03 (dd, 1H, J = 8.29, 8.29 Hz, 
CH-OH), 5.0-5.13 (m, 3H, CH=C and CH2=CH), 5.74 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, diastereomer b) 
δ (ppm) = 16.0 (q, CH3CH), 18.4 (q, CH3C=), 25.8 (q, CH3C=), 45.1 (d, CHCH3), 71.5 
(d, CH-OH), 116.1 (t, CH2=CH), 125.4 (d, CH=C), 136.1 (s, C=CH), 140.9 (d, 
CH=CH2). 
 
2-Methyloct-2-en-4-ol170 (6g) 
(elid 420b)  
OH
 
 
The preparation and work-up were carried out according to GP-2 using n-BuLi (39 mL of 1.6 
M solution, 62.4 mmol) and 3-methyl-2-butenal (25) (4.41 g, 52.5 mmol). The crude product 
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was purified by column chromatography (SiO2, EA/n-hex, 1:8, Rf = 0.31) to give the pure 
allylic alcohol as colorless oil. 
 
Yield:  6.0 g (81 %) 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.84 (t, 3H, J = 6.91 Hz, CH3CH2), 1.13-1.58 (m, 6H, CH2CH2CH2), 1.62 
(d, 3H, J = 1.47 Hz, CH3C=), 1.67 (d, 3H, J = 1.32 Hz, CH3C=), 4.26 (ddd, 1H, J = 
6.47, 6.47, 8.82 Hz, CH-OH), 5.08 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.0 (q, CH3CH2), 18.1 (q, CH3C=), 22.6 (t, CH2CH3), 25.7 (q, CH3C=), 
27.6 (t, CH2CH2), 37.4 (t, CH2CH), 68.6 (d, CH-OH), 128.3 (d, CH=C), 134.7 (s, 
C=CH). 
 
2,6-Dimethylhept-2-en-4-ol (6h) 
(elid 483g)  
OH
 
 
The preparation and work-up were carried out according to GP-1 using isobutyl bromide 
(6.85 g, 50 mmol), magnesium turnings (1.20 g, 50 mmol) and 3-methyl-2-butenal (25) (3.36 
g, 40 mmol). Büchi distillation of the crude product using water vacuum pump at about 150 
°C, 90 torr (Lit. 74-76 °C, 12 torr171) afforded the pure allylic alcohol (3.87 g, 28.2 mmol) as 
colorless oil. 
 
Yield:  70 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.83 (m, 6H, (CH3)2CH), 1.16 (m, 1H, CH2CH), 1.40 (m, 1H, CH2CH), 1.55 
(m, 1H, CH(CH3)2), 1.60 (d, 3H, J = 3.39 Hz, CH3C=), 1.63 (d, 3H, J = 3.09 Hz, 
CH3C=), 4.32 (m, 1H, CH-OH), 5.05 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3C=), 22.5 (q, CH3CH), 22.8 (q, CH3CH), 24.4 (d, CH(CH3)2), 
25.5 (q, CH3C=), 46.7 (t, CH2CH), 66.6 (d, CH-OH), 128.7 (d, CH=C), 133.9 (s, 
C=CH). 
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2,5-Dimethylhept-2-en-4-ol (6i) 
(elid 500p, 496r, 465d) 
OHOH
 
 
The preparation and work-up were carried out according to GP-2 using sec-butyl lithium 
(48.1 mL of 1.3 M solution, 62.5 mmol), and 3-methyl-2-butenal (25) (4.41 g, 52.5 mmol) in 
dry THF. The crude product was purified by column chromatography (SiO2; EA/n-hex; 1:5, 
Rf = 0.67) to afford the pure allylic alcohol (4. 48 g, 31.5 mmol) as yellow oil. 
 
Yield:  60 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.77 (m, 6H, CH3CH and CH3CH2), 0.92-1.56 (m, 6H, CH2CH3 and 
CHCH3), 1.59 (d, 3H, J = 1.46 Hz, CH3C=), 1.63 (d, 3H, J = 1.32 Hz, CH3C=), 4.19 
(m, 1H, CH-OH), 5.06 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3, major product) 
δ (ppm) = 11.2 (q, CH3CH2), 18.0 (q, CH3CH), 19.0 (q, CH3C=), 25.6 (q, CH3C=), 
29.2 (t, CH2CH3), 32.0 (t, CH2), 34.3 (d, CHCH3), 25.1 (t, CH2), 68.8 (d, CH-OH), 
128.4 (d, CH=C), 134.3 (s, C=CH). 
13C-NMR: (75.5 MHz, CDCl3, significant additional signals of minor product) 
δ (ppm) = 11.2 (q, CH3CH2), 19.0 (q, CH3C=), 29.3 (t, CH2CH3), 128.4 (d, CH=C), 
134.4 (s, C=CH). 
IR: (Film) 
ν (cm-1) = 3200-3600, 2962, 2929, 1677, 1376, 1017. 
Elemental Analysis: (C9H18O, M =142.24) 
Calcd: C 76.00   H 12.76 
Found: C 76.21   H 12.76 
 
2,2,5-Trimethylhex-4-en-3-ol168 (6j) 
(elid 449e)  
OH
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The preparation and work-up were carried out according to GP-2 using tert-BuLi (25 mL of 
1.5 M solution, 37.5 mmol), and 3-methyl-2-butenal (25) (2.63 g, 31.3 mmol) in dry Et2O 
(100 mL). The crude product was purified by column chromatography (SiO2, EA/n-hex, 1:8, 
Rf = 0.49) to afford 0.90 g (6.3 mmol) of the pure allylic alcohol as yellow oil. 
 
Yield:  20 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.83 (s, 9H, (CH3)3C), 1.62 (d, 3H, J = 1.47 Hz, CH3C=), 1.68 (d, 3H, J = 
1.47 Hz, CH3C=), 3.93 (d, 1H, J = 9.24 Hz, CH-OH), 5.15 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.3 (q, CH3C=), 25.4 (q, (CH3)3C), 26.0 (q, CH3C=), 35.3 (s, C(CH3)3), 
75.9 (d, CH-OH), 124.9 (d, CH=C), 135.6 (s, C=CH). 
 
3,3,6-Trimethylhepta-1,5-dien-4-ol (artemesia alcohol) (6k) 
(elid 483l)  
OH
 
 
The preparation and work-up were carried out according to GP-1 using prenyl magnesium 
bromide (12.37 g, 83 mmol), and 3-methyl-2-butenal (25) (5.0 g, 59.5 mmol). The crude 
product was purified by column chromatography (SiO2, EA/n-hex, 1:8, Rf = 0.43) to give the 
pure allylic alcohol (1.50 g, 9.7 mmol) as faint yellow oil. 
 
Yield:  16 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.94 (s, 3H, (CH3)2C),0.96 (s, 3H, (CH3)2C), 1.65 (s, 3H, CH3C=), 1.71 (s, 
3H, CH3C=), 3.99 (d, 1H, J = 9.24 Hz, CH-OH), 4.99-5.16 (m, 3H, CH2=CH and 
CH=C), 5.85 (dd, 1H, J = 10.86, 17.34 Hz, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.4 (q, CH3C=), 21.2 (q, (CH3)2C), 23.9 (q, (CH3)2C), 26.0 (q, CH3C=), 
41.9 (s, C(CH3)2), 74.5 (d, CH-OH), 113.2 (t, CH2=CH), 124.1 (d, CH=C), 136.3 (s, 
C=CH), 145.1 (d, CH=CH2). 
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(E)-2-Methyl-4-phenylbut-3-en-2-ol170 (6m) 
(elid 422c)  
HO
 
 
The preparation and work-up were carried out according to GP-2 using Phenyl lithium (34.7 
mL of 1.8 M solution, 62.5 mmol), and 3-methyl-2-butenal (25) (4.41 g, 52.5 mmol) in dry 
THF. The crude product was purified by column chromatography (SiO2; EA/n-hex; 1:8, Rf = 
0.22) to afford the pure allylic alcohol (6.89 g, 42.5 mmol) as yellow oil. 
 
Yield:  81% 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.29 (s, 6H, (CH3)2C), 6.22 (d, 1H, J = 16.14 Hz, CH=CH), 6.45 (d, 1H, J = 
16.14 Hz, CH=CH), 7.05-7.31 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 29.7 (q, (CH3)2C), 70.8 (s, C-OH), 126.2 (d, CHarom), 126.3 (d, 2 x CHarom), 
127.2 (d, CH=CH), 128.4 (d, 2 x CHarom), 136.9 (s, Cqarom), 137.5 (d, CH=CH). 
 
2,4-Dimethylpent-3-en-2-ol172 (6n) 
(elid 67)  
OH 
 
Magnesium turnings (3.65 g, 150 mmol) in dry Et2O (30 mL) are allowed to react with some 
methyl iodide [ca. 1/20 of 150 mmol (10.7 g)]. After the reaction has started, the rest of the 
methyl iodide in dry Et2O is added dropwise at r.t. in a rate which sustains gentle boiling of 
the solvent. The reaction mixture is refluxed for 30 min and then cooled at 0 °C using ice 
bath. Freshly distilled mesityl oxide (11.8 g, 120 mmol) in dry Et2O (30 mL) is added over a 
period of 3-4 h. The reaction mixture is stirred at 0 °C for 1 h and then left stirring overnight 
at r.t. then re-cooled to 0 °C and ice-cold water is added over 2-3 h (the temperature should be 
kept below 10 °C). As soon as the evolution of gas has ceased and the temperature does not 
rise further, the mixture is poured into saturated NH4Cl solution, the phases were separated 
and the organic phase is washed with 10 % aqueous K2CO3, water, brine and dried over 
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MgSO4. Evaporation of solvent under reduced pressure followed by Büchi-distillation of the 
residue using water vacuum pump at about 90 torr (temperature should not exceed 80 °C) 
gives the pure alcohol (9.5 g, 83.3 mmol) as yellow oil. 
 
Yield:  69 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.30 (s, 6H, (CH3)2)C), 1.64 (d, 3H, J = 1.47 Hz, CH3C=), 1.80 (d, 3H, J = 
1.32 Hz, CH3C=), 5.28 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.6 (q, CH3C=), 27.1 (q, CH3C=), 31.2 (q, (CH3)2C), 70.8 (s, C-OH), 132.1 
(d, CH=C), 133.9 (s, C=CH). 
 
(E)-2-Methylbut-2-en-1-ol173 (6o) 
(elid 258c)  
OH 
 
According to GP-5, tiglic acid (1.50 g, 15 mmol) was reduced by LiAlH4 (1.13 g, 30 mmol) 
to afford 0.93 g (10.8 mmol) of the allylic alcohol which was obtained as oil. 
 
Yield:  72 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.56 (m, 3H, CH3CH=), 1.60 (m, 3H, CH3C=), 3.92 (s, 2H, CH2-OH), 5.42 
(m., 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.0 (q, CH3), 13.2 (q, CH3), 68.7 (t, CH2-OH), 120.4 (d, CH=C), 135.3 (s, 
C=CH). 
 
1-Cyclopropyl-3-hydroxy-3-methylbutan-1-one (28a) 
(elid 498x) 
O
HO
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The preparation and work-up were carried out according to GP-3 using LDA (256.0 mmol) in 
THF, cyclopropyl methyl ketone (20 g, 238.1 mmol) and acetone (13.8 g, 238.1 mmol). The 
crude product (24.1 g, 169.7 mmol, 71 %) was fractionally distilled (b.p. 80 °C, 3.25 torr) to 
give the pure aldol (18.9 g, 133.1 mmol, 56 %) as faint yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.76 (m, 2H, CH2CH2), 0.88 (m, 2H, CH2CH2), 1.09 (s, 6H, (CH3)2C), 1.79 
(m, 1H, CH), 2.59 (s, 2H, CH2CO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 10.9 (t, CH2CH2), 21.6 (d, CH), 29.0 (q, 2 x CH3), 53.6 (t, CH2CO), 69.3 (s, 
C-OH), 212.4 (s, C=O). 
IR: (Film) 
ν (cm-1) = 3200-3600, 3008, 2973, 2933, 1687, 1391, 1076. 
MS: (EI, 70 eV) 
m/z (%) = 142 (M+, not observed), 127 (M+-CH3, 100), 124 (M+-H2O, 34), 69 
(C4H5O+, 17). 
Elemental Analysis: (C8H14O2, M = 142.20) 
Calcd: C 67.57   H 9.92 
Found: C 66.93   H 9.98 
 
1-Cyclopropyl-3-methylbut-2-en-1-one174 (29a) 
(elid 494b)  
O
 
 
The preparation and work-up were carried out according to GP-4 using 1-cyclopropyl-3-
hydroxy-3-methylbutan-1-one (28a) (35.0 g, 246.5 mmol) and p-toluenesulfonic acid (4.70 g, 
24.7 mmol). The crude product was purified either by Büch-distillation (137.5 °C, at about 90 
torr using water vacuum pump, Lit. 46-48 °C, 10 torr174) or by column chromatography (SiO2, 
EA/n-hex, 1:10, Rf = 0.59) to afford the pure enone (25.0 g, 201.6 mmol) as colorless oil. 
 
Yield:  82 %  
1H-NMR: (300 MHz, CDCl3) 
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δ (ppm) = 0.74 (m, 2H, CH2CH2), 0.92 (m, 2H, CH2CH2), 1.80 (d, 3H, J = 0.75 Hz, 
CH3C=), 1.82 (m, 1H, CH), 2.04 (s, 3H, CH3C=), 6.13 (s, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 10.5 (t, 2 x CH2), 20.5 (d, CH), 21.9 (q, CH3C=), 27.4 (q, CH3C=), 124.2 (d, 
CH=C), 153.9 (s, C=CH), 200.5 (s, C=O). 
 
1-Cyclopropyl-3-methylbut-2-en-1-ol (6p) 
(elid 379a)  
OH
 
 
The preparation and work-up were carried out according to GP-5 using 1-cyclopropyl-3-
methylbut-2-en-1-one (29a) (11.4 g, 91.9 mmol) and LiAlH4 (3.65 g, 96.0 mmol). Büch-
distillation (162.5 °C at about 90 torr using water vacuum pump) gives the pure allylic alcohol 
(7.70 g, 61.1 mmol) as colorless oil. 
 
Yield:  67 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.22 (m, 2H, CH2), 0.44 (m, 2H, CH2), 0.93 (m, 1H, CH), 1.62 (d, 3H, J = 
1.47 Hz, CH3C=), 1.70 (d, 3H, J = 1.32 Hz, CH3C=), 3.76 (dd, 1H, J = 8.22, 8.25 Hz, 
CH-OH), 5.22 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.6 (t, CH2), 2.7 (t, CH2), 17.8 (q, CH3C=), 18.2 (d, CH), 25.7 (q, CH3C=), 
72.5 (d, CH-OH), 126.5 (d, CH=C), 135.0 (s, C=CH). 
 
1-Cyclohexyl-3-hydroxy-3-methylbutan-1-one (28b) 
(elid 482y) 
O
OH
 
 
The preparation and work-up were carried out according to GP-3 using LDA (107.7 mmol), 
cyclohexylmethylketone (12.37 g, 98.2 mmol) and acetone (5.7 g, 98.2 mmol). The crude 
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product was fractionally distilled (b.p. 113-115 °C, 0.84 torr) to give the pure aldol (9.9 g, 
53.8 mmol) as colorless oil. 
 
Yield:  55 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.15 (2 x s, 6H, (CH3)2C), 1.20 (m, 4H, 2 x CH2), 1.59-1.85 (m, 6H, 3 x 
CH2), 2.22 (m, 1H, CH), 2.55 (s, 2H, CH2CO), 3.88 (br. s, 1H, OH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 25.4 (t, 2 x CH2), 25.6 (t, CH2), 27.9 (t, 2 x CH2), 29.2 (q, 2 x CH3), 50.7 (t, 
CH2CO), 51.9 (d, CH), 69.5 (s, C-OH), 216.4 (s, CO). 
 
1-Cyclohexyl-3-methylbut-2-en-1-one (29b) 
(elid 483n) 
O
 
 
The preparation and work-up were carried out according to GP-4 using 1-cyclohexyl-3-
hydroxy-3-methylbutan-1-one (28b) (16.1 g, 87.5 mmol) and p-toluenesulfonic acid (1.7 g, 
8.95 mmol). Distillation of the solvent gives the enone (11.82 g, 71.2 mmol) as yellow oil. 
 
Yield:  81 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.10-1.30 (m, 6H, 3 x CH2), 1.60-1.80 (m, 4H, 2 x CH2), 1.83 (s, 3H, 
CH3C=), 2.07 (m, 3H, CH3C=), 2.24 (m, 1H, CH), 6.06 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.6 (q, CH3), 25.7 (t, 2 x CH2), 25.9 (t, CH2), 27.6 (q, CH3), 28.5 (t, 2 x 
CH2), 51.5 (d, CH), 122.9 (d, CH=C), 155.1 (s, C=CH), 204.0 (s, CO). 
 
1-Cyclohexyl-3-methylbut-2-en-1-ol (6q) 
(elid 483t)  
OH
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The preparation and work-up were carried out according to GP-5 using 1-cyclohexyl-3-
methylbut-2-en-1-one (29b) (10.0 g, 60 mmol) and LiAlH4 (2.27 g, 60 mmol). Distillation of 
the solvent gives the allylic alcohol (8.0 g, 47.6 mmol) as faint yellow oil. 
 
Yield:  79 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.80-1.89 (m, 11H, CH and 5 x CH2), 1.62 (s, 3H, CH3C=), 1.69 (s, 3H, 
CH3C=), 4.0 (dd, 1H, J = 7.20, 8.97 Hz, CH-OH), 5.13 (d, 1H, J = 9.09 Hz, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.3 (q, CH3C=), 25.8 (q, CH3C=), 26.0 (t, CH2), 26.1 (t, CH2), 26.5 (t, 
CH2), 28.5 (t, CH2), 28.9 (t, CH2), 44.2 (d, CH), 72.9 (d, CH-OH), 126.7 (d, CH=C), 
135.2 (s, C=CH). 
 
(E)-2,5-Dimethylhexa-3,5-dien-2-ol175 (6u) 
(elid 475f)  
HO
 
 
The preparation and work-up were carried out according to GP-1 using Isopropenyl bromide 
(6.05 g, 50.0 mmol), magnesium turnings (1.20 g, 50.0 mmol) and 3-methyl-2-butenal (25) 
(3.36 g, 40.0 mmol). The crude product was purified either by fractional distillation or by 
column chromatography (SiO2; EA/n-hex; 1:10, Rf = 0.08) to give the pure dienol (3.62 g, 
28.7 mmol) as yellow oil. 
 
Yield:  72% 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.31 (s, 6H, (CH3)2C), 1.80 (s, 3H, CH3C=), 4.93 (s, 2H, CH2=C), 5.75 (d, 
1H, J = 16.02 Hz, CH=CH), 6.27 (d, 1H, J = 16.02 Hz, CH=CH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.5 (q, CH3C=), 29.8 (q, (CH3)2C), 70.7 (s, C-OH), 116.3 (t, CH2=C), 
129.2 (d, CH=CH), 137.4 (d, CH=CH), 141.4 (s, C=CH2). 
 
1-cyclohexenylethanone176 (31) 
(elid 474n) 
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O
 
 
A mixture of cyclohexene (26.16 g, 319 mmol) and stannic chloride (55.42 g, 212.7 mmol) 
was placed in half-liter, three-necked round-bottomed flask equipped with magnetic stirring 
bar, dropping funnel, reflux condenser having a CaCl2 tube and a thermometer extending into 
the reaction mixture. The reaction mixture is cooled in ice bath and then acetic anhydride 
(21.7 g, 212.7 mmol) was added dropwise over a period of 30 min (during the addition, the 
temperature in the solution varied from 25-35 °C). After complete addition the mixture is 
stirred for 15 min in ice and then poured over cracked ice (100 g). The resulting mixture is 
extracted with ether (3 x 30 mL) and the combined ether extract was washed with aqueous 
NaHCO3, water and brine then dried over Na2SO4. Evaporation of the solvent under reduced 
pressure followed by fractional distillation of the residue (b.p. 59-61 °C, 5 torr, Lit. 88-89 °C, 
19.5 torr177) gives the pure enone (13.2 g, 106.5 mmol) as yellow oil. 
 
Yield:  50 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.50 (m, 4H, 2 x CH2), 2.05-2.25 (m, 4H, 2 x CH2), 2.16 (s, 3H, CH3), 6.79 
(m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 21.3 (t, CH2), 21.7 (t, CH2), 22.7 (t, CH2), 24.9 (t, CH2), 25.9 (q, CH3), 
139.4 (s, C=CH), 140.7 (d, CH=C), 199.0 (s, C=O). 
 
1-Cyclohexenylethanol177 (32) 
(elid 474y)  
OH
 
 
The preparation and work-up were carried out according to GP-5 using 1-
cyclohexenylethanone (31) (7.55 g, 60.9 mmol) and LiAlH4 (2.9 g, 76.3 mmol). Excess 
reducing reagent was hydrolyzed by cold 10% sulfuric acid. The crude product was 
fractionally distilled using Büchi-distillation apparatus connected to water vacuum pump at 
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about 165 °C, 90 torr (Lit. 87-88 °C, 14 torr177) to give the pure allylic alcohol (4.53 g, 36.0 
mmol) as colorless oil. 
 
Yield:  59 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.18 (dd, 3H, J = 1.31, 6.45 Hz, CH3CH), 1.52 (m, 4H, 2 x CH2), 1.95 (m, 
4H, 2 x CH2), 4.08 (q, 1H, J = 6.45 Hz, CH-OH), 5.58 (m., 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 21.3 (q, CH3), 22.5 (2 x t, 2 x CH2), 23.5 (t, CH2), 24.8 (t, CH2), 71.9 (t, 
CH-OH), 121.2 (d, CH=C), 141.2 (s, C=CH). 
 
(1R)-6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde (myrtenal)178 (34) 
(elid 390c, 390e) 
CHO 
 
A solution of β-pinene (40 g, 294 mmol), acetic anhydride (29.1 mL, 303 mmol), pyridine 
(11.9 mL, 147 mmol), TPP (21 mg), and DMAP (716 mg, 6 mmol) in CH2Cl2 (270 mL) was 
irradiated at r.t. while a gentle stream of air was bubbled through the reaction mixture. The 
course of the reaction is monitored by TLC and after complete consumption of the starting 
material the solution was diluted with CH2Cl2 (250 mL) and extracted with sat. NaHCO3 
solution until it becomes basic (to remove the acetic acid by-product). The organic layer was 
then washed with 1N HCl solution until it turned mint green and the aqueous washes are 
acidic. Further extraction with saturated CuSO4 (100 mL) and then with brine (2 x 100 mL) 
followed by drying over MgSO4 and concentration under vacuum gives the crude product 
which was fractionally distilled (b.p. = 90-93 °C at 2 torr, Lit. 52-54 °C at 0.45 torr)179 to 
afford the pure product (15 g, 100 mmol) as yellow oil.  
 
Yield:  34 %  
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.70 (s, 3H, CH3), 1.01 (d, 1H, J = 9.27 Hz, CH2), 1.29 (s, 3H, CH3), 2.14 
(m, 1H, CH), 2.41-2.54 (m, 3H, CH2 and CH2), 2.82 (dt, 1H, J = 1.20, 5.61 Hz, CH), 
6.63 (m, 1H, CH=C), 9.36 (s, 1H, CHO).  
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13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.8 (q, CH3), 25.5 (q, CH3), 30.9 (t, CH2), 32.8 (t, CH2), 37.4 (s, Cq), 37.9 
(d, CH), 40.5 (d, CH), 147.6 (d, CH=C), 151.3 (s, C =CH), 191.0 (d, CHO). 
 
1-((1R)-6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethanol [2-(1-hydroxyethyl)apopinene] 
(35) (elid 390d) 
OH 
 
Under an inert atmosphere, a solution of myrtenal (34) (8 g, 53.3 mmol) in freshly distilled 
Et2O (50 mL) was added slowly at 0 °C to a solution of methyllithium in Et2O (160 mmol). 
After complete addition the reaction mixture is refluxed for 1 h. The reaction mixture is 
allowed to cool to r.t. and then poured into a cold solution of saturated NH4Cl. The phases 
were separated and the aqueous phase is extracted with ether (3 x 50 mL). The organic phases 
were combined, washed with brine and dried over MgSO4. The solvent is removed under 
reduced pressure and the residue is fractionally distilled (b.p. = 82-83 °C at 0.72 torr, Lit. 60-
62 °C at 0.40 torr)179 to give the product (7.61 g, 45.8 mmol) as colorless oil in a 2:3 
diastereomeric mixture a and b. 
 
Yield:  86 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.70 (s, 3H, CH3 of a), 0.73 (s, 3H, CH3 of b), 1.06 (m, 3H, 2 x CH3CH of a 
and b), 1.19 (s, 3H, CH3 of a and b), 1.98-2.34 (m, 6H, 2 x CH and 2 x CH2 of a and 
b), 4.05 (m, 1H, CH-OH of a and b), 5.30 (m, 1H, CH=C of a and b). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.7/20.8 (q, CH3 of a and b), 21.0/21.1 (q, CH3 of a and b), 26.0 (q, 2 x 
CH3 of a and b), 30.8 (2 x t, 2 x CH2 of b and a), 31.5 (2 x t, 2 x CH2 of a and b), 
37.4/37.5 (s, Cq of a and b), 40.8 (2 x d, CH of a and b), 41.4 (d, CH of a and b), 42.2 
(d, CH of a and b), 69.7/70.2 (d, CH-OH of b and a), 115.3/116.3 (d, CH=C of b and 
a), 151.3/151.4 (s, C =CH of b and a). 
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L-Alanine methyl ester hydrochloride180 (18a) 
 
ClH3N
O
O
 
 
The preparation and work-up were carried out according to GP-11 using L-alanine (2.67 g, 30 
mmol) and thionyl chloride (4.2 mL, 60 mmol) to give the product (3.6 g, 25.8 mmol) as 
white solid. 
 
Yield:  86 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.72 (d, 3H, J = 7.20 Hz, CH3), 3.79 (s, 3H, OCH3), 4.26 (m, 1H, CH-N), 
8.67 (br s, 3H, NH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.0 (q, CH3), 49.3 (d, CH-N), 53.2 (q, OCH3), 170.5 (s, COOCH3). 
 
L-Valine methyl ester hydrochloride181 (18b) 
 
ClH3N
O
O
 
 
The preparation and work-up were carried out according to GP-11 using L-valine (3.51 g, 30 
mmol) and thionyl chloride (4.2 mL, 60 mmol) to give the product (4.60 g, 27.5 mmol) as 
white solid. 
 
Yield:  92 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.85 (d, 6H, J = 7.50 Hz, (CH3)2CH), 2.0 (m, 1H, CH(CH3)2), 3.70 (s, 3H, 
OCH3), 4.51 (m, 1H, CH-N), 8.50 (br s, 3H, NH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.7 (q, CH3), 18.7 (q, CH3), 30.0 (d, CH), 51.9 (q, OCH3), 56.0 (d, CH-N), 
173.0 (s, COOCH3). 
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L-Leucine methyl ester hydrochloride182 (18c) 
(elid 287a) 
ClH3N
O
O
 
 
The preparation and work-up were carried out according to GP-11 using L-leucine (3.93 g, 30 
mmol) and thionyl chloride (4.2 mL, 60 mmol) to give the product (4.72 g, 26.0 mmol) as 
white solid. 
 
Yield:  87 % 
1H-NMR: (300 MHz, D2O/acetone-d6)  
δ (ppm) = 0.88 (d, 3H, J = 6.33 Hz, (CH3)2CH), 0.89 (d, 3H, J = 6.30 Hz, (CH3)2CH), 
1.75 (m, 3H, CHCH2), 3.76 (s, 3H, OCH3), 4.10 (m, 1H, CH-N). 
13C-NMR: (75.5 MHz, D2O/acetone-d6)  
δ (ppm) = 22.0 (q, CH3), 22.0 (q, CH3), 24.7 (d, CH), 39.6 (t, CH2), 51.8 (q, OCH3), 
53.5 (d, CH-N), 170.8 (s, COOCH3). 
 
(S)-Methyl 2-acetamidopropanoate183 (19a) 
(elid 276b)  
N
H
O
O
O
 
 
The preparation and work-up were carried out according to GP-12 using L- alanine methyl 
ester hydrochloride 18a (11.80 g, 84.6 mmol), Et3N (19.0 g, 188.1 mmol) and acetyl chloride 
(6.64 g, 84.6 mmol) to give the amide (9.0 g, 62.1 mmol) in good purity. 
 
Yield:  73 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.34 (d, 3H, J = 7.20 Hz, CH3), 1.98 (s, 3H, CH3CO), 3.70 (s, 3H, OCH3), 
4.51 (m, 1H, CH-NH). 
13C-NMR: (75.5 MHz, CDCl3) 
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δ (ppm) = 18.0 (q, CH3), 22.7 (q, CH3CO), 47.8 (d, CH-NH), 52.2 (q, OCH3), 169.8 (s, 
CONH), 173.5 (s, COOCH3). 
 
(S)-Methyl 2-acetamido-3-methylbutanoate184 (19b) 
 
N
H
O
O
O
 
 
The preparation and work-up were carried out according to GP-12 using L-valine methyl 
ester hydrochloride 18b (12.54 g, 74.9 mmol), Et3N (18.0 g, 178.2 mmol) and acetyl chloride 
(6.25 g, 79.6 mmol) to give the amide (12.0 g, 69.4 mmol) in good purity. 
 
Yield:  93 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.83 (d, 3H, J = 9.40 Hz, (CH3)2CH), 0.86 (d, 3H, J = 9.40 Hz, (CH3)2CH), 
1.97 (s, 3H, CH3CO), 2.06 (m, 1H, CH(CH3)2), 3.67 (s, 3H, OCH3), 4.49 (dd, 1H, J = 
2.5, 5.1 Hz, CH-NH), 6.13 (d, 1H, J = 5.1 Hz, NH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.7 (q, (CH3)2CH), 18.7 (q, (CH3)2CH), 23.0 (q, CH3CO), 31.1 (d, 
CH(CH3)2), 51.9 (q, OCH3), 56.9 (d, CH-NH), 169.9 (s, CONH), 172.6 (s, COOCH3). 
 
(S)-Methyl 2-(propionamido)propanoate185 (19c) 
(elid 279a)  
N
H
O
O
O
 
 
The preparation and work-up were carried out according to GP-12 using L-alanine methyl 
ester hydrochloride 18a (3.30 g, 23.7 mmol), Et3N (6.7 mL, 53 mmol) and propionyl chloride 
(2.10 mL, 24 mmol) to give the amide (3.10 g, 19.5 mmol) in good purity. 
 
Yield:  82 % 
1H-NMR: (300 MHz, CDCl3) 
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δ (ppm) = 1.03 (t, 3H, J = 7.64 Hz, CH3CH2), 1.27 (d, 3H, J = 7.20 Hz, CH3CH), 2.13 
(q, 2H, J = 7.64 Hz, CH2CH3), 3.62 (s, 3H, OCH3), 4.46 (m, 1H, CH-NH), 6.37 (br. s, 
1H, NH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.4 (q, CH3CH2), 18.0 (q, CH3CH), 29.1 (t, CH2CH3), 47.6 (d, CH-NH), 
52.1, (q, OCH3) 173.3 (s, CONH), 173.5 (s, COOCH3) 
 
(S)-Methyl 2-(pivalamido)propanoate (19d) 
(elid 280a)  
N
H
O
O
O
 
 
The preparation and work-up were carried out according to GP-12 using L-alanine methyl 
ester hydrochloride 18a (3.30 g, 23.7 mmol), Et3N (6.7 mL, 53 mmol) and pivaloyl chloride 
(3.0 mL, 24.0 mmol) to give the amide (4.0 g, 21.4 mmol) in good purity 
 
Yield:  90 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.13 (s, 9H, (CH3)3C), 1.31 (d, 3H, J = 7.21 Hz, CH3CH), 3.67 (s, 3H, 
OCH3), 4.48 (m, 1H, CH-NH), 6.16 (br. s, 1H, NH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = = 18.2 (q, CH3CH), 27.3 (q, (CH3)3C), 38.4 (s, C(CH3)3), 47.8 (d, CH-NH), 
52.2 (q, OCH3), 173.7 (s, CONH), 177.9 (s, COOCH3). 
 
2,4-Dimethyl-5-methoxyoxazole186 (20a) 
(elid 497g) 
N
O
OMe
 
 
The preparation and work-up were carried out according to GP-13 using Methyl 2-
acetamidopropanoate (19a) (9.0 g, 62.1 mmol) and PCl5 (13.5 g, 62.1 mmol), the crude 
product is fractionally distilled using Büchi-distillation apparatus (112.5 °C at about 90 torr 
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using water-vacuum pump, Lit. 61-63 °C/10 torr186) to give the oxazole ( 4.0 g, 31.7 mmol) as 
yellow oil. 
 
Yield: 51 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.90 (s, 3H, CH3), 2.21 (s, 3H, CH3), 3.77 (s, 3H, OCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.7 (q, CH3C=C), 14.0 (q, CH3C=N), 61.0 (q, OCH3), 111.1 (s, C-4), 151.7 
(s, C-5), 154.5 (s, C-2). 
 
2-Ethyl-5-methoxy-4-methyloxazole185 (20b) 
(elid 497u, 497v) 
N
O
OMe
 
 
The preparation and work-up were carried out according to GP-13 using Methyl 2-
(propionamido)propanoate (19c) (13.28 g, 83.5 mmol) and PCl5 (20.0 g, 92.0 mmol), the 
crude product is fractionally distilled using Büchi-distillation apparatus (137 °C at about 90 
torr using water-vacuum pump, Lit. 83 °C/31 torr185) to give the oxazole (6.83 g, 48.4 mmol) 
as faint yellow oil. 
 
Yield:  58 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.15 (t, 3H, J = 7.56 Hz, CH3CH2), 1.88 (s, 3H, CH3), 2.50 (q, 2H, J = 7.56 
Hz, CH2CH3), 3.74 (s, 3H, OCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.7 (q, CH3), 10.7 (q, CH3CH2), 21.7 (t, CH2), 60.9 (q, OCH3), 110.6 (s, C-
4), 154.3 (s, C-5), 156.0 (s, C-2). 
 
2-tert-Butyl-5-methoxy-4-methyloxazole (20c) 
(elid 497w, 497x) 
4. Experimental Part 
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N
O
OMe
 
 
The preparation and work-up were carried out according to GP-13 using Methyl 2-
(pivalamido)propanoate (19d) (15.0 g, 80.2 mmol) and PCl5 (20.0 g, 92.0 mmol), the crude 
product is fractionally distilled using Büchi-distillation apparatus (187 °C at about 90 torr 
using water-vacuum pump) to give the oxazole (9.52 g, 56.3 mmol) as yellow oil. 
 
Yield:  70 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.24 (s, 9H, (CH3)3C), 1.94 (s, 3H, CH3), 3.80 (s, 3H, OCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.8 (q, CH3), 28.2 (q, CH3)3C), 33.5 (s, C(CH3)3), 61.0 (q, OCH3), 110.6 (s, 
C-4), 154.2 (s, C-5), 161.4 (s, C-2). 
 
4-Isopropyl-2-methyl-5-methoxyoxazole187 (20d) 
(elid 489p) 
N
O
OMe
 
 
The preparation and work-up were carried out according to GP-13 using Methyl 2-acetamido-
3-methylbutanoate (19b) (15.40 g, 89.0 mmol) and PCl5 (19.30 g, 89.0 mmol), the crude 
product is fractionally distilled using Büchi-distillation apparatus (150 °C at about 90 torr 
using water-vacuum pump, Lit. 72 °C/10 torr187) to give the oxazole (8.69 g, 56.1 mmol) as 
yellow oil. 
 
Yield:  63 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.01 (d, 6H, J = 6.93 Hz, (CH3)2CH), 2.13 (s, 3H, CH3), 2.57 (septet, 1H, J 
= 6.93 Hz, CH(CH3)2), 3.67 (s, 3H, OCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
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δ (ppm) = 13.9 (q, CH3), 21.4 (2 x q, (CH3)2CH), 24.6 (d, CH), 61.1 (q, OCH3), 121.0 
(s, C-4), 151.7 (s, C-5), 153.1 (s, C-2). 
 
2-Ethyl-4-isopropyl-5-ethoxyoxazole (20e) 
(elid 489n) 
N
O
OMe
 
 
The preparation and work-up were carried out according to GP-13 using Methyl 3-methyl-2-
(propionamido)butanoate (13.61 g, 72.8 mmol) and PCl5 (15.3 g, 70.3 mmol), the crude 
product is fractionally distilled using Büchi-distillation apparatus (125 °C at about 90 torr 
using water-vacuum pump) to give the oxazole (7.38 g, 43.7 mmol) as yellow oil. 
 
Yield: 60 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.07 (d, 6H, J = 6.90 Hz, (CH3)2CH), 1.13 (t, 3H, J = 7.50 Hz, CH3CH2), 
2.50 (q, 2H, J = 6.50 Hz, CH2CH3), 2.64 (septet, 1H, J = 6.90 Hz, CH(CH3)2), 3.72 (s, 
3H, OCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 11.0 (q, CH3CH2), 21.4 (2 x q, (CH3)2CH), 21.8 (t, CH2CH3), 24.9 (d, 
CH(CH3)2), 61.1 (q, OCH3), 120.9 (s, C-4), 153.0 (s, C-5), 156.0 (s, C-2). 
 
2-Ethyl-4-isobutyl-5-methoxyoxazole (20f) 
(elid 489a) 
N
O
OMe
 
 
The preparation and work-up were carried out according to GP-13 using Methyl 4-methyl-2-
(propionamido)pentanoate (16.63 g, 82.7 mmol) and PCl5 (18.0g, 82.7 mmol), the crude 
product is fractionally distilled using Büchi-distillation apparatus (237.5 °C at about 90 torr 
using water-vacuum pump) to give the oxazole (9.85 g, 53.8 mmol) as yellow oil. 
4. Experimental Part 
169 
Yield: 65 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.74 (d, 6H, J = 6.75 Hz, (CH3)2CH), 1.10 (t, 3H, J = 7.65 Hz, CH3CH2), 
1.75 (septet, 1H, J = 6.75 Hz, CH(CH3)2), 2.04 (d, 2H, CH2CH), 2.47 (q, 2H, J = 7.65 
Hz, CH2CH3), 3.69 (s, 3H, OCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 10.8 (q, CH3CH2), 21.7 (t, CH2CH3), 22.0 (2 x q, (CH3)2CH), 27.5 (d, 
CHCH2), 33.4 (t, CH2CH), 60.7 (q, OCH3), 114.5 (s, C-4), 154.7 (s, 5-C), 155.9 (s, C-
2).  
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4.5 Singlet Oxygen Photooxygenation Reactions of Different Substrates 
 
(2RS,3RS)-3-Hydroperoxy-4-methylpent-4-en-2-ol37a (syn-7a) 
(elid 278c)  
OH
OOH  
 
Photooxygenation of 4-methylpent-3-en-2-ol (6a) (1.0 g, 10 mmol) for 48 h according to GP-
9a afforded a diastereomeric mixture (d.r. syn:anti, 75:25) of β-hydroxy allylic 
hydroperoxides (1.10 g, 8.33 mmol, 83 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.07 (d, 3H, J = 6.48 Hz, CH3CH), 1.67 (s, 3H, CH3C=), 3.80 (dq, 1H, J = 
6.45, 8.52 Hz, CH-OH), 4.08 (d, 1H, J = 8.67 Hz, CH-OOH), 5.0 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.7 (q, CH3CH), 18.7 (q, CH3C=), 67.1 (d, CH-OH), 94.8 (d, CH-OOH), 
116.5 (t, CH2=C), 141.4 (s, C=CH2). 
 
(2RS,3SR)-3-Hydroperoxy-4-methylpent-4-en-2-ol (anti-7a) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.14 (d, 3H, J = 6.45 Hz, CH3CH), 1.74 (s, 3H, CH3C=), 3.94 (dq, 1H, J = 
4.56, 6.48 Hz, CH-OH), 4.25 (d, 1H, J = 4.56 Hz, CH-OOH), 5.03 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.0 (q, CH3CH), 19.2 (q, CH3C=), 67.0 (d, CH-OH), 92.1 (d, CH-OOH), 
115.1 (t, CH2=C), 141.1 (s, C=CH2). 
 
(3RS,4RS)-4-Hydroperoxy-5-methylhex-5-en-3-ol (syn-7b) 
(elid 322b)  
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OH
OOH  
 
Photooxygenation of 5-methylhex-4-en-3-ol (6b) (1.0 g, 8.77 mmol) for 48 h according to 
GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 77:23) of β-hydroxy allylic 
hydroperoxides (0.92 g, 6.30 mmol, 72 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92 (t, 3H, J = 7.50 Hz, CH3CH2), 1.23-1.58 (m, 2H, CH2CH3 ), 1.68 (m, 
3H, CH3C=), 3.55 (ddd, 1H, J = 5.95, 5.95, 8.53 Hz, CH-OH), 4.15 (d, 1H, J = 8.53 
Hz, CH-OOH), 5.01 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.6 (q, CH3CH2), 17.8 (q, CH3C=), 25.5 (t, CH2CH3), 71.8 (d, CH-OH), 
93.4 (d, CH-OOH), 116.5 (t, CH2=C), 141.4 (s, C=CH2). 
 
(3RS,4SR)-4-Hydroperoxy-5-methylhex-5-en-3-ol (anti-7b) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.93 (t, 3H, J = 7.35 Hz, CH3CH2), 1.76 (s, 3H, CH3C=), 3.69 (m, 1H, CH-
OH), 4.30 (d, 1H, J = 4.70 Hz, CH-OOH), 5.04 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 10.3 (q, CH3CH2), 19.3 (q, CH3C=), 25.0 (t, CH2CH3), 72.2 (d, CH-OH), 
91.4 (d, CH-OOH), 115.3 (t, CH2=C), 141.2 (s, C=CH2). 
 
(3RS,4RS)-4-Hydroperoxy-2,5-dimethylhex-5-en-3-ol (syn-7c) 
(elid 326b)  
OH
OOH  
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Photooxygenation of 2,5-dimethylhex-4-en-3-ol (6c) (1.0 g, 7.81 mmol) for 48 h according to 
GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 81:19) of β-hydroxy allylic 
hydroperoxides (0.90 g, 5.63 mmol, 72 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.85 (d, 3H, J = 6.75 Hz, CH3CH), 0.95 (d, 3H, J = 7.05 Hz, CH3CH), 1.65 
(m, 1H, CH(CH3)2), 1.70 (m, 3H, CH3C=), 3.49 (dd, 1H, J = 2.79, 8.67 Hz, CH-OH), 
4.28 (d, 1H, J = 8.67 Hz, CH-OOH), 5.07 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.7 (q, CH3CH), 17.7 (q, CH3CH), 20.3 (q, CH3C=), 29.0 (d, CH(CH3)2), 
74.5 (d, CH-OH), 92.0 (d, CH-OOH), 116.5 (t, CH2=C), 141.3 (s, C=CH2). 
 
(3RS,4SR)-4-Hydroperoxy-2,5-dimethylhex-5-en-3-ol (anti-7c) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.85 (d, 3H, CH3CH), 0.92 (d, 3H, CH3CH), 1.78 (m, 3H, CH3C=), 3.51 
(dd, 1H, CH-OH), 4.34 (d, 1H, J = 8.67 Hz, CH-OOH), 5.10 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.7 (q, CH3CH), 18.7 (q, CH3CH), 19.7 (q, CH3C=), 29.5 (d, CH(CH3)2), 
74.2 (d, CH-OH), 89.9 (d, CH-OOH), 116.4 (t, CH2=C), 141.8 (s, C=CH2). 
 
(3RS,4RS)-3-Hydroperoxy-2-methylhept-1-en-4-ol (syn-7d) 
(elid 451q)  
OH
OOH  
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Photooxygenation of 2-methylhept-2-en-4-ol (6d) (1.0 g, 7.81 mmol) for 48 h according to 
GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 79:21) of β-hydroxy allylic 
hydroperoxides (0.98 g, 6.13 mmol, 78 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 3H, J = 7.05 Hz, CH3CH2), 1.20-1.58 (m, 4H, CH2CH2 ), 1.68 (m, 
3H, CH3C=), 3.63 (m, 1H, CH-OH), 4.13 (d, 1H, J = 8.52 Hz, CH-OOH), 5.01 (m, 
2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.8 (q, CH3CH2), 17.8 (t, CH2CH3), 18.3 (q, CH3C=), 34.6 (t, CH2CH2) 
70.3 (d, CH-OH), 93.8 (d, CH-OOH), 116.6 (t, CH2=C), 141.4 (s, C=CH2). 
 
(3RS,4SR)-3-Hydroperoxy-2-methylhept-1-en-4-ol (anti-7d) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.87 (t, 3H, J = 7.05 Hz, CH3CH2), 1.76 (m, 3H, CH3C=), 3.78 (m, 1H, CH-
OH), 4.29 (d, 1H, J = 4.41 Hz, CH-OOH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 19.0 (t, CH2CH3), 19.4 (q, CH3C=), 34.0 (t, CH2CH2) 
70.5 (d, CH-OH), 91.6 (d, CH-OOH), 115.2 (t, CH2=C), 141.2 (s, C=CH2). 
 
(3RS,4RS)-3-Hydroperoxy-2-methylhepta-1,6-dien-4-ol (syn-7e) 
(elid 465n)  
OH
OOH  
 
Photooxygenation of 6-methylhepta-1,5-dien-4-ol (6e) (1.16 g, 9.21 mmol) for 60 h according 
to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 75:25) of β-hydroxy allylic 
hydroperoxides (1.0 g, 6.33 mmol, 69 %) as faint yellow oil. 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.70 (m, 3H, CH3C=), 2.02-2.37 (m, 2H, CH2), 3.71 (ddd, 1H, J = 3.66, 
8.31, 8.31 Hz, CH-OH), 4.17 (d, 1H, J = 8.40 Hz, CH-OOH), 5.05 (m, 4H, CH2=C 
and CH2=CH), 5.79 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3C=), 37.1 (t, CH2), 70.0 (d, CH-OH), 92.8 (d, CH-OOH), 116.8 
(t, CH2=CH), 118.1 (t, CH2=C), 133.8 (d, CH=CH2), 141.1 (s, C=CH2). 
 
(3RS,4SR)-3-Hydroperoxy-2-methylhepta-1,6-dien-4-ol (anti-7e) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.76 (m, 3H, CH3C=), 3.82 (m, 1H, CH-OH), 4.31 (d, 1H, J = 4.86 Hz, CH-
OOH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.1 (q, CH3C=), 36.6 (t, CH2), 69.9 (d, CH-OH), 91.0 (d, CH-OOH), 115.6 
(t, CH2=CH), 117.9 (t, CH2=C), 134.5 (d, CH=CH2), 141.0 (s, C=CH2). 
 
(3RS,4RS,5SR)-3-Hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (syn,syn-7f) and 
(3RS,4RS,5RS)-3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (syn,anti-7f) (elid 498s)  
 
OH
OOH
OH
OOH  
 
Photooxygenation of 3,6-dimethylhepta-1,5-dien-4-ol (6f) (1.20 g, 8.57 mmol) for 60 h 
according to GP-9a afforded an oil composed of the inseparable diastereomeric mixture (0.92 
g, 5.35 mmol, 63 %) composed of syn,syn-7f, syn,anti-7f (d.r. 1:1) of β-hydroxy allylic 
hydroperoxides as major product and a diastereomeric mixture of anti,syn-7f, anti,anti-7f (d.r. 
1:1) as minor product. 
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1H-NMR: (300 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 0.90 (d, 3H, J = 6.84 Hz, CH3CH), 1.63 (s, 3H, CH3C=), 2.17 (m, 1H, 
CHCH3), 3.50 (m, 1H, CH-OH), 4.12 (d, 1H, J = 8.76 Hz, CH-OOH), 4.94 (m, 4H, 
CH2=C and CH2=CH), 5.74 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 12.1 (q, CH3CH), 17.8 (q, CH3C=), 38.7 (d, CHCH3), 73.1 (d, CH-OH), 
90.8 (d, CH-OOH), 114.3 (t, CH2=CH), 116.2 (t, CH2=C), 141.1 (s, C=CH2), 141.2 (d, 
CH=CH2). 
 
1H-NMR: (300 MHz, CDCl3, 2nd diastereomer, additional significant signals) 
δ (ppm) = 0.99 (d, 3H, J = 5.40 Hz, CH3CH), 3.52 (m, 1H, CH-OH), 4.22 (d, 1H, J = 
8.04 Hz, CH-OOH). 
13C-NMR: (75.5 MHz, CDCl3, 2nd diastereomer, additional significant signals) 
δ (ppm) = 17.6 (q, CH3C=), 39.0 (d, CHCH3), 73.4 (d, CH-OH), 91.3 (d, CH-OOH), 
116.2 (t, CH2=CH), 116.8 (t, CH2=C), 137.8 (d, CH=CH2), 140.6 (s, C=CH2). 
 
(3RS,4SR,5RS)-3-Hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (anti,syn-7f) and 
(3RS,4SR,5SR)-3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (anti,anti-7f) 
 
OH
OOH
OH
OOH  
 
Only the signal of CH3C= in 1H-NMR (δ = 1.69 ppm) can be seen for both minor 
diastereomers.  
 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer, additional significant signals) 
δ (ppm) = 72.5 (d, CH-OH), 89.2 (d, CH-OOH). 
 
13C-NMR: (75.5 MHz, CDCl3, 2nd diastereomer, additional significant signals) 
δ (ppm) = 72.5 (d, CH-OH), 89.5 (d, CH-OOH). 
 
(3RS,4RS)-3-Hydroperoxy-2-methyloct-1-en-4-ol (syn-7g) 
(elid 451j)  
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OH
OOH  
 
Photooxygenation of 2-methyloct-2-en-4-ol (6g) (1.19 g, 8.38 mmol) for 60 h according to 
GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 79:21) of β-hydroxy allylic 
hydroperoxides (1.14 g, 6.55 mmol, 78 %) as faint yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.85 (t, 3H, J = 7.05 Hz, CH3CH2), 1.21-1.57 (m, 6H, CH2CH2CH2), 1.70 
(s, 3H, CH3C=), 3.64 (m, 1H, CH-OH), 4.15 (d, 1H, J = 8.37 Hz, CH-OOH), 5.03 (m, 
2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 17.9 (q, CH3C=), 22.5 (t, CH2CH3), 27.3 (t, CH2CH2), 32.2 (t, 
CH2CH2) 70.6 (d, CH-OH), 93.7 (d, CH-OOH), 116.6 (t, CH2=C), 141.3 (s, C=CH2). 
 
(3RS,4SR)-3-Hydroperoxy-2-methyloct-1-en-4-ol (anti-7g) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.77 (s, 3H, CH3C=), 3.75 (m, 1H, CH-OH), 4.30 (d, 1H, J = 4.68 Hz, CH-
OOH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 19.3 (q, CH3C=), 22.5 (t, CH2CH3), 28.0 (t, CH2CH2), 
32.2 (t, CH2CH2) 70.7 (d, CH-OH), 91.7 (d, CH-OOH), 116.6 (t, CH2=C), 141.2 (s, 
C=CH2). 
 
(3RS,4RS)-3-Hydroperoxy-2,6-dimethylhept-1-en-4-ol (syn-7h) 
(elid 365a)  
4. Experimental Part 
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OH
OOH  
 
Photooxygenation of 2,6-dimethylhept-2-en-4-ol (6h) (1.25 g, 8.80 mmol) for 60 h according 
to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 80:20) of β-hydroxy allylic 
hydroperoxides (1.18 g, 6.78 mmol, 77 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.83 (d, 3H, J = 6.48 Hz, CH3CH), 0.87 (d, 3H, J = 6.75 Hz, CH3CH), 1.03 
(m, 1H, CH2CH), 1.32 (m, 1H, CH2CH), 1.68 (s, 3H, CH3C=), 1.81 (m, 1H, CHCH2), 
3.68 (m, 1H, CH-OH), 4.09 (d, 1H, J = 8.37 Hz, CH-OOH), 5.0 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3CH), 21.1 (q, CH3C=), 23.8 (d, CHCH2) 24.0 (q, CH3CH), 41.6 
(t, CH2CH), 68.7 (d, CH-OH), 94.2 (d, CH-OOH), 116.6 (t, CH2=C), 141.4 (s, 
C=CH2). 
 
(3RS,4SR)-3-Hydroperoxy-2,6-dimethylhept-1-en-4-ol (anti-7h) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.84 (d, 3H, J = 6.72 Hz, CH3CH), 1.76 (s, 3H, CH3C=), 3.83 (m, 1H, CH-
OH), 4.26 (d, 1H, J = 4.53 Hz, CH-OOH), 5.05 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.4 (q, CH3CH), 21.4 (q, CH3C=), 23.6 (d, CHCH2) 24.7 (q, CH3CH), 41.1 
(t, CH2CH), 68.9 (d, CH-OH), 92.0 (d, CH-OOH), 115.2 (t, CH2=C), 141.3 (s, 
C=CH2). 
 
(3RS,4RS,5SR)-3-Hydroperoxy-2,5-dimethylhept-1-en-4-ol (syn,syn-7i) and 
(3RS,4RS,5RS)-3-hydroperoxy-2,5-dimethylhept-1-en-4-ol (syn,anti-7i) (elid 473i, 497t)  
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OH
OOH
OH
OOH  
 
Photooxygenation of 2,5-dimethylhept-2-en-4-ol (6i) (1.10 g, 7.75 mmol) for 60 h according 
to GP-9a afforded an oil composed of the β-hydroxy allylic hydroperoxides (0.98 g, 5.63 
mmol, 73 %) in 83:17 diastereomeric mixtures of syn,syn-7i, syn,anti-7i as major products 
and anti,syn-7i , anti,anti-7i as minor products. 
 
1H-NMR: (300 MHz, CDCl3, both major diastereomers) 
δ (ppm) = 0.80 (m, 6H, CH3CH and CH3CH2), 1.02-1.55 (m, 3H, CH2CH ), 1.70 (s, 
3H, CH3C=), 3.60 (m, 1H, CH-OH), 4.15 (d, 1H, J = 8.37 Hz, CH-OOH), 5.05 (m, 
2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 11.1 (q, CH3CH2), 17.7 (q, CH3CH), 19.0 (q, CH3C=), 29.4 (t, CH2), 34.1 
(d, CHCH3), 70.8 (d, CH-OH), 93.4 (d, CH-OOH), 116.2 (t, CH2=C), 141.5 (s, 
C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, 2nd diastreomer, additional significant signals) 
δ (ppm) = 11.0 (q, CH3CH2), 18.7 (q, CH3CH), 29.0 (t, CH2), 34.0 (d, CHCH3), 70.6 
(d, CH-OH), 93.5 (d, CH-OOH), 116.2 (t, CH2=C), 141.5 (s, C=CH2). 
 
(3RS,4SR,5RS)-3-Hydroperoxy-2,5-dimethylhept-1-en-4-ol (anti,syn-7i) and 
(3RS,4SR,5SR)-3-hydroperoxy-2,5-dimethylhept-1-en-4-ol (anti,anti-7i) 
 
OH
OOH
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals for both minor diastereomers) 
δ (ppm) = 1.77 (s, 3H, CH3C=), 3.73 (m, 1H, CH-OH), 4.29 (d, 1H, J = 4.71 Hz, CH-
OOH). 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer, significant signals) 
δ (ppm) = 11.1 (q, CH3CH2), 33.9 (d, CHCH3), 70.9 (d, CH-OH), 92.3 (d, CH-OOH), 
116.0 (t, CH2=C), 141.2 (s, C=CH2). 
4. Experimental Part 
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13C-NMR: (75.5 MHz, CDCl3, 2nd diastereomer, significant signals) 
δ (ppm) = 34.2 (d, CHCH3), 71.1 (d, CH-OH), 92.4 (d, CH-OOH), 116.1 (t, CH2=C), 
141.2 (s, C=CH2). 
 
(3RS,4RS)-4-Hydroperoxy-2,2,5-trimethylhex-5-en-3-ol (syn-7j) 
(elid 454a)  
OH
OOH  
 
Photooxygenation of 2,2,5-trimethylhex-4-en-3-ol (6j) (1.25 g, 8.80 mmol) for 60 h according 
to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 78:22) of β-hydroxy allylic 
hydroperoxides (0.90 g, 5.17 mmol, 59 %) as faint yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92 (s, 9H, (CH3)3C), 1.75 (m, 3H, CH3C=), 3.28 (d, 1H, J = 4.56 Hz, CH-
OH), 4.33 (d, 1H, J = 4.41 Hz, CH-OOH), 5.0 (m, 1H, CH2=C), 5.07 (m, 1H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.8 (q, CH3C=), 26.2 (q, (CH3)3C), 34.9 (s, C(CH3)3), 78.6 (d, CH-OH), 
88.0 (d, CH-OOH), 114.7 (t, CH2=C), 143.2 (s, C=CH2). 
 
(3RS,4SR)-4-Hydroperoxy-2,2,5-trimethylhex-5-en-3-ol (anti-7j) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92 (s, 9H, (CH3)3C), 1.75 (m, 3H, CH3C=), 3.28 (d, 1H, J = 4.56 Hz, CH-
OH), 4.33 (d, 1H, J = 4.41 Hz, CH-OOH), 5.0 (m, 1H, CH2=C), 5.07 (m, 1H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.2 (q, CH3C=), 27.0 (q, (CH3)3C), 34.6 (s, C(CH3)3), 76.1 (d, CH-OH), 
90.1 (d, CH-OOH), 116.4 (t, CH2=C), 143.8 (s, C=CH2). 
 
4. Experimental Part 
180 
(3RS,4RS)-3-Hydroperoxy-2,5,5-trimethylhepta-1,6-dien-4-ol (syn-7k) 
(elid 451m) 
OH
OOH  
 
Photooxygenation of 3,3,6-trimethylhepta-1,5-dien-4-ol (artemesia alcohol) (6k) (1.04 g, 6.75 
mmol) for 60 h according to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 72:28) of 
β-hydroxy allylic hydroperoxides (0.92 g, 4.95 mmol, 73 %) as faint yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.01 (d, 6H, (CH3)2C), 1.70 (s, 3H, CH3C=), 3.34 (d, 1H, J = 4.41 Hz, CH-
OH), 4.28 (d, 1H, J = 4.14 Hz, CH-OOH), 4.97 (m, 4H, CH2=C and CH2=CH), 5.84 
(dd, 1H, J = 10.42 , 17.92 Hz, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.8 (q, CH3C=), 22.6 (q, CH3C), 23.9 (q, CH3C), 41.2 (s, C(CH3)2), 77.8 
(d, CH-OH), 87.5 (d, CH-OOH), 112.8 (t, CH2=CH), 114.7 (t, CH2=C), 142.8 (s, 
C=CH2), 144.5 (d, CH=CH2). 
 
(3RS,4SR)-3-Hydroperoxy-2,5,5-trimethylhepta-1,6-dien-4-ol (anti-7k) 
(elid 482l) 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.95 (d, 6H, (CH3)2C), 1.72 (s, 3H, CH3C=), 3.26 (d, 1H, J = 6.62 Hz, CH-
OH), 4.27 (d, 1H, J = 6.76 Hz, CH-OOH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.2 (q, CH3C=), 23.0 (q, CH3C), 23.3 (q, CH3C), 40.9 (s, C(CH3)2), 75.1 
(d, CH-OH), 89.8 (d, CH-OOH), 112.8 (t, CH2=CH), 116.4 (t, CH2=C), 143.2 (s, 
C=CH2), 144.3 (d, CH=CH2). 
 
 
4. Experimental Part 
181 
(1RS,2RS)-1-Cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (syn-7p) 
(elid 384a)  
OH
OOH  
 
Photooxygenation of 1-cyclopropyl-3-methylbut-2-en-1-ol (6p) (1.0 g, 7.94 mmol) for 60 h 
according to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 62:38) of β-hydroxy 
allylic hydroperoxides (1.0 g, 6.33 mmol, 80 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.20-0.52 (m, 4H, CH2CH2), 0.78-0.99 (m, 1H, CH), 1.75 (m, 3H, CH3C=), 
3.07 (dd, 1H, J = 7.95, 7.95 Hz, CH-OH), 4.29 (d, 1H, J = 9.30 Hz, CH-OOH), 5.05 
(m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.8 (t, CH2CH2), 3.2 (t, CH2CH2), 14.0 (d, CH), 18.9 (q, CH3C=), 75.0 (d, 
CH-OH), 93.3 (d, CH-OOH), 115.5 (t, CH2=C), 141.6 (s, C=CH2). 
 
(1RS,2SR)-1-Cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (anti-7p) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.82 (m, 3H, CH3C=), 3.14 (dd, 1H, J = 4.26, 8.82 Hz, CH-OH), 4.41 (d, 
1H, J = 4.26 Hz, CH-OOH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 2.6 (t, CH2CH2), 2.9 (t, CH2CH2), 13.3 (d, CH), 19.6 (q, CH3C=), 75.6 (d, 
CH-OH), 91.2 (d, CH-OOH), 115.4 (t, CH2=C), 141.3 (s, C=CH2). 
 
(1RS,2RS)-1-Cyclohexyl-2-hydroperoxy-3-methylbut-3-en-1-ol (syn-7q) 
(elid 500c)  
4. Experimental Part 
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OH
OOH  
 
Photooxygenation of 1-cyclohexyl-3-methylbut-2-en-1-ol (6q) (1.30 g, 7.74 mmol) for 60 h 
according to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 88:12) of β-hydroxy 
allylic hydroperoxides (1.0 g, 5.0 mmol, 65 %) as faint yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.83-1.90 (m, 11H, CH and CH2), 1.64 (s, 3H, CH3C=), 3.43 (m, 1H, CH-
OH), 4.24 (d, 1H, J = 8.49 Hz, CH-OOH), 4.97 (s, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.7 (q, CH3C=), 25.3 (t, CH2), 25.9 (t, CH2), 26.1 (t, CH2), 26.4 (t, CH2), 
30.3, 30.5 (t, CH2), 39.1 (d, CH), 74.3 (d, CH-OH), 91.0 (d, CH-OOH), 115.9 (t, 
CH2=C), 141.6 (s, C=CH2). 
 
(1RS,2SR)-1-Cyclohexyl-2-hydroperoxy-3-methylbut-3-en-1-ol (anti-7q) 
 
OH
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) =  4.29 (d, 1H, J = 5.97 Hz, CH-OOH). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 39.3 (d, CH), 89.2 (d, CH-OOH), 112.9 (t, CH2=C). 
 
1-(6-Methyl-3,4-dihydro-[1,2]dioxin-3-yl)ethanol188 (syn-9 and anti-9) 
(elid 477a) 
O
O
OH
O
O
OH
 
 
4. Experimental Part 
183 
Photooxygenation of (3E,5E)-hepta-3,5-dien-2-ol (8) (100 mg, 0.89 mmol) for 5 h according 
to GP-9b using TSP-S-DVB copolymer afforded a diastereomeric mixture (d.r. 59:41) of the 
endoperoxide (97 mg, 0.67 mmol, 76 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer) 
δ (ppm) = 1.17 (d, 3H, CH3CHOO), 1.19 (d, 3H, J = 6.78 Hz, CH3CHOH), 4.03 (m, 
1H, CHOH), 4.17 (m, 1H, CHOO), 4.64 (m, 1H, CHCH3), 5.85 (m, 1H, CH=CH), 
5.95 (m, 1H, CH=CH). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer) 
δ (ppm) = 17.7 (q, CH3CHOO), 19.0 (q, CH3CHOH), 68.1 (d, CHOH), 74.2 (d, 
CHOO(CH3)), 81.6 (s, CHOO(CH)), 123.1 (d, CH=CH), 130.7 (d, CH=CH). 
 
1H-NMR: (300 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 1.11 (d, 3H, J = 6.75 Hz CH3CHOO), 1.16 (d, 3H, CH3CHOH), 3.93-4.0 
(m, 2H, CHOO and CHOH), 4.74 (q, 1H, J = 6.78 Hz, CHCH3), 5.85 (m, 1H, 
CH=CH), 5.95 (m, 1H, CH=CH). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 17.3 (q, CH3CHOO), 17.9 (q, CH3CHOH), 69.7 (d, CHOH), 74.2 (d, 
CHOO(CH3)), 83.2 (s, CHOO(CH)), 122.9 (d, CH=CH), 130.8 (d, CH=CH). 
 
(E)-7-Hydroperoxy-3,7-dimethyloct-5-en-1-ol (11) and 6-hydroperoxy-3,7-dimethyloct-
7-en-1-ol (12) (elid 371a) 
OHOH
HOO
OOH 11 12  
 
Photooxygenation of 3,7-Dimethyloct-6-en-1-ol (citronellol, 10) (350 mg, 2.24 mmol) for 37 
h according to GP-9b using TSP-S-DVB copolymer afforded 310 mg (1.66 mmol, 74 %) 
yellow oil composed of a regioisomeric mixture of the hydroperoxides 11 and 12 in ratio 
1.3:1, respectively. The regioisomer 12 is obtained as 1:1 diastereomeric mixture. 
 
 
4. Experimental Part 
184 
1H-NMR: (300 MHz, CDCl3, 11 and 12) 
δ (ppm) = 0.79 (d, 3H, J = 6.45 Hz, CH3CH), 0.80 (d, 3H, J = 6.60 Hz, CH3CH), 1.10-
1.60 (m, 10H, CH2CHCH2 of 11 and 12), 1.21 (s, 6H, (CH3)2C of 11), 1.62 (s, 3H, 
CH3C= of 12), 1.90 (m, 2H, CH2CHOOH of 12), 3.55 (m, 2H, CH2OH of 11 and 12), 
4.14 (m, 1H, CH-OOH of 12), 4.86 (s, 2H, CH2=C of 12), 5.45 (d, 1H, J = 15.87 Hz, 
CH=CH of 11), 5.53 (m, 1H, CH=CH of 11). 
13C-NMR: (75.5 MHz, CDCl3, regioisomer 11) 
δ (ppm) = 19.5 (q, CH3CH), 27.8 (d, CHCH3), 29.4 (q, (CH3)2C), 38.6 (t, 
CH2CH=CH), 39.6 (t, CH2CH2OH), 60.5 (t, CH2OH), 81.6 (s, Cq-OOH), 129.2 (d, 
CH=CH-Cq), 135.1 (d, CH=CH). 
13C-NMR: (75.5 MHz, CDCl3, two diastereomers of regioisomer 12) 
δ (ppm) = 16.7/16.8 (q, CH3CH), 19.2/19.3 (q, CH3C=), 24.1/24.2 (t, CH2CH-OOH), 
28.8/29.1 (d, CHCH3), 32.4/32.6 (t, CH2CH2CH-OOH), 39.1/39.3 (t, CH2CH2OH), 
60.5 (t, CH2OH), 89.1/89.5 (d, CH-OOH), 113.5/113.8 (t, CH2=C), 143.8/144.0 (s, 
C=CH2). 
 
(3,6-Dihydro-6-methyl-1,2-dioxin-3-yl)methanol189 (14) 
(elid 368a, 477e) 
O
O
OH
 
 
Photooxygenation of (2E,4E)-hexa-2,4-dien-1-ol (13) (100 mg, 1.02 mmol) for 6 h according 
to GP-9b using TSP-S-DVB copolymer afforded the endoperoxide (110 mg, 0.85 mmol, 83 
%) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.16 (d, 3H, J = 6.75 Hz, CH3CH), 3.65 (dd, 1H, J = 3.06, 12.21 Hz, 
CH2OH), 3.82 (dd, 1H, J = 7.80, 12.33 Hz, CH2OH), 4.39 (m, 1H, CHCH2), 4.77 (m, 
1H, CHCH3), 5.83 (m, 1H, CH=CH), 5.93 (m, 1H, CH=CH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.5 (q, CH3CH), 63.2 (t, CH2), 74.3 (d, CHCH3), 79.7 (d, CHCH2), 84.3 (d, 
CH), 122.9 (d, CH=CH), 131.3 (d, CH=CH). 
4. Experimental Part 
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Ethyl 3-hydroperoxy-2-methylenebutanoate (16) 
(elid 444a, 451w, 490p) 
EtOOC
HOO  
 
Photooxygenation of (E)-ethyl 2-methylbut-2-enoate (15) (1.0 g, 7.81 mmol) for 48 h 
according to GP-9a afforded the allylic hydroperoxides (1.02 g, 6.38 mmol, 82 %) as 
colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.23 (m, 6H, CH3CH and CH3CH2), 4.14 (dq, 2H, J = 1.17, 7.05 Hz, 
CH2CH3), 4.90 (dq, 1H, J = 1.02, 6.63 Hz, CH-OOH), 5.85 (d, 1H, J = 1.02 Hz, 
CH2=C), 6.26 (s, 1H, CH2=C).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3), 18.4 (q, CH3), 60.8 (t, CH2), 79.0 (d, CH-OOH), 125.4 (t, 
CH2=C), 140.6 (s, C=CH2), 166.2 (s, COO). 
 
3,5-Dimethyl-3-methoxycarbonyl-1,2,4-dioxazole (21a) 
(elid 497k) 
N
O
O
COOMe
 
 
Photooxygenation of (20a) 0.20 g (1.6 mmol) according to GP-14 affords the dioxazole as 
yellow oil. 
 
Yield:  0.18 g (60 %) using TSP-S-DVB and 0.13 g (44 %) using PP-S-DVB. 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.63 (s, 3H, CH3), 1.98 (s, 3H, CH3-C=), 3.71 (s, 3H, COOCH3).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.4 (q, CH3C=), 22.1 (q, CH3), 52.8 (q, COOCH3), 106.1 (s, Cq), 160.7 (s, 
C=N), 168.4 (s, COOCH3). 
 
 
4. Experimental Part 
186 
5-Ethyl-3-methoxycarbonyl-3-methyl-1,2,4-dioxazole (21b) 
(elid 498e) 
N
O
O
COOMe
 
 
Photooxygenation of 20b 0.20 g (1.4 mmol) according to GP-14 affords the dioxazole as 
yellow oil. 
 
Yield:  0.20 g (86 %) using TSP-S-DVB and 0.21 g (90 %) using PP-S-DVB. 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.18 (t, 3H, J = 7.5 Hz, CH3CH2), 1.66 (s, 3H, CH3), 2.30 (q, 2H, J = 7.5 
Hz, CH2CH3), 3.72 (s, 3H, COOCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.9 (q, CH3CH2), 17.4 (t, CH2CH3), 22.2 (q, CH3), 52.9 (q, COOCH3), 
106.0 (s, Cq), 164.9 (s, C=N), 168.6 (s, COOCH3). 
 
3-Methoxycarbonyl-3-methyl-5-tert-butyl-1,2,4-dioxazole (21c) 
(elid 498d) 
N
O
O
COOMe
 
 
Photooxygenation of 20c 0.20 g (1.2 mmol) according to GP-14 affords the dioxazole as 
yellow oil. 
 
Yield:  0.20 g (84 %) using PP-S-DVB. 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.18 (s, 9H, (CH3)3C), 1.62 (s, 3H, CH3), 3.69 (s, 3H, COOCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 22.0 (q, CH3), 27.2 (s, C(CH3)3), 27.6 (q, (CH3)3C), 52.7 (q, COOCH3), 
105.9 (s, Cq), 168.6 (s, COOCH3), 170.0 (s, C=N).  
 
 
4. Experimental Part 
187 
3-Isopropyl-3-methoxycarbonyl-5-methyl-1,2,4-dioxazole (21d) 
(elid 499c) 
N
O
O
COOMe
 
 
Photooxygenation of 20d 0.20 g (1.3 mmol) according to GP-14 affords the dioxazole as 
yellow oil. 
 
Yield:  0.19 g (79 %) using PP-S-DVB. 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (d, 3H, J = 6.91 Hz, (CH3)2CH), 0.92 (d, 3H, J = 6.91 Hz, (CH3)2CH), 
2.01 (s, 3H, CH3C=), 2.40 (septet, 1H, CH), 3.79 (s, 3H, COOCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.4 (q, CH3C=), 15.6 (q, (CH3)2CH), 15.7 (q, (CH3)2CH), 33.3 (d, CH), 52.7 
(q, COOCH3), 111.3 (s, Cq), 160.3 (s, C=N), 168.8 (s, COOCH3). 
 
5-Ethyl-3-isopropyl-3-methoxy-carbonyl-1,2,4-dioxazole (21e) 
(elid 490b) 
N
O
O
COOMe
 
 
Photooxygenation of 20e 0.30 g (1.8 mmol) according to GP-14 affords the dioxazole as 
yellow oil. 
 
Yield:  0.32 g (90 %) using TSP-S-DVB and 0.31 g (86 %) using PP-S-DVB. 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.80 (d, 3H, J = 6.91 Hz, (CH3)2CH), 0.85 (d, 3H, J = 6.91 Hz, (CH3)2CH), 
1.12 (t, 3H, J = 7.64 Hz, CH3CH2), 2.25 (q, 2H, J = 7.64 Hz, CH2CH3), 2.34 (septet, 
CH), 3.68 (s, 3H, COOCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
4. Experimental Part 
188 
δ (ppm) = 10.0 (q, CH3CH2), 15.4 (q, (CH3)2CH), 15.5 (q, (CH3)2CH), 17.3 (t, 
CH2CH3), 33.1 (d, CH), 52.5 (q, COOCH3), 111.0 (s, Cq), 164.3 (s, C=N), 168.6 (s, 
COOCH3). 
 
5-Ethyl-3-isobutyl-3-methoxy-carbonyl-1,2,4-dioxazole (21f) 
(elid 489m) 
N
O
O
COOMe
 
 
Photooxygenation of 20f 0.20 g (1.09 mmol) according to GP-14 affords the dioxazole as 
yellow oil. 
 
Yield:  209 mg (89 %) using TSP-S-DVB and 186 mg (79 %) using PP-S-DVB. 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.81 (d, 6H, J = 6.6 Hz, (CH3)2CH), 1.11 (t, 3H, J= 7.5 Hz CH3CH2), 1.66 
(m, 1H, CH), 1.86 (dd, 2H, CH2CH), 2.23 (q, 2H, J = 7.5 Hz, CH2CH3), 3.66 (s, 3H, 
COOCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.9 (q, CH3CH2), 17.3 (t, CH2CH3), 23.1 (q, (CH3)2CH), 23.3 (q, 
(CH3)2CH), 23.5 (t, CH2CH), 43.4 (d, CH), 52.5 (q, COOCH3), 108.3 (s, Cq), 164.4 (s, 
C=N), 168.7 (s, COOCH3). 
 
3-Hydroperoxy-2,3-dimethylbut-1-ene190 (24) 
(elid 473f) 
HOO
 
 
Irradiation of tetramethylethylene (1g, 11.9 mmol) for 24 h according to GP-7a followed by 
usual work-up gives the allylic hydroperoxide (0.87 g, 7.50 mmol, 63 %) as an oil which is 
used without further purification.  
 
4. Experimental Part 
189 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.31 (s, 6H, 2 x CH3), 1.76 (t, 3H, J = 0.75 Hz, CH3C=), 4.89-4.94 (m, 2H, 
CH2=C), 7.99 (br s, 1H, OOH).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.6 (q, CH3C=), 23.8 (q, 2 x CH3), 84.2 (s, C-OOH), 111.7 (t, CH2=C), 
148.0 (s, C=CH2). 
 
2-Hydroperoxy-2-methylbut-3-en-1-ol (36a) and 3-hydroperoxy-2-methylenebutan-1-
ol191 (36b) (elid 433b)  
HOO OHOH
OOH
36a 36b  
 
Photooxygenation of (E)-2-methylbut-2-en-1-ol (6o) (1.2 g, 14.0 mmol) for 60 h according to 
GP-9a afforded 0.88 g (7.5 mmol, 54 %) of a faint yellow oil composed of a regioisomeric 
mixture of the allylic hydroperoxides 36a and 36b in ratio 53:47, respectively. 
 
1H-NMR: (300 MHz, CDCl3, regioisomer 36a) 
δ (ppm) = 1.24 (m, 3H, CH3), 3.57 (dd, 1H, J = 1.62, 12.03 Hz, CH2-OH), 3.70 (d, 1H, 
J = 12.06 Hz, CH2-OH), 5.20 (m, 2H, CH2=CH), 5.90 (ddd, 1H, J = 0.87, 11.01, 17.76 
Hz, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, regioisomer 36a) 
δ (ppm) = 19.1 (q, CH3), 65.3 (t, CH2-OH), 84.6 (s, Cq-OOH), 116.5 (t, CH2=CH), 
137.9 (d, CH=CH2). 
 
1H-NMR: (300 MHz, CDCl3, regioisomer 36b) 
δ (ppm) = 1.25 (d, 3H, J = 6.78 Hz, CH3CH), 4.08 (d, 1H, J = 12.93 Hz, CH2-OH), 
4.22 (m, 1H, CH2-OH), 4.59 (q, 1H, J = 6.60 Hz, CH-OOH), 5.20 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3, regioisomer 36b) 
δ (ppm) = 17.5 (q, CH3), 62.4 (t, CH2-OH), 82.9 (d, CH-OOH), 115.6 (t, CH2=C), 
147.5 (s, C=CH2). 
 
(E)-4-(hydroperoxymethyl)-2-methylpent-3-en-2-ol (37b) 
(elid 139)  
4. Experimental Part 
190 
OH
HOO
 
 
Photooxygenation of 2,4-dimethylpent-3-en-2-ol (6n) (1.0 g, 8.77 mmol) for 48 h according 
to GP-7b afforded the rearranged allylic hydroperoxides (1.03 g, 7.05 mmol, 80 %) as yellow 
oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.22 (s, 6H, 2 x CH3), 1.63 (s, 3H, CH3C=), 4.26 (s, 2H, CH2-OOH), 5.46 
(s, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3C=), 25.2 (q, 2 x CH3), 72.3 (t, CH2-OOH), 77.7 (s, C-OH), 
126.9 (d, CH=C), 129.6 (s, C=CH2). 
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4.6 Synthesis of 1,2,4-Trioxanes 
 
4.6.1 Derived from 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
 
(5RS,6RS)-5-Cyclopropyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-adam- 
antane] (38) (elid 409c) 
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(1.88 g, 11.9 mmol) and adamantanone (1.78 g, 11.9 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.81) affords 
the pure 1,2,4-trioxane as faint yellow oil which crystallizes upon standing (0.25 g, 0.86 
mmol, 7 %). 
 
M.p. 79-81 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.31-0.49 (m, 4H, CH2CH2), 0.78 (m, 1H, CH(CH2)2), 1.50-2.19 (m, 13H, 
CH and CH2), 1.79 (m, 3H, CH3C=), 2.82 (m, 1H, CH), 3.33 (dd, 1H, J = 7.35, 9.41 
Hz, OCH), 4.38 (d, 1H, J = 9. 40 Hz, OOCH), 5.04 (m, 2H, CH2=).     
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.9 (t, CH2), 3.1 (t, CH2), 12.2 (d, CH(CH2)2), 21.0 (q, CH3C=), 27.5 (d, 
CH), 27.6 (d, CH), 30.2 (d, CH), 36.9 (d, CH), 33.4 (t, CH2), 33.7 (t, CH2), 33.8 (t, 
CH2), 34.0 (t, CH2), 37.6 (t, CH2), 73.0 (d, OCH), 87.9 (d, OOCH), 105.0 (s, OCOO), 
117.2 (t, CH2=), 140.4 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3079, 2931, 2917, 1653, 1112, 1079, 1025, 926, 910, 891. 
MS: (EI, 70 eV) 
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m/z (%) = 290 (M+, less than 1), 220 (M+-C4H6O, 1), 150 (C10H14O+, 57), 108 
(C8H12+, 47), 93 (C7H9+, 57), 81 (C6H9+, 37), 80 (C6H8+, 97), 79 (C6H7+, 100), 67 
(C5H7+, 32), 55 (C3H3O+, 27). 
Elemental Analysis: (C18H26O3, M = 290.40) 
Calcd: C 74.45   H 9.02 
Found: C 73.61   H 8.94 
 
(3RS,4RS)-4-Cyclopropyl-3-isopropenyl-1,2,5-trioxa-spiro[5.5]undecan-9-one (39) 
(elid 495p)  
O
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(1.10 g, 6.96 mmol) and cyclohex-1,4-dione (0.40 g, 3.57 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of excess ketone 
followed by purification of the crude product by preparative thick-layer chromatography 
(SiO2, EA/n-hex, 1:10, Rf = 0.30) affords the pure 1,2,4-trioxane as yellow oil (0.15 g, 0.60 
mmol, 17 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.09-0.62 (m, 4H, (CH2)2CH), 0.66-0.97 (m, 1H, CH(CH2)2), 1.03-1.23 (m, 
2H, CH2CH2), 1.78 (s, 3H, CH3C=), 1.95 (m, 2H, CH2CH2), 2.20-2.52 (m, 4H, 2 x 
CH2CO), 3.30 (dd, 1H, J = 7.50, 9.54 Hz, OCH), 4.43 (d, 1H, J = 9. 54 Hz, OOCH), 
5.04 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.7 (t, CH2CH), 2.7 (t, CH2CH), 11.7 (d, CH(CH2)2), 20.5 (q, CH3C=), 27.6 
(t, CH2), 33.5 (t, CH2), 36.4 (t, CH2), 36.6 (t, CH2), 74.6 (d, OCH), 87.6 (d, OOCH), 
101.1 (s, OCOO), 117.2 (t, CH2=C), 139.4 (s, C=CH2), 209.8 (s, C=O). 
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(5RS,6RS)-5-Cyclopropyl-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (40) 
(elid 391a) 
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(1.0 g, 6.33 mmol) and excess acetone (2.0 g, 34.5 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of excess ketone 
affords the pure 1,2,4-trioxane as yellow oil (0.51 g, 2.58 mmol, 41 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.20-0.60 (m, 4H, CH2CH2), 0.70-0.81 (m, 1H, CH(CH2)2), 1.33 (s, 3H, 
CH3), 1.57 (s, 3H, CH3), 1.79 (s, 3H, CH3C=), 3.24 (dd, 1H, J = 7.95, 9.42 Hz, OCH), 
4.35 (d, 1H, J = 9.54 Hz, OOCH), 5.07 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.9 (t, CH2), 2.8 (t, CH2), 11.9 (d, CH(CH2)2), 20.4 (q, CH3C=), 20.5 (q, 
CH3), 25.9 (q, CH3), 74.8 (d, OCH), 87.4 (d, OOCH), 102.6 (s, OCOO), 116.7 (t, 
CH2=), 139.9 (s, C=CH2). 
 
(5RS,6RS)-5-Cyclopropyl-3,3-diethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (41) 
(elid 496m)  
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(0.69 g, 4.37 mmol) and excess 3-pentanone (2.0 g, 23.3 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of excess ketone 
followed by purification of the crude product by preparative thick-layer chromatography 
(SiO2, EA/n-hex, 1:10, Rf = 0.81) affords the pure 1,2,4-trioxane as yellow oil (0.10 g, 0.44 
mmol, 10 %). 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.25-0.53 (m, 4H, CH2CH2), 0.76 (m, 1H, CH(CH2)2), 0.84 (t, 3H, J = 7.44 
Hz, CH3CH2), 0.88 (t, 3H, J = 7.44 Hz, CH3CH2), 1.60 (m, 2H, CH2CH3), 1.79 (s, 3H, 
CH3C=), 1.80-2.16 (m, 2H, CH2CH3), 3.28 (dd, 1H, J = 7.41, 9.24 Hz, OCH), 4.33 (d, 
1H, J = 9. 48 Hz, OOCH), 5.05 (s, 2H, CH2=C).    
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.7 (t, CH2CH), 2.4 (t, CH2CH), 6.8 (q, CH3CH2), 8.0 (q, CH3CH2),  11.8 
(d, CH(CH2)2), 20.6 (q, CH3C=), 22.9 (t, CH2CH3), 28.3 (t, CH2CH3), 73.4 (d, OCH), 
87.2 (d, OOCH), 105.8 (s, OCOO), 116.7 (t, CH2=C), 140.0 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Cyclopropyl-3-ethyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (42a) 
and (3RS,5SR,6SR)-5-cyclopropyl-3-ethyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(42b) (elid 391b) major 
 
O
O
O
42a    
O
O
O
42b  
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(0.6 g, 3.80 mmol) and excess 2-butanone (2.0 g, 27.8 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of excess ketone 
affords a yellow oil of 1,2,4-trioxanes diastereomeric mixture 42a,b in 72:28 ratio (0.50 g, 
2.36 mmol, 62 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 42a) 
δ (ppm) = 0.18-0.56 (m, 4H, CH2CH2), 0.75 (m, 1H, CH(CH2)2), 0.91 (t, 3H, J = 7.47 
Hz, CH3CH2), 1.51 (s, 3H, CH3), 1.60 (q, 2H, J = 7.65 Hz, CH2CH3), 1.79 (m, 3H, 
CH3C=), 3.34 (dd, 1H, J = 7.35, 9.41 Hz, OCH), 4.31 (d, 1H, J = 9. 41 Hz, OOCH), 
5.03 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 42a) 
δ (ppm) = 1.5 (t, CH2), 2.3 (t, CH2), 7.1 (q, CH3CH2), 11.8 (d, CH(CH2)2), 18.5 (q, 
CH3), 20.4 (q, CH3C=), 32.1 (t, CH2CH3), 73.6 (d, OCH), 87.6 (d, OOCH), 103.9 (s, 
OCOO), 116.7 (t, CH2=), 139.9 (s, C=CH2). 
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1H-NMR: (300 MHz, CDCl3, minor diastereomer 42b) 
δ (ppm) = 0.18-0.56 (m, 4H, CH2CH2), 0.75 (m, 1H, CH(CH2)2), 0.84 (t, 3H, J = 7.65 
Hz, CH3CH2), 1.24 (s, 3H, CH3), 1.87-2.13 (m, 2H, CH2CH3), 1.78 (m, 3H, CH3C=), 
3.16 (dd, 1H, J = 7.86, 9.41 Hz, OCH), 4.34 (d, 1H, J = 9. 41 Hz, OOCH), 5.03 (m, 
2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 42b) 
δ (ppm) = 1.9 (t, CH2), 2.8 (t, CH2), 8.2 (q, CH3CH2), 11.9 (d, CH(CH2)2), 20.5 (q, 
CH3C=), 22.6 (q, CH3), 25.1 (t, CH2CH3), 74.5 (d, OCH), 87.1 (d, OOCH), 104.9 (s, 
OCOO), 116.7 (t, CH2=), 139.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Cyclopropyl-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (43) 
(elid 440c) 
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(1.25 g, 7.91 mmol) and β-naphthaldehyde (1.23 g, 7.88 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.67) affords 
the pure 1,2,4-trioxane as yellow oil which crystallizes upon standing (0.72 g, 2.43 mmol, 31 
%). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.39-0.64 (m, 4H, CH2CH2), 0.98 (m, 1H, CH(CH2)2), 1.87 (m, 3H, 
CH3C=), 3.44 (dd, 1H, J = 7.43, 9.12 Hz, OCH), 4.68 (d, 1H, J = 9.12 Hz, OOCH), 
5.14 (m, 2H, CH2=), 6.31 (s, 1H, OCHOO), 7.46-7.98 (m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 2.0 (t, CH2), 2.8 (t, CH2), 11.6 (d, CH(CH2)2), 20.7 (q, CH3C=), 81.0 (d, 
OCH), 87.8 (d, OOCH), 104.0 (d, OCHOO), 117.5 (t, CH2=), 124.2 (d, CHarom), 126.2 
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(d, CHarom), 126.7 (d, CHarom), 127.0 (d, CHarom), 127.7 (d, CHarom), 128.2 (d, CHarom), 
128.5 (d, CHarom), 131.8 (s, Cqarom), 132.9 (s, Cqarom), 134.1 (s, Cqarom), 139.9 (s, 
C=CH2). 
IR: (Film) 
ν (cm-1) = 3088, 3011, 2968, 2934, 1647, 1603, 1126, 1071, 904, 859, 814. 
HRMS: (EI, 70 eV, C19H20O3) 
Calcd: M = 296.141 g/mol  
Found: M = 296.141 ±0.005 g/mol 
Elemental Analysis: (C19H20O3, M = 296.36) 
Calcd: C 77.00   H 6.80 
Found: C 76.47   H 6.83 
 
(3RS,5RS,6RS)-5-Cyclopropyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (44a) 
(elid 493w)  
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(1.20 g, 7.59 mmol) and acetaldehyde diethylacetal (0.93 g, 7.88 mmol) in CH2Cl2 was 
treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification 
of the crude product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 
0.70) afforded colorless oil composed of a diastereomeric mixture of the pure 1,2,4-trioxanes 
44a as major product and 44b,c as minor products (363 mg, 1.97 mmol, 26 %). 
 
1H-NMR: (300 MHz, CDCl3, 44a) 
δ (ppm) = 0.20-0.60 (m, 4H, CH2CH2), 0.78 (m, 1H, CH(CH2)2), 1.21 (d, 3H, J = 5.46 
Hz, CH3), 1.73 (m, 3H, CH3C=), 3.03 (dd, 1H, J = 8.07, 8.79 Hz, OCH), 4.39 (d, 1H, J 
= 8.97 Hz, OOCH), 5.0 (m, 2H, CH2=), 5.26 (q, 1H, J = 5.46 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, 44a) 
δ (ppm) = 1.7 (t, CH2), 2.8 (t, CH2), 11.4 (d, CH(CH2)2), 17.7 (q, CH3), 20.4 (q, 
CH3C=), 80.6 (d, OCH), 87.3 (d, OOCH), 101.1 (d, OCHOO), 117.0 (t, CH2=C), 
139.2 (s, C=CH2). 
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(3RS,5RS,6RS)-5-Cyclopropyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (44b) 
and (3RS,5RS,6SR)-5-cyclopropyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (44c) 
 
O
O
O O
O
O
44b 44c  
 
1H-NMR: (300 MHz, CDCl3, additional signals of both minor diastreomers 44b,c) 
δ (ppm) = 0.20-0.60 (m, 4H, CH2CH2), 0.78 (m, 1H, CH(CH2)2), 1.19 (d, 3H, J = 5.31 
Hz, CH3), 1.66 (s, 3H, CH3C=), 3.10 (m, 1H, OCH), 4.05 (d, 1H, J = 3.81 Hz, 
OOCH), 5.06 (m, 2H, CH2=), 5.67 (q, 1H, J = 5.31 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, additional signals of both minor diastreomers 44b,c) 
δ (ppm) = 3.6/6.5 (t, CH2), 8.0/11.6 (d, CH(CH2)2), 18.0 (q, CH3) 19.8/22.9 (q, 
CH3C=), 78.7/81.4 (d, OCH), 83.5/84.0 (d, OOCH), 95.9/101.4 (d, OCHOO), 
111.9/118.1 (t, CH2=C), 138.9/141.8 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Cyclopropyl-3-ethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (45a) 
(elid 493u) major 
O
O
O
 
 
Following GP-15, a solution of 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) 
(1.20 g, 7.59 mmol) and propionaldehyde diethylacetal (1.0 g, 7.58 mmol) in CH2Cl2 was 
treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification 
of the crude product (0.67 g, 3.38 mmol, 45 %) by preparative thick-layer chromatography 
(SiO2, EA/n-hex, 1:10, Rf = 0.76) afforded colorless oil composed of a diastereomeric mixture 
of the pure 1,2,4-trioxanes 45a as major product and 45b,c as minor products (315 mg, 1.59 
mmol, 21 %). 
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1H-NMR: (300 MHz, CDCl3, 45a) 
δ (ppm) = 0.31-0.62 (m, 4H, CH2CH2), 0.79 (m, 1H, CH(CH2)2), 0.90 (t, 3H, J = 7.50 
Hz, CH3CH2), 1.56 (dq, 2H, J = 5.31, 7.50 Hz, CH2CH3), 1.75 (m, 3H, CH3C=), 3.08 
(dd, 1H, J = 7.65, 9.09 Hz, OCH), 4.41 (d, 1H, J = 9.09 Hz, OOCH), 5.01 (m, 2H, 
CH2=), 5.08 (t, 1H, J = 5.37 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, 45a) 
δ (ppm) = 1.6 (t, CH2), 2.6 (t, CH2), 8.1 (q, CH3CH2), 11.4 (d, CH(CH2)2), 20.4 (q, 
CH3C=), 25.3 (t, CH2CH3), 80.3 (d, OCH), 87.6 (d, OOCH), 105.1 (d, OCHOO), 
117.0 (t, CH2=C), 139.3 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3085, 3009, 2973, 2927, 2881, 1653, 1648, 1116, 1088, 1047, 943, 904. 
Elemental Analysis: (C11H18O3, M = 198.26) 
Calcd: C 66.64   H 9.15 
Found: C 66.55   H 9.15 
 
(3RS,5RS,6RS)-5-Cyclopropyl-3-ethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (45b) 
and (3RS,5RS,6SR)-5-cyclopropyl-3-ethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (45c) 
 
O
O
O O
O
O
45b 45c  
 
1H-NMR: (300 MHz, CDCl3, additional signals of both minor diastreomers 45b,c) 
δ (ppm) = 0.91 (t, 3H, J = 7.62 Hz, CH3CH2), 1.57 (m, 2H, CH2CH3), 1.68 (m, 3H, 
CH3C=), 3.10 (m, 1H, OCH), 4.07 (d, 1H, J = 3.84 Hz, OOCH), 4.87 (m, 2H, CH2=), 
5.48 (t, 1H, J = 5.37 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, signals of both minor diastreomers 45b,c) 
δ (ppm) = 1.4/1.7 (t, CH2), 3.6/6.7 (t, CH2), 7.9/8.0 (q, CH3CH2), 8.1/11.6 (d, 
CH(CH2)2), 19.8/22.0 (q, CH3C=), 25.3/25.7 (t, CH2CH3), 78.6/81.4 (d, OCH), 
83.8/84.3 (d, OOCH), 99.9/105.4 (d, OCHOO), 111.9/118.1 (t, CH2=C), 139.0/141.9 
(s, C=CH2). 
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4.6.2 Derived from 1-cyclohexyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7q) 
 
(3RS,5RS,6RS)-5-Cyclohexyl-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (46) 
(elid 493t)  
O
O
O
 
 
Following GP-15, a solution of 1-cyclohexyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7q) 
(1.20 g, 6.0 mmol) and β-naphthaldehyde (0.94 g, 6.03 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.65) afforded 
the pure 1,2,4-trioxanes (0.83 mg, 2.46 mmol, 41 %) as white solid. 
 
M.p. 88-90 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.06-1.94 (m, 11H, CH and CH2), 1.85 (s, 3H, CH3C=), 3.87 (d, 1H, J = 
9.54 Hz, OCH), 4.87 (d, 1H, J = 9.54 Hz, OOCH), 5.18 (m, 2H, CH2=), 6.38 (s, 1H, 
OCHOO), 7.47-8.02 (m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (q, CH3C=), 26.2 (t, CH2), 26.2 (t, CH2), 26.3 (t, CH2), 26.5 (t, CH2), 
30.1 (t, CH2), 38.4 (d, CH), 81.4 (d, OCH), 85.2 (d, OOCH), 104.1 (d, OCHOO), 
118.5 (t, CH2=C), 124.1 (d, CHarom), 126.1 (d, CHarom), 126.6 (d, CHarom), 126.9 (d, 
CHarom), 127.6 (d, CHarom), 128.0 (d, CHarom), 128.4 (d, CHarom), 132.1 (s, Cqarom), 
132.8 (s, Cqarom), 133.9 (s, Cqarom), 138.9 (s, C=CH2). 
IR: (CsI) 
ν (cm-1) = 2933, 2856, 1653, 1647, 1605, 1560, 1112, 1074, 1004, 906, 822. 
MS: (EI, 70 eV) 
m/z (%) = 338 (M+, 1), 226 (M+-C5H10O, 2), 156 (C11H8O+, 95), 155 (C11H7O+, 96), 
128 (C10H8+, 27), 127 (C10H7+, 100), 83 (C6H11+, 17). 
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HRMS: (EI, 70 eV, C22H26O3) 
 Calcd: M = 338.188 g/mol  
Found: M = 338.188 ±0.005 g/mol 
Elemental Analysis: (C22H26O3, M = 338.44) 
 Calcd: C 78.07   H 7.74 
Found: C 77.49   H 7.90 
 
(5RS,6RS)-5-Cyclohexyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-adamant- 
tane] (47) (elid 496i, 500h)  
O
O
O
 
 
Following GP-15, a solution of 1-cyclohexyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7q) 
(1.20 g, 6.0 mmol) and adamantanone (0.91 g, 6.07 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.69) afforded 
the 1,2,4-trioxanes 47 and 48 in a ratio 3:1, respectively, as colorless oil (0.20 g, 10 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92-2.12 (m, 24H, CH and CH2), 1.73 (s, 3H, CH3C=), 2.88 (br. s, 1H, 
CH), 3.77 (d, 1H, J = 9.93 Hz, OCH), 4.49 (d, 1H, J = 9.93 Hz, OOCH), 5.05 (m, 2H, 
CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.9 (q, CH3C=), 25.6 (t, cyclohexane CH2), 26.2 (t, cyclohexane CH2), 
26.4 (t, cyclohexane CH2), 26.6 (t, cyclohexane CH2), 27.2 (d, CH), 27.3 (d, CH), 29.6 
(d, CH),  30.4 (t, cyclohexane CH2), 32.9 (t, adamantane CH2), 33.3 (t, adamantane 
CH2), 33.3 (t, adamantane CH2), 33.6 (t, adamantane CH2), 36.6 (d, CH), 37.2 (t, 
adamantane CH2), 38.2 (d, cyclohexane CH), 72.3 (d, OCH), 84.9 (d, OOCH), 104.5 
(s, OCOO), 117.7 (t, CH2=C), 139.6 (s, C=CH2). 
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IR: (Film) 
ν (cm-1) = 3080, 2922, 2851, 1648, 1450, 1111, 1097, 1071, 1026, 1005, 926, 908. 
 
(3RS,5RS,6RS)-3,5-Dicyclohexyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (48) 
 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92-2.12 (m, 22H, CH and CH2), 1.71 (s, 3H, CH3C=), 3.48 (d, 1H, J = 
9.63 Hz, OCH), 4.54 (d, 1H, J = 9.51 Hz, OOCH), 4.95 (d, 1H, J = 5.55 Hz, 
OCHOO), 5.05 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (q, CH3C=), 25.7 (t, CH2), 25.7 (t, CH2), 25.8 (t, CH2), 26.0 (t, CH2), 
26.2 (t, CH2), 26.3 (t, CH2), 26.5 (t, CH2), 27.1 (t, CH2), 27.3 (t, CH2), 30.1 (t, CH2), 
38.3 (d, CH), 40.6 (d, CH), 80.6 (d, OCH), 85.2 (d, OOCH), 107.1 (d, OCHOO), 
118.1 (t, CH2=C), 139.1 (s, C=CH2). 
 
4.6.3 Derived from 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) 
 
(3RS,5RS,6RS)-5-Butyl-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (49) 
(elid 464k)  
O
O
O
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Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.24 g, 7.13 
mmol) and β-naphthaldehyde (1.11 g, 7.12 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.85) afforded the pure 
1,2,4-trioxane (0.96 g, 3.08 mmol, 43 %) as viscous oil which crystallizes on standing. 
 
M.p. 51-53 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.96 (t, 3H, J = 7.20 Hz, CH3CH2), 1.25-1.70 (m, 6H, CH2), 1.85 (s, 3H, 
CH3C=), 4.01 (m, 1H, OCH), 4.64 (d, 1H, J = 9.26 Hz, OOCH), 5.18 (m, 1H, CH2=), 
5.22 (s, 1H, CH2=), 6.41 (s, 1H, OCHOO), 7.49-8.05 (m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 19.7 (q, CH3C=), 22.6 (t, CH2CH3), 27.0 (t, CH2CH2), 
30.1 (t, CH2CH2), 77.4 (d, OCH), 87.7 (d, OOCH), 104.1 (d, OCHOO), 118.5 (t, 
CH2=C), 124.1 (d, CHarom), 126.1 (d, CHarom), 126.6 (d, CHarom), 126.8 (d, CHarom), 
127.6 (d, CHarom), 128.1 (d, CHarom), 128.4 (d, CHarom), 132.0 (s, Cqarom), 132.8 (s, 
Cqarom), 133.9 (s, Cqarom), 138.8 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 312 (M+, 1), 226 (M+-C5H10O, less than 1), 156 (C11H8O+, 100), 155 
(C11H7O+, 93), 127 (C10H7+, 72), 124 (C9H16+, 38). 
HRMS: (EI, 70 eV, C20H24O3) 
 Calcd: M = 312.173 g/mol  
Found: M = 312.173 ±0.005 g/mol 
Elemental Analysis: (C20H24O3, M = 312.40) 
 Calcd: C 76.89   H 7.74 
Found: C 76.61   H 7.78 
 
(3RS,5RS,6RS)-3-(2-Bromophenyl)-5-butyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (50) 
(elid 464m, 492l)  
O
O
O
Br
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Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.24 g, 7.13 
mmol) and 2-bromobenzaldehyde (1.30 g, 7.03 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.83) afforded the pure 
1,2,4-trioxane (0.69 g, 2.02 mmol, 29 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.82 (t, 3H, J = 7.20 Hz, CH3CH2), 1.17-1.55 (m, 6H, CH2), 1.72 (m, 3H, 
CH3C=), 3.88 (m, 1H, OCH), 4.48 (d, 1H, J = 9.24 Hz, OOCH), 5.06 (m, 1H, CH2=), 
5.09 (s, 1H, CH2=), 6.42 (s, 1H, OCHOO), 7.12-7.60 (m, 4H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 19.8 (q, CH3C=), 22.5 (t, CH2CH3), 26.9 (t, CH2CH2), 
30.1 (t, CH2CH2), 77.5 (d, OCH), 87.7 (d, OOCH), 103.1 (d, OCHOO), 118.6 (t, 
CH2=C), 123.2 (s, Cqarom), 127.4 (d, CHarom), 128.9 (d, CHarom), 131.1 (d, CHarom), 
132.7 (d, CHarom), 133.8 (s, Cqarom), 138.6 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3078, 2955, 2930, 2871, 1651, 1647, 1570, 1125, 1081, 1025, 1000, 948, 
911. 
MS: (EI, 70 eV) 
m/z (%) = 342/340 (M+, not observed), 256/254 (M+-C5H10O, 2), 186 (C7H581Br+, 73), 
185 (C7H481Br+, 100), 184 (C7H579Br+, 80), 183 (C7H479Br+, 50), 157 (C6H481Br+, 28), 
155 (C6H479Br+, 25), 124 (C9H16+, 57), 95 (C7H11+, 30), 76 (C6H4+, 55), 69 (C4H5O+, 
51), 51 (C4H3+, 32), 50 (C4H2+, 31). 
Elemental Analysis: (C16H21BrO3, M = 341.24) 
Calcd: C 56.32   H 6.20 
Found: C 56.33   H 6.33 
 
(3RS,5RS,6RS)-5-Butyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (51) 
(elid 464v, 491r,v) 
O
O
O
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Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.32 g, 7.59 
mmol) and benzaldehyde dimethylacetal (1.15 g, 7.57 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.76) afforded 
the pure 1,2,4-trioxane (0.96 g, 3.66 mmol, 48 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.91 (t, 3H, J = 7.21 Hz, CH3CH2), 1.23-1.61 (m, 6H, CH2), 1.80 (m, 3H, 
CH3C=), 3.92 (m, 1H, OCH), 4.54 (d, 1H, J = 9.27 Hz, OOCH), 5.13 (m, 1H, CH2=), 
5.16 (s, 1H, CH2=), 6.22 (s, 1H, OCHOO), 7.37-7.54 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 19.7 (q, CH3C=), 22.6 (t, CH2CH3), 27.0 (t, CH2CH2), 
30.1 (t, CH2CH2), 77.3 (d, OCH), 87.6 (d, OOCH), 104.0 (d, OCHOO), 118.5 (t, 
CH2=C), 126.9 (d, CHarom), 128.3 (d, CHarom), 129.7 (d, CHarom), 134.6 (s, Cqarom), 
138.8 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 262 (M+, not observed), 124 (C9H16+, 13), 106 (C7H6O+, 32), 105 (C7H5O+, 
100), 77 (C6H5+, 33), 51 (C4H3+, 13). 
Elemental Analysis: (C16H22O3, M = 262.34) 
Calcd: C 73.25   H 8.45 
Found: C 73.11   H 8.46 
 
(5RS,6RS)-5-n-Butyl-6-(prop-1-en-2yl)-spiro[1,2,4-trioxacyclohexane-3,2´-adamantane] 
(52) (elid 437a)  
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (0.49 g, 2.82 
mmol) and adamantanone (0.52 g, 3.47 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
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preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.88) afforded the pure 
1,2,4-trioxane (0.10 g, 0.33 mmol, 12 %) as viscous colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.88 (t, 3H, J = 7.35 Hz, CH3CH2), 1.15-2.10 (m, 17H, CH and CH2), 1.73 
(m, 3H, CH3C=), 2.90 (m, 1H, CH), 3.86 (m, 1H, OCH), 4.24 (d, 1H, J = 9.55 Hz, 
OOCH), 5.05 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.0 (q, CH3CH2), 19.8 (q, CH3C=), 22.6 (t, CH2CH3), 27.1 (t, CH2CH2), 
27.2 (d, CH), 27.3 (d, CH), 29.8 (d, CH), 30.6 (t, CH2CH2), 36.7 (d, CH), 33.0 (t, 
CH2), 33.3 (t, CH2), 33.4 (t, CH2), 33.6 (t, CH2), 37.2 (t, CH2), 68.6 (d, OCH), 87.7 (d, 
OOCH), 104.8 (s, OCOO), 117.9 (t, CH2=C), 139.4 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Butyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (53) 
(elid 464s)  
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.22 g, 7.01 
mmol) and acetaldehyde diethylacetal (0.83 g, 7.03 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.84) afforded 
the pure 1,2,4-trioxane (0.37 g, 1.85 mmol, 26 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 3H, J = 7.05 Hz, CH3CH2), 1.19-1.57 (m, 6H, CH2), 1.26 (d, 3H, J = 
5.44 Hz, CH3CH), 1.70 (m, 3H, CH3C=), 3.65 (m, 1H, OCH), 4.33 (d, 1H, J = 9.26 
Hz, OOCH), 5.05 (m, 2H, CH2=), 5.36 (q, 1H, J = 5.44 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 17.9 (CH3CH), 19.7 (q, CH3C=), 22.6 (t, CH2CH3), 27.0 
(t, CH2CH2), 30.1 (t, CH2CH2), 76.8 (d, OCH), 87.4 (d, OOCH), 101.5(d, OCHOO), 
118.3 (t, CH2=C), 138.8 (s, C=CH2). 
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(3RS,5RS,6RS)-5-Butyl-3-ethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (54) 
(elid 464t, 491y) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.27 g, 7.30 
mmol) and propionaldehyde diethylacetal (0.96 g, 7.27 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.79) afforded 
the pure 1,2,4-trioxane (0.41 g, 1.92 mmol, 26 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 3H, J = 7.35 Hz, CH3(CH2)3), 0.94 (t, 3H, J = 7.65 Hz, CH3CH2), 
1.15-1.64 (m, 8H, CH2), 1.71 (m, 3H, CH3C=), 3.65 (m, 1H, OCH), 4.32 (d, 1H, J = 
9.12 Hz, OOCH), 5.05 (m, 2H, CH2=), 5.16 (t, 1H, J = 5.43 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 8.2 (q, CH3CH2), 13.9 (q, CH3(CH2)3), 19.7 (q, CH3C=), 22.6 (t, 
CH3CH2(CH2)2), 25.4 (t, CH2CH3), 27.1 (t, CH2CH2), 30.1 (t, CH2CH2), 76.7 (d, 
OCH), 87.7 (d, OOCH), 105.5 (d, OCHOO), 118.2 (t, CH2=C), 138.9 (s, C=CH2). 
IR: (Film) 
 ν (cm-1) = 2962, 2875, 1653, 1260, 1096, 1020, 865, 800. 
 
4.6.4 Derived from 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) 
 
(3RS,5RS,6RS)-5-Isobutyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (55) 
(elid 408c, 467c, 492q) 
O
O
O
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Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (0.87 g, 5.0 
mmol) and benzaldehyde (0.53 g, 5.0 mmol) in CH2Cl2 was treated with a catalytic amount of 
BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product (0.74 g, 2.82 
mmol, 56.5 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10) affords the 
1,2,4-trioxane (0.26 g, 1.0 mmol, 20 %) as an oil  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.93 (d, 3H, J = 6.63 Hz, CH3CH), 0.96 (d, 3H, J = 6.78 Hz, CH3CH), 1.25 
(m, 1H, CH2CH), 1.57 (m, 1H, CH2CH), 1.79 (m, 3H, CH3C=), 1.97 (m, 1H, CHCH2), 
4.0 (ddd, 1H, J = 2.34, 9.24, 12.04 Hz, OCH), 4.51 (d, 1H, J = 9.24 Hz, OOCH), 5.13 
(m, 2H, CH2=), 6.22 (s, 1H, OCHOO), 7.36-7.52 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (q, CH3C=), 21.5 (q, CH3CH), 23.6 (d, CHCH2), 23.7 (q, CH3CH), 
39.2 (t, CH2CH), 75.6 (d, OCH), 88.1 (d, OOCH), 103.9 (d, OCHOO), 118.7 (t, 
CH2=C), 126.9 (d, CHarom), 128.3 (d, CHarom), 129.7 (d, CHarom), 134.6 (s, Cqarom), 
138.7 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 262 (M+, not observed), 106 (C7H6O+, 30), 105 (C7H5O+, 100), 77 (C6H5+, 
35), 51 (C4H3+, 13). 
Elemental Analysis: (C16H22O3, M = 262.34) 
 Calcd: C 73.25   H 8.45 
Found: C 73.02   H 8.43 
 
(3RS,5RS,6RS)-5-Isobutyl-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (56) 
(elid 493n) 
O
O
O
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Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.21 g, 6.95 
mmol) and β-naphthaldehyde (1.09 g, 6.99 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.71) affords the 1,2,4-
trioxane (0.46 g, 1.47 mmol, 21 %) as an oil which crystallizes on standing to white solid.  
 
M.p. 60-62 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.01 (d, 3H, J = 6.60 Hz, CH3CH), 1.04 (d, 3H, J = 6.75 Hz, CH3CH), 1.33 
(m, 1H, CH2CH), 1.70 (m, 1H, CH2CH), 1.87 (s, 3H, CH3C=), 2.08 (m, 1H, CHCH2), 
4.12 (ddd, 1H, J = 2.34, 9.09, 10.32 Hz, OCH), 4.65 (d, 1H, J = 9.09 Hz, OOCH), 5.19 
(m, 1H, CH2=), 5.24 (m, 1H, CH2=), 6.45 (s, 1H, OCHOO), 7.49-8.07 (m, 5H, Harom) .  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.6 (q, CH3C=), 21.5 (q, CH3CH), 23.6 (d, CHCH2), 23.7 (q, CH3CH), 
39.2 (t, CH2CH), 75.6 (d, OCH), 88.0 (d, OOCH), 104.0 (d, OCHOO), 118.7 (t, 
CH2=), 124.0 (d, CHarom), 126.1 (d, CHarom), 126.6 (d, CHarom), 126.7 (d, CHarom), 
127.6 (d, CHarom), 128.0 (d, CHarom), 128.3 (d, CHarom), 131.9 (s, Cqarom), 132.8 (s, 
Cqarom), 133.9 (s, Cqarom), 138.6 (s, C=CH2). 
IR: (CsI) 
 ν (cm-1) = 3095, 2956, 2934, 1605, 1347, 1098, 1080, 997, 863, 817. 
MS: (EI, 70 eV) 
m/z (%) = 312 (M+, 3), 226 (M+-C5H10O, 2), 156 (C11H8O+, 100), 155 (C11H7O+, 97), 
128 (C10H8+, 30), 127 (C10H7+, 70), 124 (C9H16+, 27), 109 (C8H13+, 17). 
HRMS: (EI, 70 eV, C20H24O3) 
 Calcd: M = 312.173 g/mol  
Found: M = 312.173 ±0.005 g/mol 
Elemental Analysis: (C20H24O3, M = 312.40 g/mol) 
 Calcd: C 76.89   H 7.74 
Found: C 76.61   H 7.63 
 
(3RS,5RS,6RS)-3-(2-Chlorophenyl)-5-isobutyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (57a) 
and (3RS,5SR,6RS)-3-(2-chlorophenyl)-5-isobutyl-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(57b) (elid 450k)  
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Cl
57a    
O
O
O
Cl
57b  
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.42 g, 8.16 
mmol) and 2-chlorobenzaldehyde (1.40 g, 9.69 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.82) afforded a 
diastereomeric mixture of the 1,2,4-trioxanes 57a,b in a ratio 88:12 (0.46 g, 1.55 mmol, 19 %) 
as oil. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 57a) 
δ (ppm) = 0.85 (d, 3H, J = 6.32 Hz, CH3CH), 0.87 (d, 3H, J = 6.47 Hz, CH3CH), 1.16 
(m, 1H, CH2CH), 1.49 (m, 1H, CH2CH), 1.73 (m, 3H, CH3C=), 1.85 (m, 1H, CHCH2), 
3.96 (ddd, 1H, J = 2.35, 9.26, 10.14 Hz, OCH), 4.44 (d, 1H, J = 9.26 Hz, OOCH), 5.06 
(m, 2H, CH2=), 6.46 (s, 1H, OCHOO), 7.17-7.60 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 57a) 
δ (ppm) = 19.7 (q, CH3C=), 21.4 (q, CH3CH), 23.6 (d, CHCH2), 23.7 (q, CH3CH), 
39.2 (t, CH2CH), 75.9 (d, OCH), 88.2 (d, OOCH), 101.0 (d, OCHOO), 118.9 (t, 
CH2=C), 126.8 (d, CHarom), 128.6 (d, CHarom), 129.5 (d, CHarom), 130.9 (d, CHarom), 
132.2 (s, Cqarom), 133.5 (s, Cqarom), 138.6 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of 57b) 
δ (ppm) = 1.38 (m, 1H, CH2CH), 2.02 (s, 3H, CH3C=), 4.06 (d, 1H, J = 3.82 Hz, 
OOCH), 4.30 (m, 1H, OCH), 6.50 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of 57b) 
δ (ppm) = 75.6 (d, OCH), 85.1 (d, OOCH), 101.4 (d, OCHOO), 118.7 (t, CH2=C), 
126.9 (d, CHarom), 128.6 (d, CHarom), 129.5 (d, CHarom), 130.9 (d, CHarom), 132.4 (s, 
Cqarom), 133.5 (s, Cqarom), 141.6 (s, C=CH2). 
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(5RS,6RS)-5-Isobutyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-
adamantane] (58) (elid 375f)  
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.70 g, 9.77 
mmol) and adamantanone (2.10 g, 13.5 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.80) affords the 1,2,4-
trioxane (0.28 g, 0.92 mmol, 10 %) as an oil which crystallizes on standing to white solid.  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (d, 3H, J = 6.63 Hz, CH3CH), 0.90 (d, 3H, J = 6.78Hz, CH3CH), 1.01-
1.10 (m, 1H, CH2CH), 1.34 (m, 1H, CH2CH), 1.50-2.09 (m, 14H, CH, CH2 and 
CH(CH3)2), 1.72 (t, 3H, J = 1.17 Hz, CH3C=), 2.91 (br. d, 1H, CH), 3.99 (ddd, 1H, J = 
2.97, 9.54, 9.54 Hz, OCH), 4.20 (d, 1H, J = 9.54 Hz, OOCH), 5.03 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (q, CH3C=), 21.4 (q, CH3CH), 23.5 (d, CHCH2), 23.8 (q, CH3CH), 
27.2 (2 x d, CH), 29.9 (d, CH), 33.1 (t, CH2), 33.3 (2 x t, CH2), 33.5 (t, CH2), 36.6 (d, 
CH), 37.2 (t, CH2), 39.9 (t, CH2CH), 66.6 (d, OCH), 87.8 (d, OOCH), 104.7 (s, 
OCOO), 118.0 (t, CH2=C), 139.3 (s, C=CH2). 
MS: (EI, 20 eV) 
m/z (%) = 150 (C10H14O+, 100), 124 (C9H16+, 27). 
HRMS: (EI, 70 eV, C19H30O3) 
 Calcd: M = 306.2195 g/mol  
Found: M = 306.219 ± 0.005 g/mol 
Elemental Analysis: (C19H30O3, M = 306.44 g/mol) 
 Calcd: C 74.47   H 9.87 
Found: C 74.06   H 9.78 
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(3RS,4RS)-4-Isobutyl-3-isopropenyl-1,2,5-trioxa-spiro[5.5]undecane (59) 
(elid 368i) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (0.75 g, 4.31 
mmol) and cyclohexanone (0.41 g, 4.18 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up, evaporation of excess ketone affords the 1,2,4-trioxane 
No (0.52 g, 2.05 mmol, 48 %) as an oil  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (d, 3H, J = 6.60 Hz, CH3CH), 0.90 (d, 3H, J = 6.60 Hz, CH3CH), 1.05 
(m, 1H, CH2CH), 1.34 (m, 1H, CH2CH), 1.30-1.65 (m, 8H, CH2), 1.73 (m, 3H, 
CH3C=), 1.85 (m, 1H, CHCH2), 2.0 (m, 1H, CH2), 2.18 (m, 1H, CH2), 3.98 (ddd, 1H, J 
= 2.37, 9.54, 10.14 Hz, OCH), 4.22 (d, 1H, J = 9.56 Hz, OOCH), 5.04 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (q, CH3C=), 21.3 (q, CH3CH), 22.3 (t, CH2), 22.5 (t, CH2), 23.6 (d, 
CHCH2), 23.7 (q, CH3CH), 25.7 (t, CH2), 29.4 (t, CH2), 35.1 (t, CH2), 39.7 (t, 
CH2CH), 67.2 (d, OCH), 88.0 (d, OOCH), 102.8 (s, OCOO), 118.0 (t, CH2=C), 139.3 
(s, C=CH2). 
 
(8RS,9RS)-9-Isobutyl-8-isopropenyl-6,7,10-trioxa-spiro[4.5]decane (60) 
(elid 368j, 389a) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.04 g, 5.98 
mmol) and cyclopentanone (0.50 g, 5.95 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of excess ketone affords the crude 
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product (0.50 g, 2.08 mmol, 35 %) as yellow oil which is further purified by preparative 
thick-layer chromatography (SiO2, EA/n-hex, 1:10) to afford the pure 1,2,4-trioxane (0.16 g, 
0.67 mmol, 11 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.84 (d, 3H, J = 6.45 Hz, CH3CH), 0.88 (d, 3H, J = 6.75 Hz, CH3CH), 1.05 
(m, 1H, CH2CH), 1.34 (m, 1H, CH2CH), 1.48-1.90 (m, 8H, CHCH2 and CH2), 1.71 (t, 
3H, J = 1.17 Hz, CH3C=), 2.51 (m, 1H, CH2), 3.85 (ddd, 1H, J = 2.52, 9.39, 10.14 Hz, 
OCH), 4.29 (d, 1H, J = 9.39 Hz, OOCH), 5.03 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.5 (q, CH3C=), 21.2 (q, CH3CH), 23.1 (d, CHCH2), 23.5 (q, CH3CH), 
23.6 (t, CH2), 24.7 (t, CH2), 32.9 (t, CH2), 37.3 (t, CH2), 39.3 (t, CH2CH), 70.1 (d, 
OCH), 87.9 (d, OOCH), 114.7 (s, OCOO), 118.1 (t, CH2=C), 138.7 (s, C=CH2). 
 
(5RS,6RS)-5-Isobutyl-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (61) 
(elid 368a, 476y) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.50 g, 8.62 
mmol) and excess acetone (2.0 g, 34.5 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.88) affords the 1,2,4-
trioxane (0.60 g, 2.80 mmol, 33 %) as colorless oil  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.81 (d, 3H, J = 6.61 Hz, CH3CH), 0.84 (d, 3H, J = 6.77 Hz, CH3CH), 1.01 
(m, 1H, CH2CH), 1.28 (s, 3H, CH3), 1.33 (m, 1H, CH2CH), 1.59 (s, 3H, CH3), 1.70 
(m, 3H, CH3C=), 1.80 (m, 1H, CHCH2), 3.93 (ddd, 1H, J = 2.50, 8.0, 9.55 Hz, OCH), 
4.17 (d, 1H, J = 9.55 Hz, OOCH), 5.0 (m, 2H, CH2=).  
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13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.4 (q, CH3C=), 20.3 (q, CH3), 21.1 (q, CH3CH), 23.4 (d, CHCH2), 23.6 
(q, CH3CH), 25.8 (q, CH3), 39.5 (t, CH2CH), 68.0 (d, OCH), 87.8 (d, OOCH), 102.6 
(s, OCOO), 118.0 (t, CH2=C), 139.1 (s, C=CH2). 
 
(5RS,6RS)-5-Isobutyl-6-(prop-1-en-2-yl)-3,3-dipropyl-1,2,4-trioxane (62) 
(elid 402b) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.0 g, 5.75 
mmol) and 4-heptanone (0.66 g, 5.79 mmol) in CH2Cl2 was treated with a catalytic amount of 
BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by preparative 
thick-layer chromatography (SiO2, EA/n-hex, 1:10) affords the 1,2,4-trioxane (0.28 g, 1.0 
mmol, 18 %) as an oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.84-0.97 (m, 12 H, 2 x CH3CH and 2 x CH3CH2), 1.06 (m, 1H, CH2CH), 
1.22-1.57 (m, 8H, CH2CH and CH2CH2), 1.73 (s, 3H, CH3C=), 1.83 (m, 1H, CHCH2), 
1.99 (m, 1H, CH2CH2), 3.95 (ddd, 1H, J = 2.22, 9.54, 9.99 Hz, OCH), 4.17 (d, 1H, J = 
9.54 Hz, OOCH), 5.04 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.4 (q, CH3CH2), 14.5 (q, CH3CH2), 15.9 (t, CH2CH3), 17.1 (t, CH2CH3), 
19.7 (q, CH3C=), 21.4 (q, CH3CH), 23.6 (d, CHCH2), 23.7 (q, CH3CH), 32.8 (t, 
CH2CH2), 38.2 (t, CH2CH2), 39.8 (t, CH2CH), 67.4 (d, OCH), 87.8 (d, OOCH), 105.6 
(s, OCOO), 117.9 (t, CH2=C), 139.4 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-tert-Butyl-5-isobutyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (63) 
(elid 368g) 
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O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (0.75 g, 4.31 
mmol) and excess 3,3-dimethyl2-butanone (2.0 g, 20.0 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of excess ketone affords 
the 1,2,4-trioxane (0.24 g, 0.94 mmol, 22 %) as yellow oil  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.84 (d, 3H, J = 6.61 Hz, CH3CH), 0.88 (d, 3H, J = 6.76 Hz, CH3CH), 0.94 
(s, 9H, (CH3)3)C), 1.03 (m, 1H, CH2CH), 1.32 (m, 1H, CH2CH), 1.55 (s, 3H, CH3), 
1.72 (m, 3H, CH3C=), 1.81 (m, 1H, CHCH2), 3.97 (ddd, 1H, J = 2.35, 9.56, 10.14 Hz, 
OCH), 4.13 (d, 1H, J = 9.56 Hz, OOCH), 5.03 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.3 (q, CH3), 19.6 (q, CH3C=), 21.4 (q, CH3CH), 23.7 (d, CHCH2), 23.8 
(q, CH3CH), 24.7 (q, (CH3)3C), 38.6 (s, C(CH3)3), 39.5 (t, CH2CH), 67.7 (d, OCH), 
87.8 (d, OOCH), 106.4 (s, OCOO), 117.8 (t, CH2=C), 139.2 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-Ethyl-5-isobutyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (64a) 
(elid 368e)  
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.0 g, 5.75 
mmol) and excess 2-butanone (2.0 g, 27.8 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of excess ketone afforded yellow 
oil of the 1,2,4-trioxanes diastereomeric mixture 64a as major product (85 %), 64b-d as minor 
products (0.68 g, 2.98 mmol, 52 %). 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.82 (d, 3H, J = 6.45 Hz, CH3CH), 0.88 (d, 3H, J = 7.05 Hz, CH3CH), 0.89 
(t, 3H, J = 7.65 Hz, CH3CH2), 1.04 (m, 1H, CH2CH), 1.31 (m, 1H, CH2CH), 1.55 (s, 
3H, CH3), 1.56 (q, 2H, J = 7.65 Hz, CH2CH3), 1.71 (m, 3H, CH3C=), 1.82 (m, 1H, 
CHCH2), 3.96 (ddd, 1H, J = 2.50, 7.64, 9.41 Hz, OCH), 4.17 (d, 1H, J = 9.41 Hz, 
OOCH), 5.02 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.1 (q, CH3CH2), 18.2 (q, CH3), 19.5 (q, CH3C=), 21.3 (q, CH3CH), 23.6 (d, 
CHCH2), 23.6 (q, CH3CH), 32.0 (t, CH2CH3), 39.4 (t, CH2CH), 67.9 (d, OCH), 88.0 
(d, OOCH), 104.0 (s, OCOO), 117.9 (t, CH2=C), 139.2 (s, C=CH2). 
 
(3RS,5SR,6SR)-3-Ethyl-5-isobutyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (64b) 
Minor (9%) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.83 (d, 3H, J = 6.46 Hz, CH3CH), 1.21 (s, 3H, CH3), 1.69 (m, 3H, CH3C=), 
3.89 (ddd, 1H, J = 2.36, 8.23, 11.3 Hz, OCH), 4.10 (d, 1H, J = 8.23 Hz, OOCH). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 8.3 (q, CH3CH2), 39.8 (t, CH2CH), 67.6 (d, OCH), 87.6 (d, OOCH), 105.0 
(s, OCOO), 118.0 (t, CH2=C), 141.3 (s, C=CH2). 
 
(3RS,5SR,6RS)-3-Ethyl-5-isobutyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (64c) 
Minor (6%) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 3.83 (m, 1H, OCH), 4.24 (d, 1H, J = 4.70 Hz, OOCH). 
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13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 41.6 (t, CH2CH), 68.8 (d, OCH), 94.1 (d, OOCH), 116.6 (t, CH2=C), 141.3 
(s, C=CH2). 
 
(3RS,5RS,6SR)-3-Ethyl-5-isobutyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (64d) 
(less than 6%) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
All signals are overlapped. 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 41.2 (t, CH2CH), 68.6 (d, OCH), 92.1 (d, OOCH), 115.3 (t, CH2=C), 141.5 
(s, C=CH2). 
 
(3RS,5RS,6RS)-3-Ethyl-5-isobutyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (65) 
(elid 387) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.14 g, 6.55 
mmol) and propionaldehyde diethylacetal (0.87 g, 6.59 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of excess orthoester 
affords the 1,2,4-trioxane (0.70 g, 3.27 mmol, 50 %) as yellow oil  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.85 (d, 3H, J = 6.48 Hz, CH3CH), 0.89 (d, 3H, J = 6.75 Hz, CH3CH), 0.92 
(t, 3H, J = 7.50 Hz, CH3CH2), 1.10 (m, 1H, CH2CH), 1.38 (m, 1H, CH2CH), 1.55 (m, 
2H, CH2CH3), 1.68 (m, 3H, CH3C=), 1.85 (m, 1H, CHCH2), 3.71 (ddd, 1H, J = 2.34, 
4. Experimental Part 
217 
9.09, 10.44 Hz, OCH), 4.28 (d, 1H, J = 9.09 Hz, OOCH), 5.03 (m, 2H, CH2=), 5.14 (t, 
1H, J = 5.58 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 8.2 (q, CH3CH2), 19.6 (q, CH3C=), 21.4 (q, CH3CH), 23.6 (d, CHCH2), 23.6 
(q, CH3CH), 25.3 (t, CH2CH3), 39.1 (t, CH2CH), 75.0 (d, OCH), 88.0 (d, OOCH), 
105.5 (d, OCHOO), 118.4 (t, CH2=C), 138.7 (s, C=CH2). 
 
4.6.5 Derived from 4-hydroperoxy-2,2,5-trimethylhex-5-en-3-ol 
 
(8RS,9RS)-9-tert-Butyl-8-isopropenyl-6,7,10-trioxa-spiro[4.5]decane (66) 
(elid 415c)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,2,5-trimethylhex-5-en-3-ol (7j) (0.75 g, 4.31 
mmol) and excess cyclopentanone (2.0 g, 23.8 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum 
afforded the crude product (206.9 mg, 0.86 mmol, 20 %) which was further purified by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.82) afforded the pure 
1,2,4-trioxanes (82.8 mg, 0.34 mmol, 8 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.91 (s, 9H, (CH3)3C), 1.55-1.90 (m, 7H, CH2), 1.75 (m, 3H, CH3C=), 2.37 
(m, 1H, CH2), 3.57 (d, 1H, J = 9.70 Hz, OCH), 4.90 (d, 1H, J = 9.70 Hz, OOCH), 5.04 
(m, 1H, CH2=), 5.13 (s, 1H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.3 (q, CH3C=), 23.1 (t, CH2), 24.6 (t, CH2), 26.3 (q, (CH3)3C), 32.8 (t, 
CH2), 33.8 (s, C(CH3)3), 37.1 (t, CH2), 77.7 (d, OCH), 85.8 (d, OOCH), 114.3 (s, 
OCOO), 118.9 (t, CH2=), 141.0 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 240 (M+, not observed), 109 (C8H13+, 27), 85 (C5H9O+, 57), 84 (C5H8O+, 
33), 57 (C4H9+, 100), 55 (C4H7+, 71). 
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(3RS,4RS)-4-tert-Butyl-3-isopropenyl-1,2,5-trioxa-spiro[5.5]undecane (67) 
(elid 450w)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,2,5-trimethylhex-5-en-3-ol (7j) (0.75 g, 4.31 
mmol) and cyclohexanone (0.48 g, 4.90 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum and 
further purification by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 
0.79) afforded the pure 1,2,4-trioxanes (0.12 g, 0.47 mmol, 11 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92 (s, 9H, (CH3)3C), 1.27-1.60 (m, 9H, CH2), 1.78 (m, 3H, CH3C=), 2.26 
(m, 1H, CH2), 3.67 (d, 1H, J = 9.71 Hz, OCH), 4.43 (d, 1H, J = 9.70 Hz, OOCH), 5.04 
(m, 1H, CH2=), 5.13 (s, 1H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.5 (q, CH3C=), 22.2 (t, CH2), 22.4 (t, CH2), 25.7 (t, CH2), 26.3 (q, 
(CH3)3C), 29.3 (t, CH2), 33.9 (s, C(CH3)3), 34.9 (t, CH2), 74.9 (d, OCH), 85.8 (d, 
OOCH), 102.4 (s, OCOO), 118.8 (t, CH2=), 141.2 (s, C=CH2). 
 
(5RS,6RS)-5-tert-Butyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-adamanta- 
ne] (68a) and (5RS,6SR)-5-tert-butyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-
3,2´-adamantane] (68b) (elid 491s or elid 450j)  
 
O
O
O
68a     
O
O
O
68b  
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Following GP-15, a solution of 4-hydroperoxy-2,2,5-trimethylhex-5-en-3-ol (7j) (0.76 g, 4.37 
mmol) and adamantanone (1.30 g, 8.67 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up followed by further purification by preparative thick-
layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.82) afforded a colorless oil of the pure 
1,2,4-trioxanes diastereomeric mixture 68a,b in ratio 84:16, respectively, (0.16 g, 0.52 mmol, 
12 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 68a) 
δ (ppm) = 0.93 (s, 9H, (CH3)3C), 1.50-2.19 (m, 13H, CH and CH2), 1.77 (m, 3H, 
CH3C=), 2.85 (br. s, 1H, CH), 3.70 (d, 1H, J = 9.69 Hz, OCH), 4.43 (d, 1H, J = 9.69 
Hz, OOCH), 5.05 (m, 1H, CH2=), 5.13 (s, 1H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 68a) 
δ (ppm) = 19.6 (q, CH3C=), 26.4 (q, (CH3)3C), 27.2 (d, CH), 27.3 (d, CH), 29.8 (d, 
CH), 33.0 (t, CH2), 33.3 (2 x t, 2 x CH2), 33.6 (t, CH2), 34.1 (s, C(CH3)3), 36.6 (d, 
CH), 37.2 (t, CH2), 74.4 (d, OCH), 85.5 (d, OOCH), 104.3 (s, OCOO), 118.9 (t, 
CH2=C), 141.2 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 68b) 
δ (ppm) = 0.88 (s, 9H, (CH3)3C), 1.77 (m, 3H, CH3C=), 3.63 (d, 1H, J = 3.39 Hz, 
OCH), 4.83 (d, 1H, J = 3.36 Hz, OOCH). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 68b) 
δ (ppm) = 15.3 (q, CH3C=), 25.5 (q, (CH3)3C), 26.8 (d, CH), 27.1 (d, CH), 29.8 (d, 
CH), 32.3 (t, CH2), 34.5 (2 x t, 2 x CH2), 34.8 (t, CH2), 35.0 (s, C(CH3)3), 36.8 (d, 
CH), 38.1 (t, CH2), 63.4 (d, OCH), 89.0 (d, OOCH), 102.4 (s, OCOO), 113.0 (t, 
CH2=C), 141.2 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 306 (M+, less than 1), 150 (C10H14O+, 100), 124 (C9H16+, 31), 109 (C8H13+, 
32), 81 (C6H9+, 19), 80 (C6H8+, 38), 79 (C6H7+, 47), 67 (C5H7+, 17), 55 (C3H3O+, 16). 
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4.6.6 Derived from 3-hydroperoxy-2,5-dimethylhept-1-en-4-ol (7i) 
 
(5RS,6RS)-5-((RS)-But-2-yl)-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-ada-
mantane] (69a) (5RS,6RS)-5-((SR)-but-2-yl)-6-(prop-1-en-2-yl)-spiro[1,2,4-
trioxacyclohexane-3,2´-adamantane] (69b) (elid 474a, 491x)  
 
O
OO
H
H
O
OO
H
H
69a 69b  
 
Following GP-15, a solution of 3-hydroperoxy-2,5-dimethylhept-1-en-4-ol (7i) (1.50 g, 8.62 
mmol) and adamantanone (1.58 g, 10.5 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product (2.07 g, 
6.76 mmol, 78.5 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 
0.83) afforded a diastereomeric mixture of the pure 1,2,4-trioxanes 69a,b in a 1:1 ratio (0.52 
g, 1.70 mmol, 20 %) as viscous colorless liquid. 
 
1H-NMR: (300 MHz, CDCl3, both diastereomers) 
δ (ppm) = 0.81 (m, 6H, CH3CH2 and CH3CH), 1.01-1.45 (m, 3H, CHCH2), 1.49-2.10 
(m, 13H, CH and CH2), 1.72 (s, 3H, CH3C=), 2.88 (br. d, 1H, CH), 3.83 (m, 1H, 
OCH), 4.22 (d, 1H, J = 9.54 Hz, OOCH), 5.03 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 11.2 (q, CH3CH2), 19.0 (q, CH3CH), 19.8 (q, CH3C=), 27.1 (d, CH), 27.2 
(d, CH), 28.2 (t, CH2), 29.6 (t, CH2), 29.8 (d, CH), 32.0 (t, CH2), 33.0 (t, CH2), 33.2 (t, 
CH2), 33.3 (t, CH2), 33.5 (t, CH2), 34.3 (d, CHCH3), 36.6 (d, CH), 37.2 (t, CH2), 68.6 
(d, OCH), 87.6 (d, OOCH), 104.7 (s, OCOO), 117.8 (t, CH2=C), 139.4 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of 2nd diastereomer) 
δ (ppm) = 11.4 (q, CH3CH2), 19.2 (q, CH3CH), 19.8 (q, CH3C=), 28.3 (t, CH2), 29.1 (t, 
CH2), 29.8 (d, CH), 31.6 (t, CH2), 33.0 (t, CH2), 33.2 (t, CH2), 33.3 (t, CH2), 33.5 (t, 
CH2), 34.1 (d, CHCH3), 37.2 (t, CH2), 69.1 (d, OCH), 87.7 (d, OOCH), 104.7 (s, 
OCOO), 117.8 (t, CH2=C), 139.4 (s, C=CH2). 
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IR: (Film) 
ν (cm-1) = 3081, 2914, 2857, 1648, 1450, 1379, 1109, 1096, 1024, 925, 908. 
Elemental Analysis: (C19H30O3, M = 306.44) 
 Calcd: C 74.47   H 9.87 
Found: C 74.58   H 10.05 
 
(3RS,5RS,6RS)-5-((RS)-But-2-yl)-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(70a) and (3RS,5RS,6RS)-5-((SR)-but-2-yl)-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-
trioxane (70b) (elid 499f)  
O
OO
H
H
O
OO
H
H
70a 70b  
 
Following GP-15, a solution of 3-hydroperoxy-2,5-dimethylhept-1-en-4-ol (7i) (1.0 g, 5.75 
mmol) and β-naphthaldehyde (0.90 g, 5.77 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.82) afforded a 
diastereomeric mixture of the pure 1,2,4-trioxanes 70a,b in a 1:1 ratio (0.31 g, 0.99 mmol, 17 
%) as viscous colorless liquid. 
 
1H-NMR: (300 MHz, CDCl3, both diastereomers) 
δ (ppm) = 0.90 (m, 12H, CH3CH2 and CH3CH), 1.08-1.71 (m, 12H, CHCH2), 1.84 (s, 
3H, CH3C=) 3.98 (m, 1H, OCH), 4.62 (d, 1H, J = 9.21 Hz, OOCH), 5.17 (m, 1H, 
CH2=), 5.21 (s, 1H, CH2=), 6.39 (s, 1H, OOCHO), 7.46-8.02 (m, 1H, Harom).  
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 11.2 (q, CH3CH2), 18.9 (q, CH3CH), 19.8 (q, CH3C=), 28.0 (t, CH2), 29.5 (t, 
CH2), 31.5 (t, CH2), 34.3 (d, CHCH3), 77.6 (d, OCH), 87.7 (d, OOCH), 104.1 (s, 
OCHOO), 118.5 (t, CH2=C), 124.1 (d, CH), 126.2 (d, CH), 126.7 (d, CH), 126.8 (d, 
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CH), 127.7 (d, CH), 128.1 (d, CH), 128.4 (d, CH), 132.0 (Cqarom), 132.8 (Cqarom), 
134.0 (Cqarom), 138.8 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of 2nd diastereomer) 
δ (ppm) = 11.4 (q, CH3CH2), 19.2 (q, CH3CH), 28.1 (t, CH2), 29.0 (t, CH2), 31.7 (t, 
CH2), 34.3 (d, CHCH3). 
 
4.6.7 Derived from 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) 
 
(5RS,6RS)-6-(Prop-1-en-2-yl)-5-n-propyl-spiro[1,2,4-trioxacyclohexane-3,2´-adamantan- 
e] (71) (elid 437b) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.34 g, 8.38 
mmol) and adamantanone (1.57 g, 10.5 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.88) afforded the pure 
1,2,4-trioxane (0.73 g, 2.50 mmol, 30 %) as viscous colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.89 (t, 3H, J = 7.05 Hz, CH3CH2), 1.28-1.40 (m, 4H, CH2CH2), 1.50-2.10 
(m, 13H, CH and CH2), 1.72 (m, 3H, CH3C=), 2.90 (br. s, 1H, CH), 3.88 (m, 1H, 
OCH), 4.22 (d, 1H, J = 9.54 Hz, OOCH), 5.03 (s, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 18.3 (t, CH2CH3), 19.8 (q, CH3C=), 27.1 (d, CH), 27.2 
(d, CH), 29.8 (d, CH), 32.9 (t, CH2CH2), 33.0 (t, CH2), 33.3 (t, CH2), 33.3 (t, CH2), 
33.5 (t, CH2), 37.1 (t, CH2), 68.3 (d, OCH), 87.6 (d, OOCH), 104.7 (s, OCOO), 117.8 
(t, CH2=C), 139.4 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 2913, 2858, 1648, 1135, 1109, 1095, 1002, 926, 908. 
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MS: (EI, 70 eV) 
m/z (%) = 292 (M+, not observed), 150 (C10H14O+, 100), 110 (C8H14+, 37), 81 (C6H9+, 
21), 80 (C6H8+, 32), 79 (C6H7+, 47). 
Elemental Analysis: (C18H28O3, M = 292.41) 
Calcd: C 73.93   H 9.65 
Found: C 73.93   H 9.65 
 
(3RS,4RS)-3-Isopropenyl-4-propyl-1,2,5-trioxa-spiro[5.6]dodecane (72) 
(elid 425a) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.56 g, 9.75 
mmol) and cycloheptanone (1.10 g, 9.82 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.83) afforded the pure 
1,2,4-trioxane (0.45 g, 1.77 mmol, 18 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.88 (t, 3H, J = 7.05 Hz, CH3CH2), 1.30-1.65 (m, 14H, CH2 and CH2CH2), 
1.73 (s, 3H, CH3C=), 2.21 (m, 2H, CH2), 3.85 (m, 1H, OCH), 4.22 (d, 1H, J = 9.54 
Hz, OOCH), 5.03 (s, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 18.1 (t, CH2CH3), 19.6 (q, CH3C=), 22.0 (t, CH2), 22.2 
(t, CH2), 29.0 (t, CH2), 29.5 (t, CH2), 31.2 (t, CH2), 33.0 (t, CH2CH2) 38.6 (t, CH2), 
69.1 (d, OCH), 87.6 (d, OOCH), 107.2 (s, OCOO), 117.7 (t, CH2=C), 139.5 (s, 
C=CH2). 
 
(3RS,4RS)-3-Isopropenyl-4-propyl-1,2,5-trioxa-spiro[5.5]undecane (73) 
(elid 467j) 
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Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.20 g, 7.50 
mmol) and propionaldehyde diethylacetal (0.73 g, 7.45 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.80) afforded 
the pure 1,2,4-trioxane (0.88 g, 3.67 mmol, 49 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 3H, J = 6.90 Hz, CH3CH2), 1.20-1.65 (m, 12H, CH2 and CH2CH2), 
1.71 (m, 3H, CH3C=), 2.0 (m, 1H, CH2), 2.14 (m, 1H, CH2), 3.87 (m, 1H, OCH), 4.21 
(d, 1H, J = 9.54 Hz, OOCH), 5.02 (s, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.8 (q, CH3CH2), 18.1 (t, CH2CH3), 19.6 (q, CH3C=), 22.2 (t, CH2), 22.4 
(t, CH2), 25.6 (t, CH2), 29.4 (t, CH2), 35.0 (t, CH2), 32.9 (t, CH2CH2), 68.8 (d, OCH), 
87.7 (d, OOCH), 102.7 (s, OCOO), 117.7 (t, CH2=), 139.3 (s, C=CH2). 
 
(8RS,9RS)-8-Isopropenyl-9-propyl-6,7,10-trioxa-spiro[4.5]decane (74) 
(elid 425c) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.55 g, 9.69 
mmol) and cyclopentanone (0.81 g, 9.64 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10) afforded the pure 1,2,4-
trioxane (0.42 g, 1.86 mmol, 19 %) as oil. 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.86 (t, 3H, J = 6.90 Hz, CH3CH2), 1.29-1.55 (m, 4H, CH2CH2), 1.59-1.85 
(m, 7H, CH2), 1.71 (s, 3H, CH3C=), 2.48 (m, 1H, CH2), 3.77 (m, 1H, OCH), 4.30 (d, 
1H, J = 9.54 Hz, OOCH), 5.03 (s, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.8 (q, CH3CH2), 18.0 (t, CH2CH3), 19.5 (q, CH3C=), 23.1 (t, CH2), 24.7 
(t, CH2), 32.6 (t, CH2), 32.9 (t, CH2CH2), 37.2 (t, CH2), 71.6 (d, OCH), 87.5 (d, 
OOCH), 114.7 (s, OCOO), 117.9 (t, CH2=C), 139.1 (s, C=CH2). 
 
(5RS,6RS)-3,3-Diethyl-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (75) 
(elid 496n) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.10 g, 6.88 
mmol) and 3-pentanone (2.0 g, 23.3 mmol) in CH2Cl2 was treated with a catalytic amount of 
BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by preparative 
thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.79) afforded the pure 1,2,4-
trioxane (0.22 g, 0.96 mmol, 14 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.84-0.91 (m, 9H, 2 x CH3CH2 and CH3(CH2)2), 1.21-1.65 (m, 6H, CH2CH3 
and CH2CH2), 1.88-2.19 (m, 2H, CH2CH3), 1.73 (m, 3H, CH3C=), 3.86 (m, 1H, OCH), 
4.21 (d, 1H, J = 9.48 Hz, OOCH), 5.04 (s, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 6.8 (q, CH3CH2), 8.0 (q, CH3CH2), 14.0 (q, CH3CH2CH2), 18.1 (t, 
CH2CH2), 19.7 (q, CH3C=), 22.8 (t, CH2CH3), 28.3 (t, CH2CH3), 33.0 (t, CH2CH2), 
69.1 (d, OCH), 87.3 (d, OOCH), 106.0 (d, OCOO), 117.8 (t, CH2=), 139.4 (s, C=CH2). 
IR: (Film) 
 ν (cm-1) = 3082, 2971, 2940, 2880, 1648, 1460, 1162, 1146, 1091, 1004, 924. 
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(3RS,5RS,6RS)-3-(Naphthalen-2-yl)-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (76) 
(elid 493m) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.20 g, 7.50 
mmol) and β-naphthaldehyde (1.18 g, 7.56 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.66) afforded the pure 
1,2,4-trioxane (0.89 g, 2.99 mmol, 40 %) as colorless oil which crystallizes on standing. 
 
M.p. 78-80 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.02 (t, 3H, J = 7.06 Hz, CH3CH2), 1.47-1.79 (m, 4H, CH2CH2), 1.86 (m, 
3H, CH3C=), 4.04 (ddd, 1H, J = 3.09, 8.09, 9.26 Hz, OCH), 4.67 (d, 1H, J = 9.26 Hz, 
OOCH), 5.19 (m, 1H, CH2=), 5.24 (s, 1H, CH2=),  6.43 (s, 1H, OCHOO), 7.47-8.07 
(m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 18.1 (t, CH2CH3), 19.7 (q, CH3C=), 32.5 (t, CH2CH2), 
77.1 (d, OCH), 87.7 (d, OOCH), 104.0 (d, OCHOO), 118.5 (t, CH2=), 124.0 (d, 
CHarom), 126.1 (d, CHarom), 126.6 (d, CHarom), 126.7 (d, CHarom), 127.6 (d, CHarom), 
128.0 (d, CHarom), 128.3 (d, CHarom), 131.9 (s, Cqarom) , 132.8 (s, Cqarom), 133.9 (s, 
Cqarom), 138.7 (s, C=CH2). 
IR: (CsI) 
 ν (cm-1) = 2957, 2934, 1664, 1605, 1576, 1362, 1340, 1092, 1075, 907. 
MS: (EI, 70 eV) 
m/z (%) = 298 (M+, 3), 226 (M+-C4H8O, 2), 156 (C11H8O+, 92), 155 (C11H7O+, 100), 
128 (C10H8+, 22), 127 (C10H7+, 77), 110 (C8H14+, 27), 95 (C7H11+, 8). 
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HRMS: (EI, 70 eV, C19H22O3) 
 Calcd: M = 298.157 g/mol  
Found: M = 298.157 ±0.005 g/mol 
Elemental Analysis: (C19H22O3, M = 298.39) 
 Calcd: C 76.48   H 7.43 
Found: C 76.25   H 7.27 
 
(3RS,5RS,6RS)-3-Phenyl-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (77) 
(elid 467e)  
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.20 g, 7.50 
mmol) and benzaldehyde dimethylacetal (1.13 g, 7.43 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.80) afforded 
the pure 1,2,4-trioxane (0.67 g, 2.70 mmol, 36 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.96 (t, 3H, J = 7.05 Hz, CH3CH2), 1.40-1.74 (m, 4H, CH2CH2), 1.81 (m, 
3H, CH3C=), 3.95 (m, 1H, OCH), 4.56 (d, 1H, J = 9.26 Hz, OOCH), 5.14 (m, 2H, 
CH2=), 6.24 (s, 1H, OCHOO), 7.36-7.60 (m, 4H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 18.0 (t, CH2CH3), 19.7 (q, CH3C=), 32.5 (t, CH2CH2), 
77.0 (d, OCH), 87.6 (d, OOCH), 103.9 (d, OCHOO), 118.5 (t, CH2=C), 126.9 (d, 
CHarom), 128.2 (d, CHarom), 129.6 (d, CHarom), 134.6(s, Cqarom), 138.7 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-(2-Chlorophenyl)-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (78a) and 
(3RS,5SR,6RS)-3-(2-chlorophenyl)-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (78b) 
(elid 450e)  
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Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7d) (0.85 g, 5.31 
mmol) and 2-chlorobenzaldehyde (0.93 g, 6.62 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.67) afforded a diastereomeric mixture of the 
pure 1,2,4-trioxanes 78a,b in a ratio 88:12 (0.60 g, 2.13 mmol, 40 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 78a) 
δ (ppm) = 0.86 (t, 3H, J = 7.05 Hz, CH3CH2), 1.32-1.58 (m, 4H, CH2CH2), 1.73 (m, 
3H, CH3C=), 3.90 (m, 1H, OCH), 4.48 (d, 1H, J = 9.26 Hz, OOCH), 5.07 (m, 2H, 
CH2=), 6.47 (s, 1H, OCHOO), 7.18-7.61 (m, 4H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 78a) 
δ (ppm) = 13.9 (q, CH3CH2), 18.0 (t, CH2CH3), 19.7 (q, CH3C=), 32.5 (t, CH2CH2), 
77.3 (d, OCH), 87.7 (d, OOCH), 101.0 (d, OCHOO), 118.7 (t, CH2=C), 126.8 (d, 
CHarom), 128.7 (d, CHarom), 129.5 (d, CHarom), 130.9 (d, CHarom), 132.1 (s, Cqarom), 
133.5 (s, Cqarom), 138.7 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 78b) 
δ (ppm) = 0.88 (t, 3H, J = 7.08 Hz, CH3CH2), 2.03 (m, 3H, CH3C=), 3.62 (m, 1H, 
OCH), 4.09 (d, 1H, J = 3.82 Hz, OOCH), 6.49 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of minor diastereomer 78b) 
δ (ppm) = 77.1 (d, OCH), 85.0 (d, OOCH), 101.4 (d, OCHOO), 118.2 (t, CH2=C), 
126.9 (d, CHarom), 128.6 (d, CHarom), 129.5 (d, CHarom), 130.9 (d, CHarom), 132.1 (s, 
Cqarom), 133.5 (s, Cqarom), 141.6 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-Ethyl-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (79) 
(elid 467i) 
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Following GP-15, a solution of 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (1.43 g, 8.94 
mmol) and propionaldehyde diethylacetal (1.17 g, 8.86 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.80) afforded 
the pure 1,2,4-trioxane (0.73 g, 3.65 mmol, 41 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.89 (t, 3H, J = 6.90 Hz, CH3(CH2)2), 0.93 (t, 3H, J = 7.65 Hz, CH3CH2), 
1.30-1.63 (m, 6H, CH2CH3 and CH2CH2), 1.70 (m, 3H, CH3C=), 3.66 (m, 1H, OCH), 
4.33 (d, 1H, J = 9.12 Hz, OOCH), 5.05 (m, 2H, CH2=), 5.15 (t, 1H, J = 5.43 Hz, 
CHCH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 8.2 (q, CH3CH2), 13.9 (q, CH3(CH2)2), 18.1 (t, CH2CH2), 19.7 (q, CH3C=), 
25.4 (t, CH2CH3), 32.5 (t, CH2CH2), 76.5 (d, OCH), 87.7 (d, OOCH), 105.5 (d, 
OCHOO), 118.2 (t, CH2=C), 138.8 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-Methyl-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (80a) and 
(3RS,5SR,6SR)-3-methyl-6-(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (80b) 
(elid 467l)  
O
O
O
80a    
O
O
O
80b  
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7d) (1.0 g, 6.25 
mmol) and acetaldehyde diethylacetal (0.73 g, 6.19 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer 
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chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.77) afforded a diastereomeric mixture of the 
pure 1,2,4-trioxanes 80a,b in a ratio 90:10 (0.55 g, 2.96 mmol, 48 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 80a) 
δ (ppm) = 0.88 (t, 3H, J = 6.91 Hz, CH3CH2), 1.25 (d, 3H, J = 5.44 Hz, CH3CH), 1.27-
1.60 (m, 4H, CH2CH2), 1.72 (m, 3H, CH3C=), 3.66 (m, 1H, OCH), 4.32 (d, 1H, J = 
9.12 Hz, OOCH), 5.05 (m, 2H, CH2=C), 5.35 (q, 1H, J = 5.44 Hz, CHCH3). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 80a) 
δ (ppm) = 13.8 (q, CH3CH2), 17.8 (q, CH3CH), 18.0 (t, CH2CH3), 19.5 (CH3C=), 32.4 
(t, CH2CH), 76.4 (d, OCH), 87.4 (d, OOCH), 101.4 (d, OOCHO), 118.2 (t, CH2=C), 
138.7 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 80b) 
δ (ppm) = 1.75 (m, 3H, CH3C=), 3.75 (m, 1H, OCH), 4.38 (d, 1H, J = 9.27 Hz, 
OOCH). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 80b) 
δ (ppm) = 13.9 (q, CH3CH2), 17.6 (q, CH3CH), 17.9 (t, CH2CH3), 19.5 (CH3C=), 33.4 
(t, CH2CH), 75.9 (d, OCH), 84.5 (d, OOCH), 101.6 (d, OOCHO), 118.3 (t, CH2=C), 
138.8 (s, C=CH2). 
 
4.6.8 Derived from 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) 
 
(5RS,6RS)-6-(Prop-1-en-2-yl)-5-isopropyl-spiro[1,2,4-trioxacyclohexane-3,2´-adamanta- 
ne] (81) (elid 475z) 
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (1.35 g, 8.44 
mmol) and adamantanone (1.27 g, 8.47 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer chromatography 
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(SiO2, EA/n-hex, 1:10, Rf = 0.76) afforded the pure 1,2,4-trioxane (0.69 g, 2.36 mmol, 28 %) 
as viscous colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.89 (d, 3H, J = 6.77 Hz, CH3CH), 0.97 (d, 3H, J = 7.06 Hz, CH3CH), 1.48-
2.10 (m, 14H, CH(CH3)2, CH and CH2), 1.72 (m, 3H, CH3C=), 2.87 (br. s, 1H, CH), 
3.78 (dd, 1H, J = 2.65, 9.85 Hz, OCH), 4.41 (d, 1H, J = 9.85 Hz, OOCH), 5.02 (m, 
2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.9 (q, CH3CH), 19.6 (q, CH3C=), 20.2 (q, CH3CH), 27.17 (d, CH), 27.22 
(d, CH), 29.7 (d, CH), 36.5 (d, CH), 28.1 (d, CH(CH3)2), 32.9 (t, CH2), 33.2 (2 x t, 
CH2), 33.5 (t, CH2), 37.2 (t, CH2), 72.1 (d, OCH), 85.4 (d, OOCH), 104.4 (s, OCOO), 
117.6 (t, CH2=C), 139.5 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3081, 2913, 2857, 1649, 1450, 1380, 1110, 1097, 1077, 1025, 925, 908 
MS: (EI, 70 eV) 
m/z (%) = 292 (M+, less than 1), 220 (M+-C4H8O, 1), 150 (C10H14O+, 58), 110 
(C8H14+, 78), 95 (C7H11+, 50), 81 (C6H9+, 36), 80 (C6H8+, 88), 79 (C6H7+, 100), 67 
(C5H7+, 31), 55 (C3H3O+, 27). 
Elemental Analysis: (C18H28O3, M = 292.41) 
Calcd: C 73.93   H 9.65 
Found: C 73.64   H 9.33 
 
(8RS,9RS)-8-Isopropenyl-9-isopropyl-6,7,10-trioxa-spiro[4.5]decane (82) 
(elid 348f)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.90 g, 5.63 
mmol) and excess cyclopentanone (2.0 g, 23.8 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum 
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followed by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10) afforded the pure 
1,2,4-trioxane (0.19 g, 0.84 mmol, 15 %) as colorless liquid. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.89 (d, 3H, J = 6.91 Hz, CH3CH), 0.94 (d, 3H, J = 6.90 Hz, CH3CH),1.58-
1.85 (m, 7H, CH2 (cyclopentane)), 1.70 (m, 1H, CH(CH3)2), 1.72 (m, 3H, CH3C=), 
2.45 (m, 1H, CH2 (cyclopentane)), 3.67 (dd, 1H, J = 2.35, 9.70 Hz, OCH), 4.49 (d, 1H, 
J = 9.70 Hz, OOCH), 5.04 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 15.2 (q, CH3CH), 19.4 (q, CH3C=), 19.9 (q, CH3CH), 23.1 (t, CH2), 24.7 (t, 
CH2), 33.0 (t, CH2), 37.2 (t, CH2), 28.0 (d, CH(CH3)2), 75.6 (d, OCH), 85.6 (d, 
OOCH), 114.7 (s, OCOO), 117.8 (t, CH2=C), 139.4 (s, C=CH2). 
 
(5RS,6RS)-5-Isopropyl-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (83) 
(elid 330e) 
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.86 g, 5.38 
mmol) and excess acetone (2.0 g, 34.5 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum affords 
the 1,2,4-trioxane (0.46 g, 2.30 mmol, 43 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.88 (d, 3H, J = 6.91 Hz, CH3CH), 0.94 (d, 3H, J = 7.05 Hz, CH3CH), 1.31 
(s, 3H, CH3), 1.60 (s, 3H, CH3), 1.68 (m, 1H, CH(CH3)2), 1.74 (m, 3H, CH3C=), 3.79 
(dd, 1H, J = 2.35, 9.84 Hz, OCH), 4.41 (d, 1H, J = 10.0 Hz, OOCH), 5.05 (m, 2H, 
CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 15.0 (q, CH3CH), 19.5 (q, CH3C=), 19.8 (q, CH3CH), 20.5 (q, CH3), 25.8 
(q, CH3), 28.0 (d, CH(CH3)2), 73.6 (d, OCH), 85.5 (d, OOCH), 102.6 (s, OCOO), 
117.8 (t, CH2=C), 139.5 (s, C=CH2). 
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(5RS,6RS)-3,3-Diethyl-5-isopropyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (84) 
(elid 330a) 
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.17 g, 1.06 
mmol) and excess 3-pentanone (2.0 g, 23.3 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum 
affords the 1,2,4-trioxane (0.12 g, 0.53 mmol, 50 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.83 (t, 3H, J = 7.62 Hz, CH3CH2), 0.86 (t, 3H, J = 7.50 Hz, CH3CH2), 0.93 
(d, 3H, J = 6.90 Hz, CH3CH), 1.43-1.65 (m, 2H, CH2CH3), 1.69 (m, 1H, CH(CH3)2), 
1.71 (m, 3H, CH3C=), 1.80-2.20 (m, 2H, CH2CH3), 3.72 (dd, 1H, J = 2.34, 9.84 Hz, 
OCH), 4.37 (d, 1H, J = 9.99 Hz, OOCH), 5.0 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 6.6 (q, CH3CH2), 7.9 (q, CH3CH2), 14.9 (q, CH3CH), 19.5 (q, CH3C=), 19.9 
(q, CH3CH), 23.2 (t, CH2CH3), 28.2 (d, CH(CH3)2), 28.4 (t, CH2CH3), 72.8 (d, OCH), 
85.2 (d, OOCH), 105.6 (s, OCOO), 117.6 (t, CH2=C), 139.5 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Isopropyl-3-methyl-6-(prop-1-en-2-yl)-3-propyl-1,2,4-trioxane (85a) 
and (3RS,5SR,6SR)-5-isopropyl-3-methyl-6-(prop-1-en-2-yl)-3-propyl-1,2,4-trioxane 
(85b) (elid 400b)  
O
O
O
85a    
O
O
O
85b  
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.85 g, 5.31 
mmol) and excess 2-pentanone (2.0 g, 23.3 mmol) in CH2Cl2 was treated with a catalytic 
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amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum 
followed by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10) afforded a 
diastereomeric mixture of the pure 1,2,4-trioxanes 85a,b in a ratio 87:13 (0.21 g, 0.92 mmol, 
17 %) as colorless liquid. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 85a) 
δ (ppm) = 0.89 (t, 3H, J = 7.20 Hz, CH3CH2), 0.89 (d, 3H, J = 6.90 Hz, CH3CH), 0.94 
(d, 3H, J = 6.90 Hz, CH3CH), 0.91-0.98 (m, 2H, CH2CH3), 1.38-1.62 (m, 2H, 
CH2CH2), 1.56 (s, 3H, CH3), 1.69 (m, 1H, CH(CH3)2), 1.75 (m, 3H, CH3C=), 3.80 (dd, 
1H, J = 2.35, 9.85 Hz, OCH), 4.41 (d, 1H, J = 9.99 Hz, OOCH), 5.05 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 85a) 
δ (ppm) = 14.4 (q, CH3CH2), 15.1 (q, CH3CH), 16.1 (t, CH2CH3), 19.2 (q, CH3C=), 
19.6 (q, CH3CH), 19.9 (q, CH3), 28.2 (d, CH(CH3)2), 41.4 (t, CH2CH2), 73.4 (d, 
OCH), 85.6 (d, OOCH), 103.8 (s, OCOO), 117.8 (t, CH2=C), 139.6 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signal of minor diastereomer 85b) 
δ (ppm) = 3.74 (dd, 1H, J = 2.27, 9.84 Hz, OCH). 
13C-NMR: (75.5 MHz, CDCl3, of minor diastereomer 85b) 
δ (ppm) = 14.4 (q, CH3CH2), 14.7 (q, CH3CH), 17.1 (t, CH2CH3), 19.1 (q, CH3C=), 
19.6 (q, CH3CH), 23.1 (q, CH3), 27.8 (d, CH(CH3)2), 34.4 (t, CH2CH2), 73.0 (d, 
OCH), 85.1 (d, OOCH), 104.3 (s, OCOO), 117.9 (t, CH2=C), 139.2 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-tert-Butyl-5-isopropyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (86a) 
and (3RS,5SR,6SR)-3-tert-butyl-5-isopropyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(86b) (elid 330d)  
O
O
O
86a    
O
O
O
86b  
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.58 g, 3.63 
mmol) and excess 3,3-dimethyl-2-butanone (2.0 g, 20 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under 
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vacuum afforded a diastereomeric mixture of the pure 1,2,4-trioxanes 86a,b in a ratio 83:17 
(0.32 g, 1.32 mmol, 36 %) as oil. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 86a) 
δ (ppm) = 0.88 (d, 3H, J = 6.76 Hz, CH3CH), 0.93 (d, 3H, J = 7.05 Hz, CH3CH), 0.95 
(s, 9H, (CH3)3C), 1.51 (s, 3H, CH3), 1.68 (m, 1H, CH(CH3)2), 1.72 (m, 3H, CH3C=), 
3.78 (dd, 1H, J = 2.35, 9.85 Hz, OCH), 4.37 (d, 1H, J = 9.85 Hz, OOCH), 5.03 (m, 
2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 86a) 
δ (ppm) = 14.3 (q, CH3), 15.1 (q, CH3CH), 19.5 (q, CH3C=), 20.0 (q, CH3CH), 24.7 
(q, (CH3)3C), 28.3 (d, CH(CH3)2), 39.0 (s, C(CH3)3), 73.1 (d, OCH), 85.3 (d, OOCH), 
106.3 (s, OCOO), 117.6 (t, CH2=C), 139.4 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 86b) 
δ (ppm) = 1.10 (s, 9H, (CH3)3C), 3.50 (m, 1H, OCH), 4.29 (d, 1H, J = 8.22 Hz, 
OOCH). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of minor diastereomer 86b) 
δ (ppm) = 74.7 (d, OCH), 91.7 (d, OOCH), 104.8 (s, OCOO), 141.2 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-(2-Chlorophenyl)-5-isopropyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (87a) 
and (3RS,5SR,6RS)-3-(2-chlorophenyl)-5-isopropyl-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(87b) (elid 450g)  
O
O
O
Cl
87a     
O
O
O
Cl
87b  
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.90 g, 5.63 
mmol) and 2-chlorobenzaldehyde (0.98 g, 6.98 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.80) afforded a diastereomeric mixture of the 
pure 1,2,4-trioxanes 87a,b in a ratio 91:9 (0.52 g, 1.84 mmol, 33 %) as oil. 
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1H-NMR: (300 MHz, CDCl3, major diastereomer 87a) 
δ (ppm) = 0.97 (d, 3H, J = 6.75 Hz, CH3CH), 0.98 (d, 3H, J = 7.05 Hz, CH3CH), 1.71 
(m, 3H, CH3C=), 1.81 (m, 1H, CH(CH3)2), 3.78 (dd, 1H, J = 2.20, 9.41 Hz, OCH), 
4.64 (d, 1H, J = 9.57 Hz, OOCH), 5.04-5.10 (m, 2H, CH2=), 6.46 (s, 1H, OCHOO), 
7.15-7.61 (m, 4H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 87a) 
δ (ppm) = 15.5 (q, CH3CH), 19.5 (q, CH3C=), 20.0 (q, CH3CH), 28.2 (d, CH(CH3)2), 
81.2 (d, OCH), 85.8 (d, OOCH), 101.0 (d, OCHOO), 118.6 (t, CH2=C), 126.8 (d, 
CHarom), 128.7 (d, CHarom), 129.4 (d, CHarom), 130.9 (d, CHarom), 132.2 (s, Cqarom), 
133.5 (s, Cqarom), 138.7 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 87b) 
δ (ppm) = 0. 79 (br. s, 3H, CH3CH), 0.81 (br. s, 3H, CH3CH), 2.0 (m, 3H, CH3C=), 
3.74 (dd, 1H, J = 3.54, 10.29 Hz, OCH), 4.15 (d, 1H, J = 3.54 Hz, OOCH), 6.44 (s, 
1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 87b) 
δ (ppm) = 17.9 (q, CH3CH), 19.2 (q, CH3C=), 23.2 (q, CH3CH), 29.4 (d, CH(CH3)2), 
83.1 (d, OCH), 83.7 (d, OOCH), 101.5 (d, OCHOO), 119.1 (t, CH2=C), 127.0 (d, 
CHarom), 128.3 (d, CHarom), 128.5 (d, CHarom), 129.3 (d, CHarom), 130.5 (s, Cqarom), 
135.0 (s, Cqarom), 141.0 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-Ethyl-5-isopropyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (88) 
(elid 387b)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.92 g, 5.75 
mmol) and propionaldehyde diethyl acetal (0.76 g, 5.76 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under 
vacuum afforded the pure 1,2,4-trioxane (0.51 g, 2.55 mmol, 44 %) as faint yellow oil. 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.90 (d, 3H, J = 6.76 Hz, CH3CH), 0.92 (t, 3H, J = 7.64 Hz, CH3CH2), 0.97 
(d, 3H, J = 6.91 Hz, CH3CH), 1.52-1.62 (dq, 2H, J = 5.29, 7.64 Hz, CH2CH3), 1.70 
(m, 3H, CH3C=), 1.72 (m, 1H, CH(CH3)2), 3.54 (dd, 1H, J = 2.34, 9.42 Hz, OCH), 
4.49 (d, 1H, J = 9.42 Hz, OOCH), 5.03 (m, 2H, CH2=), 5.13 (t, 1H, J = 5.29 Hz, 
CHCH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 8.0 (q, CH3CH2), 15.3 (q, CH3CH), 19.5 (q, CH3C=), 19.9 (q, CH3CH), 25.3 
(t, CH2CH3), 28.1 (d, CH(CH3)2), 80.4 (d, OCH), 85.7 (d, OOCH), 105.3 (d, CHCH2), 
118.1 (t, CH2=), 138.9 (s, C=CH2). 
 
4.6.9 Derived from 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) 
 
(3RS,5RS,6RS)-5-Ethyl-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (89) 
(elid 493l)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (1.22 g, 8.36 
mmol) and β-naphthaldehyde (1.30 g, 8.33 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.71) affords the 1,2,4-
trioxane (0.57 g, 2.0 mmol, 24 %) as viscous oil which crystallizes into white solid on 
standing. 
 
M.p. 73-75 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.14 (dd, 3H, J = 7.35, 7.35 Hz, CH3CH2), 1.70 (m, 2H, CH2CH3), 1.86 (m, 
3H, CH3C=), 3.96 (ddd, 1H, J = 3.75, 7.86, 9.26 Hz, OCH), 4.67 (d, 1H, J = 9.26 Hz, 
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OOCH), 5.18 (m, 1H, CH2=), 5.23 (s, 1H, CH2=), 6.43 (s, 1H, OCHOO), 7.48- 8.07 
(m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.4 (q, CH3CH2), 19.9 (q, CH3C=), 23.6 (t, CH2CH3), 78.5 (d, OCH), 87.4 
(d, OOCH), 104.0 (d, OCHOO), 118.4 (t, CH2=C), 124.0 (d, CHarom), 126.1 (d, 
CHarom), 126.6 (d, CHarom), 126.8 (d, CHarom), 127.6 (d, CHarom), 128.0 (d, CHarom), 
128.3 (d, CHarom), 131.9 (s, Cqarom), 132.8 (s, Cqarom), 133.9 (s, Cqarom), 138.7 (s, 
C=CH2). 
IR: (CsI) 
ν (cm-1) = 3064, 2980, 2925, 2898, 1664, 1605, 1071, 908, 824. 
MS: (EI, 70 eV) 
m/z (%) = 284 (M+, 4), 156 (C11H8O+, 100), 155 (C11H7O+, 95), 128 (C10H8+, 22), 127 
(C10H7+, 73), 96 (C7H12+, 47), 81 (C6H9+, 17). 
HRMS: (EI, 70 eV, C18H20O3) 
 Calcd: M = 284.141 g/mol  
Found: M = 284.141 ±0.005 g/mol 
Elemental Analysis: (C18H20O3, M = 284.35 g/mol) 
 Calcd: C 76.03   H 7.09 
Found: C 75.53   H 7.11 
 
(3RS,5RS,6RS)-3-(2-Chlorophenyl)-5-ethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (90) 
(elid 446b, 492n)  
O
O
O
Cl
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (1.50 g, 10.3 
mmol) and 2-chlorobenzaldehyde (1.44 g, 10.2 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10) affords the 1,2,4-trioxane 
(0.60 g, 2.23 mmol, 22 %) as an oil. 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.97 (dd, 3H, J = 7.41, 7.41 Hz, CH3CH2), 1.43-1.62 (m, 2H, CH2CH3), 
1.73 (m, 3H, CH3C=), 3.82 (ddd, 1H, J = 3.54, 8.10, 9.24 Hz, OCH), 4.48 (d, 1H, J = 
9.24 Hz, OOCH), 5.05 (m, 2H, CH2=), 5.48 (s, 1H, OCHOO), 7.21- 7.65 (m, 4H, 
Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.3 (q, CH3CH2), 19.7 (q, CH3C=), 23.6 (t, CH2CH3), 78.7 (d, OCH), 87.4 
(d, OOCH), 101.0 (d, OCHOO), 118.5 (t, CH2=C), 126.8 (d, CHarom), 128.7 (d, 
CHarom), 129.5 (d, CHarom), 130.9 (d, CHarom), 132.1 (s, Cqarom), 133.5 (s, Cqarom), 
138.7 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3079, 2971, 2925, 2879, 1647, 1597, 1576, 1445, 1086, 1053, 1003, 960, 
916. 
MS: (EI, 70 eV) 
m/z (%) = 268 (M+, not observed), 142 (C7H537Cl+, 13), 141 (C7H437Cl+, 42), 140 
(C7H535Cl+, 39), 139 (C7H435Cl+, 100), 113 (C6H537Cl+, 7), 111 (C6H535Cl+, 21), 96 
(C7H12+, 30), 81 (C6H9+, 20). 
Elemental Analysis: (C14H17ClO3, M = 268.74 g/mol) 
 Calcd: C 62.57   H 6.38 
Found: C 62.55   H 6.36 
 
(5RS,6RS)-5-Ethyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-adamantane] 
(91) (elid 489r, 489z)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (1.56 g, 10.7 
mmol) and adamantanone (1.62 g, 10.8 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
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preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.83) affords the 1,2,4-
trioxane (0.15 g, 0.54 mmol, 5 %) as viscous colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.97 (dd, 3H, J = 7.35, 7.35 Hz, CH3CH2), 1.16-2.10 (m, 15H, CH2CH3, CH 
and CH2), 1.73 (m, 3H, CH3C=), 2.90 (br. s, 1H, CH), 3.80 (ddd, 1H, J = 2.79, 9.42, 
9.54 Hz, OCH), 4.24 (d, 1H, J = 9.54 Hz, OOCH), 5.04 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.7 (q, CH3CH2), 19.9 (q, CH3C=), 24.0 (t, CH2CH3), 27.2 (d, CH), 27.3 (d, 
CH), 29.8 (d, CH), 36.7 (d, CH), 33.0 (t, CH2), 33.3 (t, CH2), 33.4 (t, CH2), 33.6 (t, 
CH2), 37.2 (t, CH2), 70.0 (d, OCH), 87.5 (d, OOCH), 104.8 (s, OCOO), 117.7 (t, 
CH2=C), 139.5 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3082, 2937, 2914, 2857, 1648, 1450, 1379, 1109, 1093, 1072, 1024, 925, 
910. 
MS: (EI, 70 eV) 
m/z (%) = 278 (M+, less than 1), 220 (M+-C3H6O, 1), 150 (C10H14O+, 65), 96 (C7H12+, 
100), 81 (C6H9+, 25), 80 (C6H8+, 36), 79 (C6H7+, 43). 
 
(5RS,6RS)-5-Ethyl-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (92) 
(elid 329e) 
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (0.64 g, 4.38 
mmol) and excess 2,2-dimethoxy propane (2.0 g, 19.2 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under 
vacuum affords the 1,2,4-trioxane (0.26 g, 1.40 mmol, 32 %) as yellow oil. 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.91 (dd, 3H, J = 7.42, 7.42 Hz, CH3CH2), 1.25-1.54 (m, 2H, CH2CH3), 
1.32 (s, 3H, CH3), 1.61 (s, 3H, CH3), 1.73 (m, 3H, CH3C=), 3.81 (ddd, 1H, J = 3.24, 
8.25, 9.69 Hz, OCH), 4.24 (d, 1H, J = 9.69 Hz, OOCH), 5.04 (m, 2H, CH2=).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.3 (q, CH3CH2), 19.6 (q, CH3C=), 20.6 (q, CH3), 23.9 (t, CH2CH3), 25.9 (q, 
CH3), 71.2 (d, OCH), 87.2 (d, OOCH), 102.7 (s, OCOO), 117.8 (t, CH2=C), 139.3 (s, 
C=CH2). 
 
(5RS,6RS)-3,3,5-Triethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (93) 
(elid 399b, 413c, 491t)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (1.14 g, 7.80 
mmol) and 3-pentanone (0.67 g, 7.79 mmol) in CH2Cl2 was treated with a catalytic amount of 
BF3.Et2O (0.2 ml). Usual work-up affords the 1,2,4-trioxane (0.37 g, 1.73 mmol, 22 %) as an 
oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 3H, J = 7.65 Hz, CH3CH2), 0.88 (t, 3H, J = 7.50 Hz, CH3CH2), 0.91 
(dd, 3H, J = 7.35, 7.35 Hz, CH3CH2CH), 1.30-1.74 (m, 4H, CH2CH and CH2CH3), 
1.74 (m, 3H, CH3C=), 1.88-2.20 (m, 2H, CH2CH3), 3.78 (ddd, 1H, J = 3.06, 8.25, 9.69 
Hz, OCH), 4.21 (d, 1H, J = 9.69 Hz, OOCH), 5.04 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 6.8 (q, CH3), 8.0 (q, CH3), 9.3 (q, CH3CH2CH), 19.7 (q, CH3C=), 23.0 (t, 
CH2CH), 24.0 (t, CH2CH3), 28.4 (t, CH2CH3), 70.5 (d, OCH), 87.0 (d, OOCH), 106.0 
(s, OCOO), 117.7 (t, CH2=C), 139.5 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-tert-Butyl-5-ethyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (94) 
(elid 329b, 413b) 
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Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (0.50 g, 3.42 
mmol) and excess 3,3-dimethyl-2-butanone (2.0 g, 20.0 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under 
vacuum affords the 1,2,4-trioxane (0.30 g, 1.32 mmol, 39 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92 (dd, 3H, J = 7.42, 7.42 Hz, CH3CH2), 0.96 (s, 9H, (CH3)3C), 1.22-1.51 
(m, 2H, CH2CH3), 1.55 (s, 3H, CH3), 1.74 (m, 3H, CH3C=), 3.82 (ddd, 1H, J = 3.17, 
8.18, 9.69 Hz, OCH), 4.20 (d, 1H, J = 9.69 Hz, OOCH), 5.03 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.2 (q, CH3CH2), 14.4 (q, CH3), 19.7 (q, CH3C=), 24.0 (t, CH2CH3), 24.7 (q, 
(CH3)3C), 38.7 (s, C(CH3)3), 70.6 (d, OCH), 87.1 (d, OOCH), 106.4 (s, OCOO), 117.6 
(t, CH2=C), 139.4 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Ethyl-3-methyl-6-(prop-1-en-2-yl)-3-propyl-1,2,4-trioxane (95a) and 
(3RS,5SR,6SR)-5-ethyl-3-methyl-6-(prop-1-en-2-yl)-3-propyl-1,2,4-trioxane (95b) 
(elid 329c)  
O
O
O
95a    
O
O
O
95b  
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (0.50 g, 3.42 
mmol) and excess 2-pentanone (2.0 g, 23.2 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up, evaporation of the excess ketone under vacuum 
affords a yellow oil of the 1,2,4-trioxanes diastereomeric mixture 95a,b in 83:17 ratio (0.28 g, 
1.31 mmol, 38 %). 
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1H-NMR: (300 MHz, CDCl3, major diastereomer 95a) 
δ (ppm) = 0.88 (t, 3H, J = 7.20 Hz, CH3(CH2)2), 0.91 (dd, 3H, J = 7.40, 7.40 Hz, 
CH3CH2), 1.25-1.55 (m, 6H, CH2CH3 and CH2CH2), 1.57 (s, 3H, CH3), 1.73 (s, 3H, 
CH3C=), 3.82 (ddd, 1H, J = 3.24, 8.22, 9.54 Hz, OCH), 4.23 (d, 1H, J = 9.54 Hz, 
OOCH), 5.03 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 95a) 
δ (ppm) = 9.2 (q, CH3CH2), 14.3 (q, CH3), 16.1 (q, CH3), 19.0 (t, CH2), 19.7 (q, 
CH3C=), 23.9 (t, CH2CH3), 41.4 (t, CH2), 70.9 (d, OCH), 87.3 (d, OOCH), 104.0 (s, 
OCOO), 117.7 (t, CH2=C), 139.4 (s, C=CH2).  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 95b) 
δ (ppm) = 0.89 (t, 3H, CH3(CH2)2), 0.94 (dd, 3H, J = 7.20, 7.20 Hz, CH3CH2), 3.76 
(ddd, 1H, J = 3.09, 8.22, 9.57 Hz, OCH). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 95b) 
δ (ppm) = 9.3 (q, CH3CH2), 14.3 (q, CH3), 17.3 (q, CH3), 19.0 (t, CH2), 19.6 (t, 
CH3C=), 23.3 (t, CH2CH3), 34.7 (t, CH2), 70.1 (d, OCH), 87.0 (d, OOCH), 104.6 (s, 
OCOO), 117.7 (t, CH2=C), 139.4 (s, C=CH2).  
 
(3RS,5RS,6RS)-5-Ethyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (96) 
(elid 413a)  
O
O
O
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (1.0 g, 6.85 
mmol) and acetaldehyde diethylacetal (0.81 g, 6.86 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up affords the 1,2,4-trioxane (0.44 g, 2.56 
mmol, 37 %) as an oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.93 (dd, 3H, J = 7.50, 7.50 Hz, CH3CH2), 1.23 (d, 3H, J = 5.43 Hz, 
CH3CH), 1.10-1.54 (m, 2H, CH2CH3), 1.68 (m, 3H, CH3C=), 3.57 (ddd, 1H, J = 3.21, 
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8.55, 9.24 Hz, OCH), 4.30 (d, 1H, J = 9.24 Hz, OOCH), 5.0 (m, 2H, CH2=), 5.33 (q, 
1H, J = 5.43 Hz, CHCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.3 (q, CH3CH2), 17.8 (q, CH3CH), 19.6 (q, CH3C=), 23.5 (t, CH2CH3), 
77.9 (d, OCH), 87.2 (d, OOCH), 101.5 (d, CHCH3), 118.1 (t, CH2=C), 138.7 (s, 
C=CH2). 
 
(3RS,5RS,6RS)-3,5-Diethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129b) and (3RS,5SR,6RS)-
3,5-diethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (97) 
(elid 387a)  
O
O
O
129b     
O
O
O
97  
 
Following GP-15, a solution of 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (0.67 g, 4.59 
mmol) and propionaldehyde diethyl acetal (0.61 g, 4.62 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up afforded the 1,2,4-trioxanes 
diastereomeric mixture 129b and 97 in 89:11 ratio (0.42 g, 2.26 mmol, 49 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 129b) 
δ (ppm) = 0.93 (dd, 3H, J = 7.65, 7.65 Hz, CH3CH2), 0.96 (dd, 3H, J = 7.35, 7.35 Hz, 
CH3CH2), 1.34-1.63 (m, 4H, 2 x CH2CH3), 1.70 (m, 3H, CH3C=), 3.57 (ddd, 1H, J = 
3.24, 8.70, 9.24 Hz, OCH), 4.32 (d, 1H, J = 9.24 Hz, OOCH), 5.04 (m, 2H, CH2=), 
5.16 (t, 1H, J = 5.45 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 129b) 
δ (ppm) = 8.1 (q, CH3), 9.4 (q, CH3), 19.7 (q, CH3C=), 23.6 (t, CH2), 25.4 (t, CH2), 
77.9 (d, OCH), 87.5 (d, OOCH), 105.5 (d, OCHOO), 118.1 (t, CH2=C), 138.9 (s, 
C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, minor diastereomer 97) 
δ (ppm) = 0.93 (dd, 3H, J = 7.65, 7.65 Hz, CH3CH2), 0.96 (dd, 3H, J = 7.35, 7.35 Hz, 
CH3CH2), 1.34-1.63 (m, 4H, 2 x CH2CH3), 1.98 (m, 3H, CH3C=), 3.88 (m, 1H, OCH), 
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4.02 (d, 1H, J = 3.84 Hz, OOCH), 5.04 (m, 2H, CH2=), 5.16 (t, 1H, J = 5.45 Hz, 
OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of minor diastereomer 97) 
δ (ppm) = 18.5 (q, CH3C=), 77.7 (d, OCH), 84.6 (d, OOCH), 105.6 (d, OCHOO), 
118.3 (t, CH2=), 141.8 (s, C=CH2). 
 
4.6.10 Derived from 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) 
 
(5RS,6RS)-5-Methyl-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-adamantane] 
(98) (elid 487j) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (2.0 g, 15.2 
mmol) and adamantanone (2.28 g, 15.2 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.89) afforded the pure 
1,2,4-trioxane as colorless oil which crystallizes on standing (0.47 g, 1.78 mmol, 12 %). 
 
M.p. 48-49 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.07 (d, 3H, J = 6.18 Hz, CH3CH), 1.52-2.11 (m, 13H, CH and CH2), 1.73 
(m, 3H, CH3C=), 2.90 (br. d, 1H, CH), 4.04 (dq, 1H, J = 6.18, 9.56 Hz, OCH), 4.17 (d, 
1H, J= 9.56 Hz, OOCH), 5.04 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.0 (q, CH3CH), 19.8 (q, CH3C=), 27.1 (d, CH), 27.2 (d, CH), 29.8 (d, CH) 
, 36.5 (d, CH), 33.1 (t, CH2), 33.3 (t, CH2), 33.4 (t, CH2), 33.5 (t, CH2), 37.2 (t, CH2), 
65.0 (d, OCH), 88.7 (d, OOCH), 104.8 (s, OCOO), 117.6 (t, CH2=), 139.3 (s, C=CH2).   
IR: (Film) 
 ν (cm-1) = 2912, 1648, 1222, 1109, 1090, 1023, 999, 926. 
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MS: (EI, 70 eV) 
m/z (%) = 264 (M+, 4), 220 (M+-C2H4O, 55), 150 (C10H14O+, 34), 82 (C6H10+, 100), 81 
(C6H9+, 53), 80 (C6H8+, 82), 79 (C6H7+, 97), 67 (C5H7+, 67), 55 (C3H3O+, 42). 
Elemental Analysis: (C16H24O3, M = 264.36) 
Calcd: C 72.69   H 9.15 
Found: C 72.69   H 9.05 
 
(3RS,4RS)-3-Isopropenyl-4-methyl-1,2,5-trioxa-spiro[5.6]dodecane (99) 
(elid 382f) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.73 g, 5.53 
mmol) and cycloheptanone (0.61 g, 5.45 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product 
(0.52 g, 2.30 mmol, 42 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, 
Rf = 0.82) afforded the pure 1,2,4-trioxane as colorless oil (0.20 g, 0.88 mmol, 16 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.07 (d, 3H, J = 6.18 Hz, CH3CH), 1.50-1.70 (m, 10H, CH2), 1.73 (m, 3H, 
CH3C=), 2.15 (m, 1H, CH2), 2.33 (m, 1H, CH2), 4.01 (dq, 1H, J = 6.18, 9.57 Hz, 
OCH), 4.17 (d, 1H, J = 9.57 Hz, OOCH), 5.03 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.0 (q, CH3CH), 19.7 (q, CH3C=), 22.2 (t, CH2), 22.3 (t, CH2), 29.4 (t, 
CH2), 29.9 (t, CH2), 31.4 (t, CH2), 38.9 (t, CH2), 65.9 (d, OCH), 88.7 (d, OOCH), 
107.5 (s, OCOO), 117.5 (t, CH2=), 139.4 (s, C=CH2). 
 
(3RS,4RS)-3-Isopropenyl-4-methyl-1,2,5-trioxa-spiro[5.5]undecane (100) 
(elid 474z) 
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Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.26 g, 9.55 
mmol) and cyclohexanone (0.94 g, 9.59 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). After usual work-up the crude product (1.40 g, 6.59 mmol, 69 %) was 
purified by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.82) to 
afford the pure 1,2,4-trioxane (0.53 g, 2.50 mmol, 26 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.06 (d, 3H, J = 6.0 Hz, CH3CH), 1.30-1.60 (m, 8H, 4 x CH2), 1.73 (m, 3H, 
CH3C=), 1.94 (m, 1H, CH2), 2.24 (m, 1H, CH2), 4.07 (dq, 1H, J = 9.50, 6.0 Hz, OCH), 
4.18 (d, 1H, J = 9.50 Hz, OOCH), 5.04 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.0 (q, CH3CH), 19.7 (q, CH3C=), 22.3 (t, CH2), 22.4 (t, CH2), 25.6 (t, 
CH2), 29.5 (t, CH2), 35.1 (t, CH2), 65.6 (d, OCH), 88.8 (d, OOCH), 102.8 (s, OCOO), 
117.6 (t, CH2=C), 139.3 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 2937, 1684, 1669, 1653, 1646, 1362, 1163, 1095, 1008, 919. 
MS: (EI, 70 eV) 
m/z (%) = 98 (C6H10O+, 80), 82 (C6H10+, 94), 70 (C4H6O+, 52), 69 (C4H5O+, 62), 67 
(C5H7+, 33), 55 (C3H3O+, 100). 
Elemental Analysis: (C12H20O3, M = 212.29) 
Calcd: C 67.89   H 9.50 
Found: C 67.45   H 9.45 
 
(8RS,9RS)-8-Isopropenyl-9-methyl-6,7,10-trioxa-spiro[4.5]decane (101) 
(elid 121) 
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Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.0 g, 7.58 
mmol, prepared according to GP-7b) and excess cyclopentanone (6.37 g, 75.8 mmol) in 
CH2Cl2 was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and 
evaporation of the excess ketone under vacuum afforded the product (1.10 g, 5.53 mmol, 73 
%) as an oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.07 (d, 3H, J = 6.3 Hz, CH3CH), 1.60-1.87 (m, 7H, CH2), 1.71 (m, 3H, 
CH3C=), 2.50 (m, 1H, CH2), 3.29 (dq, 1H, J = 9.40, 6.30 Hz, OCH), 4.24 (d, 1H, J = 
9.40 Hz, OOCH), 5.03 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.7 (q, CH3CH), 19.5 (q, CH3C=), 23.1 (t, CH2), 24.7 (t, CH2), 32.9 (t, 
CH2), 37.3 (t, CH2), 68.4 (d, OCH), 88.6 (d, OOCH), 114.7 (s, OCOO), 117.7 (t, 
CH2=C), 139.1 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 84 (C5H8O+, 81), 82 (C6H10+, 69), 67 (C5H7+, 30), 56 (C3H4O+, 52), 55 
(C3H3O+, 100). 
 
(5RS,6RS)-5-Methyl-6-(prop-1-en-2-yl)-3,3-dipropyl-1,2,4-trioxane (102) 
(elid 383b, 476z) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.40 g, 10.6 
mmol) and 4-heptanone (1.30 g, 11.4 mmol) in CH2Cl2 was treated with a catalytic amount of 
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BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product (0.60 g, 2.63 
mmol, 24.8 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.79) 
afforded the pure 1,2,4-trioxane as colorless oil (0.33 g, 1.45 mmol, 14 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) =0.86 (t, 3H, J = 7.35 Hz, CH3CH2), 0.94 (t, 3H, J = 7.35 Hz, CH3CH2), 1.06 
(d, 3H, J = 6.03 Hz, CH3CH), 1.23-1.57 (m, 6H, 3 x CH2), 1.75 (m, 3H, CH3C=), 
1.88-2.11 (m, 2H, CH2CH2), 4.01 (dq, 1H, J = 6.03, 9.57 Hz, OCH), 4.14 (d, 1H, J = 
9.57 Hz, OOCH), 5.04 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 14.3 (q, CH3CH2), 14.4 (q, CH3CH2), 15.8 (t, CH2CH3), 16.9 (q, CH3CH), 
17.1 (t, CH2CH3), 19.7 (q, CH3C=), 33.1 (t, CH2CH2), 38.3 (t, CH2CH2), 65.9 (d, 
OCH), 88.5 (d, OOCH), 105.6 (s, OCOO), 117.5 (t, CH2=), 139.4 (s, C=CH2). 
 
(5RS,6RS)-3,3,5-Trimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (103) 
(elid 151) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.0 g, 7.58 
mmol, prepared according to GP-7b) and excess acetone (5.0 g, 86.2 mmol) in CH2Cl2 was 
treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of the 
excess ketone under vacuum afforded the product (0.85 g, 4.93 mmol, 65 %) as an oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.93 (d, 3H, J = 6.20 Hz, CH3CH), 1.19 (s, 3H, CH3), 1.50 (s, 3H, CH3), 
1.61 (t, 3H, J = 1.32 Hz, CH3C=), 3.91 (dq, 1H, J = 9.57, 6.20 Hz, OCH), 4.03 (d, 1H, 
J = 9.57 Hz, OOCH), 4.92 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.6 (q, CH3CH), 19.2 (q, CH3C=), 20.2 (q, CH3), 25.6 (q, CH3), 66.2 (d, 
OCH), 88.4 (d, OOCH), 102.3 (s, OCOO), 117.3 (t, CH2=C), 139.0 (s, C=CH2). 
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MS: (EI, 70 eV) 
m/z (%) = 115 (M+-C3H7O, 35), 97 (C6H9O+, 41), 85 (C5H9O+, 38), 83 (C5H7O+, 34), 
69 (C4H5O+, 54), 59 (C3H7O+, 100). 
 
(5RS,6RS)-3,3-Diethyl-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (104a) 
(elid 109) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.0 g, 7.58 
mmol, prepared according to GP-7b) and excess 3-pentanone (6.52 g, 75.8 mmol) in CH2Cl2 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of 
the excess ketone under vacuum afforded the product (1.06 g, 5.31 mmol, 70 %) as an oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 6H, J = 7.30 Hz, 2 x CH3CH2), 1.06 (d, 3H, J = 6.20 Hz, CH3CH), 
1.52-1.61 (m, 2H, CH2CH3), 1.72 (t, 3H, J = 1.25 Hz, CH3C=), 1.91-2.16 (m, 2H, 
CH2CH3), 3.99 (dq, 1H, J = 9.55, 6.20 Hz, OCH), 4.13 (d, 1H, J = 9.55 Hz, OOCH), 
5.03 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 6.7 (q, CH3CH2), 8.1 (q, CH3CH2), 16.9 (q, CH3CH), 19.7 (q, CH3C=), 23.0 
(t, CH2CH3), 28.3 (t, CH2CH3), 65.8 (d, OCH), 88.4 (d, OOCH), 106.0 (s, OCOO), 
117.5 (t, CH2=C), 139.3 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 82 (C6H10+, 87), 70 (C4H6O+, 74), 69 (C4H5O+, 100), 67 (C5H7+, 57). 
 
(5RS,6SR)-3,3-Diethyl-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (104b) 
(elid 163) 
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O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.0 g, 7.58 
mmol, prepared according to GP-7a) and excess 3-pentanone (6.52 g, 75.8 mmol) in CH2Cl2 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). After usual work-up and 
evaporation of the excess ketone under vacuum, a diastereomeric mixture of the 1,2,4-
trioxanes 104a,b were obtained as an oil in the ratio 78:22, respectively. 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.06 (d, 3H, J = 6.40 Hz, CH3CH), 1.69 (m, 3H, CH3C=), 3.80 (m, 1H, 
OCH), 4.19 (d, 1H, J = 5.40 Hz, OOCH), 4.95 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 7.8 (q, CH3CH2), 8.2 (q, CH3CH2), 30.4 (t, CH2CH3), 30.7 (t, CH2CH3), 
75.1 (d, OCH), 87.0 (d, OOCH), 114.0 (t, CH2=C), 141.6 (s, C=CH2). 
 
3,5,5-Trimethyl-1,2-dioxolan-3-ol (104c) 
(elid 163)  
O O
OH
 
 
This compound is obtained in traces amount as byproduct in the photooxygention of 4-
methylpent-3-en-2-ol (6a) using GP-7 by cyclization of the minor regioisomer. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.16 (d, 1H, J = 6.0 Hz, CH2), 1.22 (d, 1H, J = 6.0 Hz, CH2), 1.26 (s, 3H, 
CH3), 1.30 (s, 3H, CH3), 1.67 (s, 3H, CH3C-OH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.2 (t, CH2), 24.9 (q, CH3), 25.0 (q, CH3), 30.1 (q, CH3), 93.3 (s, OOC), 
114.9 (s, OOCOH). 
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4-((3RS,5SR,6SR)-5-Methyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxan-3-yl)-1-phenyl-
butan-1-one (105) (elid 482o or elid 488a) 
O
O
O
Ph
Ph
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (2.0 g, 15.2 
mmol) and 1,5-diphenyl-1,5-pentandione (1.90 g, 7.54 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.49) afforded 
the pure 1,2,4-trioxane as viscous colorless oil (0.10 g, 0.27 mmol, 4 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.03 (d, 3H, J = 6.33 Hz, CH3CH), 1.06-1.30 (m, 2H, CH2CH2CH2), 1.40 (s, 
3H, CH3C=), 1.62-1.83 (m, 2H, CH2), 2.82 (t, 2H, J = 7.20 Hz, CH2CO), 3.74 (dq, 1H, 
J = 6.33, 9.39 Hz, OCH), 4.27 (d, 1H, J = 9.39 Hz, OOCH), 4.78 (s, 1H, CH2=), 4.86 
(m, 1H, CH2=), 7.18-7.82 (m, 10H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.4 (q, CH3CH), 17.5 (t, CH2), 19.4 (q, CH3C=), 38.3 (t, CH2), 40.9 (t, 
CH2), 67.2 (d, OCH), 88.6 (d, OOCH), 106.4 (s, OCOO), 117.7 (t, CH2=), 127.1 (d, 
CHarom), 127.7 (d, CHarom), 127.9 (d, CHarom), 128.1 (d, CHarom), 128.4 (d, CHarom), 
132.8 (d, CHarom), 136.9 (s, Cqarom), 138.9 (s, Cqarom), 139.7 (s, C=CH2), 199.7 (s, 
C=O). 
IR: (Film) 
ν (cm-1) = 2975, 1726, 1687, 1642, 1598, 1378, 1176, 1003, 917. 
 
(3RS,5RS,6RS)-3,5-Dimethyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (106a) and 
(3RS,5SR,6SR)-3,5-dimethyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (106b) 
(elid 255h)  
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O
O
O
106a    
O
O
O
106b  
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.24 g, 1.82 
mmol, prepared according to GP-7b) and acetophenone (0.22 g, 1.83 mmol) in Et2O was 
treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up afforded an oil 
composed of a diastereomerc mixture of the 1,2,4-trioxanes 106a, b in the ratio 1:1 (128 mg, 
0.55 mmol, 30 %). 
 
1H-NMR: (300 MHz, CDCl3, first diastereomer 106a) 
δ (ppm) = 1.16 (d, 3H, J = 6.03 Hz, CH3CH), 1.54 (m, 3H, CH3), 1.81 (m, 3H, 
CH3C=), 3.99 (dq, 1H, J = 6.03, 8.4 Hz, OCH), 3.84 (d, 1H, J = 8.4 Hz, OOCH), 4.89-
4.99 (m, 2H, CH2=), 7.25-7.55 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, first diastereomer 106a) 
δ (ppm) = 17.7 (q, CH3CH), 17.3 (q, CH3C=), 29.4 (q, CH3), 76.0 (d, OCH), 86.3 (d, 
OOCH), 108.4 (s, OCOO), 114.1 (t, CH2=), 125.1 (d, CHarom), 127.5 (d, CHarom), 
127.9 (d, CHarom), 141.1 (s, C=CH2), 144.9 (s, Cqarom). 
 
1H-NMR: (300 MHz, CDCl3, other diastereomer 106b) 
δ (ppm) = 1.29 (d, 3H, J = 6.03 Hz, CH3CH), 1.64 (m, 3H, CH3C=), 1.80 (m, 3H, 
CH3), 3.71 (dq, 1H, J = 6.03, 8.82 Hz, OCH), 4.05 (d, 1H, J = 8.82 Hz, OOCH), 4.89-
4.99 (m, 2H, CH2=), 7.25-7.55 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, other diastereomer 106b) 
δ (ppm) = 16.4 (q, CH3CH), 17.7 (q, CH3C=), 28.6 (q, CH3), 75.0 (d, OCH), 87.4 (d, 
OOCH), 108.3 (s, OCOO), 114.5 (t, CH2=), 124.9 (d, CHarom), 127.4 (d, CHarom), 
127.9 (d, CHarom), 141.3 (s, C=CH2), 144.8 (s, Cqarom). 
 
(3RS,5RS,6RS)-3-Ethyl-3,5-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (107a) and 
(3RS,5SR,6SR)-3-ethyl-3,5-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (107b) 
(elid 141b)  
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107a     
O
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O
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Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.60 g, 4.55 
mmol, prepared according to GP-7b) and excess 2-butanone (5.0 g, 69.4 mmol) in CH2Cl2 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of 
the excess ketone under vacuum afforded a diastereomerc mixture of the 1,2,4-trioxanes a, b 
as an oil in the ratio 80:20, respectively, (0.65 g, 3.49 mmol, 77 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 107a) 
δ (ppm) = 0.92 (t, 3H, J = 7.60 Hz, CH3CH2), 1.06 (d, 3H, J = 6.0 Hz, CH3CH), 1.59 
(s, 3H, CH3), 1.62 (q, 2H, J = 7.60 Hz, CH2CH3), 1.75 (m, 3H, CH3C=), 4.06 (dq, 1H, 
J = 9.50, 6.0 Hz, OCH), 4.16 (d, 1H, J = 9.54 Hz, OOCH), 5.05 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 107a) 
δ (ppm) = 7.1 (q, CH3CH2), 16.9 (q, CH3CH), 18.6 (q, CH3), 19.7 (q, CH3C=), 32.2 (t, 
CH2CH3), 66.3 (d, OCH), 88.8 (d, OOCH), 104.1 (s, OCOO), 117.6 (t, CH2=C), 139.3 
(s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of the minor diastereomer 107b) 
δ (ppm) = 1.26 (s, 3H, CH3), 4.0 (m, 1H, OCH), 4.18 (d, 1H, J = 9.54 Hz, OOCH),  
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 107b) 
δ (ppm) = 8.4 (q, CH3CH2), 16.9 (q, CH3CH), 19.7 (q, CH3C=), 22.7 (q, CH3), 25.2 (t, 
CH2CH3), 66.1 (d, OCH), 88.4 (d, OOCH), 105.0 (s, OCOO), 117.7 (t, CH2=C), 139.2 
(s, C=CH2). 
 
(3RS,5RS,6RS)-3-(Furan-2-yl)-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (108) 
(elid 493e) 
O
O
O
O
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Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.71 g, 5.38 
mmol) and furan-2-carboxaldehyde (0.65 g, 6.77 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.57) afforded 
the pure 1,2,4-trioxane as viscous colorless oil (0.38 g, 1.81 mmol, 34 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.22 (d, 3H, J = 6.33 Hz, CH3CH), 1.74 (m, 3H, CH3C=), 4.0 (dq, 1H, J = 
6.33, 9.12 Hz, OCH), 4.45 (d, 1H, J = 9.12 Hz, OOCH), 5.09 (m, 2H, CH2=), 6.25 (s, 
1H, OCHOO), 6.34 (m, 1H, CH), 6.53 (m, 1H, CH), 7.39 (m, 1H, CH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.2 (q, CH3CH), 19.5 (q, CH3C=), 74.1 (d, OCH), 88.7 (d, OOCH), 98.4 
(d, OCHOO), 110.0 (d, CH=), 110.3 (d, CH=), 118.4 (t, CH2=C), 138.4 (s, C=CH2), 
143.3 (d, OCH=), 147.3 (s, OCq=). 
IR: (Film) 
ν (cm-1) = 3126, 3085, 2979, 2901, 1647, 1636, 1601, 1149, 1087, 1065, 1000, 984, 
915. 
Elemental Analysis: (C11H14O4, M = 210.23) 
Calcd: C 62.85   H 6.71 
Found: C 62.80   H 6.70 
 
(3RS,5RS,6RS)-5-Methyl-3-(naphthalen-1-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (109) 
(elid 450b) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.77 g, 5.83 
mmol) and 1-naphthaldehyde (0.91 g, 5.83 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
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preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.56) afforded the pure 
1,2,4-trioxane as yellow solid (0.72 g, 2.67 mmol, 46 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.33 (d, 3H, J = 6.76 Hz, CH3CH), 1.85 (m, 3H, CH3C=), 4.20 (dq, 1H, J = 
6.76, 9.12 Hz, OCH), 4.61 (d, 1H, J = 9.12 Hz, OOCH), 5.16-5.21 (m, 2H, CH2=), 
6.84 (s, 1H, OCHOO), 7.45-7.61 (m, 3H, Harom), 7.81-7.89 (m, 3H, Harom), 8.30 (d, 1H, 
J = 8.52 Hz, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.5 (q, CH3CH), 19.8 (q, CH3C=), 74.2 (d, OCH), 88.9 (d, OOCH), 102.6 
(d, OCHOO), 118.4 (t, CH2=), 123.9 (d, CHarom), 125.0 (d, CHarom), 125.6 (d, CHarom), 
125.8 (d, CHarom), 126.5 (d, CHarom), 128.5 (d, CHarom), 130.4 (d, CHarom), 129.8 (s, 
Cqarom), 130.7 (s, Cqarom), 133.6 (s, Cqarom), 138.7 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-(2-Bromophenyl)-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (110) 
(elid 501c) 
O
O
O
Br
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.77 g, 5.83 
mmol) and 2-bromobenzaldehyde (1.10 g, 5.95 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.57) afforded the pure 
1,2,4-trioxane as viscous colorless oil (0.92 g, 3.08 mmol, 53 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.24 (d, 3H, J = 6.27 Hz, CH3CH), 1.77 (t, 3H, J = 1.17Hz, CH3C=), 4.08 
(dq, 1H, J = 6.42, 9.21 Hz, OCH), 4.47 (d, 1H, J = 9.21 Hz, OOCH), 5.09 (m, 1H, 
CH2=C), 5.14 (s, 1H, CH2=C), 6.52 (s, 1H, OCHOO), 7.16-7.67 (m, 4H, Harom). 
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13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.3 (q, CH3CH), 19.5 (q, CH3C=), 73.8 (d, OCH), 88.7 (d, OOCH), 102.9 
(d, OCHOO), 118.4 (t, CH2=), 122.9 (s, Cqarom), 127.3 (d, CHarom), 128.9 (d, CHarom), 
131.1 (d, CHarom), 132.6 (d, CHarom), 133.4 (s, Cqarom), 138.5 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Methyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (111a) 
(elid 491u, 128)  
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.88 g, 6.67 
mmol) and benzaldehyde dimethyl acetal (1.0 g, 6.58 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and purification by preparative thick-
layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.88) afforded the pure diastereomerc 
mixture 111a,b in the ratio 97:3, respectively, (0.47 g, 2.14 mmol, 33 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.26 (d, 3H, J = 6.30 Hz, CH3CH), 1.79 (t, 3H, J = 1.20 Hz, CH3C=), 4.05 
(dq, 1H, J = 9.10, 6.30 Hz, OCH), 4.46 (d, 1H, J = 9.10 Hz, OOCH), 5.13 (m, 2H, 
CH2=C), 6.21 (s, 1H, OCHOO), 7.34-7.51 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.5 (q, CH3CH), 19.7 (q, CH3C=), 73.8 (d, OCH), 88.8 (d, OOCH), 104.1 
(d, OCHOO), 118.3 (t, CH2=C), 127.0 (d, CHarom), 128.5 (d, CHarom), 129.9 (d, 
CHarom), 134.4 (s, Cqarom), 138.7 (s, C=CH2). 
IR: (Film) 
 ν (cm-1) = 2978, 1635, 1617, 1374, 1134, 1089, 1061, 1000, 914. 
MS: (EI, 70 eV) 
m/z (%) = 106 (C7H6O+, 59), 105 (C7H5O+, 100), 82 (C6H10+, 63), 77 (C6H5+, 65), 67 
(C5H7+, 24), 51 (C4H3+, 23). 
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Elemental Analysis: (C13H16O3, M = 220.26) 
 Calcd: C 70.89   H 7.32 
Found: C 70.81   H 7.29 
 
(3RS,5SR,6SR)-5-Methyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (111b) 
 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.33 (d, 3H, J = 6.75 Hz, CH3CH), 1.72 (s, 3H, CH3C=), 3.90 (m, 1H, 
OCH), 6.40 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 15.3 (q, CH3CH), 18.3 (q, CH3C=), 79.7 (d, OCH), 84.2 (d, OOCH), 126.0 
(d, CHarom), 128.4 (d, CHarom). 
 
(3RS,5RS,6RS)-3,5-Dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129e) 
(elid 162) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.60 g, 4.55 
mmol, prepared according to GP-7b) and excess acetaldehyde (2.0 g, 45.5 mmol) in Et2O was 
treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of the 
excess ketone under vacuum afforded an oil composed of a mixture (0.49 g, 78 %).of the 
1,2,4-trioxane 129e and 1,3,5-trioxane 112 in a ratio 23:77 respectively.  
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.12 (d, 3H, J = 6.33 Hz, CH3CH), 1.25 (d, 3H, J = 5.43 Hz, CH3CH), 1.70 
(t, 3H, J = 1.32 Hz, CH3C=), 3.79 (dq, 1H, J = 9.10, 6.30 Hz, OCH), 4.25 (d, 1H, J = 
9.10 Hz, OOCH), 5.04 (m, 2H, CH2=C), 5.36 (q, 1H, J = 5.40 Hz, CHCH3). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.3 (q, CH3CH), 17.9 (q, CH3CH), 19.6 (q, CH3C=), 73.2 (d, OCH), 88.5 
(d, OOCH), 101.4 (d, OCHOO), 118.1 (t, CH2=C), 138.7 (s, C=CH2). 
 
2,4,6-Trimethyl-1,3,5-trioxane (112) 
(elid 162) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.34 (d, 3H, J = 5.10 Hz, CH3), 5.0 (q, 1H, J = 5.10 Hz, CH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.5 (q, CH3), 98.4 (d, CH). 
 
(3RS,5RS,6RS)-3-Ethyl-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (113) 
(elid 158) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.60 g, 4.55 
mmol, prepared according to GP-7b) and excess propionaldehyde (2.0 g, 34.5 mmol) in Et2O 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of 
the excess ketone under vacuum afforded an oil composed of a mixture of the 1,2,4-trioxane 
113 and 1,3,5-trioxane 114 in a ratio 16:84, respectively.  
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.90 (t, 3H, J = 7.70 Hz, CH3CH2), 1.10 (d, 3H, J = 6.30 Hz, CH3CH), 1.56 
(m, 2H, CH2CH3), 1.68 (m, 3H, CH3C=), 3.78 (dq, 1H, J = 9.10, 6.30 Hz, OCH), 4.24 
(d, 1H, J = 9.10 Hz, OOCH), 5.02 (m, 2H, CH2=C), 5.15 (t, 1H, J = 5.50 Hz, 
OCHOO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.9 (q, CH3CH2), 16.3 (q, CH3CH), 19.6 (q, CH3C=), 25.4 (t, CH2CH3), 
73.0 (d, OCH), 88.7 (d, OOCH), 105.4 (d, OCHOO), 118.0 (t, CH2=C), 138.7 (s, 
C=CH2). 
 
2,4,6-Triethyl-1,3,5-trioxane (114) 
(elid 158) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.89 (t, 3H, J = 7.50 Hz, CH3), 1.63 (m, 2H, CH2), 4.73 (t, 1H, J = 5.30 Hz, 
CH). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.8 (q, CH3), 27.5 (t, CH2), 102.4 (d, CH). 
 
(3RS,5RS,6RS)-3-Isopropyl-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (115) 
(elid 159) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.60 g, 4.55 
mmol, prepared according to GP-7b) and excess propionaldehyde (2.0 g, 34.5 mmol) in Et2O 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and evaporation of 
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the excess ketone under vacuum afforded an oil composed of a mixture of the 1,2,4-trioxane 
115 and 1,3,5-trioxane 116 in a ratio 27:73, respectively.  
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.92 (d, 3H, J = 6.90 Hz, (CH3)2CH), 1.08 (d, 3H, J = 7.05 Hz, CH3CH), 
1.12 (d, 3H, J = 6.45 Hz, (CH3)2CH), 1.69 (m, 3H, CH3C=), 2.38 (m, 1H, CH(CH3)2), 
3.76 (dq, 1H, J = 9.09, 6.30 Hz, OCH), 4.24 (d, 1H, J = 9.09 Hz, OOCH), 4.96 (d, 1H, 
J = 5.43 Hz, OCHOO), 5.02 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 15.4 (q, CH3CH), 16.3 (q, CH3CH), 16.9 (q, CH3CH), 19.6 (q, CH3C=), 
31.1 (d, CH), 73.1 (d, OCH), 88.8 (d, OOCH), 107.8 (d, OCHOO), 117.9 (t, CH2=C), 
138.8 (s, C=CH2). 
 
2,4,6-Triisopropyl-1,3,5-trioxane (116) 
(elid 159) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.89 (d, 6H, J = 6.70 Hz, CH3), 1.81 (m, 1H, CH(CH3)2), 4.45 (d, 1H, J = 
5.40 Hz, OCHO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.6 (q, 2 x CH3), 32.4 (d, CH), 104.7 (d, CH). 
 
(3RS,5RS,6RS)-3-Methoxy-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (117a) and 
(3RS,5SR,6SR)-3-methoxy-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (117b) 
(elid 332a) 
O
O
O O
O
O
OMe OMe
117a 117b  
4. Experimental Part 
262 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.50 g, 3.79 
mmol, prepared according to GP-7b) and excess trimethyl orthoformate (0.50 g, 4.72 mmol) 
in Et2O was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up afforded an 
oil composed of a diastereomerc mixture of the 1,2,4-trioxanes in the ratio 57:43 (0.21 g, 1.21 
mmol, 32 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer) 
δ (ppm) = 1.18 (d, 3H, J = 6.33 Hz, CH3CH), 1.72 (t, 3H, J = 1.32 Hz, CH3C=), 3. 54 
(s, 3H, OCH3), 4.02 (dq, 1H, J = 6.33, 9.27 Hz, OCH), 4.20 (d, 1H, J = 9.27 Hz, 
OOCH), 5.07 (m, 2H, CH2=), 5.72 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer) 
δ (ppm) = 16.2 (q, CH3CH), 19.6 (q, CH3C=), 54.5 (q, OCH3), 74.2 (d, OCH), 87.5 (d, 
OOCH), 113.6 (d, OCHOO), 118.6 (t, CH2=), 137.7 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 1.08 (d, 3H, J = 5.88 Hz, CH3CH), 1.74 (m, 3H, CH3C=), 3.41 (s, 3H, 
OCH3), 4.30 (dq, 1H, J = 5.88, 9.27 Hz, OCH), 4.36 (d, 1H, J = 9.27 Hz, OOCH), 
5.07 (m, 2H, CH2=), 5.48 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 16.1 (q, CH3CH), 19.6 (q, CH3C=), 53.4 (q, OCH3), 65.9 (d, OCH), 88.9 (d, 
OOCH), 111.0 (d, OCHOO), 118.3 (t, CH2=), 138.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-3-Ethoxy-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (118a) and 
(3RS,5SR,6SR)-3-ethoxy-5-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (118b) 
(elid 115) 
O
O
O
HEtO
118a     
O
O
O
OEtH
118b  
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.75 g, 5.68 
mmol, prepared according to GP-7b) and triethylorthoformate (5.0 g, 33.8 mmol) in CH2Cl2 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up followed by 
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evaporation of excess orthoester afforded an oil composed of a diastereomerc mixture of the 
1,2,4-trioxanes 118a,b in the ratio 72:28, respectively, (0.75 g, 3.99 mmol, 70 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 118a) 
δ (ppm) = 1.19 (d, 3H, J = 6.33 Hz, CH3CH), 1.24 (t, 3H, J = 7.20 Hz, CH3CH2), 1.72 
(t, 3H, J = 1.32 Hz, CH3C=), 3.83 (m, 2H, CH2CH3), 4.02 (dq, 1H, J = 9.20, 6.30 Hz, 
OCH), 4.20 (d, 1H, J = 9.20 Hz, OOCH), 5.07 (m, 2H, CH2=C), 5.77 (s, 1H, 
OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 118a) 
δ (ppm) = 15.2 (q, CH3CH2), 16.2 (q, CH3CH), 19.6 (q, CH3C=), 63.8 (d, OCH), 74.3 
(t, CH2CH3), 87.5 (d, OOCH), 113.3 (d, OCHOO), 118.5 (t, CH2=C), 137.8 (s, 
C=CH2). 
1H-NMR: (300 MHz, CDCl3, additional significant signals of the minor diastereomer 118b) 
δ (ppm) = 1.74 (t, 3H, J = 1.05 Hz, CH3C=), 3.60 (dq, 1H, J = 9.70, 7.06 Hz, OCH), 
3.71 (m, 2H, CH2CH3), 5.58 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 118b) 
δ (ppm) = 14.7 (q, CH3CH2), 16.1 (q, CH3CH), 19.5 (q, CH3C=), 61.6 (t, CH2CH3), 
65.8 (d, OCH), 88.9 (d, OOCH), 110.0 (d, OCHOO), 118.2 (t, CH2=C), 139.0 (s, 
C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 82 (C6H10+, 100), 70 (C4H6O+, 28), 69 (C4H5O+, 27), 67 (C5H7+, 68). 
 
(3RS,5RS,6RS)-3-Ethoxy-3,5-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (119a) and 
(3RS,5SR,6SR)-3-ethoxy-3,5-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (119b) 
(elid 126)  
O
O
O
EtO
O
O
O
OEt
119a 119b  
 
Following GP-15, a solution of 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (0.75 g, 5.68 
mmol, prepared according to GP-7b) and triethylorthoacetate (4.0 g, 24.7 mmol) in CH2Cl2 
was treated with a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up followed by 
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evaporation of excess orthoester afforded an oil composed of a diastereomerc mixture of the 
1,2,4-trioxanes 119a,b in the ratio 1:1 (0.86 g, 4.26 mmol, 75 %). 
 
1H-NMR: (300 MHz, CDCl3, both diastereomers) 
δ (ppm) = 1.06 (d, 3H, J = 6.20 Hz, CH3CH), 1.21 (t, 3H, J = 7.05 Hz, CH3CH2), 1.42 
(s, 3H, CH3), 1.72 (m, 3H, CH3C=), 3.68 (q, 2H, J = 7.05 Hz, CH2CH3), 4.14 (dq, 1H, 
J = 9.40, 6.20 Hz, OCH), 4.24 (d, 1H, J = 9.42 Hz, OOCH), 5.06 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3)  
δ (ppm) = 15.1 (q, CH3CH2), 16.1 (q, CH3CH), 19.4 (q, CH3C=), 20.5 (q, CH3), 58.4 
(t, CH2CH3), 66.1 (d, OCH), 87.8 (d, OOCH), 113.8 (s, OCOO), 118.1 (t, CH2=C), 
138.9 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 18.3 (q, CH3CH2), 18.6 (q, CH3), 59.3 ( t, CH2CH3), 114.3 (s, OCOO). 
MS: (EI, 70 eV) 
m/z (%) = 82 (C6H10+, 100), 70 (C4H6O+, 58), 67 (C5H7+, 56). 
 
4.6.11 Derived from 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) 
 
(3RS,5RS,6RS)-5-Allyl-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane (120) 
(elid 474q, 475e, 497p) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (0.39 g, 2.47 
mmol) and β-naphthaldehyde (388 mg, 2.49 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.69) afforded the pure 
1,2,4-trioxanes (30 mg, 0.10 mmol, 4 %) as viscous colorless oil which crystallizes on 
standing. 
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M.p. 55-57 °C 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.82 (m, 3H, CH3C=), 2.47 (m, 2H, CH2), 4.06 (ddd, 1H, J = 3.96, 7.23, 
9.24 Hz, OCH), 4.64 (d, 1H, J = 9.24 Hz, OOCH), 5.15 (m, 4H, CH2=CH and 
CH2=C), 6.0 (m, 1H, CH=CH2), 6.37 (s, 1H, OCHOO), 7.45-8.0 (m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (q, CH3C=), 35.1 (t, CH2), 76.8 (d, OCH), 87.1 (d, OOCH), 104.1 (d, 
OCHOO), 117.7 (t, CH2=CH), 119.0 (t, CH2=C), 124.1 (d, CHarom), 126.2 (d, CHarom), 
126.7 (d, CHarom), 126.9 (d, CHarom), 127.7 (d, CHarom), 128.2 (d, CHarom), 128.5 (d, 
CHarom), 131.8 (s, Cqarom), 132.9 (s, Cqarom), 134.0 (s, Cqarom), 133.4 (d, CH=CH2), 
138.5 (s, C=CH2). 
MS: (EI, 70 eV) 
m/z (%) = 296 (M+, 7), 156 (C11H8O+, 100). 155 (C11H7O+, 86), 127 (C10H7+, 62). 
HRMS: (EI, 70 eV, C19H20O3) 
 Calcd: M = 296.141 g/mol  
Found: M = 296.141 ±0.005 g/mol 
Elemental Analysis: (C19H20O3, M = 296.36) 
 Calcd: C 77.00   H 6.80 
Found: C 76.85   H 6.71 
 
(5RS,6RS)-5-Allyl-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (121) 
(elid 475y, 480f, 480z, 480n, 496p) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (1.20 g, 7.59 
mmol) and excess acetone (2.0 g, 34.5 mmol) in CH2Cl2 was treated with a catalytic amount 
of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product (1.11 g, 
5.61 mmol, 73.9 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 
0.80) the pure 1,2,4-trioxane as colorless oil (0.25 g, 1.26 mmol, 17 %). 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.32 (s, 3H, CH3), 1.62 (s, 3H, CH3), 1.74 (s, 3H, CH3C=), 2.23 (m, 2H, 
CH2), 3.98 (ddd, 1H, J = 3.83, 7.20, 9.70 Hz, OCH), 4.28 (d, 1H, J = 9.70 Hz, 
OOCH), 5.04 (m, 4H, CH2=CH and CH2=C), 5.80 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.5 (q, CH3C=), 20.5 (q, CH3), 25.8 (q, CH3), 35.3 (t, CH2), 69.6 (d, OCH), 
86.7 (d, OOCH), 102.7 (s, OCOO), 117.0 (t, CH2=CH), 118.2 (t, CH2=C), 133.7 (d, 
CH=CH2), 138.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Allyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (122a) and 
(3RS,5SR,6RS)-5-allyl-3-phenyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (122b) 
(elid 473z, 501t) 
O
O
O
122a     
O
O
O
122b  
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (1.0 g, 6.33 
mmol) and benzaldehyde dimethyl acetal (0.96 g, 6.32 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.74) afforded 
a diastereomeric mixture of the pure 1,2,4-trioxanes 122a,b in a ratio 93:7 respectively (0.41 
g, 1.66 mmol, 26 %) as colorless oil. 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer 122a) 
δ (ppm) = 1.81 (t, 3H, J = 1.02 Hz, CH3C=), 2.41 (m, 2H, CH2), 4.03 (ddd, 1H, J = 
3.96, 7.05, 9.27 Hz, OCH), 4.61 (d, 1H, J = 9.27 Hz, OOCH), 5.15 (m, 4H, CH2=CH 
and CH2=C), 5.97 (m, 1H, CH=CH2), 6.23 (s, 1H, OCHOO), 7.37-7.54 (m, 5H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer 122a) 
δ (ppm) = 19.6 (q, CH3C=), 35.0 (t, CH2), 76.6 (d, OCH), 86.9 (d, OOCH), 103.9 (d, 
OCHOO), 117.6 (t, CH2=CH), 118.8 (t, CH2=C), 126.9 (d, CHarom), 128.3 (d, CHarom), 
129.8 (d, CHarom), 133.3 (d, CH=CH2), 134.4 (s, Cqarom), 138.4 (s, C=CH2). 
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1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer 122b) 
δ (ppm) = 2.12 (m, 3H, CH3C=), 4.22 (d, 1H, J = 3.66 Hz, OOCH), 4.31 (m, 1H, 
OCH), 5.85 (m, 1H, CH=CH2), 6.38 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer 122b) 
δ (ppm) = 19.7 (q, CH3C=), 35.8 (t, CH2), 76.4 (d, OCH), 84.1 (d, OOCH), 104.4 (d, 
OCHOO), 117.2 (t, CH2=CH), 118.8 (t, CH2=C), 127.0 (d, CHarom), 128.2 (d, CHarom), 129.7 
(d, CHarom), 133.0 (d, CH=CH2), 134.5 (s, Cqarom), 138.4 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Allyl-3-methyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (123) 
(elid 467k) 
O
O
O
 
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (1.0 g, 6.33 
mmol) and acetaldehyde diethyl acetal (0.74 g, 6.27 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product (1.13 g, 6.14 mmol, 98 %) by preparative thick-layer chromatography (SiO2, EA/n-
hex, 1:10, Rf = 0.77) the pure 1,2,4-trioxane as colorless oil (0.47 g, 2.55 mmol, 41 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.27 (d, 3H, J = 5.43 Hz, CH3), 1.71 (s, 3H, CH3C=), 2.36 (m, 2H, CH2), 
3.76 (ddd, 1H, J = 3.70, 7.64, 9.24 Hz, OCH), 4.38 (d, 1H, J = 9.24 Hz, OOCH), 5.04 
(m, 4H, CH2=CH and CH2=C), 5.37 (q, 1H, J = 5.43 Hz, CH), 5.86 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.8 (q, CH3), 19.6 (q, CH3C=), 34.9 (t, CH2), 76.2 (d, OCH), 86.8 (d, 
OOCH), 101.5 (d, OCHOO), 117.3 (t, CH2=CH), 118.7 (t, CH2=C), 133.5 (d, 
CH=CH2), 138.5 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Allyl-3-methoxy-6-(prop-1-en-2-yl)-1,2,4-trioxane (124a) and 
(3RS,5SR,6SR)-5-allyl-3-methoxy-6-(prop-1-en-2-yl)-1,2,4-trioxane (124b) 
(elid 475v,u)  
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Following GP-15, a solution of 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (1.20 g, 7.59 
mmol) and excess trimethyl orthoformate (2.0 g, 18.9 mmol) in CH2Cl2 was treated with a 
catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product by preparative thick-layer chromatography allowed the separation of one of the 1,2,4-
trioxane diastereoisomers (SiO2, EA/n-hex, 1:10, Rf = 0.58). Besides, a diastereomeric 
mixture of the pure 1,2,4-trioxanes (SiO2, EA/n-hex, 1:10, Rf = 0.78) in a ratio 45:55 were 
obtained as colorless oil (0.32 g, 1.6 mmol, 21 %). 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer) 
δ (ppm) = 1.70 (m, 3H, CH3C=), 2.0-2.40 (m, 2H, CH2), 3.50 (s, 3H, OCH3), 3.94 (m, 
1H, OCH), 4.28 (d, 1H, J = 9.39 Hz, OOCH), 5.02 (m, 4H, CH2=CH and CH2=C), 
5.69 (s, 1H, OCHOO), 5.81 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer) 
δ (ppm) = 19.4 (q, CH3C=), 34.7 (t, CH2), 54.2 (q, OCH3), 76.9 (d, OCH), 85.5 (d, 
OOCH), 113.5 (d, OCHOO), 117.8 (t, CH2=CH), 119.0 (t, CH2=C), 132.7 (d, 
CH=CH2), 137.5 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 1.72 (m, 3H, CH3C=), 2.0-2.40 (m, 2H, CH2), 3.38 (s, 3H, OCH3), 4.25 (m, 
1H, OCH), 4.45 (d, 1H, J = 9.54 Hz, OOCH), 5.02 (m, 4H, CH2=CH and CH2=C), 
5.48 (s, 1H, OCHOO), 5.81 (m, 1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 19.4 (q, CH3C=), 34.6 (t, CH2), 53.2 (q, OCH3), 68.8 (d, OCH), 87.0 (d, 
OOCH), 111.0 (d, OCHOO), 117.6 (t, CH2=CH), 118.7 (t, CH2=C), 133.0 (d, 
CH=CH2), 138.6 (s, C=CH2). 
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4.6.12 Derived from 3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (7f) 
 
(3RS,5RS,6RS)-5-((RS)-But-3-en-2-yl)-3-(naphthalen-2-yl)-6-(prop-1-en-2-yl)-1,2,4-
trioxa-ne (125a) and (3RS,5RS,6RS)-5-((SR)-but-3-en-2-yl)-3-(naphthalen-2-yl)-6-(prop-
1-en-2-yl)-1,2,4-trioxane (125b)  
(elid 493r) 
O
O
O
H
H
O
O
O
H
H
125a 125b  
 
Following GP-15, a solution of 3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (7f) (1.16 g, 
6.74 mmol) and 2-naphthaldehyde (1.07 g, 6.86 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product 
(1.62 g, 5.23 mmol, 77.5 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 
1:10, Rf = 0.69) afforded a diastereomeric mixture of the pure 1,2,4-trioxanes 125a,b in a 
ratio 1:1 (0.31 g, 1.0 mmol, 15 %) as white solid. 
 
1H-NMR: (300 MHz, CDCl3, one diastereomer) 
δ (ppm) = 1.30 (d, 3H, J = 7.05 Hz, CH3CH), 1.88 (t, 3H, J = 1.47 Hz, CH3C=), 2.55 
(m, 1H, CHCH3), 4.02 (dd, 1H, J = 1.90, 9.54 Hz, OCH), 4.83 (d, 1H, J = 9.54 Hz, 
OOCH), 5.20 (m, 4H, CH2=CH and CH2=), 6.15 (m, 1H, CH=CH2), 6.40 (s, 1H, 
OCHOO), 7.50-8.10 (m, 7H, Harom). 
13C-NMR: (75.5 MHz, CDCl3, one diastereomer) 
δ (ppm) = 13.5 (q, CH3CH), 19.5 (q, CH3C=), 38.1 (d, CHCH3), 79.9 (d, OCH), 85.4 
(d, OOCH), 103.9 (d, OCHOO), 114.3 (t, CH2=CH), 118.9 (t, CH2=C), 124.0 (d, 
CHarom), 126.1 (d, CHarom), 126.6 (d, CHarom), 126.8 (d, CHarom), 126.9 (d, CHarom), 
127.6 (d, CHarom), 128.0 (d, CHarom), 131.9 (s, Cqarom), 132.7 (s, Cqarom), 133.9 (s, 
Cqarom), 138.5 (d, CH=CH2), 138.6 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional signals of the other diastereomer) 
δ (ppm) = 4.12 (dd, 1H, J = 2.51, 9.57 Hz, OCH), 4.89 (d, 1H, J = 9.57 Hz, OOCH), 
6.41 (s, 1H, OCHOO). 
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13C-NMR: (75.5 MHz, CDCl3, other diastereomer) 
δ (ppm) = 18.2 (q, CH3CH), 19.5 (q, CH3C=), 38.8 (d, CHCH3), 80.0 (d, OCH), 85.6 
(d, OOCH), 104.0 (d, OCHOO), 116.1 (t, CH2=CH), 118.9 (t, CH2=C), 124.0 (d, 
CHarom), 126.1 (d, CHarom), 126.6 (d, CHarom), 126.8 (d, CHarom), 126.9 (d, CHarom), 
127.6 (d, CHarom), 128.3 (d, CHarom), 131.9 (s, Cqarom), 132.7 (s, Cqarom), 133.9 (s, 
Cqarom), 138.4 (s, C=CH2), 140.8 (d, CH=CH2). 
IR: (CsI) 
 ν (cm-1) = 3078, 2978, 2923, 1653, 1647, 1605, 1127, 1076, 999, 987, 904, 866, 818. 
MS: (EI, 70 eV) 
m/z (%) = 310 (M+, 2), 226 (M+-C5H8O, 1), 156 (C11H8O+, 100), 155 (C11H7O+, 89), 
128 (C10H8+, 20), 127 (C10H7+, 68), 107 (C8H11+, 20). 
HRMS: (EI, 70 eV, C20H22O3) 
 Calcd: M = 310.157 g/mol  
Found: M = 310.157 ±0.005 g/mol 
Elemental Analysis: (C20H22O3, M = 310.39) 
 Calcd: C 77.39   H 7.14 
Found: C 77.28   H 7.02 
 
(5RS,6RS)-5-((RS)-But-3-en-2-yl)-6-(prop-1-en-2-yl)-spiro[1,2,4-trioxacyclohexane-3,2´-
adamantane] (126a) (5RS,6RS)-5-((SR)-but-3-en-2-yl)-6-(prop-1-en-2-yl)-spiro[1,2,4-
trioxacyclohexane-3,2´-adamantane] (126b) 
(elid 487w)  
O
O
O
H
H
O
O
O
H
H
126a 126b  
 
Following GP-15, a solution of 3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (7f) (1.40 g, 
8.14 mmol) and adamantanone (1.22 g, 8.13 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product 
(1.57 g, 5.16 mmol, 63.5 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 
1:10, Rf = 0.81) afforded a diastereomeric mixture of the pure 1,2,4-trioxanes 126a,b in a 
ratio 31:69 (0.10 g, 3.29 mmol, 4 %) as viscous colorless liquid. 
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1H-NMR: (300 MHz, CDCl3, major diastereomer) 
δ (ppm) = 1.10 (d, 3H, J = 7.05 Hz, CH3CH), 1.50-2.30 (m, 14H, CHCH3, CH and 
CH2), 1.74 (s, 3H, CH3C=), 2.88 (br. s, 1H, CH), 3.86 (dd, 1H, J = 2.13, 9.99 Hz, 
OCH), 4.39 (d, 1H, J = 9.99 Hz, OOCH), 4.92 (m, 4H, CH2=CH and CH2=), 5.88 (m, 
1H, CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer) 
δ (ppm) = 18.5 (q, CH3CH), 19.7 (q, CH3C=), 27.2 (d, CH), 27.3 (d, CH), 29.6 (d, 
CH), 33.0 (t, CH2), 33.3 (t, CH2), 33.6 (t, CH2), 34.5 (t, CH2), 36.5 (d, CH), 37.2 (t, 
CH2), 38.8 (d, CHCH3), 71.5 (d, OCH), 85.3 (d, OOCH), 104.6 (s, OCOO), 115.6 (t, 
CH2=CH), 118.1 (t, CH2=C), 138.9 (d, CH=CH2), 139.4 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional signals of the minor diastereomer) 
δ (ppm) = 1.04 (d, 3H, J = 6.75 Hz, CH3CH), 3.93 (dd, 1H, J = 3.09, 9.84 Hz, OCH), 
4.44 (d, 1H, J = 9.84 Hz, OOCH). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 13.3 (q, CH3CH), 19.9 (q, CH3C=), 26.8 (d, CH), 27.0 (d, CH), 29.8 (d, 
CH), 32.9 (t, CH2), 33.3 (t, CH2), 33.6 (t, CH2), 34.9 (t, CH2), 36.5 (d, CH), 37.2 (t, 
CH2), 38.4 (d, CHCH3), 71.5 (d, OCH), 85.2 (d, OOCH), 103.5 (s, OCOO), 113.8 (t, 
CH2=CH), 118.2 (t, CH2=C), 139.1 (s, C=CH2), 141.5 (d, CH=CH2). 
IR: (Film) 
 ν (cm-1) = 3078, 2913, 1647, 1315, 1222, 1110, 1031, 912. 
Elemental Analysis: (C19H28O3, M = 304.42) 
 Calcd: C 74.96   H 9.27 
Found: C 74.11   H 9.36 
 
(5RS,6RS)-5-((RS)-But-3-en-2-yl)-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (127a) 
and (5RS,6RS)-5-((SR)-but-3-en-2-yl)-3,3-dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(127b) (elid 487x) 
 
O
O
O
H
H
O
O
O
H
H
127a 127b  
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Following GP-15, a solution of 3-hydroperoxy-2,5-dimethylhepta-1,6-dien-4-ol (7f) (0.99 g, 
5.76 mmol) and excess acetone (3.3 g, 56.9 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product 
(0.65 g, 3.07 mmol, 53.2 %) by preparative thick-layer chromatography (SiO2, EA/n-hex, 
1:10, Rf = 0.80) afforded a diastereomeric mixture of the pure 1,2,4-trioxanes 127a,b in a 
ratio 48:52 (0.17 g, 0.8 mmol, 14 %) as colorless liquid. 
 
1H-NMR: (300 MHz, CDCl3, one diastereomer) 
δ (ppm) = 1.0 (d, 3H, J = 6.90 Hz, CH3CH), 1.31 (s, 3H, CH3), 1.59 (s, 3H, CH3), 1.73 
(m, 3H, CH3C=), 2.24 (m, 1H, CHCH3), 3.84 (dd, 1H, J = 2.07, 9.99 Hz, OCH), 4.36 
(d, 1H, J = 9.99 Hz, OOCH), 5.0 (m, 4H, CH2=CH and CH2=), 5.85 (m, 1H, 
CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, one diastereomer) 
δ (ppm) = 18.1 (q, CH3CH), 19.4 (q, CH3C=), 20.4 (q, CH3), 25.7 (q, CH3), 38.7 (d, 
CHCH3), 72.8 (d, OCH), 85.3 (d, OOCH), 102.6 (s, OCOO), 115.6 (t, CH2=CH), 
118.2 (t, CH2=C), 139.0 (d, CH=CH2), 139.2 (s, C=CH2). 
 
1H-NMR: (300 MHz, CDCl3, additional signals of the other diastereomer) 
δ (ppm) = 1.04 (d, 3H, J = 7.08 Hz, CH3CH), 1.74 (m, 3H, CH3C=), 3.94 (dd, 1H, J = 
2.79, 9.84 Hz, OCH), 4.43 (d, 1H, J = 9.84 Hz, OOCH). 
13C-NMR: (75.5 MHz, CDCl3, additional signals of the other diastereomer) 
δ (ppm) = 13.0 (q, CH3CH), 19.5 (q, CH3C=), 20.3 (q, CH3), 37.9 (d, CHCH3), 72.7 
(d, OCH), 85.1 (d, OOCH), 113.8 (t, CH2=CH), 118.2 (t, CH2=), 138.8 (s, C=CH2), 
141.2 (d, CH=CH2). 
 
4.6.13 Derived from 3-hydroperoxy-2,5,5-trimethylhepta-1,6-dien-4-ol (7k) 
 
(5RS,6RS)-3,3-Dimethyl-5-(2-methylbut-3-en-2-yl)-6-(prop-1-en-2-yl)-1,2,4-trioxane 
(128) (elid 482k) 
O
O
O
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Following GP-15, a solution of 3-hydroperoxy-2,5,5-trimethylhepta-1,6-dien-4-ol (7k) (0.90 
g, 4.84 mmol) and excess acetone (2.0 g, 34.5 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.87) afforded the pure 
1,2,4-trioxane as colorless oil (0.06 g, 0.27 mmol, 6 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.01 (s, 3H, CH3C(vinyl)CH3), 1.03 (s, 3H, CH3C(vinyl)CH3), 1.32 (s, 3H, 
CH3), 1.58 (s, 3H, CH3), 1.75 (m, 3H, CH3C=), 3.74 (d, 1H, J = 9.70 Hz, OCH), 4.34 
(d, 1H, J = 9.70 Hz, OOCH), 4.90-5.10 (m, 4H, 2 x CH2=), 5.92 (dd, 1H, J = 17.49, 
10.88 Hz, CH=CH2).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.9 (q, CH3C=), 20.4 (q, CH3), 23.5 (q, CH3C(vinyl)CH3), 24.0 (q, 
CH3C(vinyl)CH3), 25.7 (q, CH3), 39.6 (s, C(vinyl)(CH3)2), 75.5 (d, OCH), 85.3 ( d, 
OOCH), 102.4 (s, OCOO), 111.8 (t, CH2=CH), 119.0 (t, CH2=C), 142.8 (s, C=CH2), 
144.3 (d, CH=CH2). 
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4.7 Lewis-Acid Catalyzed Cleavage of β-Hydroperoxy Alcohols and 
Subsequent Cross-Peroxyacetalization Reaction 
 
(3RS,5RS,6RS)-3,5-Dicyclopropyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129a) 
(elid 495s, 488u, 477l) 
O
O
O
 
 
Following GP-16 using 1-cyclopropyl-2-hydroperoxy-3-methylbut-3-en-1-ol (7p) (1.50 g, 9.5 
mmol), followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129a, 130a in a 
61:39 ratio (0.66 g, 33 %). The yellow oil was then purified by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.81) to separate the 1,2,4-trioxane 129a as pure 
product (0.23 g, 1.1 mmol, 12 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.24-0.59 (m, 8H, 4 x CH2), 0.74-0.95 (m, 2H, 2 x CH), 1.77 (s, 3H, 
CH3C=), 3.06 (dd, 1H, J = 7.92, 8.73 Hz, OCH), 4.45 (d, 1H, J = 9. 21 Hz, OOCH), 
4.73 (d, 1H, J = 6.15 Hz, OCHOO), 5.04 (br. s, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.4 (t, CH2CH), 1.7 (t, CH2CH), 1.9 (t, CH2CH), 2.8 (t, CH2CH), 11.5 (d, 
CH(CH2)2), 12.0 (d, CH(CH2)2), 20.6 (q, CH3C=), 80.8 (d, OCH), 87.4 (d, OOCH), 
106.4 (d, OCHOO), 117.1 (t, CH2=C), 139.4 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Cyclopropyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130a) 
 
O
O
O
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.17-0.52 (m, 4H, CH2CH2), 0.67-1.24 (m, 1H, CH(CH2)2), 1.69 (m, 3H, 
CH3C=), 1.74 (t, 3H, J = 1.17 Hz, CH3C=), 3.21 (dd, 1H, J = 7.08, 8.97 Hz, OCH), 
4.43 (d, 1H, J = 9.09 Hz, OOCH), 4.98-5.04 (m, 3H, CH2=C), 5.18 (br. s, 1H, 
CH2=C), 5.45 (s, 1H, OOCHO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 1.5 (t, CH2), 2.3 (t, CH2), 11.3 (d, CH(CH2)2), 17.5 (q, CH3C=), 20.4 (q, 
CH3C=), 79.8 (d, OCH), 87.5 (d, OOCH), 104.5 (d, OOCHO), 116.5 (t, CH2=C), 
117.2 (t, CH2=C), 138.7 (s, C=CH2), 139.2 (s, C=CH2). 
 
(3RS,5RS,6RS)-3,5-Diethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129b) 
(elid 387a, 475m)  
O
O
O
 
 
Following GP-16 using 4-hydroperoxy-5-methylhex-5-en-3-ol (7b) (1.1 g, 7.53 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129b, 130b in a 63:37 
ratio (0.58 g, 41 %). The yellow oil was then purified by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0. 84) to obtain the 1,2,4-trioxane 129b as pure 
product (0. 09 g, 0.47 mmol, 6 %). 
NMR data see previously. 
 
(3RS,5RS,6RS)-5-Ethyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130b) 
(elid 407d)  
O
O
O
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1H-NMR: (300 MHz, DMSO-d6) 
δ (ppm) = 0.93 (t, 3H, J = 7.35 Hz, CH3CH2), 1.44 (m, 2H, CH2CH3), 1.69 (2 x s, 6H, 
2 x CH3C=), 3.77 (ddd, 1H, J = 3.50, 8.07, 9.27 Hz, OCH), 4.38 (d, 1H, J = 9.27 Hz, 
OOCH), 5.10 (m, 3H, 2 x CH2=C), 5.24 (br. s, 1H, CH2=C), 5.60 (s, 1H, OOCHO). 
13C-NMR: (75.5 MHz, DMSO-d6) 
δ (ppm) = 9.0 (q, CH3), 17.3 (q, CH3C=), 19.1 (q, CH3C=), 23.0 (t, CH2), 76.8 (d, 
OCH), 86.8 (d, OOCH), 104.1 (d, OCHOO), 116.6 (t, CH2=C), 118.7 (t, CH2=C), 
138.6 (2 x s, 2 x C=CH2). 
 
(3RS,5RS,6RS)-3,5-Diisobutyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129c) 
(elid 495k, 486u, 501f)  
O
O
O
 
 
Following GP-16 using 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (0.80 g, 4.6 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129c, 130c in a 83:17 
ratio (0.65 g, 59 %). The yellow oil was then purified by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.84) to separate the 1,2,4-trioxane 129c as pure 
product (184 mg, 0.76 mmol, 17 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (d, 3H, J = 6.45 Hz, CH3CH), 0.88 (d, 3H, CH3CH), 0.90 (d, 3H, J = 
6.75 Hz, CH3CH), 0.92 (d, 3H, J = 6.63 Hz, CH3CH), 1.09 (m, 1H, CH2CH), 1.35-
1.45 (m, 3H, CH2CH and CH2CH), 1.69 (m, 3H, CH3C=), 1.82 (m, 2H, 2 x CHCH2), 
3.72 (ddd, 1H, J = 3.68, 9.11, 9.11 Hz, OCH), 4.30 (d, 1H, J = 9.11 Hz, OOCH), 5.05 
(m, 2H, CH2=C), 5.26 (dd, 1H, J = 5.57, 5.73 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.6 (q, CH3C=), 21.3 (q, CH3CH), 22.5 (q, CH3CH), 22.9 (q, CH3CH), 
23.6 (q, CH3CH), 23.7 (d, CHCH2), 24.0 (d, CHCH2), 39.1 (t, CH2CH), 40.6 (t, 
CH2CH), 75.0 (d, OCH), 88.1 (d, OOCH), 103.8 (d, OCHOO), 118.4 (t, CH2=C), 
138.7 (s, C=CH2). 
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(3RS,5RS,6RS)-5-Isobutyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130c) 
 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.70 (m, 3H, CH3C=), 1.74 (m, 3H, CH3C=), 3.80 (m, 1H, OCH), 4.34 (d, 
1H, J = 9.12 Hz, OOCH), 5.54 (s, 1H, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 39.1 (t, CH2CH), 75.2 (d, OCH), 88.0 (d, OOCH), 104.6 (d, OCHOO), 
116.1 (t, CH2=C), 118.5 (t, CH2=C), 138.7 (s, C=CH2), 138.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-3,5-Dibutyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129d) 
(elid 472c, 492p) 
O
O
O
 
 
Following GP-16 using 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.60 g, 9.2 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129d, 130d in a 68:32 
ratio (1.30 g, 59.7 %). The yellow oil was then purified by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.82) to obtain the 1,2,4-trioxane 129d as pure 
product (0.32 g, 1.32 mmol, 14 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.88 (t, 6H, J = 6.99 Hz, CH3CH2), 1.18-1.65 (m, 12H, CH2), 1.71 (m, 3H, 
CH3C=), 3.65 (m, 1H, OCH), 4.33 (d, 1H, J = 9.09 Hz, OOCH), 5.06 (s, 2H, CH2=), 
5.21 (t, 1H, J = 5.36 Hz, OCHOO). 
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13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.8 (q, CH3CH2), 14.0 (q, CH3CH2), 19.7 (q, CH3C=), 22.4 (t, CH2CH3), 
22.6 (t, CH2CH3), 26.0 (t, CH2CH2), 27.1 (t, CH2CH2), 30.1 (t, CH2CH2), 31.8 (t, 
CH2CH2), 76.8 (d, OCH), 87.7 (d, OOCH), 104.8 (d, OCHOO), 118.3 (t, CH2=C), 
138.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Butyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130d) 
(elid 464p) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.87 (t, 3H, J = 7.05 Hz, CH3CH2), 1.24-1.65 (m, 6H, 3 x CH2), 1.72 (s, 3H, 
CH3C=), 1.75 (s, 3H, CH3C=), 3.74 (m, 1H, OCH), 4.38 (d, 1H, J = 9.24 Hz, OOCH), 
5.05 (m, 3H, 2 x CH2=C), 5.24 (br. s, 1H, CH2=C ), 5.55 (s, 1H, OOCHO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.8 (q, CH3CH2), 17.7 (q, CH3C=), 19.7 (q, CH3C=), 22.6 (t, CH2CH3), 
26.9 (t, CH2CH2), 30.1 (t, CH2CH2), 76.8 (d, OCH), 87.6 (d, OOCH), 104.7 (d, 
OOCHO), 116.3 (t, CH2=C), 118.3 (t, CH2=C), 138.8 (s, C=CH2) 138.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-3,5-Dimethyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129e) 
(elid 486i) 
O
O
O
 
 
Following GP-16 using 3-hydroperoxy-4-methylpent-4-en-2-ol (7a) (1.40 g, 10.6 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129e, 130e in a 79:21 
ratio (1.1 g, 62 %). The yellow oil was then purified by preparative thick-layer 
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chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.74) to separate the 1,2,4-trioxane 130e as pure 
product (0.13 g, 0.71 mmol, 7 %). 
For the NMR data of 129e see before. 
 
(3RS,5RS,6RS)-5-Methyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130e) 
(elid 477f) 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.16 (d, 3H, CH3CH), 1.72 (s, 3H, CH3C=), 1.75 (s, 3H, CH3C=), 3.88 (dq, 
1H, J = 6.33, 9.12 Hz, OCH), 4.32 (d, 1H, J = 9.12 Hz, OOCH), 5.05 (m, 3H, 
CH2=C), 5.24 (s, 1H, CH2=C), 5.56 (s, 1H, OOCHO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 16.3 (q, CH3CH), 17.6 (q, CH3C=), 19.6 (q, CH3C=), 73.2 (d, OCH), 88.7 
(d, OOCH), 104.8 (d, OCHOO), 116.6 (t, CH2=C), 118.1 (t, CH2=C), 138.7 (s, 
C=CH2), 138.8 (s, C=CH2). 
 
(3RS,5RS,6RS)-6-(Prop-1-en-2-yl)-3,5-dipropyl-1,2,4-trioxane (129f) 
(elid 473q)  
O
O
O
 
 
Following GP-16 using 3-hydroperoxy-2-methylhept-1-en-4-ol (7d) (0.78 g, 4.88 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129f, 130f (0.25 g, 24 
%). The yellow oil was then purified by preparative thick-layer chromatography (SiO2, EA/n-
hex, 1:10, Rf = 0.83) to obtain the pure 1,2,4-trioxanes mixture 129f, 130f in a 95:5 ratio (0.08 
g, 8 %). 
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.88 (t, 3H, J = 7.05 Hz, CH3CH2), 0.89 (t, 3H, J = 7.35 Hz, CH3CH2), 
1.28-1.57 (m, 8H, 2 x CH2CH2), 1.70 (m, 3H, CH3C=), 3.65 (m, 1H, OCH), 4.32 (d, 
1H, J = 9.12 Hz, OOCH), 5.04 (m, 2H, CH2=C), 5.21 (t, 1H, J = 5.28 Hz, OCHOO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, 2 x CH3CH2), 17.2 (t, CH2CH3), 18.1 (t, CH2CH3), 19.6 (q, 
CH3C=), 32.4 (t, CH2CH2), 34.0 (t, CH2CH2), 76.5 (d, OCH), 87.7 (d, OOCH), 104.5 
(d, OCHOO), 118.3 (t, CH2=C), 138.8 (s, C=CH2). 
 
(3RS,5RS,6RS)-3,6-Di(prop-1-en-2-yl)-5-propyl-1,2,4-trioxane (130f) 
 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.90 (t, 3H, J = 7.20 Hz, CH3CH2), 1.33-1.58 (m, 4H, CH2CH2), 1.73 (t, 3H, 
J = 1.47 Hz, CH3C=), 1.76 (t, 3H, J = 1.05 Hz, CH3C=), 3.76 (m, 1H, OCH), 4.39 (d, 
1H, J = 9.24 Hz, OOCH), 5.07 (m, 3H, CH2=C), 5.25 (br. s, 1H, CH2=C), 5.56 (s, 1H, 
OOCHO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.9 (q, CH3CH2), 17.8 (q, CH3C=), 18.1 (t, CH2CH3), 19.7 (q, CH3C=), 
32.5 (t, CH2CH2), 76.6 (d, OCH), 87.6 (d, OOCH), 104.7 (d, OOCHO), 116.3 (t, 
CH2=C), 118.3 (t, CH2=C), 138.8 (s, C=CH2), 138.9 (s, C=CH2). 
 
(3RS,5RS,6RS)-3,5-Diallyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129g)  
(elid 474x, 486t) 
O
O
O
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Following GP-16 using 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (0.74 g, 4.68 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129g, 130g in a 80:20 
ratio (0.51 g, 2.43 mmol, 52 %). The yellow oil was then purified by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.85) to give the pure 1,2,4-trioxanes mixture 
129g, 130g in a 90:10 ratio (0.05 g, 5 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.72 (t, 3H, J = 1.32 Hz, CH3C=), 2.35 (m, 4H, 2 x CH2), 3.77 (ddd, 1H, J = 
3.81, 7.50, 9.42 Hz, OCH), 4.40 (d, 1H, J = 9.42 Hz, OOCH), 5.04-5.15 (m, 6H, 2 x 
CH2=CH and CH2=C), 5.27 (t, 1H, J = 5.46 Hz, OOCHO), 5.70-5.97 (m, 2H, 2 x 
CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.6 (q, CH3C=), 34.9 (t, CH2), 36.7 (t, CH2), 76.3 (d, OCH), 87.0 (d, 
OOCH), 103.7 (d, OOCHO), 117.4 (t, CH2=CH), 118.3 (t, CH2=), 118.7 (t, CH2=), 
131.2 (d, CH=CH2), 133.5 (d, CH=CH2), 138.4 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Allyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130g) 
 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.74 (t, 3H, J = 1.17 Hz, CH3C=), 1.76 (m, 3H, CH3C=), 2.26 (m, 2H, CH2), 
3.85 (m, 1H, OCH), 4.45 (d, 1H, J = 9.42 Hz, OOCH), 5.26 (br. s, 1H, CH2=C), 5.57 
(s, 1H, OOCHO). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.7 (q, CH3C=), 19.6 (q, CH3C=), 35.0 (t, CH2), 76.2 (d, OCH), 86.9 (d, 
OOCH), 104.7 (d, OOCHO), 116.6 (t, CH2=C), 117.5 (t, CH2=CH), 118.7 (t, CH2=C), 
133.4 (d, CH=CH2), 138.5 (s, C=CH2), 138.8 (s, C=CH2). 
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(3RS,5RS,6RS)-3,5-Diisopropyl-6-(prop-1-en-2-yl)-1,2,4-trioxane (129h) 
(elid 486s, 473p) 
O
O
O
 
 
Following GP-16 using 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (0.90 g, 5.6 mmol), 
followed by usual work-up afforded the crude 1,2,4-trioxanes mixture 129h, 130h in a 91:9 
ratio (0.60 g, 50 %). The yellow oil was then purified by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.80) to obtain the pure 1,2,4-trioxanes mixture 
129h, 130h in ratio 94:6 (0.14 g, 12 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.90-1.0 (m, 12H, 2 x (CH3)2CH), 1.70 (m, 3H, CH3C=), 1.79 (m, 2H, 2 x 
CH(CH3)2), 3.54 (dd, 1H, J = 2.34, 9.42 Hz, OCH), 4.49 (d, 1H, J = 9.54 Hz, OOCH), 
4.95 (d, 1H, J = 5.28 Hz, OOCHO), 5.02-5.12 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 15.3 (q, CH3CH), 16.7 (q, CH3CH), 17.3 (q, CH3CH), 19.5 (q, CH3C=), 
19.9 (q, CH3CH), 28.2 (d, CH(CH3)2), 31.1 (d, CH(CH3)2), 80.3 (d, OCH), 85.7 (d, 
OOCH), 107.6 (s, OCHOO), 118.1 (t, CH2=C), 139.0 (s, C=CH2). 
 
(3RS,5RS,6RS)-5-Isopropyl-3,6-di(prop-1-en-2-yl)-1,2,4-trioxane (130h) 
 
O
O
O
 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 0.98 (m, 6H, (CH3)2CH), 1.72 (m, 3H, CH3C=), 1.75 (m, 3H, CH3C=), 1.79 
(m, 1H, CH(CH3)2), 3.65 (dd, 1H, J = 2.37, 9.42 Hz, OCH), 4.56 (d, 1H, J = 9.57 Hz, 
OOCH), 5.24 (br. s, 1H, CH2=C), 5.55 (s, 1H, J = 5.28 Hz, OOCHO). 
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13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 15.4 (q, CH3CH), 17.6 (q, CH3C=), 19.5 (q, CH3C=), 20.0 (q, CH3CH), 80.5 
(d, OCH), 85.7 (d, OOCH), 104.8 (s, OCHOO), 116.3 (t, CH2=C), 118.3 (t, CH2=C), 
138.9 (s, C=CH2), 139.1 (s, C=CH2). 
 
2-(3,6-Dihydro-5-methyl-1,2-dioxin-3-yl)propan-2-ol (131) 
(elid 475l)  
O
O
OH 
 
Photooxygenation of (E)-2,5-Dimethylhexa-3,5-dien-2-ol (6u) (1.10 g, 8.73 mmol) for 65 h 
according to GP-9a afforded the endoperoxide (0.92 g, 5.82 mmol, 67 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.15 (d, 6H, (CH3)2C), 1.68 (s, 3H, CH3C=), 4.20 (m, 1H, CH), 4.28 (s, 2H, 
CH2), 5.65 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 18.2 (q, CH3C=), 25.7 (q, (CH3)2C), 72.6 (t, CH2), 72.8 (s, C(CH3)2), 84.3 
(d, CH), 117.1 (d, CH=C), 133.5 (s, C=CH). 
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4.8 Bis Spiro-1,2,4-Trioxanes Synthesis 
 
(3RS,4RS,12RS,13RS)-4,13-Dibutyl-3,12-diisopropenyl-1,2,5,10,11,14-hexaoxadispiro[5. 
2.5.2]hexadecane (syn-132) and (3RS,4RS,12SR,13SR)-4,13-dibutyl-3,12-diisopropenyl-
1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecane (anti-132)  
(elid 492j) 
O
O O
OO
O O O
O
O O
O
syn-132 anti-132  
 
Following GP-15, a solution of 3-hydroperoxy-2-methyloct-1-en-4-ol (7g) (1.45 g, 8.33 
mmol) and cyclohexane-1,4-dione (0.46 g, 4.11 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.53) afforded a diastereomeric mixture of the 
pure 1,2,4-trioxanes syn-132 and anti-132 in a ratio 1:1 (0.07 g, 0.17 mmol, 4 %) as oil which 
crystallizes on standing. 
 
1H-NMR: (300 MHz, CDCl3, both diastereomers) 
δ (ppm) = 0.86 (t, 3H, J = 7.05 Hz, CH3CH2), 1.05-1.72 (m, 8H, CH2), 1.60 (m, 3H, 
CH3C=), 2.20 (m, 2H, CH2), 3.86 (m, 1H, OCH), 4.25 (d, 1H, J = 9.55 Hz, OOCH), 
5.04 (s, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 13.9 (q, CH3CH2), 19.7 (q, CH3C=), 22.5 (t, CH2CH3), 25.2 (t, CH2), 27.0 (t, 
CH2CH2), 30.4 (t, CH2CH2), 30.8 (t, CH2), 69.8 (d, OCH), 87.7 (d, OOCH), 102.4 (s, 
OCOO), 118.1 (t, CH2=C), 139.2 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of the 2nd diastereomer) 
δ (ppm) = 19.8 (q, CH3C=), 22.5 (t, CH2CH3), 24.9 (t, CH2), 27.1 (t, CH2CH2), 30.5 (t, 
CH2CH2), 31.2 (t, CH2), 69.8 (d, OCH), 87.7 (d, OOCH), 102.3 (s, OCOO), 118.1 (t, 
CH2=C), 139.1 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3083, 2957, 2873, 1648, 1455, 1373, 1258, 1105, 1007, 928, 911. 
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Elemental Analysis: (C24H40O6, M = 424.57) 
Calcd: C 67.89   H 9.50 
Found: C 67.43   H 9.37 
 
(3RS,4RS,12RS,13RS)-3,12-Diisopropenyl-4,13-diisopropyl-1,2,5,10,11,14-hexaoxadispi- 
ro[5.2.5.2]hexadecane (syn-133) and (3RS,4RS,12SR,13SR)-3,12-diisopropenyl-4,13-
diisopropyl-1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecane (anti-133)  
(elid 476g) 
O
O O
OO
O O O
O
O O
O
syn-133 anti-133  
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7c) (1.60 g, 10.0 
mmol) and cyclohexane-1,4-dione (0.56 g, 5.0 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.70) afforded a diastereomeric mixture of the 
pure 1,2,4-trioxanes syn-133 and anti-133 in a ratio 1:1 (0.36 g, 0.91 mmol, 18 %) as oil 
which crystallizes on standing into yellow crystals. 
 
1H-NMR: (300 MHz, CDCl3, both diastereomers)  
δ (ppm) = 0.90 (d, 3H, J = 6.93 Hz, CH3CH), 0.97 (d, 3H, J = 6.75 Hz, CH3CH), 0.79-
1.10 (m, CH2), 1.60-1.80 (m, 1H, CH(CH3)2, 1.74 (m, 3H, CH3C=), 3.76 (m, 1H, 
OCH), 4.45 (d, 1H, J = 9.84 Hz, OOCH), 5.07 (m, 2H, CH2=). 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 15.0 (q, CH3CH), 19.6 (q, CH3C=), 19.9 (q, CH3CH), 24.8 (t, CH2), 28.1 (d, 
CH(CH3)2), 31.1 (t, CH2), 73.4 (d, OCH), 85.7 (d, OOCH), 102.2 (s, OCOO), 118.0 (t, 
CH2=C), 139.3 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals of 2nd diastereomer)  
δ (ppm) = 20.0 (q, CH3CH), 25.0 (t, CH2) 30.7 (t, CH2). 
IR: (Film) 
ν (cm-1) = 3083, 2965, 1731, 1649, 1469, 1373, 1258, 1118, 919, 825. 
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(3RS,4RS,12RS,13RS)-3,12-Diisopropenyl-4,13-dipropyl-1,2,5,10,11,14-hexaoxadispiro[ 
5.2.5.2]hexadecane (syn-134) and (3RS,4RS,12SR,13SR)-3,12-diisopropenyl-4,13-
dipropyl-1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecane (anti-134)  
(elid 495m) 
O
O O
OO
O O O
O
O O
O
syn-134 anti-134  
 
Following GP-15, a solution of 4-hydroperoxy-2,5-dimethylhex-5-en-3-ol (7d) (1.32 g, 8.25 
mmol) and cyclohexane-1,4-dione (0.46 g, 4.11 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up followed by preparative thick-layer 
chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.64) afforded a diastereomeric mixture of the 
pure 1,2,4-trioxanes syn-134 and anti-134 in a ratio 1:1 (0.31 g, 0.78 mmol, 19 %) as oil 
which crystallizes on standing into yellow crystals. 
 
1H-NMR: (300 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 0.88 (t, 3H, J = 6.90 Hz, CH3CH2), 1.26-1.58 (m, 4H, CH2CH2), 1.67 (m, 
2H, CH2), 1.72 (m, 3H, CH3C=), 2.04-2.32 (m, 2H, CH2), 3.89 (m, 1H, OCH), 4.25 (d, 
1H, J = 9.72 Hz, OOCH), 5.04 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 13.8 (q, CH3CH2), 18.1 (t, CH2CH3), 19.7 (q, CH3C=), 25.1 (t, CH2), 30.8 
(t, CH2), 32.9 (t, CH2CH2), 69.5 (d, OCH), 87.6 (d, OOCH), 102.3 (s, OCOO), 118.0 
(t, CH2=C), 139.1 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, 2nd diastereomer) 
δ (ppm) = 13.9 (q, CH3CH2), 18.1 (t, CH2CH3), 19.7 (q, CH3C=), 24.8 (t, CH2), 31.2 
(t, CH2), 32.9 (t, CH2CH2), 69.5 (d, OCH), 87.6 (d, OOCH), 102.3 (s, OCOO), 118.0 
(t, CH2=C), 139.1 (s, C=CH2). 
IR: (Film) 
 ν (cm-1) = 3083, 2956, 2873, 1680, 1649, 1454, 1374, 1258, 1105, 1006, 918. 
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(3RS,4RS,12RS,13RS)-4,13-Diallyl-3,12-diisopropenyl-1,2,5,10,11,14-hexaoxadispiro[5.2 
.5.2]hexadecane (syn-135) and (3RS,4RS,12SR,13SR)-4,13-diallyl-3,12-diisopropenyl-
1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecane (anti-135) (elid 495t) 
O
O O
OO
O O O
O
O O
O
syn-135 anti-135  
 
Following GP-15, a solution of 3-hydroperoxy-2-methylhepta-1,6-dien-4-ol (7e) (1.30 g, 8.23 
mmol) and cyclohexane-1,4-dione (0.46 g, 4.11 mmol, 0.5 equiv.) in CH2Cl2 was treated with 
a catalytic amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude 
product (0.87 g, 2.22 mmol, 54 %) by preparative thick-layer chromatography (SiO2, EA/n-
hex, 1:10, Rf = 0.55) afforded a diastereomeric mixture of the pure 1,2,4-trioxanes syn-135 
and anti-135 (0.13 g, 0.33 mmol, 8 %) as viscous colorless oil. 
 
1H-NMR: (300 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 1.60-2.39 (m, 6H, 3 x CH2), 1.74 (s, 3H, CH3C=), 3.97 (m, 1H, OCH), 4.31 
(d, 1H, J = 9.69 Hz, OOCH), 5.07 (m, 4H, CH2=CH and CH2=C), 5.82 (m, 1H, 
CH=CH2). 
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 19.7 (q, CH3C=), 24.8 (t, CH2), 31.1 (t, CH2), 35.3 (t, CH2CH=), 69.5 (d, 
OCH), 86.9 (d, OOCH), 102.4 (s, OCOO), 117.2 (t, CH2=CH), 118.4 (t, CH2=C), 
133.6 (d, CH=CH2), 138.8 (s, C=CH2). 
1H-NMR: (300 MHz, CDCl3, additional significant signals of 2nd diastereomer) 
δ (ppm) = 3.35 (m, 1H, OCH), 4.30 (d, 1H, J = 9.69 Hz, OOCH). 
13C-NMR: (75.5 MHz, CDCl3, 2nd diastereomer) 
δ (ppm) = 19.7 (q, CH3C=), 24.8 (t, CH2), 31.1 (t, CH2), 35.3 (t, CH2CH=), 69.5 (d, 
OCH), 87.1 (d, OOCH), 102.4 (s, OCOO), 117.1 (t, CH2=CH), 118.4 (t, CH2=C), 
133.7 (d, CH=CH2), 138.9 (s, C=CH2). 
 
(3RS,4RS,12RS,13RS)-4,13-Diisobutyl-3,12-diisopropenyl-1,2,5,10,11,14-hexaoxadispiro 
[5.2.5.2]hexadecane (syn-136) and (3RS,4RS,12SR,13SR)-4,13-diisobutyl-3,12-
diisopropenyl-1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecane (anti-136) (elid 496d) 
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O
O O
OO
O O O
O
O O
O
syn-136 anti-136  
 
Following GP-15, a solution of 3-hydroperoxy-2,6-dimethylhept-1-en-4-ol (7h) (1.32 g, 7.59 
mmol) and cyclohexane-1,4-dione (0.42 g, 3.75 mmol) in CH2Cl2 was treated with a catalytic 
amount of BF3.Et2O (0.2 ml). Usual work-up and further purification of the crude product by 
preparative thick-layer chromatography (SiO2, EA/n-hex, 1:10, Rf = 0.71) afforded a 
diastereomeric mixture of the 1,2,4-trioxanes syn-136 and anti-136 (0.23 g, 0.54 mmol, 15 %) 
as oil which crystallizes on standing. 
 
1H-NMR: (300 MHz, CDCl3, both diastereomers) 
δ (ppm) = 0.81-0.94 (m, 6H, (CH3)2CH), 1.06 (m, 1H, CH2CH), 1.33 (m, 1H, 
CH2CH), 1.59-1.89 (m, 3H, CH2 and CHCH2), 1.72 (m, 3H, CH3C=), 2.10-2.35 (m, 
2H, CH2), 3.97 (m, 1H, OCH), 4.24 (d, 1H, J = 9.54 Hz, OOCH), 5.05 (m, 2H, 
CH2=C).  
13C-NMR: (75.5 MHz, CDCl3, 1st diastereomer) 
δ (ppm) = 19.7 (q, CH3C=), 21.3 (q, CH3CH), 23.5 (d, CHCH2), 23.7 (q, CH3CH), 
25.2 (t, CH2), 31.2 (t, CH2), 39.6 (t, CH2CH), 67.8 (d, OCH), 88.1 (d, OOCH), 102.3 
(s, OCOO), 118.2 (t, CH2=C), 139.0 (s, C=CH2). 
13C-NMR: (75.5 MHz, CDCl3, additional signals of 2nd diastereomer) 
δ (ppm) = 19.6 (q, CH3C=), 23.5 (d, CHCH2), 24.7 (t, CH2), 30.7 (t, CH2), 39.6 (t, 
CH2CH), 88.1 (d, OOCH), 102.3 (s, OCOO), 139.0 (s, C=CH2). 
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4.9 Intramolecular 1,2,4-Trioxanes Synthesis 
 
2-Methyl-6-oxohept-2-enal (139) 
(elid 360a) 
O
OH
 
 
A solution of SeO2 (11 g, 100 mmol; caution, selenium compounds are highly toxic and 
should be handeled carefully !) was stirred at r.t. in CH2Cl2 (150 mL) for 30 min, then 6-
methylhept-5-en-2-one (138) (6.31 g, 50 mmol) was added portionwise over several minutes. 
The mixture is stirred at r.t. for 48 h and then washed by 10 % aqueous KOH, then with 
AcOH/Me2S (4:5, v/v) (45 mL) then with 20 % aqueous K2CO3. The aqueous phase is 
extracted with ether (3 x 50 mL), and the combined organic phase is washed with water, brine 
and dried over MgSO4. Evaporation of the solvent under reduced pressure affords the 
dicarbonyl compound (2.88 g, 20.6 mmol) in good purity. 
 
Yield:  41 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.71 (s, 3H, CH3CH), 2.13 (s, 3H, CH3CO), 2.56 (m, 4H, CH2CH2), 6.38 
(m, 1H, CH=C), 9.32 (s, 1H, CHO).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 9.1 (q, CH3CH), 22.9 (t, CH2CH), 29.8 (q, CH3CO), 41.6 (t, CH2CO), 139.9 
(s, C=CH), 152.4 (d, CH=C), 195.0 (d, CHO), 206.8 (s, CO). 
 
7-Methyloct-6-ene-2,5-dione192 (140) 
(elid 496a) 
O
O  
 
A solution of 3,3-dimethylacrolein (10.0 g, 119 mmol), methylvinylketone (8.33 g, 119 
mmol), 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazolium chloride193 (3.20 g, 11.9 mmol) 
and sodium acetate (3.90 g, 47.6 mmol) in ethanol (100 mL) was stirred under nitrogen at 80 
°C for 15 h, then the reaction mixture is cooled to r.t. and the solvent was removed under 
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reduced pressure followed by fractional distillation (b.p. 84 °C, 1.39 torr, Lit. 87-89 °C, 2.5 
torr194) of the residue to afford the pure 1,4-dione 140 (9.1 g, 59.1 mmol) as yellow oil. 
 
Yield:  50 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.81 (s, 3H, CH3C=), 2.04 (s, 3H, CH3C=), 2.12 (t, 3H, J = 2.80 Hz, 
CH3CO), 2.63 (m, 4H, CH2CH2), 6.02 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.6 (q, CH3C=), 27.5 (q, CH3C=), 29.9 (q, CH3CO), 36.9 (t, CH2), 37.4 (t, 
CH2) 123.3 (d, CH=C), 155.3 (s, C=CH), 198.6 (s, COCH=), 207.4 (s, COCH3). 
 
8-Methylnon-7-ene-3,6-dione192 (141) 
(elid 483s) 
O
O  
 
A solution of 3,3-dimethyl acrolein (18.75 g, 223.2 mmol), ethyl vinyl ketone (25 g, 297.6 
mmol), 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazolium chloride (6.0 g, 22.3 mmol) and 
sodium acetate (7.32 g, 89.3 mmol) in ethanol (250 mL) was stirred under nitrogen at 80 °C 
for 15 h, then the reaction mixture is cooled to r.t. and the solvent was removed under reduced 
pressure followed by fractional distillation (b.p. 119 °C, 0.33 torr) of the residue gives the 
pure 1,4-dione 141 (33.4 g, 198.8 mmol) as yellow oil. 
 
Yield:  89 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.95 (dt, 3H, J = 1.32, 7.35 Hz, CH3CH2), 1.78 (s, 3H, CH3C=), 2.01 (s, 3H, 
CH3C=), 2.39 (q, 2H, J = 7.35 Hz, CH2CH3), 2.60 (m, 4H, CH2CH2), 6.0 (m, 1H, 
CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.6 (q, CH3CH2), 20.5 (q, CH3C=), 27.4 (q, CH3C=), 35.6 (t, CH2), 35.7 (t, 
CH2), 37.4 (t, CH2), 123.3 (d, CH=C), 155.0 (s, C=CH), 198.7 (s, COCH=), 209.9 (s, 
COCH2). 
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5-Methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-4-en-3-one195 (142) 
(elid 496q) 
O
O O
 
 
A solution of 7-methyloct-6-ene-2,5-dione (140) (14.5 g, 94.2 mmol) and ethylene glycol 
(10.0 g, 161.3 mmol) and pyridinium tosylate (3.58 g, 14.3 mmol) in benzene (100 mL) was 
refluxed using Dean-Stark apparatus with continuous removal of the separated water. The 
solvent is removed under reduced pressure and the residue is mixed with ether, washed with 
saturated NaHCO3 solution (2 x 30 mL), dried over Na2SO4 and the ether is evaporated. 
Fractional distillation (b.p. 100 °C, 0.90 torr, Lit. 48 °C, 0.02 torr195) of the residue gives the 
pure enone acetal 142 (7.46 g, 37.7 mmol) as yellow oil. 
 
Yield:  40 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.19 (s, 3H, CH3), 1.76 (d, 3H, J = 1.29 Hz, CH3C=), 1.85 (t, 2H, J = 7.70 
Hz CH2), 2.01 (d, 3H, J = 1.02 Hz, CH3C=), 2.39 (t, 2H, J = 7.70 Hz CH2), 3.81 (m, 
4H, 2 x CH2O), 5.97 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.4 (q, CH3C=), 23.7 (q, CH3), 27.4 (q, CH3C=), 32.8 (t, CH2), 38.5 (t, 
CH2CO), 64.4 (t, 2 x OCH2), 109.2 (s, OCO), 123.6 (d, CH=C), 154.4 (s, C=CH), 
199.9 (s, CO). 
 
1-(2-Ethyl-1,3-dioxolan-2-yl)-5-methylhex-4-en-3-one (143) 
(elid 494f) 
O
O O
 
 
A solution of 8-methylnon-7-ene-3,6-dion (141) (30.0 g, 178.6 mmol) and ethylene glycol 
(12.5 g, 201.6 mmol) and pyridinium tosylate (4.46 g, 17.8 mmol) in benzene (100 mL) was 
refluxed using Dean-Stark apparatus with continuous removal of the separated water. The 
solvent is removed under reduced pressure and the residue is mixed with ether, washed with 
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saturated NaHCO3 solution (2 x 30 mL), dried over Na2SO4 and the ether is distilled to afford 
the enone acetal 143 (30.2 g, 142.3 mmol) as yellow oil. 
 
Yield:  80 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.80 (t, 3H, J = 7.35 Hz, CH3CH2), 1.51 (q, 2H, J = 7.50 Hz, CH2CH3), 1.76 
(s, 3H, CH3C=), 1.83 (m, 2H, CH2), 2.02 (s, 3H, CH3C=), 2.39 (m, 2H, CH2), 3.81 (m, 
4H, 2 x CH2O), 5.96 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.9 (q, CH3CH2), 20.5 (q, CH3C=), 27.5 (q, CH3C=), 30.0 (t, CH2), 30.5 (t, 
CH2), 38.5 (t, CH2CO), 64.9 (t, 2 x OCH2), 111.3 (s, OCO), 123.7 (d, CH=C), 154.5 
(s, C=CH), 200.2 (s, CO). 
 
5-Methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-4-en-3-ol (144) 
(elid 480o) 
OH
O O
 
 
Under an inert atmosphere, an ether solution of 5-methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-
4-en-3-one (142) (8.6 g, 43.4 mmol) was added dropwise at r.t. to a suspension of LiAlH4 
(0.64 g, 16.8 mmol) in dry ether at such a rate as to maintain gentle reflux. After complete 
addition the reaction mixture was treated slowly (caution, vigorous evolution of hydrogen gas 
!) with 2N aqueous NaOH solution. The precipitate was removed by filteration, digested with 
ether and the combined ether extracts were washed with brine and dried over MgSO4. 
Evaporation of the solvent under reduced pressure gives the pure allylic alcohol (5.40 g, 0.027 
mmol) as faint yellow oil. 
 
Yield:  62 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.25 (s, 3H, CH3), 1.44-1.78 (m, 4H, CH2CH2), 1.61 (d, 2H, J = 1.17 Hz, 
CH3C=), 1.65 (d, 3H, J = 1.02 Hz, CH3C=), 3.87 (m, 4H, 2 x OCH2), 4.26 (m, 1H, 
OCH), 5.10 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
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δ (ppm) = 18.1 (q, CH3C=), 23.7 (q, CH3), 25.6 (q, CH3C=), 31.9 (t, CH2), 34.9 (t, 
CH2), 64.5 (t, 2 x OCH2), 109.9 (s, OCO), 128.0 (d, CH=C), 134.6 (s, C=CH). 
 
1-(2-Ethyl-1,3-dioxolan-2-yl)-5-methylhex-4-en-3-ol (145) 
(elid 484v) 
OH
O O
 
 
Under an inert atmosphere, an ether solution of 1-(2-ethyl-1,3-dioxolan-2-yl)-5-methylhex-4-
en-3-one (143) (28.87 g, 136.2 mmol) was added dropwise at r.t. to a suspension of LiAlH4 
(2.0 g, 52.6 mmol) in dry ether at such a rate as to maintain gentle reflux. After complete 
addition the reaction mixture was treated slowly (caution, vigorous evolution of hydrogen gas 
!) with 2N aqueous NaOH solution. The precipitate was removed by filteration, digested with 
ether and the combined ether extracts were washed with brine and dried over MgSO4. 
Evaporation of the solvent under reduced pressure followed by fractional distillation (b.p. 110 
°C, 0.22 torr) gives the pure allylic alcohol (18.0 g, 84.1 mmol) as faint yellow oil. 
 
Yield:  62 % 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.71 (t, 3H, J = 7.65 Hz, CH3CH2), 1.25-1.59 (m, 6H, 3 x CH2), 1.48 (d, 3H, 
J = 1.02 Hz, CH3C=), 1.53 (s, 3H, CH3C=), 2.65 (br. s, 1H, OH), 3.73 (m, 4H, 2 x 
OCH2), 4.11 (m, 1H, OCH), 4.96 (m, 1H, CH=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.7 (q, CH3CH2), 17.8 (q, CH3C=), 25.3 (q, CH3C=), 29.5 (t, CH2), 31.5 (t, 
CH2), 32.0 (t, CH2), 64.5 (t, 2 x OCH2), 68.0 (d, OCH), 111.6 (s, OCO), 128.1 (d, 
CH=C), 133.6 (s, C=CH). 
 
(3RS,4RS)-4-Hydroperoxy-5-methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-5-en-3-ol (syn-
146) (elid 497e) 
OH
O O
OOH  
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Photooxygenation of 5-methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-4-en-3-ol (144) (1.13 g, 
5.65 mmol) for 108 h according to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 
77:23) of β-hydroxy allylic hydroperoxides (1.10 g, 4.74 mmol, 84%) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.21 (s, 3H, CH3), 1.64 (s, 3H, CH3C=), 1.30-1.90 (m, 4H, CH2CH2), 3.84 
(br, 4H, 2 x OCH2), 4.07 (d, 1H, J = 8.07 Hz, OOCH ), 4.08 (m, 1H, OCH), 4.95 (br. 
s, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 17.9 (q, CH3), 23.5 (q, CH3), 27.0 (t, CH2), 34.3 (t, CH2), 64.3 (t, 2 x 
OCH2), 70.4 (d, OCH), 93.2 (d, OOCH), 109.8 (s, OCO), 116.1 (t, CH2=C), 141.5 (s, 
C=CH2). 
 
(3RS,4SR)-4-Hydroperoxy-5-methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-5-en-3-ol (anti-
146)  
OH
O O
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.23 (s, 3H, CH3), 1.71 (s, 3H, CH3C=), 3.60 (s, 4H, 2 x OCH2), 3.70 (m, 
1H, OCH). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 64.6 (t, 2 x OCH2), 70.3 (d, OCH), 91.5 (d, OOCH), 110.0 (s, OCO), 115.1 
(t, CH2=C), 141.5 (s, C=CH2). 
 
(3RS,4RS)-1-(2-Ethyl-1,3-dioxolan-2-yl)-4-hydroperoxy-5-methylhex-5-en-3-ol (syn-147) 
(elid 485h) 
OH
O O
OOH  
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Photooxygenation of 1-(2-ethyl-1,3-dioxolan-2-yl)-5-methylhex-4-en-3-ol (145) (1.12 g, 5.23 
mmol) for 120 h according to GP-9a afforded a diastereomeric mixture (d.r. syn:anti, 74:26) 
of β-hydroxy allylic hydroperoxides (1.17 g, 4.76 mmol, 91 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.78 (m, 3H, CH3CH2), 1.14-1.91 (m, 6H, overlapped signals CH2CH3 and 
CH2CH2), 1.62 (s, 3H, CH3C=), 3.82 (s, 4H, 2 x OCH2), 4.05 (d, 1H, J = 8.25 Hz, 
OOCH ), 4.09 (m, 1H, OCH), 4.93 (br. s, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.8 (q, CH3CH2), 17.8 (q, CH3C=), 26.3 (t, CH2), 29.5 (t, CH2), 31.8 (t, 
CH2), 64.7 (t, 2 x OCH2), 70.5 (d, OCH), 93.1 (d, OOCH), 111.8 (s, OCO), 116.0 (t, 
CH2=C), 141.4 (s, C=CH2). 
 
(3RS,4SR)-1-(2-Ethyl-1,3-dioxolan-2-yl)-4-hydroperoxy-5-methylhex-5-en-3-ol (anti-147)  
 
OH
O O
OOH  
 
1H-NMR: (300 MHz, CDCl3, additional significant signals) 
δ (ppm) = 1.69 (s, 3H, CH3C=), 3.68 (m, 1H, OCH), 3.83 (s, 4H, 2 x OCH2), 4.17 (d, 
1H, J = 5.16 Hz, OOCH ), 4.96 (m, 2H, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3, additional significant signals) 
δ (ppm) = 64.6 (t, 2 x OCH2), 70.5 (d, OCH), 91.4 (d, OOCH), 111.9 (s, OCO), 115.0 
(t, CH2=C), 141.5 (s, C=CH2). 
 
(1RS,4RS,5RS)-1-Methyl-4-(prop-1-en-2-yl)-2,3,8-trioxa-bicyclo[3.2.1]octane (exo-148) 
(elid 481h) 
O
O
O
H3C
H
H
 
 
Following GP-15, a solution of 4-hydroperoxy-5-methyl-1-(2-methyl-1,3-dioxolan-2-yl)hex-
5-en-3-ol (146) (2.20 g, 9.48 mmol) in dichloromethane (100 ml) was treated with a catalytic 
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amount of BF3.Et2O (0.2 ml) and then stirred at r.t. for 24 h. Usual work-up and further 
purification of the crude product by preparative thick-layer chromatography allowed the 
separation of the pure major 1,2,4-trioxane as yellow oil (SiO2, EA/n-hex, 1:10, Rf = 0.39) 
beside a diastereomeric mixture of the pure exo- and endo-1,2,4-trioxanes in a ratio 77:23 
(0.30 g, 1.76 mmol, 19 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.41 (s, 3H, CH3), 1.88 (t, 3H, J = 0.75 Hz, CH3C=), 1.81-1.90 (m, 1H, 
CH2), 2.02-2.23 (m, 2H, CH2), 2.45-2.55 (m, 1H, CH2), 3.94 (d, 1H, J = 0.57 Hz, 
OOCH), 4.60 (d, 1H, J = 6.45 Hz, OCH), 5.13 (q, 1H, J = 1.62 Hz, CH2=C), 5.26 (d, 
1H, J = 0.75 Hz, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 20.4 (q, CH3), 20.9 (q, CH3), 28.9 (t, CH2), 33.7 (t, CH2), 75.0 (d, OCH), 
85.8 (d, OOCH), 111.0 (s, OOCO), 113.9 (t, CH2=C), 141.5 (s, C=CH2). 
IR: (Film) 
ν (cm-1) = 3092, 2993, 2954, 1650, 1452, 1381, 1189, 1147, 1055, 900, 865. 
Elemental Analysis: (C9H14O3, M = 170.21) 
 Calcd: C 63.51   H 8.29 
Found: C 63.17   H 8.29 
 
(1RS,4SR,5RS)-1-Methyl-4-(prop-1-en-2-yl)-2,3,8-trioxa-bicyclo[3.2.1]octane (endo-148) 
elid (497o) 
O
O
O
H3C
H
H
 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 1.34 (s, 3H, CH3), 1.61 (d, 3H, J = 0.57 Hz, CH3C=), 1.71-1.81 (m, 1H, 
CH2), 1.92-2.13 (m, 2H, CH2), 2.21-2.27 (m, 1H, CH2), 4.30 (d, 1H, J = 5.43 Hz, 
OCH), 4.65 (br. s, 1H, OOCH), 4.67 (d, 1H, J = 0.90 Hz, CH2=C), 4.84 (q, 1H, J = 
1.47 Hz, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 19.7 (2 x q, 2 x CH3), 23.9 (t, CH2), 34.1 (t, CH2), 76.3 (d, OCH), 84.4 (d, 
OOCH), 110.0 (s, OOCO), 112.4 (t, CH2=C), 138.8 (s, C=CH2). 
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(1RS,4RS,5RS)-1-Ethyl-4-(prop-1-en-2-yl)-2,3,8-trioxa-bicyclo[3.2.1]octane (exo-149) 
(elid 487k) 
O
O
O
Et
H
H
 
 
Following GP-15, a solution of 1-(2-ethyl-1,3-dioxolan-2-yl)-4-hydroperoxy-5-methylhex-5-
en-3-ol (147) (2.20 g, 8.94 mmol) in dichloromethane (100 ml) was treated with a catalytic 
amount of BF3.Et2O (0.2 ml) and then stirred at r.t. for 24 h. Usual work-up and further 
purification of the crude product by preparative thick-layer chromatography (SiO2, EA/n-hex, 
1:10, Rf = 0.68) afforded a diastereomeric mixture of the pure exo- and endo-1,2,4-trioxanes 
in a ratio 77:23 (0.19 g, 1.03 mmol, 12 %). 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.88 (t, 3H, J = 7.65, CH3CH2), 1.82 (d, 3H, J = 0.75 Hz, CH3C=), 1.53-
1.85 (m, 3H, CH2CH3 and CH2), 1.99-2.08 (m, 2H, CH2), 2.30-2.40 (m, 1H, CH2), 
3.89 (s, 1H, OOCH), 4.54 (m, 1H, OCH), 5.05 (q, 1H, J = 1.47 Hz, CH2=C), 5.19 (d, 
1H, J = 0.72 Hz, CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.5 (q, CH3CH2), 20.3 (q, CH3C=), 27.6 (t, CH2), 28.3 (t, CH2), 31.2 (t, 
CH2), 74.8 (d, OCH), 85.8 (d, OOCH), 113.1 (s, OOCO), 113.6 (t, CH2=C), 141.5 (s, 
C=CH2). 
IR: (Film) 
ν (cm-1) = 3094, 2975, 2946, 2883, 1651, 1456, 1178, 1097, 1061, 961, 904. 
Elemental Analysis: (C10H16O3, M = 184.23) 
 Calcd: C 65.19   H 8.75 
Found: C 65.13   H 8.58 
 
(1RS,4SR,5RS)-1-Ethyl-4-(prop-1-en-2-yl)-2,3,8-trioxa-bicyclo[3.2.1]octane (endo-149) 
 
O
O
O
Et
H
H
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1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.91 (t, 3H, J = 7.50, CH3CH2), 1.64 (s, 3H, CH3C=), 1.53-1.85 (m, 3H, 
CH2CH3 and CH2), 1.99-2.08 (m, 2H, CH2), 2.18-2.28 (m, 1H, CH2), 4.35 (d, 1H, J = 
6.03 Hz, OCH), 4.70 (br. s, 2H, OOCH and CH2=C), 4.87 (d, 1H, J = 1.32 Hz, 
CH2=C). 
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 7.7 (q, CH3CH2), 19.9 (q, CH3C=), 23.6 (t, CH2), 27.0 (t, CH2), 32.1 (t, 
CH2), 76.3 (d, OCH), 84.8 (d, OOCH), 112.4 (s, OOCO), 112.5 (t, CH2=C), 139.0 (s, 
C=CH2). 
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4.10 Hydroperoxides as Oxygen Donor in Dihydroxylation Reaction 
 
2,3-Dimethylbutane-1,2,3-triol196 (150) 
 
HO OH
OH
 
 
(a) According to (GP-18): (elid 475g) 
Using 3-hydroperoxy-2,3-dimethylbut-1-ene 24 (140 mg, 1.2 mmol), water (1 mL), methanol 
(1 mL) and OsO4 solution (1 mol %), affords the triol (60 mg, 0.45 mmol, 37%) as yellow oil.  
(b) According to (GP-19): (elid 500f) 
Using 3-hydroperoxy-2,3-dimethylbut-1-ene 24 (140 mg, 1.2 mmol), water (1 mL), methanol 
(1 mL) and WO3 (10 mol %), affords the triol (50 mg, 0.37 mmol, 31%) as yellow oil.  
 
1H-NMR: (300 MHz, CDCl3)  
δ (ppm) = 1.04 (s, 3H, CH3), 1.20 (s, 3H, CH3), 1.23 (s, 3H, CH3), 3.45 (d, 1H, J = 
11.30 Hz, CH2OH), 3.86 (d, 1H, J = 11.61 Hz, CH2OH). 
13C-NMR: (75.5 MHz, CDCl3)  
δ (ppm) = 20.1 (q, CH3), 24.6 (q, CH3), 25.2 (q, CH3), 68.3 (t, CH2OH), 75.3 (s, Cq-
OH), 76.1 (s, Cq-OH). 
 
Ethyl-2,3-dihydroxy-2-(hydroxymethyl)butanoate (151) 
 
EtOOC
HO
OH
OH
 
 
(a) According to (GP-17): (elid 502d) 
Using ethyl 3-hydroperoxy-2-methylenebutanoate 16 (0.10 g, 0.62 mmol), N-methyl-
morpholine-N oxide (0.145 g, 1.24 mmol), water (1 mL), tert-butanol (1 mL) and OsO4 
solution (0.03 mmol, 4.8 mol %), affords a diastereomeric mixture (d.r. 85:15) of the triol (77 
mg, 0.43 mmol, 70 %) as yellow oil.  
(b) According to (GP-18): (elid 475o) 
Using ethyl 3-hydroperoxy-2-methylenebutanoate 16 (0.19 g, 1.2 mmol), water (1 mL), 
methanol (1 mL) and OsO4 solution (0.06 mmol, 5 mol %), affords a diastereomeric mixture 
(d.r. 79:21 as calculated from 13C-NMR) of the triol (40 mg, 0.22 mmol, 19 %) as yellow oil.  
4. Experimental Part 
300 
 
1H-NMR: (300 MHz, CDCl3, major diastereomer) 
δ (ppm) = 1.17 (d, 3H, J = 6.57 Hz, CH3CH), 1.29 (t, 3H, J = 7.14 Hz, CH3CH2), 3.65 
(d, 1H, J = 11.55 Hz, CH2OH), 3.78 (d, 1H, J = 11.4 Hz, CH2OH), 3.95 (q, 1H, J = 
6.42 Hz, CHCH3), 4.28 (q, 2H, J = 7.17 Hz, CH2CH3). 
13C-NMR: (75.5 MHz, CDCl3, major diastereomer) 
δ (ppm) = 14.1 (q, CH3CH2), 17.5 (q, CH3CH), 62.6 (t, CH2CH3), 64.8 (t, CH2OH), 
69.4 (d, CHOH), 81.5 (s, Cq-OH), 174.0 (s, COO) 
 
1H-NMR: (300 MHz, CDCl3, additional significant signals of minor diastereomer) 
δ (ppm) = 1.11 (d, 3H, J = 6.42 Hz, CH3CH), 1.28 (t, 3H, J = 7.14 Hz, CH3CH2), 3.86 
(d, 1H, J = 5.25 Hz, CH2OH). 
13C-NMR: (75.5 MHz, CDCl3, minor diastereomer) 
δ (ppm) = 13.9 (q, CH3CH2), 17.4 (q, CH3CH), 62.5 (t, CH2CH3), 65.8 (t, CH2OH), 
69.4 (d, CHOH), 81.0 (s, Cq-OH), 173.3 (s, COO). 
 
(1R)-2-(hydroperoxymethyl)-6,6-dimethylbicyclo[3.1.1]hept-2-ene (152) 
(elid 462b) 
OOH
 
 
Photooxygenation of β-pinene (1.0 g, 7.35 mmol) for 38 h according to GP-9a afforded the 
allylic hydroperoxides (0.73 g, 4.35 mmol, 59 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.79 (s, 3H, CH3), 1.24 (s, 3H, CH3), 1.95-2.50 (m, 6H, 2 x CH2 and 2 x 
CH), 3.41 (d, 2H, J = 1.02 HZ, CH2-OOH), 4.30 (m, 1H, CH=C).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 21.0 (q, CH3), 26.0 (q, CH3), 31.3 (t, CH2), 31.5 (t, CH2), 37.9 (s, Cq), 40.6 
(d, CH), 43.6 (d, CH), 80.1 (t, CH2-OOH), 123.6 (d, CH=C), 143.3 (s, C=CH). 
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(1R)-3-hydroperoxy-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane197 (153) 
(elid 451n, 462a) 
OOH
H
 
 
Photooxygenation of α-pinene (1.0 g, 7.35 mmol) for 38 h according to GP-9a afforded the 
allylic hydroperoxides (0.62 g, 3.69 mmol, 50 %) as yellow oil. 
 
1H-NMR: (300 MHz, CDCl3) 
δ (ppm) = 0.65 (s, 3H, CH3), 1.24 (s, 3H, CH3), 1.48 (d, 1H, J = 9.99 Hz, CH), 1.87-
1.95 (m, 2H, CH2), 2.14-2.35 (m, 2H, CH2), 2.46 (t, 1H, J = 5.37 Hz, CH), 4.59 (d, 
1H, J = 7.92 HZ, CH-OOH), 4.96 (m, 1H, CH2=C), 5.10 (m, 1H, CH2=C).  
13C-NMR: (75.5 MHz, CDCl3) 
δ (ppm) = 21.9 (q, CH3), 25.9 (q, CH3), 27.5 (t, CH2), 30.6 (t, CH2), 39.3 (s, Cq), 41.1 
(d, CH), 50.4 (d, CH), 80.6 (d, CH-OOH), 115.1 (t, CH2=C), 148.4 (s, C=CH2). 
 
3-Hydroperoxycyclohex-1-ene198 (154) 
(elid 476e) 
OOH
 
 
Irradiation of cyclohexene (2.0 g, 24.4 mmol) according to the GP-7b for 48 h affords the 
crude product as an oil (2.61 g, 22.9 mmol, 94 %) which was used without further 
purification. 
 
1H-NMR: (300 MHz, CDCl3)  
δ (ppm) = 1.47-2.06 (m, 6H, 3 x CH2), 4.43 (m, 1H, CH-OOH), 5.68-5.72 (m, 1H, 
CH=CH), 5.92-5.98 (m, 1H, CH=CH). 
13C-NMR: (75.5 MHz, CDCl3)  
δ (ppm) = 18.2 (t, CH2), 25.2 (t, CH2), 26.2 (t, CH2), 78.3 (d, CH-OOH), 124.0 (d, 
CH=CH), 134.2 (d, CH=CH). 
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                           58                                               38                                         98 
 
 
Crystal data 58 38 98 
Empirical formula C19H30O3 C18H26O3 C16H24O3 
Formula weight 306.43 290.39 264.35 
Temperature [°K] 293(2) 100(2) 100(2) 
Crystal system monoclinic monoclinic monoclinic 
Space group Pc P21/n P21/cx 
a [Å] 10.682(1) 7.403(1) 10.776(1) 
b [Å] 8.716(1) 10.416(1) 10.691(1) 
c [Å] 10.611(1) 20.310(1) 12.315(1) 
α [°] 90 90 90 
β [°] 117.34(1) 94.18 93.42(1) 
γ [°] 90 90 90 
Volume [Å3] 877.57(15) 1561.9(3) 1416.2(2) 
Z 2 4 4 
dcalcd [g cm-3] 1.160 1.235 1.240 
Crystal size [mm] 0.30 x 0.15 x 0.15 0.30 x 0.30 x 0.08 0.25 x 0.20 x 0.20 
No. Refl. collected 7019 9191 6037 
No. unique Refl. 3717 3393 3083 
No. obs. Refl.a  3318 1676 1610 
R1a  0.0312 0.1796 0.0554 
wR2a 0.0751 0.4146 0.0999 
Largest diff. peak / 
hole[e/Å-3] 
0.150 / -0.115 0.732 / -0.472 0.239 / -0.222 
a For [I>2sigma(I)] 
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                                 43                                        89                                       76 
 
 
Crystal data 43 89 76 
Empirical formula C19H20O3 C18H20O3 C19H22O3 
Formula weight 296.35 284.34 298.37 
Temperature [°K] 293(2) 100(2) 100(2) 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/c P21/c C2/c 
a [Å] 12.8550(6) 13.614(2) 34.338(1) 
b [Å] 14.8204(5) 5.6245(5) 5.362(1) 
c [Å] 8.3185(3) 19.903(3) 20.740(1) 
α [°] 90 90 90 
β [°] 94.9510(10) 97.456(4) 121.32(1) 
γ [°] 90 90 90 
Volume [Å3] 1578.90(11) 1511.1(4) 3262.2(6) 
Z 4 4 8 
dcalcd [g cm-3] 1.247 1.250 1.215 
Crystal size [mm] 0.1 x 0.1 x 0.3 0.1 x 0.1 x 0.3 0.35 x 0.25 x 0.25 
No. Refl. collected 9705 6492 10220 
No. unique Refl. 3443 3146 3554 
No. obs. Refl.a  1851 1251 2305 
R1a  0.0507 0.0663 0.0427 
wR2a 0.1112 0.1452 0.0900 
Largest diff. peak / 
hole[e/Å-3] 
0.174 / -0.170 0.428 / -0.215 0.232 / -0.166 
a For [I>2sigma(I)] 
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                   Pivaloyl amide                           109                                    syn-7j 
 
 
Crystal data Pivaloyl amide 109 syn-7j 
Empirical formula C20H44N4O4 C17H18O3 C9H18O3 
Formula weight 404.59 270.31 174.23 
Temperature [°K] 293(2) 100(2) 293(2) 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/c P21/a P21 
a [Å] 10.37(3) 7.1270(5) 9.794(1) 
b [Å] 5.861(2) 16.2208(8) 5.958(1) 
c [Å] 10.300(9) 12.5650(8) 17.649(3) 
α [°] 90 90 90 
β [°] 102.393(10) 95.490(3) 94.05(1) 
γ [°] 90 90 90 
Volume [Å3] 611.4(19) 1445.92(15) 1027.3(3) 
Z 1 4 4 
dcalcd [g cm-3] 1.099 1.242 1.127 
Crystal size [mm] 0.2 x 0.6 x 0.03 0.3 x 0.3 x 0.5 0.25 x 0.15 x 0.10 
No. Refl. collected 1185 5394 1984 
No. unique Refl. 588 3060 1984 
No. obs. Refl.a  300 1682 1172 
R1a  0.0554 0.0595 0.2529b 
wR2a 0.1176 0.1261 0.5467b 
Largest diff. peak / 
hole[e/Å-3] 
0.134 / -0.142 0.199 / -0.289 1.094 / -0.936b 
a For [I>2sigma(I)]. b Mixture of overlapping enantiomers. 
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                                anti-133                                                        anti-132  
 
 
Crystal data anti-133 anti-132 
Empirical formula C22H36O6 C24H40O6 
Formula weight 396.51 424.56 
Temperature [°K] 293(2) 100(2) 
Crystal system monoclinic monoclinic 
Space group P21/c  P21/c 
a [Å] 6.467(1) 8.199(2) 
b [Å] 12.813(1) 5.3910(10) 
c [Å] 13.255(1) 27.400(8) 
α [°] 90 90 
β [°] 93.38(1) 92.860(10) 
γ [°] 90 90 
Volume [Å3] 1096.4(2) 1209.6(5) 
Z 2 2 
dcalcd [g cm-3] 1.201 1.166 
Crystal size [mm] 0.25 x 0.15 x 0.15 0.06 x 0.2 x 0.2 
No. Refl. collected 6664 3553 
No. unique Refl. 2398 1986 
No. obs. Refl.a  1181 1136 
R1a  0.1635 0.0495 
wR2a 0.4692 0.0826 
Largest diff. peak / 
hole[e/Å-3] 
1.073 / -0.404 0.146 / -0.208 
a For [I>2sigma(I)] 
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                                    syn-136                                                    anti-134 
 
 
Crystal data syn-136 anti-134 
Empirical formula C24H40O6 C22H36O6 
Formula weight 424.56 396.51 
Temperature [°K] 100(2) 100(2) 
Crystal system monoclinic orthorhombic 
Space group P21/c Pbcn 
a [Å] 12.200(3) 23.634(1) 
b [Å] 14.896(6) 8.201(1) 
c [Å] 14.866(5) 11.220(1) 
α [°] 90 90 
β [°] 116.92(2) 90 
γ [°] 90 90 
Volume [Å3] 2408.9(14) 2174.7(3) 
Z 4 4 
dcalcd [g cm-3] 1.171 1.211 
Crystal size [mm] 0.1 x 0.1 x 0.5 0.20 x 0.08 x 0.08 
No. Refl. collected 9309 3951 
No. unique Refl. 4095 1441 
No. obs. Refl.a  1340 321 
R1a  0.1433 0.0773 
wR2a 0.3536 0.0682 
Largest diff. peak / 
hole[e/Å-3] 
0.471 / -0.388 0.208 / -0.214 
a For [I>2sigma(I)] 
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6. Summary 
 
In this thesis, a new solvent-free protocol for type-II photooxygenation reactions was 
developed. I aimed in this protocol to combine the use of a microreactor as reaction medium, 
visible light and air as reagents. This offers a new and convenient approach towards “green” 
photooxygenation conditions. Two microreactor systems were used: (1) The commercially 
available polystyrene beads (PS) crosslinked with divinyl benzene (DVB) and loaded with 
adsorbed tetraarylporphyrine dye sensitizers; (2) Synthesized polymers covalently bound to 
porphyrin sensitizers. In the latter approach two singlet oxygen sensitizers with crosslinking 
properties were used. tetrakis(4-ethenylphenyl)porphyrin (or tetrastyrylporphyrin, TSP) and 
the natural protoporphyrin-IX (PP). Emulsifier-free emulsion polymerization was applied for 
copolymerization reaction of both TSP and PP with styrene (S) and DVB resulting in polymer 
particles that are translucent in color, polyhedral in shape having size range from 200 to 500 
nm for TSP-S-DVB and faint rose in color, spherical in shape having size range from 200 to 
400 nm for PP-S-DVB (Figure 6.1). The synthesized nanoparticles are characterized by high 
surface area accounting for their high substrate loading capacity (up to 100 % by wt for both 
catalysts). 
 
  
Figure 6.1: Scanning electron microscope (SEM) picture of TSP-S-DVB sample (left)  
and PP-S-DVB sample (right). 
 
In the developed approach, the photooxygenation reactions are carried out under atmospheric 
air and the polymeric systems can be recycled and reused several times with negligible 
decrease in efficiency or dye bleeding yielding sensitizer-free products. Evaluation of the 
efficiency of the solvent-free approach and identification of its influence on the chemo-, 
regio- and stereoselectivity pattern in type-II photooxygenation reaction was also investigated 
by means of oxidation of different substrates that react by different reaction modes. The 
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photooxygenation of citronellol (the industrial precursor of the fragrant chemical speciality 
rose oxide) was used to study the regioselectivity of the ene reaction of 1O2 (Scheme 6.1). 
 
OH OHOH
HOO
OOH
Solid support
+
1O2
 
Scheme 6.1 
 
The photooxygenation of different chiral allylic alcohols and the chiral dienol, respectively, 
where used to investigate the diastereoselectivity of the ene and [4+2]-cycloaddition reactions 
of 1O2 in the new environments (Scheme 6.2 and 6.3). The products were obtained in good 
yields and sensitizer-free (without dye-bleeding).  
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Scheme 6.2 
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Scheme 6.3 
 
The solvent-free photooxygenation reaction of a large variety of allylic alcohols resulted in 
the corresponding 1,2-hydroperoxy alcohols. A literature-novel X-ray structure was obtained 
as an unambiguous proof of the diastereoselectivity of the ene reaction with allylic alcohols 
(Figure 6.2). 
 
Figure 6.2 
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The new sensitizer/polymer systems were also used in heterogeneous photooxygenation 
reactions and compared to the homogeneous conditions. 2,3-Dimethyl-2-butene was applied 
as model substrate and the kinetics of the oxygen uptake were measured under pseudo-first 
order reaction conditions in CCl4 using TPP for the homogeneous reaction and a suspension 
of TSP-S-DVB or PP-S-DVB in the same solvent for the heterogeneous conditions. From the 
linear oxygen uptake it was concluded that pseudo-first order conditions exist for longer time 
without bleaching of the polymer-bound dyestuff. It was also found that the efficiency of 
TSP-S-DVB is nearly identical and for PP-S-DVB only slightly lower compared to the 
homogeneous conditions.  
 
I also developed a two-step synthetic route to the 1,2,4-trioxane subunit, the pharmacophore 
of the naturally occurring antimalarial drug artemisinin. The methodology is based firstly on 
the conversion of different allylic alcohols to sensitizer-free vic-hydroxy allylic 
hydroperoxides by the reaction of singlet oxygen with allylic alcohols followed by BF3-
catalyzed peroxyacetalization reaction with different carbonyl compounds. (Scheme 6.4). 
Variation of substituents at C-3 and C-5 of the trioxane pharmacophore could be efficiently 
performed with the formation of wide variety of mono-, polycyclic- and spiro-1,2,4-trioxanes.  
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Scheme 6.4 
 
The antimalarial activity of a series of the new compounds was also tested in vitro. The 
spiroadamantane-1,2,4-trioxanes with the highest lipophilic properties are the most promising 
candidates having the best antimalarial activities against the Plasmodium falciparum strain. 
Some of these compounds could be obtained in crystalline form (Figure 6.3). 
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Figure 6.3 
 
In order to insert a naphthyl group into the 1,2,4-trioxane system, several 3-napthyl 
substituted compounds were synthesized, some of which were also characterized by X-ray 
analysis (Figure 6.4). 
 
 
 
 
 
 
 
Figure 6.4 
 
The use of orthoesters in the peroxyacetalization reaction enabled a direct route to the 
synthesis of the first perortho esters with 1,2,4-trioxane substructure described in literature 
(Scheme 6.5). 
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Scheme 6.5 
In absence of external carbonyl compounds, another direct conversion of 1,2-hydroperoxy 
alcohols to the trioxanes A and B was also achieved. The reaction proceeds through slow BF3 
catalyzed cleavage of the β-hydroperoxy alcohols to carbonyl fragments that subsequently 
undergo peroxyacetalization reaction with the excess hydroxy hydroperoxide to furnish the 
trioxanes (Scheme 6.6). 
6. Summary 
311 
R
OH
OOH
BF3.Et2O / CH2Cl2
A B
O
O
O
R
R
O
O
O
R
+
 
Scheme 6.6 
 
I developed also another concept for integration of two trioxane subunits in the same 
molecule. Bis spiro-1,2,4-trioxanes are a literature-unknown class of compounds that were 
synthesized and characterized (Figure 6.5). The idea is based on coupling of two 1,2-
hydroperoxy alcohols with a central dicarbonyl component (such as cyclohexan-1,4-dione). 
 
 
 
 
 
 
 
 
 
Figure 6.5 
 
A concise synthetic route to 2,3,8-trioxabicyclo[3.2.1]octanes as ring-contracted analogues to 
the natural antimalarial artemisinine-pharmacophore was also developed. The synthesized 
bicyclic 1,2,4-trioxane systems were synthesized by a literature-unknown intramolecular 
peroxyacetalization reaction (Scheme 6.7).  
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Scheme 6.7 
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Another synthetic application of allylic hydroperoxides was investigated: their conversion to 
the corresponding triols in a dihydroxylation reaction using catalytic amounts of OsO4 or 
WO3. Unlike the usual catalyzed bishydroxylation reactions, in our case no cooxidant was 
used and the substrate itself plays role as oxygen donor that reoxidizes the reduced oxidant 
and simultaneously as oxygen acceptor in a reaction cycle leading to conversion of the allylic 
hydroperoxide to the corresponding triol product. The effect of the oxidant concentration was 
also studied showing that an OsO4 concentration up to 0.001 equivalent is still effective in 
catalyzing the reaction (Scheme 6.8). 
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Scheme 6.8 
 
The [4+2]-cycloaddition reactions of 1O2 to a series of 5-methoxyoxazoles as substrates under 
the solvent-free conditions was also studied. 1,2,4-Dioxazoles were found as the reaction 
products which decompose slowly to give the corresponding amide and dicarbonyl fragments 
(Scheme 6.9). 
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Scheme 6.9 
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7. Zusammenfassung 
 
Im Rahmen dieser Arbeit wurde eine neue lösungsmittelfreie Methode für Typ-II 
Photooxygenierungsreaktionen entwickelt. Mit dieser Methode habe ich das Ziel verfolgt, die 
Vorteile der Verwendung von Mikroreaktoren als Reaktionsmedium, sichtbares Licht und 
Luft als Reagenzien zu kombinieren. Diese Methode stellt eine brauchbare Annäherung an 
„green chemistry“ Photooxygenierungs-Bedingungen dar. Es wurden zwei verschiedene 
Mikroreaktor-Systeme verwendet: (1) kommerziell erhältliche, mit Divinylbenzol (DVB) 
quervernetzte Polystyrolkügelchen (PS), die mit Tetraarylporphyrin als Sensibilisator- 
Farbstoffe beladen wurden, (2) synthetisierte Polymere mit kovalent gebundenen Porphyrin- 
Sensibilisatoren. Im letztgenannten Fall wurden zwei verschiedene quervernetzbare 
Sensibilisatoren verwendet: Tetrakis(4-ethenylphenyl)porphyrin (oder Tetrastyrylporphyrin, 
TSP) und Protoporphyrin-IX (PP). Für beide Sensibilisatoren TSP und PP wurde eine 
Emulgator-freie Emulsions-Polymerisation zur Copolymerisierung der genannten Farbstoffe 
mit Styrol (S) und Divinylbenzol verwendet. Daraus resultieren Polymerteilchen mit licht-
durchlässigen Eigenschaften und polygonaler Gestalt, deren Grösse im Bereich von 200-500 
nm für TSP-S-DVB lag. Im Falle von PP-S-DVB wurden schwach rosa gefärbte 
Polymerkügelchen mit einer Grösse von 200-400 nm erhalten (Abb. 7.1). Die synthetisierten 
Nanopartikel zeichnen sich durch eine große Oberfläche und eine entsprechende Kapazität 
hinsichtlich der Beladung mit Substraten aus (bis 100 % der Polymerträger-Einwaage). 
 
 
  
 
Abb. 7.1: Scanning electron microscope (SEM)-Bild einer TSP-S-DVB Probe (links)  
und einer PP-S-DVB Probe (rechts). 
 
Bei dem entwickelten Verfahren wurden die Photooxygenierungen mit Hilfe von Luft- 
Sauerstoff in den polymeren Trägersystemen durchgeführt. Die Polymer-Träger mit kovalent 
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gebundenem Sensibilisator können ohne nennenswerte Abnahme ihrer Effizienz oder 
Ausblutung des Farbstoffes mehrmals wiederverwendet werden. Zur Bewertung der Effizienz 
der lösungsmittelfreien Methode und zur Untersuchung des Einflusses auf die Chemo-, 
Regio- und Stereoselektivität der Typ-II-Reaktion wurde die Oxidation einer Reihe von 
Substraten unter verschiedenen Bedingungen untersucht. Die Photooxygenierung von 
Citronellol (industrielle Vorstufe bei der Synthese des Duftstoffes Rosenoxid) diente als 
Modell, um die Regioselektivität der En- Reaktion von 1O2 zu untersuchen (Schema 7.1). 
 
OH OHOH
HOO
OOH
Polymerträger
+
1O2
 
Schema 7.1 
 
Die Photooxygenierungs-Reaktionen von verschiedenen chiralen Allylalkoholen und dem 
chiralen Dienol wurden jeweils als Modell verwendet, um die Diastereoselektivität der En- 
und [4+2]-Cycloaddition unter verschiedenen Bedingungen zu untersuchen (Schema 7.2 und 
7.3). Die Produkte wurden in guten Ausbeuten und ohne Farbstoffrückstände erhalten. 
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Schema 7.2 
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Schema 7.3 
 
Die lösungsmittelfreie Photooxygenierung einer großen Anzahl von allylischen Alkoholen 
führte zu den entprechenden 1,2-Hydroperoxy-Alkoholen. Die erhaltene Röntgenstruktur 
einer noch Literatur-unbekannten Verbindung kann als ein zweifelsfreier Beweis für die 
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Diastereoselektivität der En-Reaktion von allylischen Alkoholen aufgefasst werden (Abb. 
7.2). 
 
Abb. 7.2 
 
Die neuen polymeren Sensibilisator-Systeme wurden auch auf heterogene Photooxy-
genierungsReaktionen angewendet und die Ergebnisse mit denen der homogenen Reaktion 
verglichen. Hierbei diente 2,3-Dimethyl-2-buten als Modelsubstrat. Die Kinetik der 
Sauerstoff-Aufnahme wurde unter Reaktionsbedingungen pseudo-erster Ordnung in CCl4 und 
unter Verwendung von TPP für die homogene Reaktion bzw. einer Suspension von TSP-S-
DVB oder PP-S-DVB im gleichen Lösungsmittel gemessen. Aus der linearen 
Sauerstoffaufnahme konnte geschlossen werden, dass die Bedingungen pseudo-erster 
Ordnung über einen längeren Zeitraum gelten, ohne dass der Farbstoff ausbleicht. Für TSP-S-
DVB wurde eine nahezu gleiche Effizienz und für PP-S-DVB eine geringfügig kleinere 
Effizienz verglichen mit den homogenen Reaktionsbedingungen gefunden. 
 
Des weiteren habe ich eine zweistufige Syntheseroute zur Darstellung des 1,2,4-Trioxan- 
Grundgerüstes entwickelt, welches als pharmakophore Grundstruktur im natürlich 
vorkommenden Antimalaria Mittel Artemisinin enthalten ist. Die Methode gründet sich auf 
die Umwandlung von verschiedenen Allylalkoholen zu (farbstofffreien) vic-Hydroperoxy-
allylhydroperoxiden durch die Reaktion von Singulettsauerstoff mit Allylalkoholen und 
anschließender BF3-katalysierter Peroxoacetalysierung mit verschiedenen Carbonyl-
Verbindungen (Schema 7.4). Durch die Variation der Substituenten an C-3 und C-5 des 
Trioxan-Grundgerüstes ist ein weites Spektrum von mono-, polycyclischen- und spiro-1,2,4-
Trioxanen zugänglich. 
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Schema 7.4 
 
Die Antimalariaaktivität einer Reihe von neuen Verbindungen wurde in-vitro getestet. Die 
Spiroadamantan-1,2,4-trioxane mit den am stärksten ausgeprägten lipophilen Eigenschaften 
sind vielversprechende Kandidaten bezüglich der Antimalariaaktivität gegenüber dem 
Plasmodium falciparum-Parasiten. Einige dieser Verbindungen konnten in kristalliner Form 
erhalten werden (Abb. 7.3). 
 
 
 
 
 
 
 
Abb. 7.3 
 
Um eine Naphthyl-Gruppe in die 1,2,4-Trioxane einzuführen, wurden eine Reihe von 
3-naphthylsubstituierten Verbindungen dargestellt. Einige hiervon konnten röntgenographisch 
charakterisiert werden (Abb. 7.4). 
 
 
 
 
 
 
 
Abb. 7.4 
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Die Verwendung von Orthoestern bei der Peroxoacetalisierung eröffnete einen direkten Weg 
zur Synthese der ersten in der Literatur beschriebenen Perorthoester mit einer 1,2,4-
Trioxansubstruktur (Schema 7.5). 
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Schema 7.5 
 
In Abwesenheit von Carbonyl-Verbindungen als Reaktionspartner wurde eine direkte 
Umwandlung vom 1,2-Hydroperoxyalkohol zu den Trioxanen A und B beobachtet. Die 
Reaktion läuft über eine langsame, BF3-katalysierte Spaltung des β-Hydroperoxyalkohols zu 
Carbonyl- Fragmenten ab, die in einer nachfolgenden Peroxyacetalisierung mit dem noch 
verbliebenen Hydroxyhydroperoxid zum Trioxan reagieren (Schema 7.6). 
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Schema 7.6 
 
Darüberhinaus habe ich ein Konzept für den Einbau von zwei Trioxan-Untereinheiten in 
einem Molekül entwickelt. Bis-Spiro-1,2,4-Trioxane sind eine in der Literatur noch nicht 
bekannte Verbindungskasse. Im Rahmen der vorliegenden Arbeit konnten erstmals Beispiele 
für Verbindungen dieser Art synthetisiert und charakterisiert werden (Abb. 7.5). Die Idee 
basiert auf der Verknüpfung von zwei 1,2-Hydroperoxyalkoholen mit einer zentralen 
Dicarbonyl-Komponente (wie z.B. Cyclohexan-1,4-dion). 
 
 
 
 
 
 
 
 
Abb. 7.5 
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Desweiteren wurde eine effektive Synthesroute zu 2,3,8-Trioxabicyclo[3.2.1]octanen, als 
ringverkleinerten analogen Verbindungen zum natürlchen Artemisinin-Pharmakophor 
entwickelt. Die synthetisierten bicyclischen-1,2,4-Trioxansysteme wurden über eine noch 
literaturunbekannte intramolekulare Peroxoacetalisierungsreaktion erhalten (Schema 7.7). 
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Schema 7.7 
 
Eine weitere synthetische Anwendung der allylischen Hydroperoxide besteht in ihrer 
Umwandlung zu den entsprechenden Triolen durch Hydroxylierung unter Verwendung von 
katalytischen Mengen OsO4 oder WO3. Im Gegensatz zu den üblichen Hydroxylierungs-
reaktionen wurde in unserem Fall kein Cooxidationsmitel verwendet. Stattdessen übernimmt 
das Substrat selbst die Rolle des Sauerstoffdonors, welcher das reduzierte Oxidationsmittel 
wieder oxidiert und in einem Reaktionkreislauf die Umwandlung des allylischen 
Hydroperoxids in das entsprechende Triol-Produkt bewirkt. Bei der Betrachtung des  
Einflusses der Konzentration des Oxidationsmittels hat sich gezeigt, dass eine Konzentration 
von 0.001 äquiv  OsO4 die Reaktion noch effektiv katalysiert (Schema 7.8). 
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Schema 7.8 
 
Die [4+2]-Cycloadditions-Reaktionen von 1O2 mit einer Reihe von 5-Methoxyoxazolen als 
Substrate wurden unter lösungsmittelfreie Bedingungen untersucht. Als Reaktionsprodukte 
wurden 1,2,5-Dioxazole gefunden, welche sich langsam zu den entsprechenden Amiden und 
Dicarbonylverbindungen zersetzten (Schema 7.9). 
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Promotionsverfahrens nicht vornehmen werde. Die Bestimmungen dieser Promotionsordnung 
sind mir bekannt. 
 
Die von mir vorgelegte Dissertation ist von Herrn Prof. Dr. Axel G. Griesbeck betreut 
worden. 
 
 
                   _________________ 
          Tamer El-Idreesy 
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